data_6kox_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6kox _Structure_validation_residue.Date_analyzed 2019-08-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.325 0.583 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.68 163.73 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -122.46 132.74 54.49 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -99.12 112.82 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.024 -1.047 . . . . 0.0 108.852 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -89.68 114.5 26.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.748 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -93.84 162.03 14.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.321 -0.862 . . . . 0.0 109.842 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.97 -19.49 64.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.814 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -81.69 -5.55 58.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.998 . . . . 0.0 109.595 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.78 14.88 58.94 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -93.87 124.68 38.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.886 -1.361 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 m -102.01 124.22 47.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.532 -0.73 . . . . 0.0 109.043 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -114.99 140.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.562 -0.712 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -102.2 128.35 48.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -128.65 147.97 50.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 16' ' ' GLU . 27.2 mp0 -110.68 127.88 55.48 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.28 179.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.975 -1.078 . . . . 0.0 110.262 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -113.05 151.68 44.35 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.14 -30.42 46.75 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.993 1.795 . . . . 0.0 110.899 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -84.94 4.8 31.87 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.62 145.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 0.0 108.881 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 80.6 p -92.2 148.17 22.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -50.47 -40.76 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.085 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.68 -43.88 90.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.256 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 22.8 m120 -69.51 -37.0 76.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.92 -32.61 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -70.31 -32.69 70.56 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.74 96.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.12 -47.26 85.91 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.391 0.615 . . . . 0.0 109.418 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.44 -39.78 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.61 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.86 -47.06 88.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 109.966 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.43 -23.64 58.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.956 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -84.89 -51.71 6.54 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.807 -1.183 . . . . 0.0 111.295 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -91.18 -24.0 20.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.65 -1.281 . . . . 0.0 109.902 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.41 4.19 88.04 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.964 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.32 121.75 67.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.776 -1.426 . . . . 0.0 109.12 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.41 150.35 5.72 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.633 1.556 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.64 -28.77 25.42 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.595 2.197 . . . . 0.0 112.483 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.76 -3.32 27.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.56 -6.11 24.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.57 153.75 50.89 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.211 -0.931 . . . . 0.0 110.945 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -129.77 120.78 25.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -86.67 123.15 31.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.992 -1.068 . . . . 0.0 111.275 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.6 mp -116.46 133.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.547 0.689 . . . . 0.0 109.17 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' A' ' 47' ' ' GLY . 60.5 t80 -145.95 140.78 27.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.143 -0.973 . . . . 0.0 108.801 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 8.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 109.288 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.81 23.23 26.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -126.94 147.14 50.11 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.146 -1.208 . . . . 0.0 109.53 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -89.95 112.09 23.37 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.41 122.93 10.65 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.496 -0.753 . . . . 0.0 109.759 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -93.05 148.07 22.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.156 -0.965 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.22 131.88 47.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.942 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.65 64.27 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.309 -0.869 . . . . 0.0 111.403 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' A' ' 54' ' ' ARG . 15.5 ttt180 -89.55 156.4 18.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.402 -1.646 . . . . 0.0 109.783 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -98.23 148.01 24.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.186 -0.946 . . . . 0.0 110.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.86 -38.94 76.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 109.871 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -57.9 -28.07 63.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.992 . . . . 0.0 110.004 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.44 -16.82 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.39 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -101.86 0.54 35.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.413 -0.804 . . . . 0.0 110.133 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 m120 52.03 49.11 21.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.507 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 96.6 mt -75.67 176.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.507 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 17.4 tt0 -132.44 138.2 47.55 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.27 -0.894 . . . . 0.0 109.662 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -52.41 149.57 5.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 110.543 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.893 -0.505 . . . . 0.0 110.953 179.503 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -90.24 128.27 36.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.096 -1.003 . . . . 0.0 108.659 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.71 125.13 53.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.67 147.3 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 108.77 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.205 0.526 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 tt -144.57 165.78 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.5 m-85 -130.86 157.74 42.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.18 121.06 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 108.596 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.8 tttm -91.86 122.64 34.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.153 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 m -96.25 161.36 13.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 mt -62.65 -23.08 66.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -81.64 -0.65 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 16.25 66.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -91.18 117.78 29.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.043 -1.269 . . . . 0.0 109.37 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -93.61 118.52 31.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.475 -0.766 . . . . 0.0 109.169 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -107.63 139.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.754 . . . . 0.0 109.274 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.31 129.03 53.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 109.779 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.27 150.01 51.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.473 -0.767 . . . . 0.0 109.66 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -106.66 126.41 52.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.72 176.03 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.076 -1.015 . . . . 0.0 110.243 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -112.77 151.58 44.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.0 -33.01 64.27 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.818 1.679 . . . . 0.0 110.669 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -85.71 3.91 39.0 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.576 -0.703 . . . . 0.0 109.221 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.38 149.22 48.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 34.6 p -96.69 147.16 24.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.526 -0.734 . . . . 0.0 109.694 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.53 -41.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.226 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.13 -45.02 96.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.775 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' H ' ' HG1' ' A' ' 22' ' ' THR . 3.7 m120 -68.26 -37.4 80.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.728 . . . . 0.0 109.674 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -70.48 -31.32 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.273 -0.892 . . . . 0.0 109.901 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.46 -33.33 71.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.53 97.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -59.72 -44.94 93.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.84 -40.82 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.369 -0.832 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.59 -45.38 93.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.831 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.39 -35.6 80.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 111.284 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -89.16 -44.34 10.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.54 -27.09 22.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.75 -1.219 . . . . 0.0 110.063 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.21 83.11 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.037 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.7 mt -91.09 119.11 68.88 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.702 -1.469 . . . . 0.0 109.339 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.57 149.56 6.93 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.69 1.593 . . . . 0.0 112.326 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.06 -22.98 29.97 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.74 -6.01 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.795 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.13 -4.44 35.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 109.812 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -140.01 155.82 46.91 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.073 -1.017 . . . . 0.0 111.35 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.78 133.34 49.46 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.93 123.59 40.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 109.79 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.1 mp -112.54 138.81 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' C ' ' H ' ' A' ' 47' ' ' GLY . 89.9 t80 -147.5 137.74 23.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.025 . . . . 0.0 109.059 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 11.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.369 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.6 23.94 24.86 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -128.11 147.18 50.53 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.122 -1.222 . . . . 0.0 109.47 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -90.15 111.69 22.92 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.04 118.14 3.0 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.551 -0.718 . . . . 0.0 109.267 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -94.76 142.74 27.11 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.178 -0.951 . . . . 0.0 109.074 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.15 137.56 57.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.524 -0.735 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.78 -13.15 57.89 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -96.61 154.7 17.13 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.959 1.879 . . . . 0.0 110.367 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -99.07 152.36 19.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.025 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.61 -37.55 68.28 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.343 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -59.09 -21.46 59.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.894 -1.128 . . . . 0.0 109.732 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -70.77 -16.88 62.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -105.51 9.65 33.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.326 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 52.23 47.63 24.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 68.0 mt -79.75 172.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.421 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 29.7 mt-30 -144.03 146.95 33.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.05 -1.031 . . . . 0.0 110.062 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.32 147.71 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.622 -0.674 . . . . 0.0 110.425 179.573 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -93.05 131.89 37.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.289 -0.882 . . . . 0.0 108.766 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.65 128.73 55.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.02 150.71 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 108.757 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.314 0.578 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -146.34 167.57 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 44.1 m-85 -124.78 134.85 52.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.96 113.61 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -90.77 113.58 25.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.227 -0.92 . . . . 0.0 109.761 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.05 -21.53 66.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 110.111 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -81.25 1.32 32.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.033 -1.042 . . . . 0.0 109.641 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.96 80.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -87.77 125.56 34.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.319 . . . . 0.0 109.121 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -105.77 122.19 45.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.576 -0.703 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.91 138.28 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.7 m -105.8 135.71 46.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 0.0 109.998 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.15 156.15 48.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 109.579 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -109.4 127.11 54.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -143.57 164.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 109.923 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 62.8 mm-40 -103.89 149.63 37.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.63 -31.48 32.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.949 1.766 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 t -82.8 -0.62 48.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.441 -0.787 . . . . 0.0 109.406 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 146.81 54.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -87.88 157.66 18.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.922 . . . . 0.0 109.048 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.71 -42.07 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 108.499 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -64.03 -41.22 97.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -64.3 -36.95 85.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.029 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -74.7 -29.0 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -67.43 -37.51 83.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.45 44.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -49.04 -46.96 45.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.68 -36.63 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.867 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' GLY . 7.5 tm0? -70.78 -48.4 54.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.81 -28.21 67.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -97.53 -41.57 8.1 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.811 -1.18 . . . . 0.0 111.208 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -93.12 -19.96 20.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.771 -1.205 . . . . 0.0 110.125 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.2 -0.09 18.45 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.956 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.98 119.96 79.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 120.731 -1.453 . . . . 0.0 108.775 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.35 129.68 19.79 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.199 1.266 . . . . 0.0 112.294 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -49.92 -36.61 44.17 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.213 1.942 . . . . 0.0 112.991 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.08 -0.85 8.41 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -100.02 -3.95 31.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.153 -0.967 . . . . 0.0 110.361 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -139.25 153.82 47.89 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 110.434 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -128.61 109.88 11.75 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.13 125.73 33.71 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.655 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.39 148.17 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.621 0.724 . . . . 0.0 109.599 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 47' ' ' GLY . 80.7 t80 -149.83 142.38 24.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.369 -0.832 . . . . 0.0 109.058 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.63 5.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.04 9.96 56.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.47 148.63 40.57 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.091 -1.24 . . . . 0.0 109.202 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -82.19 116.53 21.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.82 121.04 10.13 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.363 -0.836 . . . . 0.0 109.497 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -90.69 173.51 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.666 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.59 140.4 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.335 -0.853 . . . . 0.0 110.905 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.61 53.4 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.278 -0.889 . . . . 0.0 111.612 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.663 ' NH2' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.63 176.26 9.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.01 -1.288 . . . . 0.0 110.446 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -113.15 145.36 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.55 -37.71 70.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.522 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -59.91 -26.29 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.79 -17.85 51.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.602 -0.686 . . . . 0.0 109.531 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.25 3.07 32.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.41 -0.806 . . . . 0.0 110.258 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.78 47.22 24.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.706 -1.246 . . . . 0.0 109.583 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 63.4 mt -68.93 169.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 9.7 tp-100 -135.46 139.82 44.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -54.08 147.82 12.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 110.895 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.696 -0.628 . . . . 0.0 110.765 179.396 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.8 mp . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -98.24 129.3 44.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -112.81 118.43 34.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.72 145.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.497 1.917 0 O-C-N 120.914 -1.116 . . . . 0.0 110.072 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 121.411 0.625 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -145.22 166.63 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -127.08 143.07 51.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.284 -0.885 . . . . 0.0 109.608 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.88 121.33 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.288 -0.882 . . . . 0.0 108.837 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -94.97 123.98 38.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -98.95 153.4 18.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 0.0 109.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.0 mp -59.93 -18.3 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.3 p -81.53 -3.0 51.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.022 -1.049 . . . . 0.0 109.625 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.84 69.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -93.43 121.21 34.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.855 -1.38 . . . . 0.0 109.561 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 m -103.89 129.78 51.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.474 -0.767 . . . . 0.0 109.292 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 tt -126.36 145.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.613 -0.679 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -105.53 137.18 43.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.58 -0.7 . . . . 0.0 109.552 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.4 mt -129.1 149.46 50.91 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.484 -0.76 . . . . 0.0 109.578 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.01 125.54 51.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.87 176.17 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.99 -1.069 . . . . 0.0 110.271 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -110.31 154.0 43.11 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.85 -33.54 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.023 1.816 . . . . 0.0 110.765 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.2 m -84.37 4.62 30.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.563 -0.71 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.98 147.92 50.89 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.004 -1.079 . . . . 0.0 108.951 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 p -92.64 150.45 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.309 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -53.97 -40.0 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.56 -43.6 98.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.19 -37.65 84.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.45 -28.79 36.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -70.28 -35.46 73.75 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.73 84.54 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -55.53 -47.33 76.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.732 -0.605 . . . . 0.0 109.443 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.06 -39.52 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.37 -0.831 . . . . 0.0 109.5 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.05 -45.08 93.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.37 -31.97 73.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 111.299 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -94.72 -41.6 9.18 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.802 -1.186 . . . . 0.0 111.534 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -91.65 -23.54 19.8 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.761 -1.212 . . . . 0.0 110.051 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.65 -1.47 29.21 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.059 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -83.96 118.85 72.42 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.413 . . . . 0.0 109.506 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.91 149.82 7.39 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.67 1.58 . . . . 0.0 112.027 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.68 -25.24 29.17 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.508 2.139 . . . . 0.0 112.464 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.61 -2.06 24.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 109.724 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -101.13 -7.81 22.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.237 -0.915 . . . . 0.0 110.013 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -143.04 158.88 43.19 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.008 -1.058 . . . . 0.0 110.962 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' A' ' 42' ' ' ARG . 1.6 mtp180 -132.12 121.24 23.46 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.58 121.85 28.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.07 -1.019 . . . . 0.0 110.604 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mm -115.94 133.45 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -119.12 134.95 54.9 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.04 -113.45 0.65 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.995 -1.065 . . . . 0.0 108.582 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.11 26.93 5.2 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.08 150.67 46.59 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.244 -1.151 . . . . 0.0 109.233 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -91.28 113.35 25.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.08 122.2 10.44 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.666 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.76 171.19 9.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.77 134.26 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.28 -19.07 55.43 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.752 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.59 160.75 26.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.581 -1.541 . . . . 0.0 109.095 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 p -102.58 152.97 20.55 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.478 -0.764 . . . . 0.0 109.245 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.83 -38.98 70.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.048 . . . . 0.0 109.311 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -61.22 -17.82 55.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.104 -0.998 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.5 -18.45 63.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -108.2 7.81 27.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.574 -0.703 . . . . 0.0 110.402 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 t30 50.56 47.09 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.53 -1.356 . . . . 0.0 109.562 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 90.8 mt -72.97 173.96 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.487 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 66.0 mt-30 -133.07 137.93 46.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.89 151.02 4.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 110.516 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.986 -0.446 . . . . 0.0 110.851 179.75 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.25 130.74 38.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.31 118.81 37.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.814 . . . . 0.0 109.98 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.19 146.77 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.1 mp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.979 -1.076 . . . . 0.0 109.352 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.571 HE21 ' HG1' ' A' ' 14' ' ' THR . 62.7 tt0 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.277 0.561 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.19 153.48 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -120.26 135.37 55.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.763 -1.211 . . . . 0.0 109.377 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.81 116.48 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.15 115.76 28.28 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -97.76 163.22 12.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.408 -0.808 . . . . 0.0 109.662 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 8.9 mp -68.67 -17.87 64.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 p -81.45 -1.45 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.053 -1.03 . . . . 0.0 109.751 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.12 13.69 73.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -91.26 131.84 36.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.027 -1.278 . . . . 0.0 109.307 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.8 m -107.38 113.22 26.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.163 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -106.54 139.64 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.596 -0.69 . . . . 0.0 109.221 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.571 ' HG1' HE21 ' A' ' 2' ' ' GLN . 3.0 t -108.73 134.67 51.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.672 -0.642 . . . . 0.0 109.759 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.1 mt -125.92 143.91 50.89 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.749 . . . . 0.0 109.593 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -105.51 125.2 50.72 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.35 178.76 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.952 -1.093 . . . . 0.0 110.242 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 155.2 42.38 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.5 -34.74 32.68 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.056 1.838 . . . . 0.0 110.728 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 t -81.4 5.69 16.77 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.612 -0.68 . . . . 0.0 109.318 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.76 145.51 53.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 109.052 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.0 p -91.93 152.65 19.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.197 -0.939 . . . . 0.0 109.257 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 23' ' ' ILE . 24.1 mm -58.07 -35.18 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.961 -1.087 . . . . 0.0 109.124 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.68 -51.11 68.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.27 -33.86 76.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.866 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -73.25 -34.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -62.75 -35.38 79.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.39 63.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -49.42 -47.59 47.86 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.99 -36.22 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.31 -48.84 69.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.11 -26.26 65.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.007 . . . . 0.0 111.5 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -91.77 -47.61 7.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.758 -1.214 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 7.5 mp0 -87.18 -27.0 23.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.8 -1.188 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 -2.3 87.14 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.194 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.98 118.45 68.92 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.65 -1.5 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.51 152.65 3.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.564 1.509 . . . . 0.0 112.421 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.79 -17.97 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.706 2.27 . . . . 0.0 112.292 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -78.12 -3.76 44.0 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.123 -0.986 . . . . 0.0 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -112.32 -15.16 13.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -114.78 142.39 46.6 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.495 -0.753 . . . . 0.0 110.652 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -129.17 119.23 23.73 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.35 122.83 34.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 111.278 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -110.95 140.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.57 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.7 t80 -150.77 136.38 18.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 108.726 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . . . 56.67 2.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 99.36 21.39 15.12 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -130.24 140.8 50.67 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.68 120.3 24.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.12 118.99 7.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.451 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.59 147.07 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.148 -0.97 . . . . 0.0 109.056 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 15.5 p-10 -61.77 138.08 58.3 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.767 . . . . 0.0 110.674 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.81 56.35 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.401 -0.812 . . . . 0.0 112.003 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.76 164.16 17.76 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 120.073 1.937 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -101.53 146.01 28.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.313 -0.867 . . . . 0.0 111.021 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.11 -39.25 63.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.387 -0.821 . . . . 0.0 109.645 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -68.66 -18.75 64.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.89 . . . . 0.0 109.166 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.81 -17.9 61.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.73 . . . . 0.0 109.898 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -107.74 9.85 28.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 54.8 25.32 6.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 109.419 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 18.9 mt -51.76 170.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 95.0 mm-40 -137.75 141.1 40.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.381 -0.825 . . . . 0.0 109.781 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -57.35 155.69 8.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.132 -0.98 . . . . 0.0 110.233 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 122.002 -0.436 . . . . 0.0 110.967 179.638 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -96.26 130.41 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.52 128.87 56.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.407 -0.808 . . . . 0.0 109.811 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.88 149.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.702 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.3 mm -117.45 153.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -127.03 127.36 44.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.506 -1.371 . . . . 0.0 108.64 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.68 124.9 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.712 -1.243 . . . . 0.0 109.464 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -102.31 123.31 45.89 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -101.1 153.54 19.49 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.288 -0.882 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -18.41 37.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 p -81.33 -1.01 43.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.345 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.73 86.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.81 116.18 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.926 -1.337 . . . . 0.0 110.032 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -104.68 134.85 47.15 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -130.73 143.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -100.68 130.38 46.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.238 -0.914 . . . . 0.0 109.944 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.89 145.23 50.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 0.0 109.703 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -106.27 126.63 52.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.35 -176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 110.048 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -117.68 152.07 49.3 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.29 -33.3 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.062 1.841 . . . . 0.0 110.882 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -83.47 2.51 36.42 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.89 148.37 52.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.839 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 159.37 16.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.394 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.59 -38.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.8 -47.87 83.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.929 . . . . 0.0 110.027 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.76 -46.21 86.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.865 . . . . 0.0 109.906 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.23 -30.92 50.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.572 -0.705 . . . . 0.0 109.556 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -69.38 -32.56 71.67 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.55 -58.46 8.5 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 1.3 mptm? -49.5 -43.26 45.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.513 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -63.51 -44.52 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.252 -0.905 . . . . 0.0 109.745 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.71 -48.14 67.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -64.52 -19.45 65.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.828 . . . . 0.0 111.517 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -98.19 -47.48 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.737 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -90.26 -27.64 19.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.859 -1.151 . . . . 0.0 109.772 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.32 84.2 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.087 -1.008 . . . . 0.0 111.038 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -90.05 116.57 66.69 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.716 -1.461 . . . . 0.0 108.98 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.33 149.34 6.6 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.541 1.494 . . . . 0.0 112.094 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.82 -28.44 24.96 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.532 2.155 . . . . 0.0 112.386 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.16 -1.92 28.6 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.023 -1.048 . . . . 0.0 109.703 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -106.41 1.61 25.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -141.1 154.74 46.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -0.93 . . . . 0.0 111.267 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -130.54 128.57 41.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.66 121.12 37.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.548 -0.72 . . . . 0.0 111.494 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.99 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.641 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.5 t80 -133.8 134.94 43.48 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.06 -9.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 111.79 18.56 7.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -120.63 152.1 38.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.215 -1.168 . . . . 0.0 109.569 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -91.26 110.71 22.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.31 108.81 0.46 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.771 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.4 150.36 27.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.471 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.47 137.42 57.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.33 -0.856 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.18 -12.62 65.26 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.253 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 177.89 7.86 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.301 -1.705 . . . . 0.0 109.529 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.2 p -121.85 149.69 43.0 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.419 -0.8 . . . . 0.0 110.933 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -57.1 -41.97 79.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.615 -0.678 . . . . 0.0 109.313 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -57.23 -37.03 71.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.666 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.08 -20.52 6.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 109.553 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -101.83 11.31 38.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.158 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 46.99 48.04 15.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.926 -1.109 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 91.2 mt -73.4 175.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.344 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.497 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 11.0 tp-100 -144.88 147.52 32.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.986 -1.071 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -55.41 149.36 13.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.848 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.807 -0.558 . . . . 0.0 110.788 179.194 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.2 mp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 8.0 m-70 -104.21 129.26 51.98 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.99 124.66 51.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.864 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.64 145.96 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.2 mp . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.039 -1.038 . . . . 0.0 108.872 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.592 0.711 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.82 167.6 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.0 m-85 -131.21 132.26 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.99 -1.069 . . . . 0.0 109.714 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.48 120.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 109.364 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.603 ' HZ3' ' HG1' ' A' ' 12' ' ' THR . 57.6 mmtt -97.61 112.66 24.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -94.58 160.16 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.296 -0.878 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.21 -20.79 65.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.996 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -81.53 -0.04 40.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.508 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 12.44 79.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -83.41 122.31 28.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.29 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.603 ' HG1' ' HZ3' ' A' ' 6' ' ' LYS . 86.9 m -100.64 119.28 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -117.09 131.67 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.6 m -98.21 129.4 44.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.418 -0.801 . . . . 0.0 109.726 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -129.72 148.11 51.57 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.608 -0.683 . . . . 0.0 109.618 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.26 131.49 55.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.87 -175.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.966 -1.084 . . . . 0.0 110.079 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.8 149.18 41.95 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.13 -30.56 38.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.075 1.85 . . . . 0.0 110.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -83.56 2.18 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.73 147.1 50.96 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 p -89.96 156.92 18.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.43 -36.39 40.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.82 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.95 -48.77 75.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.803 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.75 -36.91 80.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 0.0 109.903 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.47 -28.73 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -67.66 -38.01 83.19 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -57.66 11.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -48.13 -45.23 32.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.361 -0.837 . . . . 0.0 109.41 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.85 -39.73 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.491 -0.756 . . . . 0.0 109.791 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -71.05 -51.09 27.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.98 -18.4 64.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 111.541 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -98.1 -47.63 5.42 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.641 -1.287 . . . . 0.0 110.764 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -93.53 -27.62 16.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.857 -1.152 . . . . 0.0 110.108 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.48 6.99 88.13 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.115 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.06 115.61 63.23 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.661 -1.494 . . . . 0.0 109.133 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.7 146.6 10.92 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.629 1.552 . . . . 0.0 112.247 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.94 -26.29 26.89 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.354 2.036 . . . . 0.0 112.432 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.09 -0.27 21.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.082 -1.011 . . . . 0.0 109.917 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -107.97 2.01 22.95 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.0 109.653 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -145.67 157.87 43.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.856 -1.153 . . . . 0.0 111.548 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -129.53 119.02 22.99 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -88.38 115.26 25.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.881 -1.137 . . . . 0.0 110.428 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -109.04 144.75 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.622 ' C ' ' H ' ' A' ' 47' ' ' GLY . 66.6 t80 -147.15 133.48 19.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.093 . . . . 0.0 108.381 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 -5.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.634 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.01 16.34 10.71 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.2 144.99 47.42 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.084 -1.244 . . . . 0.0 109.655 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.88 119.2 25.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.31 114.88 6.38 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.811 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.99 154.66 19.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.905 -1.122 . . . . 0.0 108.994 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -63.52 140.49 58.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.504 -0.747 . . . . 0.0 111.203 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.65 -17.39 59.21 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.618 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -76.04 176.58 7.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.219 -1.754 . . . . 0.0 109.556 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.519 -0.738 . . . . 0.0 110.571 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -55.73 -41.37 73.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.364 -0.835 . . . . 0.0 109.645 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.428 ' HG ' ' N ' ' A' ' 58' ' ' ASP . 85.0 p -60.34 -33.5 72.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.428 ' N ' ' HG ' ' A' ' 57' ' ' SER . 33.2 t70 -55.22 -20.07 9.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.627 -0.67 . . . . 0.0 109.717 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.4 3.86 35.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.101 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 m120 48.91 47.09 21.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 109.624 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.521 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 90.7 mt -69.17 177.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.398 -0.814 . . . . 0.0 109.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.521 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 9.3 tp-100 -135.52 138.84 43.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.157 -0.965 . . . . 0.0 109.801 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -52.54 146.94 9.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 110.563 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.761 -0.587 . . . . 0.0 110.856 179.33 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -107.76 130.88 54.92 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.35 117.84 31.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.514 -0.742 . . . . 0.0 109.502 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.83 144.7 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 9.8 mp . . . . . 0 N--CA 1.5 2.037 0 O-C-N 120.9 -1.125 . . . . 0.0 110.936 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.261 0.553 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -132.68 159.1 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -121.12 138.08 54.36 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.431 -0.793 . . . . 0.0 109.543 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.53 113.87 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.055 -1.028 . . . . 0.0 108.875 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -90.47 115.12 27.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.127 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.4 p -94.3 158.35 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 109.507 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.04 -16.81 63.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.8 m -81.53 -10.08 59.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.438 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 10.15 55.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.86 126.63 36.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.373 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -105.84 121.93 45.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.22 144.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -116.47 138.85 51.05 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.724 -0.61 . . . . 0.0 109.782 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -113.39 129.07 56.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.16 176.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.0 -1.063 . . . . 0.0 110.173 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -109.45 151.86 42.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.21 -34.36 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.062 1.841 . . . . 0.0 110.824 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -82.4 3.94 26.06 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.27 148.84 51.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.856 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -88.97 158.08 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 109.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.27 -42.96 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 108.42 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.33 -39.13 89.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.855 . . . . 0.0 110.129 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -68.82 -41.99 77.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.805 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -69.18 -31.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.133 -0.979 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -67.72 -34.71 77.4 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.52 83.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -42.94 85.05 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.94 -42.97 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.842 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.18 -43.32 98.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 0.0 109.895 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.99 -34.99 78.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 111.189 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -91.8 -39.82 11.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.761 -1.212 . . . . 0.0 111.531 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -93.37 -17.13 23.89 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.841 -1.162 . . . . 0.0 110.112 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -1.92 37.68 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.973 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.6 mt -81.43 134.21 51.88 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.701 -1.47 . . . . 0.0 109.039 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.92 160.86 48.02 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.688 1.592 . . . . 0.0 111.982 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 -24.69 32.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.765 2.31 . . . . 0.0 112.331 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -81.88 -1.81 48.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.023 -1.048 . . . . 0.0 110.315 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.99 -31.8 6.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.04 -1.038 . . . . 0.0 109.905 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.12 136.74 37.92 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.637 ' NH2' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -126.07 111.96 15.3 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.8 mt -93.81 129.74 40.08 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.668 0.747 . . . . 0.0 112.094 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mt -124.07 140.41 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.452 0.644 . . . . 0.0 109.592 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.64 137.66 53.74 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.68 -115.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.911 -1.118 . . . . 0.0 108.465 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.75 30.23 4.94 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 145.96 52.17 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.291 -1.123 . . . . 0.0 109.651 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -88.09 120.05 29.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -57.17 119.43 6.36 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.499 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 32.0 mt-10 -95.71 168.93 10.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.36 -0.838 . . . . 0.0 109.377 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.76 142.18 27.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 111.292 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.08 6.39 55.86 Favored Glycine 0 N--CA 1.502 3.064 0 O-C-N 121.433 -0.792 . . . . 0.0 111.859 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' NH2' ' OE1' ' A' ' 51' ' ' GLU . 5.2 mtp180 -121.4 171.26 8.9 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 118.736 1.268 . . . . 0.0 109.783 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -106.37 149.08 27.34 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.078 -1.014 . . . . 0.0 110.945 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.09 -37.01 68.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 109.609 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.7 p -61.48 -21.15 63.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.84 -17.35 64.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.397 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -103.62 8.74 37.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.752 . . . . 0.0 110.493 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 57.13 47.62 16.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.628 -1.295 . . . . 0.0 109.437 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 87.3 mt -80.28 174.48 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.383 -0.823 . . . . 0.0 109.131 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.497 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 20.0 pt20 -152.95 154.5 35.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.885 -1.134 . . . . 0.0 110.055 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -54.68 147.95 13.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 122.122 -0.361 . . . . 0.0 111.159 179.867 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.7 mp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -90.82 133.73 34.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.295 -0.878 . . . . 0.0 108.777 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -110.8 123.7 50.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.508 -0.745 . . . . 0.0 110.142 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.8 146.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.502 2.159 0 O-C-N 120.874 -1.141 . . . . 0.0 109.972 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.645 HE21 ' HG1' ' A' ' 14' ' ' THR . 65.4 tt0 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.328 0.585 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -143.97 166.29 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.33 141.76 51.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.327 -0.858 . . . . 0.0 109.703 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.88 117.02 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 0.0 108.893 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -89.75 114.13 25.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 108.974 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 160.86 15.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.407 -0.808 . . . . 0.0 109.904 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 10.1 mp -69.34 -19.36 63.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.78 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -81.49 -4.13 55.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 109.49 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 12.96 62.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.68 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.367 . . . . 0.0 109.333 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -99.13 117.72 34.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.452 -0.78 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.8 139.98 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.447 -0.783 . . . . 0.0 109.118 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.645 ' HG1' HE21 ' A' ' 2' ' ' GLN . 11.6 t -113.3 135.43 53.86 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.716 -0.615 . . . . 0.0 109.676 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.04 159.89 40.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.467 -0.771 . . . . 0.0 109.7 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -115.76 132.11 56.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.43 176.69 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.004 -1.06 . . . . 0.0 110.19 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -107.23 153.81 40.88 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.08 -35.78 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.009 1.806 . . . . 0.0 110.754 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -83.35 4.83 25.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.638 -0.664 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.82 143.92 57.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.0 108.703 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -85.86 145.24 27.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 109.415 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 1.9 mp -50.25 -41.09 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 108.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.77 -40.93 94.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.92 71.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.8 -36.0 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 0.0 109.415 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 51.6 mttp -69.58 -30.77 68.62 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.72 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -53.45 -43.75 68.32 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mm -61.44 -46.07 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.7 -43.09 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.89 -32.89 72.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.374 -0.829 . . . . 0.0 111.249 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.14 -40.35 8.85 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.828 -1.17 . . . . 0.0 111.159 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.6 -21.92 25.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.767 -1.208 . . . . 0.0 109.656 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.51 53.31 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.999 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -91.09 134.39 30.13 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.838 -1.389 . . . . 0.0 108.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 131.26 20.92 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.22 1.28 . . . . 0.0 111.871 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.68 -19.14 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.341 2.027 . . . . 0.0 113.729 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.71 -8.5 56.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 110.605 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -109.02 -22.62 12.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.255 -0.903 . . . . 0.0 109.95 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -107.16 143.49 35.28 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.83 0.824 . . . . 0.0 110.998 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.71 124.61 43.12 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -93.65 121.43 35.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.442 -1.411 . . . . 0.0 110.024 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mm -112.17 129.93 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 47' ' ' GLY . 83.9 t80 -146.91 139.84 25.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 108.903 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.63 3.25 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 109.298 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.38 19.92 26.53 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -127.98 151.86 48.62 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.125 -1.22 . . . . 0.0 109.641 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.61 113.27 25.27 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.07 117.53 2.61 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.307 -0.87 . . . . 0.0 109.87 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.02 173.7 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.229 -0.919 . . . . 0.0 109.804 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.29 146.35 25.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 0.0 111.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.77 10.68 55.06 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.412 -0.805 . . . . 0.0 111.552 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -129.06 160.84 31.52 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.763 -1.433 . . . . 0.0 110.612 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -89.44 146.83 24.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 tp -55.65 -27.49 50.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.0 p -71.2 -16.45 62.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.075 -1.015 . . . . 0.0 109.236 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.42 -16.81 57.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.581 -0.7 . . . . 0.0 109.458 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.04 10.56 34.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 53.08 26.03 4.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.558 -1.339 . . . . 0.0 109.63 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 6.0 mt -52.39 170.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.323 -0.86 . . . . 0.0 108.724 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 52.2 mt-30 -138.83 142.68 38.66 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -58.04 153.62 14.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.662 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.668 -0.645 . . . . 0.0 110.565 179.605 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -90.52 128.78 36.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 108.618 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.71 122.54 48.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.614 -0.679 . . . . 0.0 109.792 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.13 150.47 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.4 mp . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 108.99 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.332 0.587 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -143.86 166.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -129.4 135.65 48.96 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.192 -0.943 . . . . 0.0 109.721 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.19 119.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 0.0 108.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -95.62 120.88 36.65 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -97.37 145.7 25.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.351 -0.843 . . . . 0.0 109.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -61.59 -13.77 24.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.9 m -81.55 -9.99 59.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.031 . . . . 0.0 109.556 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 2.5 55.85 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -91.37 136.39 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.937 -1.331 . . . . 0.0 109.273 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -123.94 134.41 53.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.468 -0.77 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.5 145.15 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.597 -0.689 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 136.75 41.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 109.797 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -126.81 146.24 50.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.55 -0.718 . . . . 0.0 109.544 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -105.88 125.34 50.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.83 174.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.349 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 12.5 mp0 -108.54 154.01 41.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.25 -35.06 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.923 1.749 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 t -84.28 4.84 29.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.512 -0.743 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.74 148.79 51.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.957 -1.089 . . . . 0.0 108.526 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -87.82 152.38 22.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.14 -39.85 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -64.12 -42.04 97.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -65.25 -38.2 89.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -72.63 -29.22 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.459 -0.775 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -69.71 -34.5 73.99 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -54.27 47.58 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -49.53 -44.54 46.51 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.437 0.637 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.35 -38.18 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -63.25 -47.96 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 109.916 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -70.38 -20.05 62.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.197 -0.94 . . . . 0.0 111.268 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -93.65 -50.89 5.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.835 -1.166 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -87.67 -24.44 23.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.879 -1.138 . . . . 0.0 109.805 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.03 3.9 89.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.137 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 134.79 32.44 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.705 -1.468 . . . . 0.0 109.039 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.83 156.03 66.74 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.579 1.519 . . . . 0.0 111.951 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.36 -18.35 38.95 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.946 2.431 . . . . 0.0 112.578 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.76 -1.6 43.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 110.039 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -112.67 -23.04 10.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.136 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -115.63 144.78 43.41 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.67 118.29 22.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt -85.92 121.25 28.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.67 0.747 . . . . 0.0 111.616 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.47 150.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -139.49 130.04 25.74 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.32 -119.5 1.51 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.62 27.61 7.87 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -135.65 -174.85 3.76 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.917 -1.343 . . . . 0.0 109.283 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -121.68 126.06 48.1 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.167 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.26 118.49 5.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.14 168.0 11.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.251 -0.906 . . . . 0.0 109.641 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.62 146.82 23.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.31 -0.868 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.46 60.85 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.341 -0.849 . . . . 0.0 111.657 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -123.66 164.12 19.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.118 -1.225 . . . . 0.0 110.189 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -96.79 147.85 23.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.922 -1.111 . . . . 0.0 110.749 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.79 -31.72 62.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -62.26 -23.58 66.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.66 -16.38 48.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -104.83 0.76 28.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 52.98 44.07 30.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.713 -1.242 . . . . 0.0 109.508 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.478 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 90.3 mt -66.87 174.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.209 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.478 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 5.8 tp-100 -135.82 140.41 44.19 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.186 -0.946 . . . . 0.0 110.009 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -51.76 143.59 12.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 110.568 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -101.81 131.89 47.88 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.68 126.58 55.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 109.496 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.4 147.43 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.3 mp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 120.915 -1.116 . . . . 0.0 108.841 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.4 0.619 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.13 166.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.72 132.31 51.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.26 116.69 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.058 -1.026 . . . . 0.0 109.001 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.04 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -92.43 153.85 18.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -59.84 -23.99 63.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 109.918 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.5 m -81.23 -6.67 59.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 1.41 63.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -73.65 113.57 10.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.908 -1.348 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.5 m -97.51 130.1 44.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.38 140.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -104.17 132.7 50.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.251 -0.905 . . . . 0.0 109.845 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -128.73 147.27 50.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.484 0.659 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -111.15 130.42 55.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.41 -178.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.021 -1.049 . . . . 0.0 110.054 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.18 154.57 46.22 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.74 -33.68 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.179 1.92 . . . . 0.0 110.71 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -84.34 5.69 25.99 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -69.14 146.51 52.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.0 108.871 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.564 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 62.2 p -93.76 152.69 18.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 23' ' ' ILE . 31.4 mm -57.55 -36.27 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 109.058 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.55 -53.03 61.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.978 . . . . 0.0 110.198 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.564 ' H ' ' HG1' ' A' ' 22' ' ' THR . 2.9 t-20 -62.79 -37.67 87.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.359 -0.838 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.69 -28.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 52' ' ' ASP . 77.7 mttt -68.88 -34.93 76.25 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -56.75 17.71 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 58.2 mttp -49.65 -46.13 49.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.625 -0.672 . . . . 0.0 109.325 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.08 -41.71 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 109.722 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -68.9 -45.64 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 111.629 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -98.41 -48.22 5.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.646 -1.284 . . . . 0.0 111.065 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 -28.51 23.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.763 -1.21 . . . . 0.0 109.673 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 5.91 88.42 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.379 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.35 119.35 68.68 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 120.557 -1.555 . . . . 0.0 108.9 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 144.02 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.567 1.512 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 -18.09 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.459 2.106 . . . . 0.0 112.226 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.16 -11.2 60.81 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.103 -0.998 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -110.06 -29.23 8.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -85.48 137.25 33.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.509 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -124.49 111.49 15.76 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -93.25 124.47 37.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.589 -0.694 . . . . 0.0 111.199 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.29 138.08 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.658 -0.651 . . . . 0.0 109.355 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 47' ' ' GLY . 85.6 t80 -140.26 139.39 35.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.447 -0.783 . . . . 0.0 109.154 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.1 -10.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.64 -0.663 . . . . 0.0 109.32 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.91 8.3 24.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -112.86 149.74 32.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.089 -1.242 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -83.4 116.73 22.62 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.85 120.68 12.38 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.687 -0.633 . . . . 0.0 110.068 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.9 151.33 20.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 68.8 m-20 -65.92 138.62 57.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 111.186 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.68 71.54 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.474 -0.766 . . . . 0.0 111.231 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -82.57 166.9 18.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.706 -1.467 . . . . 0.0 111.075 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -111.39 145.42 38.94 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.663 0.744 . . . . 0.0 111.402 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.76 -43.54 90.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.667 -0.646 . . . . 0.0 109.788 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -55.58 -34.28 64.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.25 -20.77 29.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.388 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -103.8 5.1 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.27 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 48.1 41.56 15.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.789 -1.194 . . . . 0.0 109.694 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 56.2 mt -60.1 169.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.365 -0.834 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 62.9 mt-30 -129.05 134.62 48.18 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.789 0.804 . . . . 0.0 109.848 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -54.85 150.29 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 110.797 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.87 -0.518 . . . . 0.0 110.741 179.302 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.7 mp . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 1.6 m80 -102.43 127.94 49.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.357 -0.839 . . . . 0.0 109.202 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -109.38 111.5 23.09 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.502 -0.749 . . . . 0.0 109.494 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.87 142.57 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.007 -1.058 . . . . 0.0 109.605 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.342 0.591 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.96 163.0 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.9 145.39 48.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.336 -0.852 . . . . 0.0 109.69 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.86 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.392 -0.818 . . . . 0.0 108.885 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.18 114.86 26.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -88.79 156.45 18.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.27 -24.44 64.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -81.38 -5.33 57.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 16.96 53.75 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.67 115.08 27.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.912 -1.346 . . . . 0.0 109.398 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -91.9 118.49 30.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.11 145.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.551 -0.718 . . . . 0.0 109.12 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 t -111.38 134.83 52.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.639 -0.663 . . . . 0.0 109.667 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 mt -127.89 146.59 50.58 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.497 -0.752 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.36 123.37 46.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.73 177.46 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.976 -1.078 . . . . 0.0 110.043 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.17 164.06 15.58 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -77.57 -37.07 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 110.705 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -80.52 7.77 9.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -66.41 150.24 49.2 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.81 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -94.07 164.16 13.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -70.11 -40.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.035 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -63.07 -43.86 97.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -68.01 -40.01 83.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.471 -0.768 . . . . 0.0 109.679 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.24 -31.5 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -68.64 -32.38 72.18 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.98 81.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.84 -44.86 78.39 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.2 mt -62.34 -42.56 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.416 -0.803 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.1 tt0 -65.35 -44.11 88.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.96 -33.54 73.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 111.149 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -93.86 -41.16 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.823 -1.173 . . . . 0.0 111.17 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -89.44 -26.01 21.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.676 -1.265 . . . . 0.0 109.907 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 80.21 7.28 88.68 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.189 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 36' ' ' ILE . 13.5 mm -95.45 116.81 66.6 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.803 -1.41 . . . . 0.0 109.435 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.84 150.17 6.81 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.665 1.577 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.07 -19.46 34.63 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.675 2.25 . . . . 0.0 112.605 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.7 -4.49 46.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -107.93 -12.52 15.15 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -113.45 140.86 47.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.352 -0.842 . . . . 0.0 110.508 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -127.44 108.93 11.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.78 125.19 33.05 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.743 0.782 . . . . 0.0 111.695 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.39 134.48 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.461 0.648 . . . . 0.0 109.265 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.483 ' C ' ' H ' ' A' ' 47' ' ' GLY . 65.9 t80 -148.6 142.43 25.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 109.225 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.71 8.26 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.733 . . . . 0.0 109.37 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 93.68 18.96 36.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -129.32 152.03 49.33 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.28 117.52 29.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -54.32 115.51 2.13 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.227 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -88.57 146.54 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.027 . . . . 0.0 108.994 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.07 135.6 57.82 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.387 -0.821 . . . . 0.0 109.909 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -14.8 57.3 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.256 -0.902 . . . . 0.0 112.792 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -91.72 160.83 15.15 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.219 2.01 . . . . 0.0 110.559 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -105.54 151.08 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.567 0.698 . . . . 0.0 109.374 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.97 -39.06 65.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.995 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -60.27 -20.57 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.544 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.49 -19.64 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.582 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -107.32 8.66 29.87 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 0.0 110.397 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 52.09 49.07 21.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.676 -1.265 . . . . 0.0 109.675 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 69.7 mt -76.92 172.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.488 -0.758 . . . . 0.0 109.132 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.502 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 90.8 mt-30 -138.62 142.15 39.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.114 -0.991 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.27 152.53 6.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 110.44 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 122.048 -0.407 . . . . 0.0 110.884 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -89.88 129.89 36.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.1 -1.0 . . . . 0.0 108.956 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.49 114.56 28.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.512 -0.743 . . . . 0.0 110.037 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.82 147.05 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 122.222 1.011 . . . . 0.0 110.735 -178.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.424 0.63 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.07 168.42 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -127.98 131.66 49.24 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.29 -0.881 . . . . 0.0 109.561 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.12 117.18 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 108.91 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -91.85 113.89 26.28 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -92.93 164.05 13.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.492 -0.755 . . . . 0.0 109.975 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.9 mp -72.72 -19.02 61.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.035 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.3 p -81.38 -0.4 41.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 0.0 109.649 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 12.34 71.34 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -93.16 132.26 37.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.325 . . . . 0.0 109.057 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -116.14 130.87 57.01 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.28 143.3 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.643 -0.661 . . . . 0.0 109.468 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 t -103.62 138.08 40.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 109.782 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.2 mt -131.98 153.37 50.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.536 -0.727 . . . . 0.0 109.567 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -107.13 124.45 49.71 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -143.5 163.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.0 mt-10 -101.36 152.31 37.95 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -36.05 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.936 1.757 . . . . 0.0 111.338 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.9 p -79.77 4.73 15.48 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.385 -0.822 . . . . 0.0 109.288 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.28 146.02 49.18 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.483 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 80.4 p -89.34 154.38 20.13 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 23' ' ' ILE . 22.7 mm -54.93 -37.84 43.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.016 -1.053 . . . . 0.0 108.748 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.2 -44.32 95.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.51 ' H ' ' HG1' ' A' ' 22' ' ' THR . 95.1 m-20 -65.7 -36.37 83.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.932 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.22 -30.31 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.489 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.22 -35.72 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.9 49.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -50.42 -46.84 56.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.64 -37.76 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.56 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.26 -47.15 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.8 -25.7 68.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 111.423 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -95.5 -48.8 5.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.9 -24.8 23.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.837 -1.165 . . . . 0.0 110.025 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.65 -1.6 88.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.233 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -80.68 134.28 54.25 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.657 -1.496 . . . . 0.0 108.571 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 131.8 20.78 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.36 1.373 . . . . 0.0 112.051 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -46.12 -23.21 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.237 1.958 . . . . 0.0 113.553 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -73.91 -2.68 24.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 110.59 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.64 -22.6 10.17 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -100.75 137.52 39.03 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.154 0.978 . . . . 0.0 111.212 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.5 104.41 9.64 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.15 122.02 33.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.799 -1.188 . . . . 0.0 110.075 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 mt -122.73 145.83 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 47' ' ' GLY . 74.9 t80 -149.96 144.84 26.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.64 6.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.94 15.97 49.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.47 139.95 52.81 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.074 -1.251 . . . . 0.0 109.027 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -78.59 118.69 20.95 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.24 118.91 6.0 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 109.861 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -90.62 150.18 21.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.194 -0.942 . . . . 0.0 109.936 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -66.33 134.91 53.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 110.752 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.99 -16.29 57.42 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 121.301 -0.874 . . . . 0.0 111.897 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -92.66 149.06 21.57 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-N 119.9 1.85 . . . . 0.0 109.997 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -90.81 154.48 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.587 0.708 . . . . 0.0 110.068 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.21 -36.28 72.89 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -61.94 -20.24 63.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.062 . . . . 0.0 109.188 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.37 -16.27 64.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.463 -0.773 . . . . 0.0 109.726 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -109.33 7.55 25.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.459 -0.776 . . . . 0.0 110.348 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 51.71 45.7 27.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.658 -1.276 . . . . 0.0 109.552 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 88.9 mt -71.88 174.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.258 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 15.6 tt0 -135.88 140.13 43.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.19 -0.944 . . . . 0.0 109.702 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -53.15 149.81 6.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.967 -0.458 . . . . 0.0 110.976 179.507 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.23 130.88 41.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.23 118.75 36.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.399 -0.813 . . . . 0.0 109.789 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.47 148.81 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.297 -1.686 0 O-C-N 120.806 -1.184 . . . . 0.0 109.302 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.507 0.67 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.1 pt -140.36 163.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 41.1 m-85 -121.75 136.12 54.94 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 114.03 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -90.64 117.37 29.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 109.031 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.7 p -92.12 160.64 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.882 . . . . 0.0 109.597 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -65.21 -20.1 66.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -81.67 -9.32 59.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 109.544 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.06 16.56 43.89 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -94.34 121.06 35.48 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.322 . . . . 0.0 109.563 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 m -96.65 121.33 38.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.293 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.36 141.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.488 -0.757 . . . . 0.0 109.236 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.9 p -107.53 131.64 54.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.668 . . . . 0.0 109.667 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -132.52 153.0 51.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.536 -0.728 . . . . 0.0 109.567 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.74 130.04 56.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.2 178.81 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -112.62 153.03 45.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.86 -31.51 47.61 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.997 1.798 . . . . 0.0 110.644 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 5.13 33.77 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.577 -0.702 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -69.58 146.64 51.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -95.59 148.8 22.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 109.387 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -54.2 -39.23 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.086 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.44 -47.69 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.892 . . . . 0.0 109.848 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -68.36 -37.27 80.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.758 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.19 -29.72 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -70.99 -33.99 70.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.37 76.88 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -54.12 -48.25 70.95 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -65.69 -38.08 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -59.13 -48.03 83.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.476 -0.765 . . . . 0.0 109.974 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.09 -35.06 77.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.464 -0.772 . . . . 0.0 111.198 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -79.81 -50.43 10.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.817 -1.177 . . . . 0.0 111.462 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.94 -10.08 49.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.757 -1.215 . . . . 0.0 110.015 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.24 27.13 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.68 134.27 37.97 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.744 -1.445 . . . . 0.0 108.79 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.69 156.93 59.94 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 0.0 112.073 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.43 -18.32 38.64 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.743 2.295 . . . . 0.0 112.781 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.51 -5.4 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -109.34 -27.92 9.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 109.311 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -96.86 134.72 39.82 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.244 -0.91 . . . . 0.0 110.657 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.495 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -118.83 109.21 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.93 129.89 38.69 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.683 -1.261 . . . . 0.0 111.817 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.17 141.13 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.487 0.661 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -119.54 137.41 53.85 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 -112.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.025 -1.047 . . . . 0.0 108.851 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.41 28.95 5.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -129.42 140.31 51.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.177 -1.19 . . . . 0.0 109.421 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -82.95 117.44 22.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.15 121.27 9.06 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.24 148.42 22.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 2.4 p30 -66.35 136.28 55.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 110.871 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.23 57.83 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.426 -0.796 . . . . 0.0 112.051 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.74 170.0 14.65 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.105 -1.821 . . . . 0.0 110.591 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 m -108.17 147.81 30.78 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.313 0.577 . . . . 0.0 109.802 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -56.04 -41.85 75.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -60.49 -20.57 60.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.35 -18.03 64.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.09 6.87 31.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.485 -0.76 . . . . 0.0 110.308 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 54.22 39.82 31.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 68.4 mt -64.05 169.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.497 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 53.4 tt0 -138.62 143.2 39.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.283 -0.885 . . . . 0.0 110.029 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.24 145.41 13.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 110.654 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.756 -0.59 . . . . 0.0 110.774 179.33 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -92.53 128.61 38.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 0.0 108.885 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.13 117.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.796 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.4 145.47 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.9 mp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 110.016 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.375 0.607 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -145.17 165.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -125.07 137.58 54.2 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.202 -0.936 . . . . 0.0 109.454 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.33 121.38 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.656 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -93.95 118.02 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -93.58 154.08 18.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.97 -19.3 64.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.078 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -82.11 -1.46 48.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 109.726 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.08 9.83 69.92 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -92.23 116.42 28.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.047 -1.267 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -101.81 132.01 47.81 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 109.104 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tt -129.45 145.42 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.509 -0.745 . . . . 0.0 109.44 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -102.71 139.18 38.62 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.56 -0.713 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -130.19 149.74 51.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.619 -0.676 . . . . 0.0 109.43 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -111.09 129.87 55.79 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.69 178.54 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.981 -1.074 . . . . 0.0 110.139 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.27 153.49 44.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.54 -33.68 45.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.998 1.799 . . . . 0.0 110.762 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 m -84.94 4.71 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.422 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.67 145.46 53.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.973 -1.079 . . . . 0.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -91.91 162.61 14.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.86 -40.96 90.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.144 -0.972 . . . . 0.0 108.696 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -62.21 -43.73 98.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.73 -41.59 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.116 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.63 -29.07 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.02 . . . . 0.0 109.455 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -35.13 78.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.56 82.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.75 -44.3 77.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.72 -39.3 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -59.61 -45.62 91.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 109.93 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.61 -30.28 68.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 111.187 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -88.25 -46.68 9.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.78 -1.2 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -89.21 -19.84 24.92 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.638 -1.289 . . . . 0.0 110.017 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.07 4.68 56.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.065 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -89.82 122.48 67.93 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.684 -1.48 . . . . 0.0 109.3 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.31 149.55 6.33 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.633 1.555 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.35 -19.5 33.25 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.32 -2.8 33.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -111.65 -25.25 9.63 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.15 -0.969 . . . . 0.0 110.271 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -97.59 136.03 38.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -122.37 115.82 22.95 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.02 125.56 41.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.59 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -121.73 141.16 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -150.32 144.68 25.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.099 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.66 12.11 4.36 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.56 67.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.48 148.93 44.56 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.124 -1.221 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -84.26 113.53 21.18 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -54.53 123.17 12.28 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.745 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.64 143.27 27.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.148 -0.97 . . . . 0.0 109.13 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.9 133.91 56.01 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.417 -0.802 . . . . 0.0 109.602 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -16.23 56.91 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.35 -0.844 . . . . 0.0 112.086 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -81.97 164.28 21.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 119.977 -1.896 . . . . 0.0 109.108 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 m -104.93 147.56 27.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.47 -41.89 81.54 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -59.46 -23.73 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.166 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.98 -18.52 64.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -107.19 5.87 28.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.517 -0.739 . . . . 0.0 110.106 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 49.91 48.33 21.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.615 -1.303 . . . . 0.0 109.681 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.91 165.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 108.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -126.79 135.22 50.75 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.402 -0.811 . . . . 0.0 109.75 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.11 146.21 6.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 122.133 -0.355 . . . . 0.0 110.959 179.675 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -97.79 126.37 43.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.194 -0.941 . . . . 0.0 108.999 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.85 117.59 34.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 109.585 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.65 143.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.495 1.812 0 O-C-N 120.888 -1.132 . . . . 0.0 109.608 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.453 0.644 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -145.66 166.81 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 61.2 m-85 -121.13 136.55 54.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.79 118.7 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.64 120.75 36.45 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -97.03 153.88 17.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.82 -18.88 58.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.364 -0.835 . . . . 0.0 110.16 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -81.54 -1.47 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.18 70.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.15 118.01 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.978 -1.307 . . . . 0.0 109.659 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -103.34 130.35 50.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.327 -0.858 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -131.11 138.28 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.462 -0.773 . . . . 0.0 109.732 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -97.69 142.44 29.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -132.83 155.5 48.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.461 -0.775 . . . . 0.0 109.613 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -106.81 125.55 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.37 165.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.071 -1.018 . . . . 0.0 109.969 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 39.2 mt-10 -107.67 154.06 41.09 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.52 -29.1 31.14 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.157 1.905 . . . . 0.0 111.113 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -88.7 1.26 55.43 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 151.27 47.17 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.962 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.507 ' HG1' ' CG ' ' A' ' 25' ' ' ASN . 45.8 p -96.66 150.94 20.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.257 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 23' ' ' ILE . 20.7 mm -54.4 -36.75 35.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.065 -1.022 . . . . 0.0 108.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.32 -42.81 92.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 109.935 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.507 ' CG ' ' HG1' ' A' ' 22' ' ' THR . 2.1 m120 -67.78 -37.74 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 109.682 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.96 -31.05 39.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.581 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.63 -34.98 76.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.89 78.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.3 -46.88 79.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.3 mt -63.07 -42.16 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.23 -46.11 85.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 109.974 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.02 -30.57 71.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 111.442 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -96.07 -43.74 7.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.879 -1.138 . . . . 0.0 111.278 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -87.9 -27.26 22.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.813 -1.179 . . . . 0.0 109.945 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.34 77.15 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.106 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -76.18 133.67 71.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.706 -1.467 . . . . 0.0 108.616 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.23 133.15 20.6 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.36 1.373 . . . . 0.0 112.143 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.89 -25.45 2.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 113.155 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -77.81 -3.63 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.95 -1.094 . . . . 0.0 110.338 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -111.78 -29.89 7.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -107.23 143.42 35.48 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.825 0.821 . . . . 0.0 111.016 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.429 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.4 mtp180 -130.38 125.43 34.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.43 122.79 39.71 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.032 -1.043 . . . . 0.0 111.186 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.97 134.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.84 134.79 55.12 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 -109.45 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.081 -1.012 . . . . 0.0 108.792 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.5 33.34 3.31 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -133.83 154.6 50.91 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.065 -1.256 . . . . 0.0 109.598 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -99.3 116.09 30.68 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -53.6 120.05 5.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.97 142.62 27.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.893 . . . . 0.0 109.795 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.27 135.46 57.48 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.453 -0.779 . . . . 0.0 110.31 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 -18.6 54.83 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.358 -0.839 . . . . 0.0 111.943 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -90.66 159.89 16.15 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.022 1.911 . . . . 0.0 109.996 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -102.72 154.55 19.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.587 -0.696 . . . . 0.0 109.927 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.65 -37.39 73.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.345 -0.847 . . . . 0.0 109.626 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -56.74 -18.71 13.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.008 -1.058 . . . . 0.0 109.533 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -76.22 -19.44 58.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.89 -11.92 17.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.466 -0.771 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 t30 60.58 48.01 7.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.032 -1.042 . . . . 0.0 109.577 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 97.2 mt -70.36 171.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.141 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.491 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.0 mm100 -128.27 136.16 50.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -53.6 148.1 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.703 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' OE2' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.646 -0.659 . . . . 0.0 110.308 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 4.7 m-70 -95.76 126.14 40.82 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.077 -1.015 . . . . 0.0 108.835 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tp -101.23 113.28 26.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.1 t -106.43 138.25 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.214 -0.928 . . . . 0.0 109.279 -179.716 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.324 0.583 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.14 166.53 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.33 158.51 39.62 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.02 124.73 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.1 119.64 31.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.489 -0.757 . . . . 0.0 109.094 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -91.14 151.97 20.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -58.82 -19.3 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 109.754 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.8 m -81.37 -6.71 59.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.136 -0.978 . . . . 0.0 109.402 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.67 59.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -94.09 118.94 32.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.314 . . . . 0.0 109.611 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -94.86 122.9 37.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.054 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -115.26 145.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.572 -0.705 . . . . 0.0 109.12 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -106.6 131.7 53.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.714 . . . . 0.0 109.633 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -129.71 150.44 51.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.458 -0.776 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -110.91 128.7 55.9 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.88 174.51 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 110.317 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -107.93 152.88 41.86 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.61 -34.18 26.16 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.967 1.778 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -85.66 1.78 47.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.57 -0.706 . . . . 0.0 109.233 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.67 147.91 44.35 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.996 -1.081 . . . . 0.0 108.522 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.4 p -89.0 155.81 19.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 108.847 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.73 -42.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.043 -1.035 . . . . 0.0 108.237 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.81 -37.89 89.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -69.48 -41.63 75.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.6 t -66.76 -28.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.245 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -72.92 -35.42 67.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.38 92.42 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.99 -44.93 94.67 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.0 -37.58 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.42 -0.8 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.61 -47.96 83.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.923 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -66.77 -34.82 78.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 111.274 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -85.22 -46.13 11.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 111.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -85.03 -27.24 26.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.67 -1.269 . . . . 0.0 109.72 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.66 3.58 79.32 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.441 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 36' ' ' ILE . 17.6 mm -93.29 124.34 57.97 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.673 -1.487 . . . . 0.0 108.716 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.39 130.34 21.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.294 1.329 . . . . 0.0 112.368 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -49.47 -24.56 9.17 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.223 1.949 . . . . 0.0 113.423 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.21 -9.22 58.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.645 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -103.65 -23.57 13.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -98.25 138.48 35.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 0.0 110.761 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -122.61 112.05 17.52 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -88.5 122.84 32.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.185 -0.947 . . . . 0.0 111.097 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.34 132.72 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -119.96 135.53 54.87 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 -112.76 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.014 -1.054 . . . . 0.0 109.087 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.98 28.62 5.82 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -140.13 179.2 6.77 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.881 -1.364 . . . . 0.0 109.474 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' OH ' ' A' ' 59' ' ' TYR . 39.5 mt-30 -109.63 156.45 20.2 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.995 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 4.3 mm? -83.32 108.63 16.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.095 -1.003 . . . . 0.0 108.358 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.594 ' CD ' HH21 ' A' ' 54' ' ' ARG . 40.4 tt0 -80.71 152.5 28.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.68 142.27 30.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.529 -0.732 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.02 10.47 51.96 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.301 -0.875 . . . . 0.0 111.714 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.594 HH21 ' CD ' ' A' ' 51' ' ' GLU . 3.9 mtp180 -129.69 172.87 11.17 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.893 -1.357 . . . . 0.0 109.721 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -103.59 149.73 24.63 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.037 -1.039 . . . . 0.0 111.235 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -56.65 -32.54 65.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.461 -0.774 . . . . 0.0 109.491 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -62.11 -19.27 62.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.087 -1.008 . . . . 0.0 109.213 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.35 -16.88 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.421 -0.799 . . . . 0.0 109.614 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 13.4 m-85 -103.91 10.98 36.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.427 -0.796 . . . . 0.0 110.238 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 52.46 42.46 31.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.612 -1.305 . . . . 0.0 109.416 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 60.6 mt -71.4 170.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 42.4 mt-30 -143.8 147.05 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.086 -1.009 . . . . 0.0 110.068 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -52.94 145.78 12.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 110.587 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.821 -0.549 . . . . 0.0 110.607 179.482 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -97.78 130.94 44.69 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tt -103.36 116.89 33.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 109.666 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.05 146.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.498 1.954 0 O-C-N 120.861 -1.149 . . . . 0.0 111.047 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -145.84 166.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -128.84 150.4 50.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.93 -1.107 . . . . 0.0 110.131 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.55 123.72 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.365 -0.835 . . . . 0.0 108.866 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -97.66 123.5 41.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.4 m -98.6 158.95 15.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.25 -16.31 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.924 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -82.04 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.097 -1.002 . . . . 0.0 109.641 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.83 64.97 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -94.86 133.69 38.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.312 . . . . 0.0 109.281 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.9 m -114.88 129.2 56.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 109.126 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -125.49 145.06 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.72 -0.612 . . . . 0.0 109.494 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -103.45 136.89 42.34 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.712 . . . . 0.0 109.847 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -131.99 151.75 51.55 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -103.29 122.86 45.67 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.05 164.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.114 -0.991 . . . . 0.0 110.076 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 65.0 mt-10 -107.23 151.81 40.94 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.1 -30.91 37.76 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.091 1.861 . . . . 0.0 111.04 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -82.95 -0.8 50.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.52 147.88 52.21 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.671 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.713 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 74.3 p -90.77 153.98 19.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 109.005 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.61 -38.9 44.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.846 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.3 -45.1 89.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 109.876 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.713 ' H ' ' HG1' ' A' ' 22' ' ' THR . 2.7 m120 -63.21 -36.97 85.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.983 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.28 -27.97 22.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -67.53 -38.26 83.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.51 45.55 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -48.92 -43.9 39.84 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.526 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.15 -28.61 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.014 -1.054 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -61.94 -50.31 72.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 109.871 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -72.78 -28.8 62.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -81.39 -47.52 13.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.865 -1.147 . . . . 0.0 111.039 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.14 -17.79 25.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.715 -1.241 . . . . 0.0 109.73 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.04 52.02 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.286 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -93.23 125.07 55.9 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.665 -1.491 . . . . 0.0 109.304 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.32 149.05 6.88 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.482 1.455 . . . . 0.0 112.145 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.69 -26.92 32.58 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.357 2.038 . . . . 0.0 112.29 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.33 -2.36 13.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -110.85 -13.32 14.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.02 -1.05 . . . . 0.0 109.689 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -110.05 137.75 47.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -119.81 111.02 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -92.46 120.17 32.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -113.98 144.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -123.29 140.49 52.96 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.07 -112.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.098 -1.002 . . . . 0.0 108.56 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.43 6.19 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -125.12 144.09 50.6 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.014 -1.286 . . . . 0.0 109.366 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -74.68 147.9 41.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.16 114.79 25.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.821 -1.174 . . . . 0.0 108.842 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 21.6 mp0 -81.3 175.72 10.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 108.912 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 39.3 p-10 -95.49 135.65 36.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.72 -0.613 . . . . 0.0 111.577 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.93 -8.22 61.12 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.998 -1.064 . . . . 0.0 112.18 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -95.18 154.8 17.01 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 120.307 -1.702 . . . . 0.0 109.306 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 p -92.87 149.79 21.03 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.016 -1.053 . . . . 0.0 110.895 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -53.75 -33.68 56.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 109.636 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 m -64.82 -13.63 56.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.06 -1.025 . . . . 0.0 109.085 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.17 -17.22 61.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.547 -0.721 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.68 8.19 22.55 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 0.0 110.13 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 54.76 45.73 26.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.346 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 86.5 mt -75.04 172.1 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.177 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.496 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 81.3 mt-30 -139.32 142.12 37.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -51.8 151.61 3.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.225 -0.922 . . . . 0.0 110.336 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 122.059 -0.4 . . . . 0.0 110.793 179.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.4 127.74 38.0 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.16 113.25 26.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.72 141.37 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 1.2 mm? . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 0.0 109.615 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.349 0.595 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt -141.38 163.9 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 28.4 m-85 -126.72 157.04 40.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.47 119.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -91.29 120.56 32.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 109.366 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -95.83 166.04 12.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.57 -22.12 65.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.154 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.52 -3.2 52.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.632 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 17.32 60.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -94.41 125.41 39.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.326 . . . . 0.0 109.301 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.2 m -101.1 121.95 42.73 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -108.96 141.65 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -103.74 126.77 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.72 149.78 51.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.503 -0.748 . . . . 0.0 109.712 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -103.67 123.46 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 2.1 p -144.91 166.34 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.055 -1.028 . . . . 0.0 110.19 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.6 mt-10 -109.9 152.19 42.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.27 -28.03 34.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.207 1.938 . . . . 0.0 111.28 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 t -85.34 -2.2 57.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.012 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.87 146.98 51.54 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.803 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -88.61 143.49 26.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.76 -42.38 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 108.483 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -60.25 -44.2 95.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.643 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.39 -40.0 85.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.96 -33.23 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -70.84 -35.08 72.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.89 82.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -54.57 -48.76 71.69 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.89 -37.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.68 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -61.99 -48.78 78.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -67.3 -33.11 74.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 111.115 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -45.45 12.54 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.789 -1.194 . . . . 0.0 111.179 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -88.98 -24.96 22.27 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.736 -1.228 . . . . 0.0 109.833 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 1.07 90.09 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.146 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.97 134.35 35.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 120.596 -1.532 . . . . 0.0 108.873 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.91 154.45 67.13 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.553 1.502 . . . . 0.0 112.035 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.69 -17.94 37.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.594 2.196 . . . . 0.0 112.302 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.54 -4.82 53.15 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.763 -1.21 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -107.2 -28.07 10.16 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.263 -0.898 . . . . 0.0 110.735 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -112.89 146.69 38.5 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.393 -0.817 . . . . 0.0 110.621 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.0 120.59 27.87 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.0 mt -90.43 126.19 35.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 0.0 110.844 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.6 mp -119.63 137.03 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 109.349 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -119.0 136.09 54.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.93 -112.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 108.655 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.23 4.86 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.53 147.71 52.56 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.148 -1.207 . . . . 0.0 109.545 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -90.21 116.86 28.52 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.8 mt -55.66 123.51 14.31 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 109.926 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.46 140.75 45.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.715 0.769 . . . . 0.0 109.343 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 15.8 p-10 -64.52 155.28 33.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.688 -0.632 . . . . 0.0 110.958 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.76 2.05 56.29 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.377 -0.827 . . . . 0.0 112.072 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -133.9 172.48 12.74 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.745 -1.444 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -105.26 154.67 19.93 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.165 -0.959 . . . . 0.0 110.994 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.67 -34.35 64.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.432 -0.792 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -62.55 -16.7 57.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.73 -16.87 63.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.82 . . . . 0.0 109.443 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -105.46 11.03 33.04 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 53.61 46.83 25.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.651 -1.281 . . . . 0.0 109.468 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.605 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 75.9 mt -87.47 -176.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 0.0 109.349 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.605 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.0 pt20 -157.79 158.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 110.29 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -54.58 151.08 8.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.426 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.603 179.643 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -93.18 134.58 35.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 108.624 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.71 121.43 45.01 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.479 -0.763 . . . . 0.0 109.88 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.19 151.95 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.965 -1.084 . . . . 0.0 109.46 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.371 0.605 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.91 162.57 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 37.3 m-85 -124.98 141.73 51.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.313 -0.867 . . . . 0.0 109.398 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.89 116.62 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.335 -0.853 . . . . 0.0 109.005 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.4 114.74 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.415 -0.803 . . . . 0.0 108.911 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -90.97 165.75 13.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tp -70.38 -23.48 62.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.4 p -81.27 -0.15 39.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.033 . . . . 0.0 109.45 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.29 15.74 66.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -93.15 122.06 35.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.868 -1.372 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -99.34 121.61 41.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.534 -0.729 . . . . 0.0 109.401 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.33 139.8 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.661 -0.649 . . . . 0.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.9 p -101.91 127.43 48.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.567 -0.708 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.1 mt -131.18 151.27 51.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.557 -0.714 . . . . 0.0 109.587 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -115.64 131.85 56.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.81 176.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.988 -1.07 . . . . 0.0 110.099 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.23 150.22 40.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.85 -32.1 46.55 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.876 1.717 . . . . 0.0 110.906 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -84.42 2.77 39.18 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.531 -0.731 . . . . 0.0 109.245 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.47 145.79 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.911 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -85.39 160.38 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.459 -0.775 . . . . 0.0 108.935 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.611 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 2.4 mp -61.22 -39.37 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.061 -1.025 . . . . 0.0 108.26 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -35.87 81.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -69.74 -38.92 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 109.606 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -72.45 -33.09 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.577 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 49.6 mttp -68.01 -34.17 76.0 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -51.46 -45.79 62.83 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 30' ' ' ILE . 97.1 mt -66.14 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.885 . . . . 0.0 109.801 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.5 -48.88 79.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 110.053 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -68.98 -31.95 71.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.317 -0.865 . . . . 0.0 111.052 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -82.92 -48.19 10.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.919 -1.113 . . . . 0.0 111.489 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.775 -1.203 . . . . 0.0 109.986 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.51 3.21 82.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.131 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.12 123.67 66.72 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.75 -1.441 . . . . 0.0 108.764 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.34 130.16 20.64 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.143 1.229 . . . . 0.0 112.267 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.53 -34.2 25.6 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.258 1.972 . . . . 0.0 113.444 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.45 -1.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.326 -0.859 . . . . 0.0 110.803 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' C ' HE21 ' A' ' 41' ' ' GLN . 48.0 tp60 -109.47 -21.68 12.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 0.0 110.052 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 HE21 ' C ' ' A' ' 40' ' ' GLN . 24.1 mm-40 -103.31 138.31 40.26 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.141 -0.974 . . . . 0.0 111.412 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' NH2' ' HG3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -121.14 105.34 10.5 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.04 125.14 34.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.98 -1.075 . . . . 0.0 110.239 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mt -123.5 145.18 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 47' ' ' GLY . 84.3 t80 -148.8 145.91 27.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.616 -0.678 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.86 8.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.29 16.14 51.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -121.55 146.31 47.07 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.998 -1.295 . . . . 0.0 108.853 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.48 115.82 23.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.74 119.51 5.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.941 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.82 173.35 7.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.188 -0.945 . . . . 0.0 109.89 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -94.67 149.15 21.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 110.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.7 -11.05 69.81 Favored Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.445 -0.784 . . . . 0.0 111.331 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -96.46 174.66 6.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.79 -1.418 . . . . 0.0 109.448 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -115.31 152.47 32.72 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.992 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -57.56 -41.01 80.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.493 -0.755 . . . . 0.0 109.75 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -58.95 -23.76 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 109.328 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.67 -17.09 62.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.357 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.33 3.71 35.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.0 110.314 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.27 45.13 27.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.743 -1.223 . . . . 0.0 109.413 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 91.0 mt -72.24 173.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 109.159 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.505 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 59.6 mt-30 -137.38 142.2 41.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -53.48 148.14 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.857 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.734 -0.604 . . . . 0.0 110.561 179.463 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.7 mp . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -98.57 132.36 44.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.185 -0.947 . . . . 0.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -107.22 113.68 27.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.634 -0.666 . . . . 0.0 109.508 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.58 150.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.0 mp . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.804 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -100.52 141.2 33.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 109.801 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.68 163.73 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -122.46 132.74 54.49 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -99.12 112.82 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.024 -1.047 . . . . 0.0 108.852 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -89.68 114.5 26.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.748 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -93.84 162.03 14.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.321 -0.862 . . . . 0.0 109.842 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.97 -19.49 64.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.814 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -81.69 -5.55 58.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.998 . . . . 0.0 109.595 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.78 14.88 58.94 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -93.87 124.68 38.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.886 -1.361 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 m -102.01 124.22 47.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.532 -0.73 . . . . 0.0 109.043 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -114.99 140.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.562 -0.712 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -102.2 128.35 48.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -128.65 147.97 50.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 16' ' ' GLU . 27.2 mp0 -110.68 127.88 55.48 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.28 179.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.975 -1.078 . . . . 0.0 110.262 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -113.05 151.68 44.35 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.14 -30.42 46.75 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.993 1.795 . . . . 0.0 110.899 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -84.94 4.8 31.87 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.62 145.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 0.0 108.881 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 80.6 p -92.2 148.17 22.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -50.47 -40.76 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.085 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.68 -43.88 90.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.256 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 22.8 m120 -69.51 -37.0 76.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.92 -32.61 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -70.31 -32.69 70.56 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.74 96.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.12 -47.26 85.91 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.391 0.615 . . . . 0.0 109.418 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.44 -39.78 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.61 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.86 -47.06 88.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 109.966 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.43 -23.64 58.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.956 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -84.89 -51.71 6.54 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.807 -1.183 . . . . 0.0 111.295 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -91.18 -24.0 20.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.65 -1.281 . . . . 0.0 109.902 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.41 4.19 88.04 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.964 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.32 121.75 67.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.776 -1.426 . . . . 0.0 109.12 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.41 150.35 5.72 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.633 1.556 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.64 -28.77 25.42 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.595 2.197 . . . . 0.0 112.483 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.76 -3.32 27.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.56 -6.11 24.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.57 153.75 50.89 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.211 -0.931 . . . . 0.0 110.945 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -129.77 120.78 25.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -86.67 123.15 31.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.992 -1.068 . . . . 0.0 111.275 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.6 mp -116.46 133.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.547 0.689 . . . . 0.0 109.17 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' A' ' 47' ' ' GLY . 60.5 t80 -145.95 140.78 27.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.143 -0.973 . . . . 0.0 108.801 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 8.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 109.288 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.81 23.23 26.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -126.94 147.14 50.11 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.146 -1.208 . . . . 0.0 109.53 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -89.95 112.09 23.37 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.41 122.93 10.65 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.496 -0.753 . . . . 0.0 109.759 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -93.05 148.07 22.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.156 -0.965 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.22 131.88 47.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.942 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.65 64.27 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.309 -0.869 . . . . 0.0 111.403 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' A' ' 54' ' ' ARG . 15.5 ttt180 -89.55 156.4 18.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.402 -1.646 . . . . 0.0 109.783 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -98.23 148.01 24.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.186 -0.946 . . . . 0.0 110.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.86 -38.94 76.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 109.871 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -57.9 -28.07 63.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.992 . . . . 0.0 110.004 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.44 -16.82 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.39 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -101.86 0.54 35.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.413 -0.804 . . . . 0.0 110.133 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 m120 52.03 49.11 21.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.507 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 96.6 mt -75.67 176.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.507 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 17.4 tt0 -132.44 138.2 47.55 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.27 -0.894 . . . . 0.0 109.662 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -52.41 149.57 5.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 110.543 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 64.56 13.65 8.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.893 -0.505 . . . . 0.0 110.953 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.0 mp -94.69 143.0 26.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.033 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -90.24 128.27 36.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.096 -1.003 . . . . 0.0 108.659 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.71 125.13 53.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.67 147.3 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.5 mp -79.9 -82.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 108.77 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -150.18 176.62 10.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 110.648 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.63 130.87 34.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 110.711 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.71 141.43 43.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.98 -171.38 44.42 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 118.981 -1.58 . . . . 0.0 110.837 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' VAL . 25.5 mmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 -96.08 137.01 35.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 tt -144.57 165.78 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.5 m-85 -130.86 157.74 42.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.18 121.06 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 108.596 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.8 tttm -91.86 122.64 34.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.153 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 m -96.25 161.36 13.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 mt -62.65 -23.08 66.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -81.64 -0.65 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 16.25 66.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -91.18 117.78 29.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.043 -1.269 . . . . 0.0 109.37 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -93.61 118.52 31.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.475 -0.766 . . . . 0.0 109.169 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -107.63 139.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.754 . . . . 0.0 109.274 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.31 129.03 53.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 109.779 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.27 150.01 51.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.473 -0.767 . . . . 0.0 109.66 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -106.66 126.41 52.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 m -144.72 176.03 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.076 -1.015 . . . . 0.0 110.243 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -112.77 151.58 44.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.0 -33.01 64.27 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.818 1.679 . . . . 0.0 110.669 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -85.71 3.91 39.0 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.576 -0.703 . . . . 0.0 109.221 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.38 149.22 48.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 34.6 p -96.69 147.16 24.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.526 -0.734 . . . . 0.0 109.694 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.53 -41.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.226 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.13 -45.02 96.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.775 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' H ' ' HG1' ' A' ' 22' ' ' THR . 3.7 m120 -68.26 -37.4 80.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.728 . . . . 0.0 109.674 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -70.48 -31.32 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.273 -0.892 . . . . 0.0 109.901 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.46 -33.33 71.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.53 97.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -59.72 -44.94 93.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.84 -40.82 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.369 -0.832 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.59 -45.38 93.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.831 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.39 -35.6 80.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 111.284 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -89.16 -44.34 10.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.54 -27.09 22.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.75 -1.219 . . . . 0.0 110.063 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.21 83.11 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.037 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.7 mt -91.09 119.11 68.88 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.702 -1.469 . . . . 0.0 109.339 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.57 149.56 6.93 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.69 1.593 . . . . 0.0 112.326 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.06 -22.98 29.97 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.74 -6.01 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.795 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.13 -4.44 35.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 109.812 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -140.01 155.82 46.91 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.073 -1.017 . . . . 0.0 111.35 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -127.78 133.34 49.46 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.93 123.59 40.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 109.79 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.1 mp -112.54 138.81 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' C ' ' H ' ' A' ' 47' ' ' GLY . 89.9 t80 -147.5 137.74 23.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.025 . . . . 0.0 109.059 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 11.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.369 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.6 23.94 24.86 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -128.11 147.18 50.53 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.122 -1.222 . . . . 0.0 109.47 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -90.15 111.69 22.92 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.04 118.14 3.0 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.551 -0.718 . . . . 0.0 109.267 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -94.76 142.74 27.11 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.178 -0.951 . . . . 0.0 109.074 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.15 137.56 57.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.524 -0.735 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.78 -13.15 57.89 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -96.61 154.7 17.13 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.959 1.879 . . . . 0.0 110.367 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -99.07 152.36 19.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.025 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.61 -37.55 68.28 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.343 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -59.09 -21.46 59.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.894 -1.128 . . . . 0.0 109.732 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -70.77 -16.88 62.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -105.51 9.65 33.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.326 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 52.23 47.63 24.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 68.0 mt -79.75 172.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.421 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 29.7 mt-30 -144.03 146.95 33.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.05 -1.031 . . . . 0.0 110.062 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.32 147.71 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 67.52 16.09 9.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.622 -0.674 . . . . 0.0 110.425 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.12 147.31 23.87 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -93.05 131.89 37.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.289 -0.882 . . . . 0.0 108.766 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.65 128.73 55.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.02 150.71 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.2 mp -79.88 -78.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 108.757 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -167.91 -164.43 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 0.0 110.836 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.04 109.73 1.91 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 109.766 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 75' ' ' GLY . 2.0 ttm180 -59.81 -31.04 69.34 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 74' ' ' ARG . . . -60.21 -121.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -104.03 148.44 26.22 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.387 -0.82 . . . . 0.0 109.758 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -146.34 167.57 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 44.1 m-85 -124.78 134.85 52.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.96 113.61 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -90.77 113.58 25.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.227 -0.92 . . . . 0.0 109.761 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.05 -21.53 66.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 110.111 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -81.25 1.32 32.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.033 -1.042 . . . . 0.0 109.641 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.96 80.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -87.77 125.56 34.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.319 . . . . 0.0 109.121 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -105.77 122.19 45.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.576 -0.703 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.91 138.28 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.7 m -105.8 135.71 46.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 0.0 109.998 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.15 156.15 48.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 109.579 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -109.4 127.11 54.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -143.57 164.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 109.923 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 62.8 mm-40 -103.89 149.63 37.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.63 -31.48 32.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.949 1.766 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 t -82.8 -0.62 48.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.441 -0.787 . . . . 0.0 109.406 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 146.81 54.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -87.88 157.66 18.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.922 . . . . 0.0 109.048 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.71 -42.07 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 108.499 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -64.03 -41.22 97.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -64.3 -36.95 85.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.029 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -74.7 -29.0 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -67.43 -37.51 83.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.45 44.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -49.04 -46.96 45.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.68 -36.63 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.867 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' GLY . 7.5 tm0? -70.78 -48.4 54.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.81 -28.21 67.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -97.53 -41.57 8.1 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.811 -1.18 . . . . 0.0 111.208 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -93.12 -19.96 20.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.771 -1.205 . . . . 0.0 110.125 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.2 -0.09 18.45 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.956 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.98 119.96 79.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 120.731 -1.453 . . . . 0.0 108.775 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.35 129.68 19.79 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.199 1.266 . . . . 0.0 112.294 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -49.92 -36.61 44.17 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.213 1.942 . . . . 0.0 112.991 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.08 -0.85 8.41 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -100.02 -3.95 31.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.153 -0.967 . . . . 0.0 110.361 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -139.25 153.82 47.89 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 110.434 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' NH1' ' H ' ' A' ' 73' ' ' LEU . 22.1 mtm180 -128.61 109.88 11.75 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.13 125.73 33.71 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.655 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.39 148.17 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.621 0.724 . . . . 0.0 109.599 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 47' ' ' GLY . 80.7 t80 -149.83 142.38 24.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.369 -0.832 . . . . 0.0 109.058 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.63 5.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.04 9.96 56.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.47 148.63 40.57 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.091 -1.24 . . . . 0.0 109.202 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -82.19 116.53 21.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.82 121.04 10.13 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.363 -0.836 . . . . 0.0 109.497 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -90.69 173.51 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.666 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.59 140.4 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.335 -0.853 . . . . 0.0 110.905 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.61 53.4 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.278 -0.889 . . . . 0.0 111.612 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.663 ' NH2' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.63 176.26 9.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.01 -1.288 . . . . 0.0 110.446 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -113.15 145.36 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.55 -37.71 70.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.522 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -59.91 -26.29 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.79 -17.85 51.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.602 -0.686 . . . . 0.0 109.531 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.25 3.07 32.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.41 -0.806 . . . . 0.0 110.258 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.78 47.22 24.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.706 -1.246 . . . . 0.0 109.583 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 63.4 mt -68.93 169.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 9.7 tp-100 -135.46 139.82 44.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -54.08 147.82 12.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 110.895 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 68.04 12.44 8.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.696 -0.628 . . . . 0.0 110.765 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.8 mp -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 108.97 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -98.24 129.3 44.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -112.81 118.43 34.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.72 145.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 10.6 mp -89.17 152.56 21.54 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.914 -1.116 . . . . 0.0 110.072 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.5 117.68 2.58 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.178 -0.951 . . . . 0.0 108.645 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' H ' ' NH1' ' A' ' 42' ' ' ARG . 45.2 mt -78.92 145.61 33.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.1 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.511 ' NH2' ' CG ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -65.0 119.99 11.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 11.98 82.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.176 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.736 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.83 147.86 27.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 109.875 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -145.22 166.63 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -127.08 143.07 51.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.284 -0.885 . . . . 0.0 109.608 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.88 121.33 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.288 -0.882 . . . . 0.0 108.837 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -94.97 123.98 38.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -98.95 153.4 18.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 0.0 109.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.0 mp -59.93 -18.3 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.3 p -81.53 -3.0 51.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.022 -1.049 . . . . 0.0 109.625 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.84 69.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -93.43 121.21 34.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.855 -1.38 . . . . 0.0 109.561 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 m -103.89 129.78 51.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.474 -0.767 . . . . 0.0 109.292 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 tt -126.36 145.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.613 -0.679 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -105.53 137.18 43.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.58 -0.7 . . . . 0.0 109.552 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.4 mt -129.1 149.46 50.91 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.484 -0.76 . . . . 0.0 109.578 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.01 125.54 51.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.87 176.17 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.99 -1.069 . . . . 0.0 110.271 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -110.31 154.0 43.11 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.85 -33.54 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.023 1.816 . . . . 0.0 110.765 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.2 m -84.37 4.62 30.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.563 -0.71 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.98 147.92 50.89 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.004 -1.079 . . . . 0.0 108.951 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 p -92.64 150.45 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.309 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -53.97 -40.0 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.56 -43.6 98.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.19 -37.65 84.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.45 -28.79 36.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -70.28 -35.46 73.75 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.73 84.54 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -55.53 -47.33 76.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.732 -0.605 . . . . 0.0 109.443 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.06 -39.52 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.37 -0.831 . . . . 0.0 109.5 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.05 -45.08 93.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.37 -31.97 73.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 111.299 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -94.72 -41.6 9.18 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.802 -1.186 . . . . 0.0 111.534 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -91.65 -23.54 19.8 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.761 -1.212 . . . . 0.0 110.051 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.65 -1.47 29.21 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.059 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -83.96 118.85 72.42 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.413 . . . . 0.0 109.506 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.91 149.82 7.39 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.67 1.58 . . . . 0.0 112.027 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.68 -25.24 29.17 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.508 2.139 . . . . 0.0 112.464 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.61 -2.06 24.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 109.724 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -101.13 -7.81 22.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.237 -0.915 . . . . 0.0 110.013 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -143.04 158.88 43.19 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.008 -1.058 . . . . 0.0 110.962 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' A' ' 42' ' ' ARG . 1.6 mtp180 -132.12 121.24 23.46 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.58 121.85 28.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.07 -1.019 . . . . 0.0 110.604 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mm -115.94 133.45 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -119.12 134.95 54.9 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.04 -113.45 0.65 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.995 -1.065 . . . . 0.0 108.582 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.11 26.93 5.2 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.08 150.67 46.59 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.244 -1.151 . . . . 0.0 109.233 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -91.28 113.35 25.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.08 122.2 10.44 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.666 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.76 171.19 9.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.77 134.26 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.28 -19.07 55.43 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.752 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.59 160.75 26.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.581 -1.541 . . . . 0.0 109.095 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 p -102.58 152.97 20.55 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.478 -0.764 . . . . 0.0 109.245 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.83 -38.98 70.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.048 . . . . 0.0 109.311 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -61.22 -17.82 55.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.104 -0.998 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.5 -18.45 63.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -108.2 7.81 27.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.574 -0.703 . . . . 0.0 110.402 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 t30 50.56 47.09 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.53 -1.356 . . . . 0.0 109.562 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 90.8 mt -72.97 173.96 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.487 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 66.0 mt-30 -133.07 137.93 46.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.89 151.02 4.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 110.516 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 65.71 11.55 7.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.986 -0.446 . . . . 0.0 110.851 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.6 mp -95.6 143.65 26.71 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.25 130.74 38.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.31 118.81 37.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.814 . . . . 0.0 109.98 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.19 146.77 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.1 mp -83.3 -92.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.979 -1.076 . . . . 0.0 109.352 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.29 -84.75 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.924 -1.11 . . . . 0.0 109.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 10.3 mp 48.86 47.42 21.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.082 -1.012 . . . . 0.0 110.485 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 118.53 15.16 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.279 -1.513 . . . . 0.0 108.113 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.52 -84.53 0.09 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.354 0.597 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.571 HE21 ' HG1' ' A' ' 14' ' ' THR . 62.7 tt0 -99.1 136.29 39.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.611 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.19 153.48 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -120.26 135.37 55.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.763 -1.211 . . . . 0.0 109.377 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.81 116.48 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.15 115.76 28.28 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -97.76 163.22 12.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.408 -0.808 . . . . 0.0 109.662 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 8.9 mp -68.67 -17.87 64.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 p -81.45 -1.45 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.053 -1.03 . . . . 0.0 109.751 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.12 13.69 73.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -91.26 131.84 36.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.027 -1.278 . . . . 0.0 109.307 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.8 m -107.38 113.22 26.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.163 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -106.54 139.64 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.596 -0.69 . . . . 0.0 109.221 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.571 ' HG1' HE21 ' A' ' 2' ' ' GLN . 3.0 t -108.73 134.67 51.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.672 -0.642 . . . . 0.0 109.759 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.1 mt -125.92 143.91 50.89 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.749 . . . . 0.0 109.593 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -105.51 125.2 50.72 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.35 178.76 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.952 -1.093 . . . . 0.0 110.242 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 155.2 42.38 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.5 -34.74 32.68 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.056 1.838 . . . . 0.0 110.728 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 t -81.4 5.69 16.77 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.612 -0.68 . . . . 0.0 109.318 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.76 145.51 53.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 109.052 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.0 p -91.93 152.65 19.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.197 -0.939 . . . . 0.0 109.257 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 23' ' ' ILE . 24.1 mm -58.07 -35.18 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.961 -1.087 . . . . 0.0 109.124 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.68 -51.11 68.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.27 -33.86 76.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.866 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -73.25 -34.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -62.75 -35.38 79.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.39 63.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -49.42 -47.59 47.86 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.99 -36.22 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.31 -48.84 69.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.11 -26.26 65.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.007 . . . . 0.0 111.5 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -91.77 -47.61 7.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.758 -1.214 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 7.5 mp0 -87.18 -27.0 23.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.8 -1.188 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 -2.3 87.14 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.194 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.98 118.45 68.92 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.65 -1.5 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.51 152.65 3.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.564 1.509 . . . . 0.0 112.421 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.79 -17.97 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.706 2.27 . . . . 0.0 112.292 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -78.12 -3.76 44.0 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.123 -0.986 . . . . 0.0 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -112.32 -15.16 13.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -114.78 142.39 46.6 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.495 -0.753 . . . . 0.0 110.652 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' NH1' ' HG ' ' A' ' 73' ' ' LEU . 3.4 mtm180 -129.17 119.23 23.73 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.35 122.83 34.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 111.278 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -110.95 140.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.57 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.7 t80 -150.77 136.38 18.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 108.726 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . . . 56.67 2.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 99.36 21.39 15.12 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -130.24 140.8 50.67 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.68 120.3 24.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.12 118.99 7.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.451 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.59 147.07 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.148 -0.97 . . . . 0.0 109.056 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 15.5 p-10 -61.77 138.08 58.3 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.767 . . . . 0.0 110.674 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.81 56.35 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.401 -0.812 . . . . 0.0 112.003 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.76 164.16 17.76 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 120.073 1.937 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -101.53 146.01 28.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.313 -0.867 . . . . 0.0 111.021 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.11 -39.25 63.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.387 -0.821 . . . . 0.0 109.645 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -68.66 -18.75 64.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.89 . . . . 0.0 109.166 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.81 -17.9 61.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.73 . . . . 0.0 109.898 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -107.74 9.85 28.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 54.8 25.32 6.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 109.419 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 18.9 mt -51.76 170.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 95.0 mm-40 -137.75 141.1 40.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.381 -0.825 . . . . 0.0 109.781 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -57.35 155.69 8.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.132 -0.98 . . . . 0.0 110.233 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 63.7 5.52 2.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 122.002 -0.436 . . . . 0.0 110.967 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 7.2 mp -96.04 150.59 20.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -96.26 130.41 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.52 128.87 56.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.407 -0.808 . . . . 0.0 109.811 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.88 149.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 9.3 mp -79.96 -82.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.702 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' CG ' HH21 ' A' ' 72' ' ' ARG . 1.2 mtt-85 -143.33 170.48 15.69 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.14 -0.975 . . . . 0.0 110.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.541 ' HG ' ' NH1' ' A' ' 42' ' ' ARG . 11.2 mt -63.18 152.87 36.23 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.218 -0.926 . . . . 0.0 109.231 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -65.79 160.43 23.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.51 132.74 1.72 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 CA-C-O 117.956 -1.469 . . . . 0.0 109.707 -179.635 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 61.5 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.292 0.568 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.36 115.82 28.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.842 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.3 mm -117.45 153.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -127.03 127.36 44.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.506 -1.371 . . . . 0.0 108.64 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.68 124.9 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.712 -1.243 . . . . 0.0 109.464 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -102.31 123.31 45.89 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -101.1 153.54 19.49 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.288 -0.882 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -18.41 37.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 p -81.33 -1.01 43.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.345 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.73 86.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.81 116.18 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.926 -1.337 . . . . 0.0 110.032 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -104.68 134.85 47.15 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -130.73 143.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -100.68 130.38 46.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.238 -0.914 . . . . 0.0 109.944 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.89 145.23 50.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 0.0 109.703 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -106.27 126.63 52.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.2 m -144.35 -176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 110.048 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -117.68 152.07 49.3 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.29 -33.3 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.062 1.841 . . . . 0.0 110.882 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -83.47 2.51 36.42 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.89 148.37 52.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.839 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 159.37 16.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.394 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.59 -38.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.8 -47.87 83.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.929 . . . . 0.0 110.027 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.76 -46.21 86.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.865 . . . . 0.0 109.906 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.23 -30.92 50.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.572 -0.705 . . . . 0.0 109.556 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -69.38 -32.56 71.67 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.55 -58.46 8.5 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 1.3 mptm? -49.5 -43.26 45.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.513 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -63.51 -44.52 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.252 -0.905 . . . . 0.0 109.745 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.71 -48.14 67.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -64.52 -19.45 65.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.828 . . . . 0.0 111.517 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -98.19 -47.48 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.737 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -90.26 -27.64 19.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.859 -1.151 . . . . 0.0 109.772 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.32 84.2 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.087 -1.008 . . . . 0.0 111.038 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -90.05 116.57 66.69 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.716 -1.461 . . . . 0.0 108.98 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.33 149.34 6.6 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.541 1.494 . . . . 0.0 112.094 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.82 -28.44 24.96 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.532 2.155 . . . . 0.0 112.386 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.16 -1.92 28.6 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.023 -1.048 . . . . 0.0 109.703 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -106.41 1.61 25.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -141.1 154.74 46.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -0.93 . . . . 0.0 111.267 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -130.54 128.57 41.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.66 121.12 37.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.548 -0.72 . . . . 0.0 111.494 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.99 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.641 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.5 t80 -133.8 134.94 43.48 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.06 -9.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 111.79 18.56 7.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -120.63 152.1 38.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.215 -1.168 . . . . 0.0 109.569 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -91.26 110.71 22.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.31 108.81 0.46 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.771 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.4 150.36 27.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.471 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.47 137.42 57.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.33 -0.856 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.18 -12.62 65.26 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.253 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 177.89 7.86 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.301 -1.705 . . . . 0.0 109.529 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.2 p -121.85 149.69 43.0 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.419 -0.8 . . . . 0.0 110.933 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -57.1 -41.97 79.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.615 -0.678 . . . . 0.0 109.313 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -57.23 -37.03 71.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.666 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.08 -20.52 6.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 109.553 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -101.83 11.31 38.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.158 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 46.99 48.04 15.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.926 -1.109 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 91.2 mt -73.4 175.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.344 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.497 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 11.0 tp-100 -144.88 147.52 32.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.986 -1.071 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -55.41 149.36 13.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.848 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 68.45 27.01 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.807 -0.558 . . . . 0.0 110.788 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.2 mp -94.28 157.12 16.19 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 8.0 m-70 -104.21 129.26 51.98 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.99 124.66 51.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.864 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.64 145.96 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.2 mp -79.45 151.87 30.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.039 -1.038 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 1.3 ptt180 -43.33 -62.06 1.17 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.026 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.478 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 1.8 tt 56.5 51.63 11.02 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.578 -1.326 . . . . 0.0 109.911 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.651 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.1 OUTLIER 48.46 -105.61 0.15 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 109.086 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.81 38.02 0.66 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 CA-C-O 117.749 -1.584 . . . . 0.0 109.263 -179.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 17' ' ' VAL . 18.1 mmt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.3 140.71 36.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.408 -0.807 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.82 167.6 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.0 m-85 -131.21 132.26 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.99 -1.069 . . . . 0.0 109.714 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.48 120.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 109.364 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.603 ' HZ3' ' HG1' ' A' ' 12' ' ' THR . 57.6 mmtt -97.61 112.66 24.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -94.58 160.16 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.296 -0.878 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.21 -20.79 65.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.996 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -81.53 -0.04 40.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.508 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 12.44 79.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -83.41 122.31 28.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.29 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.603 ' HG1' ' HZ3' ' A' ' 6' ' ' LYS . 86.9 m -100.64 119.28 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -117.09 131.67 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.6 m -98.21 129.4 44.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.418 -0.801 . . . . 0.0 109.726 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -129.72 148.11 51.57 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.608 -0.683 . . . . 0.0 109.618 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.26 131.49 55.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -145.87 -175.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.966 -1.084 . . . . 0.0 110.079 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.8 149.18 41.95 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.13 -30.56 38.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.075 1.85 . . . . 0.0 110.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -83.56 2.18 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.73 147.1 50.96 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 p -89.96 156.92 18.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.43 -36.39 40.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.82 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.95 -48.77 75.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.803 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.75 -36.91 80.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 0.0 109.903 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.47 -28.73 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -67.66 -38.01 83.19 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -57.66 11.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -48.13 -45.23 32.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.361 -0.837 . . . . 0.0 109.41 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.85 -39.73 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.491 -0.756 . . . . 0.0 109.791 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -71.05 -51.09 27.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.98 -18.4 64.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 111.541 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -98.1 -47.63 5.42 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.641 -1.287 . . . . 0.0 110.764 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -93.53 -27.62 16.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.857 -1.152 . . . . 0.0 110.108 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.48 6.99 88.13 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.115 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.06 115.61 63.23 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.661 -1.494 . . . . 0.0 109.133 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.7 146.6 10.92 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.629 1.552 . . . . 0.0 112.247 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.94 -26.29 26.89 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.354 2.036 . . . . 0.0 112.432 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.09 -0.27 21.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.082 -1.011 . . . . 0.0 109.917 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -107.97 2.01 22.95 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.0 109.653 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -145.67 157.87 43.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.856 -1.153 . . . . 0.0 111.548 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -129.53 119.02 22.99 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -88.38 115.26 25.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.881 -1.137 . . . . 0.0 110.428 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -109.04 144.75 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.622 ' C ' ' H ' ' A' ' 47' ' ' GLY . 66.6 t80 -147.15 133.48 19.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.093 . . . . 0.0 108.381 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 -5.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.634 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.01 16.34 10.71 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.2 144.99 47.42 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.084 -1.244 . . . . 0.0 109.655 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.88 119.2 25.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.31 114.88 6.38 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.811 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.99 154.66 19.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.905 -1.122 . . . . 0.0 108.994 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -63.52 140.49 58.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.504 -0.747 . . . . 0.0 111.203 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.65 -17.39 59.21 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.618 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -76.04 176.58 7.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.219 -1.754 . . . . 0.0 109.556 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.519 -0.738 . . . . 0.0 110.571 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -55.73 -41.37 73.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.364 -0.835 . . . . 0.0 109.645 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.428 ' HG ' ' N ' ' A' ' 58' ' ' ASP . 85.0 p -60.34 -33.5 72.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' N ' ' HG ' ' A' ' 57' ' ' SER . 33.2 t70 -55.22 -20.07 9.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.627 -0.67 . . . . 0.0 109.717 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.4 3.86 35.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.101 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 m120 48.91 47.09 21.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 109.624 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.521 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 90.7 mt -69.17 177.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.398 -0.814 . . . . 0.0 109.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.521 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 9.3 tp-100 -135.52 138.84 43.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.157 -0.965 . . . . 0.0 109.801 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -52.54 146.94 9.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 110.563 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 67.32 18.12 10.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.761 -0.587 . . . . 0.0 110.856 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.3 mp -93.03 157.38 16.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -107.76 130.88 54.92 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.35 117.84 31.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.514 -0.742 . . . . 0.0 109.502 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.83 144.7 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 9.8 mp -94.08 159.3 15.22 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.9 -1.125 . . . . 0.0 110.936 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -69.19 127.79 34.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.862 -0.524 . . . . 0.0 110.407 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.6 tp -56.31 -61.9 2.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -76.71 159.9 29.8 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.335 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.61 95.82 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.718 179.733 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.7 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -98.93 138.19 36.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -0.845 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -132.68 159.1 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -121.12 138.08 54.36 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.431 -0.793 . . . . 0.0 109.543 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.53 113.87 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.055 -1.028 . . . . 0.0 108.875 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -90.47 115.12 27.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.127 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.4 p -94.3 158.35 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 109.507 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.04 -16.81 63.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.8 m -81.53 -10.08 59.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.438 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 10.15 55.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.86 126.63 36.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.373 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -105.84 121.93 45.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.22 144.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -116.47 138.85 51.05 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.724 -0.61 . . . . 0.0 109.782 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -113.39 129.07 56.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -145.16 176.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.0 -1.063 . . . . 0.0 110.173 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -109.45 151.86 42.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.21 -34.36 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.062 1.841 . . . . 0.0 110.824 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -82.4 3.94 26.06 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.27 148.84 51.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.856 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -88.97 158.08 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 109.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.27 -42.96 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 108.42 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.33 -39.13 89.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.855 . . . . 0.0 110.129 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -68.82 -41.99 77.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.805 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -69.18 -31.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.133 -0.979 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -67.72 -34.71 77.4 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.52 83.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -42.94 85.05 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.94 -42.97 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.842 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.18 -43.32 98.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 0.0 109.895 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.99 -34.99 78.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 111.189 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -91.8 -39.82 11.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.761 -1.212 . . . . 0.0 111.531 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -93.37 -17.13 23.89 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.841 -1.162 . . . . 0.0 110.112 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -1.92 37.68 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.973 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.6 mt -81.43 134.21 51.88 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.701 -1.47 . . . . 0.0 109.039 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.92 160.86 48.02 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.688 1.592 . . . . 0.0 111.982 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 -24.69 32.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.765 2.31 . . . . 0.0 112.331 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -81.88 -1.81 48.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.023 -1.048 . . . . 0.0 110.315 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.99 -31.8 6.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.04 -1.038 . . . . 0.0 109.905 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.12 136.74 37.92 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.637 ' NH2' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -126.07 111.96 15.3 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.8 mt -93.81 129.74 40.08 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.668 0.747 . . . . 0.0 112.094 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mt -124.07 140.41 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.452 0.644 . . . . 0.0 109.592 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.64 137.66 53.74 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.68 -115.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.911 -1.118 . . . . 0.0 108.465 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.75 30.23 4.94 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 145.96 52.17 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.291 -1.123 . . . . 0.0 109.651 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -88.09 120.05 29.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -57.17 119.43 6.36 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.499 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 32.0 mt-10 -95.71 168.93 10.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.36 -0.838 . . . . 0.0 109.377 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.76 142.18 27.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 111.292 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.08 6.39 55.86 Favored Glycine 0 N--CA 1.502 3.064 0 O-C-N 121.433 -0.792 . . . . 0.0 111.859 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' NH2' ' OE1' ' A' ' 51' ' ' GLU . 5.2 mtp180 -121.4 171.26 8.9 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 118.736 1.268 . . . . 0.0 109.783 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -106.37 149.08 27.34 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.078 -1.014 . . . . 0.0 110.945 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.09 -37.01 68.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 109.609 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.7 p -61.48 -21.15 63.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.84 -17.35 64.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.397 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -103.62 8.74 37.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.752 . . . . 0.0 110.493 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 57.13 47.62 16.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.628 -1.295 . . . . 0.0 109.437 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 87.3 mt -80.28 174.48 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.383 -0.823 . . . . 0.0 109.131 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.497 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 20.0 pt20 -152.95 154.5 35.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.885 -1.134 . . . . 0.0 110.055 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -54.68 147.95 13.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 69.35 14.9 8.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.122 -0.361 . . . . 0.0 111.159 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.7 mp -95.61 147.49 23.53 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -90.82 133.73 34.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.295 -0.878 . . . . 0.0 108.777 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -110.8 123.7 50.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.508 -0.745 . . . . 0.0 110.142 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.8 146.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 10.0 mp -93.38 155.86 17.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.874 -1.141 . . . . 0.0 109.972 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.13 126.52 27.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.237 -0.915 . . . . 0.0 109.18 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.6 132.77 47.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 115.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.873 -1.142 . . . . 0.0 109.179 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 49.32 53.74 18.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.645 HE21 ' HG1' ' A' ' 14' ' ' THR . 65.4 tt0 -100.51 142.51 31.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 109.863 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -143.97 166.29 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.33 141.76 51.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.327 -0.858 . . . . 0.0 109.703 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.88 117.02 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 0.0 108.893 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -89.75 114.13 25.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 108.974 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 160.86 15.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.407 -0.808 . . . . 0.0 109.904 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 10.1 mp -69.34 -19.36 63.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.78 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -81.49 -4.13 55.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 109.49 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 12.96 62.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.68 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.367 . . . . 0.0 109.333 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -99.13 117.72 34.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.452 -0.78 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.8 139.98 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.447 -0.783 . . . . 0.0 109.118 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.645 ' HG1' HE21 ' A' ' 2' ' ' GLN . 11.6 t -113.3 135.43 53.86 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.716 -0.615 . . . . 0.0 109.676 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.04 159.89 40.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.467 -0.771 . . . . 0.0 109.7 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -115.76 132.11 56.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.43 176.69 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.004 -1.06 . . . . 0.0 110.19 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -107.23 153.81 40.88 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.08 -35.78 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.009 1.806 . . . . 0.0 110.754 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -83.35 4.83 25.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.638 -0.664 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.82 143.92 57.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.0 108.703 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -85.86 145.24 27.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 109.415 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 1.9 mp -50.25 -41.09 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 108.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.77 -40.93 94.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.92 71.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.8 -36.0 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 0.0 109.415 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 51.6 mttp -69.58 -30.77 68.62 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.72 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -53.45 -43.75 68.32 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mm -61.44 -46.07 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.7 -43.09 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.89 -32.89 72.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.374 -0.829 . . . . 0.0 111.249 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.14 -40.35 8.85 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.828 -1.17 . . . . 0.0 111.159 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.6 -21.92 25.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.767 -1.208 . . . . 0.0 109.656 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.51 53.31 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.999 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -91.09 134.39 30.13 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.838 -1.389 . . . . 0.0 108.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 131.26 20.92 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.22 1.28 . . . . 0.0 111.871 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.68 -19.14 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.341 2.027 . . . . 0.0 113.729 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.71 -8.5 56.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 110.605 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -109.02 -22.62 12.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.255 -0.903 . . . . 0.0 109.95 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -107.16 143.49 35.28 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.83 0.824 . . . . 0.0 110.998 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.71 124.61 43.12 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -93.65 121.43 35.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.442 -1.411 . . . . 0.0 110.024 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mm -112.17 129.93 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 47' ' ' GLY . 83.9 t80 -146.91 139.84 25.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 108.903 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.63 3.25 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 109.298 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.38 19.92 26.53 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -127.98 151.86 48.62 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.125 -1.22 . . . . 0.0 109.641 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.61 113.27 25.27 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.07 117.53 2.61 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.307 -0.87 . . . . 0.0 109.87 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.02 173.7 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.229 -0.919 . . . . 0.0 109.804 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.29 146.35 25.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 0.0 111.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.77 10.68 55.06 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.412 -0.805 . . . . 0.0 111.552 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -129.06 160.84 31.52 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.763 -1.433 . . . . 0.0 110.612 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -89.44 146.83 24.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 tp -55.65 -27.49 50.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.0 p -71.2 -16.45 62.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.075 -1.015 . . . . 0.0 109.236 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.42 -16.81 57.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.581 -0.7 . . . . 0.0 109.458 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.04 10.56 34.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 53.08 26.03 4.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.558 -1.339 . . . . 0.0 109.63 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 6.0 mt -52.39 170.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.323 -0.86 . . . . 0.0 108.724 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 52.2 mt-30 -138.83 142.68 38.66 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -58.04 153.62 14.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.662 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 64.72 6.31 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.668 -0.645 . . . . 0.0 110.565 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.1 mp -95.38 142.92 27.19 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -90.52 128.78 36.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 108.618 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.71 122.54 48.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.614 -0.679 . . . . 0.0 109.792 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.13 150.47 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.4 mp -99.02 157.94 15.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 108.99 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.626 HH11 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -61.94 125.6 24.4 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 108.987 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.626 ' HB2' HH11 ' A' ' 72' ' ' ARG . 8.8 mp -60.86 163.1 6.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.345 -0.847 . . . . 0.0 110.159 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -152.41 165.32 35.4 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.18 101.24 0.22 Allowed Glycine 0 N--CA 1.499 2.877 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.6 mmt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.8 144.53 30.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.37 -0.831 . . . . 0.0 109.649 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -143.86 166.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -129.4 135.65 48.96 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.192 -0.943 . . . . 0.0 109.721 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.19 119.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 0.0 108.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -95.62 120.88 36.65 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -97.37 145.7 25.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.351 -0.843 . . . . 0.0 109.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -61.59 -13.77 24.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.9 m -81.55 -9.99 59.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.031 . . . . 0.0 109.556 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 2.5 55.85 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -91.37 136.39 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.937 -1.331 . . . . 0.0 109.273 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -123.94 134.41 53.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.468 -0.77 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.5 145.15 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.597 -0.689 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 136.75 41.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 109.797 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -126.81 146.24 50.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.55 -0.718 . . . . 0.0 109.544 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -105.88 125.34 50.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.3 m -145.83 174.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.349 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 12.5 mp0 -108.54 154.01 41.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.25 -35.06 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.923 1.749 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 t -84.28 4.84 29.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.512 -0.743 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.74 148.79 51.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.957 -1.089 . . . . 0.0 108.526 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -87.82 152.38 22.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.14 -39.85 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -64.12 -42.04 97.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -65.25 -38.2 89.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -72.63 -29.22 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.459 -0.775 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -69.71 -34.5 73.99 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -54.27 47.58 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -49.53 -44.54 46.51 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.437 0.637 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.35 -38.18 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -63.25 -47.96 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 109.916 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -70.38 -20.05 62.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.197 -0.94 . . . . 0.0 111.268 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -93.65 -50.89 5.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.835 -1.166 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -87.67 -24.44 23.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.879 -1.138 . . . . 0.0 109.805 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.03 3.9 89.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.137 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 134.79 32.44 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.705 -1.468 . . . . 0.0 109.039 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.83 156.03 66.74 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.579 1.519 . . . . 0.0 111.951 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.36 -18.35 38.95 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.946 2.431 . . . . 0.0 112.578 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.76 -1.6 43.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 110.039 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -112.67 -23.04 10.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.136 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -115.63 144.78 43.41 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.67 118.29 22.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt -85.92 121.25 28.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.67 0.747 . . . . 0.0 111.616 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.47 150.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -139.49 130.04 25.74 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.32 -119.5 1.51 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.62 27.61 7.87 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -135.65 -174.85 3.76 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.917 -1.343 . . . . 0.0 109.283 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -121.68 126.06 48.1 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.167 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.26 118.49 5.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.14 168.0 11.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.251 -0.906 . . . . 0.0 109.641 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.62 146.82 23.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.31 -0.868 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.46 60.85 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.341 -0.849 . . . . 0.0 111.657 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -123.66 164.12 19.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.118 -1.225 . . . . 0.0 110.189 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -96.79 147.85 23.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.922 -1.111 . . . . 0.0 110.749 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.79 -31.72 62.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -62.26 -23.58 66.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.66 -16.38 48.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -104.83 0.76 28.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 52.98 44.07 30.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.713 -1.242 . . . . 0.0 109.508 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.478 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 90.3 mt -66.87 174.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.209 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.478 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 5.8 tp-100 -135.82 140.41 44.19 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.186 -0.946 . . . . 0.0 110.009 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -51.76 143.59 12.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 69.15 17.23 8.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 110.568 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 7.4 mp -94.22 153.76 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -101.81 131.89 47.88 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.68 126.58 55.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 109.496 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.4 147.43 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.3 mp -93.82 154.31 17.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.915 -1.116 . . . . 0.0 108.841 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -55.68 -11.72 1.02 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.756 -1.215 . . . . 0.0 110.018 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.6 mt -61.32 -10.23 6.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 108.988 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -159.26 144.47 15.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.88 -116.64 0.41 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.546 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -101.17 140.91 34.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.427 -0.796 . . . . 0.0 109.929 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.13 166.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.72 132.31 51.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.26 116.69 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.058 -1.026 . . . . 0.0 109.001 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.04 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -92.43 153.85 18.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -59.84 -23.99 63.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 109.918 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.5 m -81.23 -6.67 59.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 1.41 63.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -73.65 113.57 10.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.908 -1.348 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.5 m -97.51 130.1 44.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.38 140.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -104.17 132.7 50.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.251 -0.905 . . . . 0.0 109.845 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -128.73 147.27 50.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.484 0.659 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -111.15 130.42 55.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.41 -178.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.021 -1.049 . . . . 0.0 110.054 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.18 154.57 46.22 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.74 -33.68 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.179 1.92 . . . . 0.0 110.71 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -84.34 5.69 25.99 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -69.14 146.51 52.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.0 108.871 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.564 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 62.2 p -93.76 152.69 18.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 23' ' ' ILE . 31.4 mm -57.55 -36.27 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 109.058 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.55 -53.03 61.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.978 . . . . 0.0 110.198 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.564 ' H ' ' HG1' ' A' ' 22' ' ' THR . 2.9 t-20 -62.79 -37.67 87.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.359 -0.838 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.69 -28.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 52' ' ' ASP . 77.7 mttt -68.88 -34.93 76.25 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -56.75 17.71 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 58.2 mttp -49.65 -46.13 49.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.625 -0.672 . . . . 0.0 109.325 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.08 -41.71 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 109.722 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -68.9 -45.64 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 111.629 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -98.41 -48.22 5.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.646 -1.284 . . . . 0.0 111.065 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 -28.51 23.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.763 -1.21 . . . . 0.0 109.673 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 5.91 88.42 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.379 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.35 119.35 68.68 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 120.557 -1.555 . . . . 0.0 108.9 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 144.02 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.567 1.512 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 -18.09 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.459 2.106 . . . . 0.0 112.226 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.16 -11.2 60.81 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.103 -0.998 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -110.06 -29.23 8.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -85.48 137.25 33.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.509 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -124.49 111.49 15.76 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -93.25 124.47 37.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.589 -0.694 . . . . 0.0 111.199 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.29 138.08 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.658 -0.651 . . . . 0.0 109.355 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 47' ' ' GLY . 85.6 t80 -140.26 139.39 35.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.447 -0.783 . . . . 0.0 109.154 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.1 -10.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.64 -0.663 . . . . 0.0 109.32 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.91 8.3 24.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -112.86 149.74 32.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.089 -1.242 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -83.4 116.73 22.62 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.85 120.68 12.38 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.687 -0.633 . . . . 0.0 110.068 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.9 151.33 20.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 68.8 m-20 -65.92 138.62 57.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 111.186 -178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.68 71.54 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.474 -0.766 . . . . 0.0 111.231 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -82.57 166.9 18.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.706 -1.467 . . . . 0.0 111.075 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -111.39 145.42 38.94 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.663 0.744 . . . . 0.0 111.402 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.76 -43.54 90.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.667 -0.646 . . . . 0.0 109.788 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -55.58 -34.28 64.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.25 -20.77 29.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.388 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -103.8 5.1 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.27 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 48.1 41.56 15.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.789 -1.194 . . . . 0.0 109.694 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 56.2 mt -60.1 169.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.365 -0.834 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 62.9 mt-30 -129.05 134.62 48.18 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.789 0.804 . . . . 0.0 109.848 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -54.85 150.29 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 110.797 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 67.17 10.45 7.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.87 -0.518 . . . . 0.0 110.741 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.7 mp -92.7 156.73 16.86 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 1.6 m80 -102.43 127.94 49.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.357 -0.839 . . . . 0.0 109.202 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -109.38 111.5 23.09 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.502 -0.749 . . . . 0.0 109.494 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.87 142.57 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -79.75 -93.53 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.007 -1.058 . . . . 0.0 109.605 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -164.38 -11.14 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.131 -0.981 . . . . 0.0 108.412 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.6 mt 51.38 -141.68 0.77 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.408 -1.432 . . . . 0.0 109.028 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.645 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -61.78 -31.35 71.55 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 108.452 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.91 -105.05 0.9 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 117.898 -1.501 . . . . 0.0 109.771 179.308 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -101.71 141.57 34.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.394 -0.816 . . . . 0.0 109.685 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.96 163.0 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.9 145.39 48.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.336 -0.852 . . . . 0.0 109.69 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.86 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.392 -0.818 . . . . 0.0 108.885 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.18 114.86 26.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -88.79 156.45 18.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.27 -24.44 64.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -81.38 -5.33 57.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 16.96 53.75 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.67 115.08 27.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.912 -1.346 . . . . 0.0 109.398 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -91.9 118.49 30.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.11 145.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.551 -0.718 . . . . 0.0 109.12 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 t -111.38 134.83 52.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.639 -0.663 . . . . 0.0 109.667 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 mt -127.89 146.59 50.58 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.497 -0.752 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.36 123.37 46.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.73 177.46 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.976 -1.078 . . . . 0.0 110.043 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.17 164.06 15.58 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -77.57 -37.07 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 110.705 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -80.52 7.77 9.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -66.41 150.24 49.2 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.81 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -94.07 164.16 13.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -70.11 -40.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.035 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -63.07 -43.86 97.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -68.01 -40.01 83.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.471 -0.768 . . . . 0.0 109.679 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -71.24 -31.5 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -68.64 -32.38 72.18 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.98 81.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.84 -44.86 78.39 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.2 mt -62.34 -42.56 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.416 -0.803 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.1 tt0 -65.35 -44.11 88.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.96 -33.54 73.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 111.149 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -93.86 -41.16 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.823 -1.173 . . . . 0.0 111.17 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -89.44 -26.01 21.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.676 -1.265 . . . . 0.0 109.907 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 80.21 7.28 88.68 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.189 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 36' ' ' ILE . 13.5 mm -95.45 116.81 66.6 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.803 -1.41 . . . . 0.0 109.435 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.84 150.17 6.81 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.665 1.577 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.07 -19.46 34.63 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.675 2.25 . . . . 0.0 112.605 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.7 -4.49 46.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -107.93 -12.52 15.15 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -113.45 140.86 47.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.352 -0.842 . . . . 0.0 110.508 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -127.44 108.93 11.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.78 125.19 33.05 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.743 0.782 . . . . 0.0 111.695 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.39 134.48 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.461 0.648 . . . . 0.0 109.265 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.483 ' C ' ' H ' ' A' ' 47' ' ' GLY . 65.9 t80 -148.6 142.43 25.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 109.225 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.71 8.26 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.733 . . . . 0.0 109.37 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 93.68 18.96 36.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -129.32 152.03 49.33 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.28 117.52 29.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -54.32 115.51 2.13 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.227 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -88.57 146.54 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.027 . . . . 0.0 108.994 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.07 135.6 57.82 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.387 -0.821 . . . . 0.0 109.909 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -14.8 57.3 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.256 -0.902 . . . . 0.0 112.792 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -91.72 160.83 15.15 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.219 2.01 . . . . 0.0 110.559 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -105.54 151.08 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.567 0.698 . . . . 0.0 109.374 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.97 -39.06 65.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.995 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -60.27 -20.57 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.544 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.49 -19.64 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.582 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -107.32 8.66 29.87 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 0.0 110.397 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 52.09 49.07 21.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.676 -1.265 . . . . 0.0 109.675 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 69.7 mt -76.92 172.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.488 -0.758 . . . . 0.0 109.132 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.502 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 90.8 mt-30 -138.62 142.15 39.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.114 -0.991 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.27 152.53 6.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 110.44 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 65.0 10.04 5.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.048 -0.407 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.0 mp -95.66 143.66 26.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -89.88 129.89 36.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.1 -1.0 . . . . 0.0 108.956 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.49 114.56 28.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.512 -0.743 . . . . 0.0 110.037 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.82 147.05 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.06 -171.71 2.6 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.222 1.011 . . . . 0.0 110.735 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -65.55 138.75 58.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.939 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.59 143.27 54.91 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.5 -45.88 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 118.669 -1.213 . . . . 0.0 108.562 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.05 77.14 0.03 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.15 149.61 25.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.742 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.07 168.42 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -127.98 131.66 49.24 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.29 -0.881 . . . . 0.0 109.561 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.12 117.18 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 108.91 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -91.85 113.89 26.28 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -92.93 164.05 13.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.492 -0.755 . . . . 0.0 109.975 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.9 mp -72.72 -19.02 61.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.035 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.3 p -81.38 -0.4 41.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 0.0 109.649 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 12.34 71.34 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -93.16 132.26 37.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.325 . . . . 0.0 109.057 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -116.14 130.87 57.01 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.28 143.3 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.643 -0.661 . . . . 0.0 109.468 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 t -103.62 138.08 40.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 109.782 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.2 mt -131.98 153.37 50.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.536 -0.727 . . . . 0.0 109.567 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -107.13 124.45 49.71 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -143.5 163.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.0 mt-10 -101.36 152.31 37.95 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -36.05 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.936 1.757 . . . . 0.0 111.338 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.9 p -79.77 4.73 15.48 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.385 -0.822 . . . . 0.0 109.288 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.28 146.02 49.18 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.483 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 80.4 p -89.34 154.38 20.13 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 23' ' ' ILE . 22.7 mm -54.93 -37.84 43.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.016 -1.053 . . . . 0.0 108.748 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.2 -44.32 95.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.51 ' H ' ' HG1' ' A' ' 22' ' ' THR . 95.1 m-20 -65.7 -36.37 83.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.932 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.22 -30.31 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.489 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.22 -35.72 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.9 49.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -50.42 -46.84 56.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.64 -37.76 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.56 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.26 -47.15 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.8 -25.7 68.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 111.423 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -95.5 -48.8 5.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.9 -24.8 23.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.837 -1.165 . . . . 0.0 110.025 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.65 -1.6 88.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.233 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -80.68 134.28 54.25 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.657 -1.496 . . . . 0.0 108.571 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 131.8 20.78 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.36 1.373 . . . . 0.0 112.051 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -46.12 -23.21 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.237 1.958 . . . . 0.0 113.553 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -73.91 -2.68 24.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 110.59 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.64 -22.6 10.17 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -100.75 137.52 39.03 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.154 0.978 . . . . 0.0 111.212 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.5 104.41 9.64 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.15 122.02 33.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.799 -1.188 . . . . 0.0 110.075 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 mt -122.73 145.83 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 47' ' ' GLY . 74.9 t80 -149.96 144.84 26.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.64 6.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.94 15.97 49.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.47 139.95 52.81 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.074 -1.251 . . . . 0.0 109.027 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -78.59 118.69 20.95 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.24 118.91 6.0 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 109.861 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -90.62 150.18 21.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.194 -0.942 . . . . 0.0 109.936 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -66.33 134.91 53.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 110.752 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.99 -16.29 57.42 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 121.301 -0.874 . . . . 0.0 111.897 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -92.66 149.06 21.57 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-N 119.9 1.85 . . . . 0.0 109.997 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -90.81 154.48 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.587 0.708 . . . . 0.0 110.068 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.21 -36.28 72.89 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -61.94 -20.24 63.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.062 . . . . 0.0 109.188 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.37 -16.27 64.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.463 -0.773 . . . . 0.0 109.726 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -109.33 7.55 25.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.459 -0.776 . . . . 0.0 110.348 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 51.71 45.7 27.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.658 -1.276 . . . . 0.0 109.552 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 88.9 mt -71.88 174.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.258 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 15.6 tt0 -135.88 140.13 43.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.19 -0.944 . . . . 0.0 109.702 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -53.15 149.81 6.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 64.54 13.91 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.967 -0.458 . . . . 0.0 110.976 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.2 mp -94.42 149.29 21.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.23 130.88 41.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.23 118.75 36.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.399 -0.813 . . . . 0.0 109.789 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.47 148.81 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.0 mp -81.2 -76.96 0.22 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.806 -1.184 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.88 174.03 13.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 109.775 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -25.11 17.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.0 110.054 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -70.56 -2.6 14.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.661 -1.274 . . . . 0.0 109.315 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.91 35.86 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.286 0.565 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -103.78 145.26 30.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.445 -0.784 . . . . 0.0 110.014 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.1 pt -140.36 163.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 41.1 m-85 -121.75 136.12 54.94 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 114.03 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -90.64 117.37 29.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 109.031 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.7 p -92.12 160.64 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.882 . . . . 0.0 109.597 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -65.21 -20.1 66.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -81.67 -9.32 59.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 109.544 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.06 16.56 43.89 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -94.34 121.06 35.48 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.322 . . . . 0.0 109.563 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 m -96.65 121.33 38.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.293 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.36 141.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.488 -0.757 . . . . 0.0 109.236 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.9 p -107.53 131.64 54.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.668 . . . . 0.0 109.667 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -132.52 153.0 51.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.536 -0.728 . . . . 0.0 109.567 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.74 130.04 56.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.2 178.81 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -112.62 153.03 45.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.86 -31.51 47.61 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.997 1.798 . . . . 0.0 110.644 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 5.13 33.77 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.577 -0.702 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -69.58 146.64 51.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -95.59 148.8 22.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 109.387 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -54.2 -39.23 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.086 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.44 -47.69 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.892 . . . . 0.0 109.848 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -68.36 -37.27 80.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.758 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.19 -29.72 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -70.99 -33.99 70.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.37 76.88 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -54.12 -48.25 70.95 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -65.69 -38.08 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -59.13 -48.03 83.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.476 -0.765 . . . . 0.0 109.974 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.09 -35.06 77.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.464 -0.772 . . . . 0.0 111.198 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -79.81 -50.43 10.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.817 -1.177 . . . . 0.0 111.462 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.94 -10.08 49.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.757 -1.215 . . . . 0.0 110.015 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.24 27.13 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.68 134.27 37.97 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.744 -1.445 . . . . 0.0 108.79 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.69 156.93 59.94 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 0.0 112.073 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.43 -18.32 38.64 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.743 2.295 . . . . 0.0 112.781 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.51 -5.4 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -109.34 -27.92 9.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 109.311 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -96.86 134.72 39.82 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.244 -0.91 . . . . 0.0 110.657 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.495 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -118.83 109.21 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.93 129.89 38.69 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.683 -1.261 . . . . 0.0 111.817 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.17 141.13 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.487 0.661 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -119.54 137.41 53.85 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 -112.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.025 -1.047 . . . . 0.0 108.851 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.41 28.95 5.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -129.42 140.31 51.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.177 -1.19 . . . . 0.0 109.421 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -82.95 117.44 22.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.15 121.27 9.06 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.24 148.42 22.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 2.4 p30 -66.35 136.28 55.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 110.871 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.23 57.83 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.426 -0.796 . . . . 0.0 112.051 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.74 170.0 14.65 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.105 -1.821 . . . . 0.0 110.591 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 m -108.17 147.81 30.78 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.313 0.577 . . . . 0.0 109.802 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -56.04 -41.85 75.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -60.49 -20.57 60.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.35 -18.03 64.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.09 6.87 31.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.485 -0.76 . . . . 0.0 110.308 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 54.22 39.82 31.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 68.4 mt -64.05 169.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.497 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 53.4 tt0 -138.62 143.2 39.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.283 -0.885 . . . . 0.0 110.029 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.24 145.41 13.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 110.654 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 69.88 14.48 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.756 -0.59 . . . . 0.0 110.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.5 mp -95.8 145.88 24.99 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -92.53 128.61 38.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 0.0 108.885 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.13 117.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.796 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.4 145.47 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.9 mp -82.29 -82.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 110.016 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.477 ' NH2' ' CG ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -149.95 171.81 16.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.129 -0.982 . . . . 0.0 110.315 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.97 124.95 46.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -72.94 135.14 45.0 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.088 -1.632 . . . . 0.0 109.443 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.51 89.58 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.591 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' VAL . 66.7 mtt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.15 142.03 33.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -145.17 165.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -125.07 137.58 54.2 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.202 -0.936 . . . . 0.0 109.454 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.33 121.38 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.656 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -93.95 118.02 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -93.58 154.08 18.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.97 -19.3 64.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.078 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -82.11 -1.46 48.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 109.726 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.08 9.83 69.92 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -92.23 116.42 28.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.047 -1.267 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -101.81 132.01 47.81 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 109.104 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tt -129.45 145.42 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.509 -0.745 . . . . 0.0 109.44 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -102.71 139.18 38.62 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.56 -0.713 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -130.19 149.74 51.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.619 -0.676 . . . . 0.0 109.43 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -111.09 129.87 55.79 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -146.69 178.54 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.981 -1.074 . . . . 0.0 110.139 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.27 153.49 44.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.54 -33.68 45.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.998 1.799 . . . . 0.0 110.762 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 m -84.94 4.71 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.422 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.67 145.46 53.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.973 -1.079 . . . . 0.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -91.91 162.61 14.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.86 -40.96 90.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.144 -0.972 . . . . 0.0 108.696 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -62.21 -43.73 98.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.73 -41.59 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.116 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.63 -29.07 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.02 . . . . 0.0 109.455 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -35.13 78.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.56 82.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.75 -44.3 77.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.72 -39.3 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -59.61 -45.62 91.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 109.93 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.61 -30.28 68.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 111.187 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -88.25 -46.68 9.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.78 -1.2 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -89.21 -19.84 24.92 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.638 -1.289 . . . . 0.0 110.017 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.07 4.68 56.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.065 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -89.82 122.48 67.93 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.684 -1.48 . . . . 0.0 109.3 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.31 149.55 6.33 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.633 1.555 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.35 -19.5 33.25 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.32 -2.8 33.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -111.65 -25.25 9.63 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.15 -0.969 . . . . 0.0 110.271 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -97.59 136.03 38.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -122.37 115.82 22.95 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.02 125.56 41.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.59 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -121.73 141.16 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -150.32 144.68 25.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.099 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.66 12.11 4.36 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.56 67.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.48 148.93 44.56 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.124 -1.221 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -84.26 113.53 21.18 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -54.53 123.17 12.28 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.745 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.64 143.27 27.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.148 -0.97 . . . . 0.0 109.13 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.9 133.91 56.01 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.417 -0.802 . . . . 0.0 109.602 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -16.23 56.91 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.35 -0.844 . . . . 0.0 112.086 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -81.97 164.28 21.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 119.977 -1.896 . . . . 0.0 109.108 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 m -104.93 147.56 27.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.47 -41.89 81.54 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -59.46 -23.73 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.166 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.98 -18.52 64.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -107.19 5.87 28.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.517 -0.739 . . . . 0.0 110.106 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 49.91 48.33 21.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.615 -1.303 . . . . 0.0 109.681 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.91 165.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 108.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -126.79 135.22 50.75 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.402 -0.811 . . . . 0.0 109.75 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.11 146.21 6.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 66.99 16.09 10.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 122.133 -0.355 . . . . 0.0 110.959 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 9.4 mp -95.19 153.24 17.75 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -97.79 126.37 43.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.194 -0.941 . . . . 0.0 108.999 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.85 117.59 34.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 109.585 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.65 143.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 73' ' ' LEU . 7.3 mp -94.64 112.5 24.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.888 -1.132 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.83 -88.64 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.977 0.894 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 71' ' ' LEU . 13.6 tp -111.19 147.51 34.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -59.44 -37.3 77.74 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.436 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.74 170.49 23.4 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.52 151.59 24.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.386 -0.821 . . . . 0.0 109.735 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -145.66 166.81 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 61.2 m-85 -121.13 136.55 54.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.79 118.7 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.64 120.75 36.45 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -97.03 153.88 17.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.82 -18.88 58.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.364 -0.835 . . . . 0.0 110.16 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -81.54 -1.47 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.18 70.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.15 118.01 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.978 -1.307 . . . . 0.0 109.659 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -103.34 130.35 50.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.327 -0.858 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -131.11 138.28 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.462 -0.773 . . . . 0.0 109.732 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -97.69 142.44 29.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -132.83 155.5 48.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.461 -0.775 . . . . 0.0 109.613 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -106.81 125.55 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.37 165.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.071 -1.018 . . . . 0.0 109.969 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 39.2 mt-10 -107.67 154.06 41.09 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.52 -29.1 31.14 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.157 1.905 . . . . 0.0 111.113 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -88.7 1.26 55.43 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 151.27 47.17 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.962 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.507 ' HG1' ' CG ' ' A' ' 25' ' ' ASN . 45.8 p -96.66 150.94 20.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.257 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 23' ' ' ILE . 20.7 mm -54.4 -36.75 35.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.065 -1.022 . . . . 0.0 108.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.32 -42.81 92.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 109.935 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.507 ' CG ' ' HG1' ' A' ' 22' ' ' THR . 2.1 m120 -67.78 -37.74 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 109.682 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.96 -31.05 39.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.581 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.63 -34.98 76.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.89 78.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.3 -46.88 79.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.3 mt -63.07 -42.16 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.23 -46.11 85.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 109.974 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.02 -30.57 71.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 111.442 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -96.07 -43.74 7.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.879 -1.138 . . . . 0.0 111.278 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -87.9 -27.26 22.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.813 -1.179 . . . . 0.0 109.945 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.34 77.15 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.106 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -76.18 133.67 71.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.706 -1.467 . . . . 0.0 108.616 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.23 133.15 20.6 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.36 1.373 . . . . 0.0 112.143 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.89 -25.45 2.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 113.155 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -77.81 -3.63 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.95 -1.094 . . . . 0.0 110.338 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -111.78 -29.89 7.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -107.23 143.42 35.48 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.825 0.821 . . . . 0.0 111.016 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.429 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.4 mtp180 -130.38 125.43 34.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.43 122.79 39.71 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.032 -1.043 . . . . 0.0 111.186 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.97 134.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.84 134.79 55.12 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 -109.45 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.081 -1.012 . . . . 0.0 108.792 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.5 33.34 3.31 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -133.83 154.6 50.91 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.065 -1.256 . . . . 0.0 109.598 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -99.3 116.09 30.68 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -53.6 120.05 5.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.97 142.62 27.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.893 . . . . 0.0 109.795 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.27 135.46 57.48 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.453 -0.779 . . . . 0.0 110.31 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 -18.6 54.83 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.358 -0.839 . . . . 0.0 111.943 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -90.66 159.89 16.15 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.022 1.911 . . . . 0.0 109.996 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -102.72 154.55 19.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.587 -0.696 . . . . 0.0 109.927 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.65 -37.39 73.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.345 -0.847 . . . . 0.0 109.626 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -56.74 -18.71 13.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.008 -1.058 . . . . 0.0 109.533 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -76.22 -19.44 58.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.89 -11.92 17.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.466 -0.771 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 t30 60.58 48.01 7.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.032 -1.042 . . . . 0.0 109.577 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 97.2 mt -70.36 171.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.141 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.491 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.0 mm100 -128.27 136.16 50.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -53.6 148.1 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.703 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' OE2' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 68.77 11.88 8.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.646 -0.659 . . . . 0.0 110.308 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 8.1 mp -95.57 154.31 17.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 4.7 m-70 -95.76 126.14 40.82 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.077 -1.015 . . . . 0.0 108.835 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tp -101.23 113.28 26.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.1 t -106.43 138.25 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.15 167.4 10.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.214 -0.928 . . . . 0.0 109.279 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 112.17 5.6 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.8 tp -82.3 -53.22 6.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HG3' ' NH2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.61 117.19 10.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.315 0.579 . . . . 0.0 110.254 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.88 -126.28 3.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.085 -1.397 . . . . 0.0 110.086 -179.442 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -99.81 143.16 30.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.14 166.53 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.33 158.51 39.62 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.02 124.73 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.1 119.64 31.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.489 -0.757 . . . . 0.0 109.094 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -91.14 151.97 20.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -58.82 -19.3 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 109.754 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.8 m -81.37 -6.71 59.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.136 -0.978 . . . . 0.0 109.402 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.67 59.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -94.09 118.94 32.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.314 . . . . 0.0 109.611 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -94.86 122.9 37.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.054 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -115.26 145.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.572 -0.705 . . . . 0.0 109.12 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -106.6 131.7 53.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.714 . . . . 0.0 109.633 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -129.71 150.44 51.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.458 -0.776 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -110.91 128.7 55.9 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.88 174.51 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 110.317 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -107.93 152.88 41.86 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.61 -34.18 26.16 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.967 1.778 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -85.66 1.78 47.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.57 -0.706 . . . . 0.0 109.233 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.67 147.91 44.35 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.996 -1.081 . . . . 0.0 108.522 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.4 p -89.0 155.81 19.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 108.847 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.73 -42.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.043 -1.035 . . . . 0.0 108.237 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.81 -37.89 89.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -69.48 -41.63 75.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.6 t -66.76 -28.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.245 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -72.92 -35.42 67.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.38 92.42 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.99 -44.93 94.67 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.0 -37.58 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.42 -0.8 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.61 -47.96 83.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.923 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -66.77 -34.82 78.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 111.274 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -85.22 -46.13 11.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 111.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -85.03 -27.24 26.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.67 -1.269 . . . . 0.0 109.72 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.66 3.58 79.32 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.441 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 36' ' ' ILE . 17.6 mm -93.29 124.34 57.97 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.673 -1.487 . . . . 0.0 108.716 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.39 130.34 21.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.294 1.329 . . . . 0.0 112.368 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -49.47 -24.56 9.17 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.223 1.949 . . . . 0.0 113.423 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.21 -9.22 58.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.645 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -103.65 -23.57 13.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -98.25 138.48 35.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 0.0 110.761 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.55 HH21 ' HA ' ' A' ' 72' ' ' ARG . 9.7 mtp180 -122.61 112.05 17.52 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -88.5 122.84 32.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.185 -0.947 . . . . 0.0 111.097 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.34 132.72 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -119.96 135.53 54.87 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 -112.76 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.014 -1.054 . . . . 0.0 109.087 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.98 28.62 5.82 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -140.13 179.2 6.77 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.881 -1.364 . . . . 0.0 109.474 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' OH ' ' A' ' 59' ' ' TYR . 39.5 mt-30 -109.63 156.45 20.2 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.995 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 4.3 mm? -83.32 108.63 16.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.095 -1.003 . . . . 0.0 108.358 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.594 ' CD ' HH21 ' A' ' 54' ' ' ARG . 40.4 tt0 -80.71 152.5 28.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.68 142.27 30.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.529 -0.732 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.02 10.47 51.96 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.301 -0.875 . . . . 0.0 111.714 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.594 HH21 ' CD ' ' A' ' 51' ' ' GLU . 3.9 mtp180 -129.69 172.87 11.17 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.893 -1.357 . . . . 0.0 109.721 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -103.59 149.73 24.63 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.037 -1.039 . . . . 0.0 111.235 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -56.65 -32.54 65.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.461 -0.774 . . . . 0.0 109.491 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -62.11 -19.27 62.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.087 -1.008 . . . . 0.0 109.213 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.35 -16.88 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.421 -0.799 . . . . 0.0 109.614 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 13.4 m-85 -103.91 10.98 36.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.427 -0.796 . . . . 0.0 110.238 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 52.46 42.46 31.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.612 -1.305 . . . . 0.0 109.416 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 60.6 mt -71.4 170.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 42.4 mt-30 -143.8 147.05 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.086 -1.009 . . . . 0.0 110.068 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -52.94 145.78 12.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 110.587 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.32 14.51 8.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.821 -0.549 . . . . 0.0 110.607 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.99 155.83 17.49 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -97.78 130.94 44.69 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tt -103.36 116.89 33.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 109.666 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.05 146.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.6 mp -82.42 -102.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.861 -1.149 . . . . 0.0 111.047 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HA ' HH21 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -163.78 -29.79 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 -179.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.16 -58.16 3.65 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.624 -0.673 . . . . 0.0 110.016 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -71.75 86.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.766 0.793 . . . . 0.0 109.326 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.25 -8.14 0.13 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.827 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.53 144.97 29.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.309 -0.87 . . . . 0.0 109.405 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -145.84 166.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -128.84 150.4 50.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.93 -1.107 . . . . 0.0 110.131 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.55 123.72 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.365 -0.835 . . . . 0.0 108.866 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -97.66 123.5 41.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.4 m -98.6 158.95 15.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.25 -16.31 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.924 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -82.04 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.097 -1.002 . . . . 0.0 109.641 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.83 64.97 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -94.86 133.69 38.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.312 . . . . 0.0 109.281 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.9 m -114.88 129.2 56.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 109.126 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -125.49 145.06 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.72 -0.612 . . . . 0.0 109.494 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -103.45 136.89 42.34 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.712 . . . . 0.0 109.847 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -131.99 151.75 51.55 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -103.29 122.86 45.67 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.05 164.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.114 -0.991 . . . . 0.0 110.076 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 65.0 mt-10 -107.23 151.81 40.94 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.1 -30.91 37.76 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.091 1.861 . . . . 0.0 111.04 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -82.95 -0.8 50.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.52 147.88 52.21 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.671 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.713 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 74.3 p -90.77 153.98 19.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 109.005 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.61 -38.9 44.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.846 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.3 -45.1 89.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 109.876 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.713 ' H ' ' HG1' ' A' ' 22' ' ' THR . 2.7 m120 -63.21 -36.97 85.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.983 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.28 -27.97 22.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -67.53 -38.26 83.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.51 45.55 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -48.92 -43.9 39.84 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.526 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.15 -28.61 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.014 -1.054 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -61.94 -50.31 72.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 109.871 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -72.78 -28.8 62.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -81.39 -47.52 13.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.865 -1.147 . . . . 0.0 111.039 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.14 -17.79 25.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.715 -1.241 . . . . 0.0 109.73 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.04 52.02 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.286 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -93.23 125.07 55.9 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.665 -1.491 . . . . 0.0 109.304 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.32 149.05 6.88 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.482 1.455 . . . . 0.0 112.145 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.69 -26.92 32.58 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.357 2.038 . . . . 0.0 112.29 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.33 -2.36 13.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -110.85 -13.32 14.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.02 -1.05 . . . . 0.0 109.689 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -110.05 137.75 47.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -119.81 111.02 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -92.46 120.17 32.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -113.98 144.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -123.29 140.49 52.96 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.07 -112.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.098 -1.002 . . . . 0.0 108.56 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.43 6.19 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -125.12 144.09 50.6 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.014 -1.286 . . . . 0.0 109.366 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -74.68 147.9 41.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.16 114.79 25.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.821 -1.174 . . . . 0.0 108.842 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 21.6 mp0 -81.3 175.72 10.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 108.912 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 39.3 p-10 -95.49 135.65 36.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.72 -0.613 . . . . 0.0 111.577 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.93 -8.22 61.12 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.998 -1.064 . . . . 0.0 112.18 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -95.18 154.8 17.01 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 120.307 -1.702 . . . . 0.0 109.306 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 p -92.87 149.79 21.03 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.016 -1.053 . . . . 0.0 110.895 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -53.75 -33.68 56.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 109.636 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 m -64.82 -13.63 56.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.06 -1.025 . . . . 0.0 109.085 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.17 -17.22 61.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.547 -0.721 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.68 8.19 22.55 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 0.0 110.13 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 54.76 45.73 26.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.346 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 86.5 mt -75.04 172.1 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.177 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.496 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 81.3 mt-30 -139.32 142.12 37.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -51.8 151.61 3.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.225 -0.922 . . . . 0.0 110.336 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 64.71 14.86 9.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.059 -0.4 . . . . 0.0 110.793 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.95 150.57 20.31 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.4 127.74 38.0 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.16 113.25 26.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.72 141.37 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 1.2 mm? -90.35 157.35 17.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 0.0 109.615 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.38 134.56 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -113.55 142.03 46.45 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.517 -0.739 . . . . 0.0 109.854 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.639 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -156.77 144.79 19.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.683 -1.261 . . . . 0.0 110.427 177.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 26.11 63.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.56 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.236 0.541 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.8 141.6 32.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.657 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tt -141.38 163.9 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 28.4 m-85 -126.72 157.04 40.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.47 119.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -91.29 120.56 32.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 109.366 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -95.83 166.04 12.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.57 -22.12 65.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.154 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.52 -3.2 52.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.632 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 17.32 60.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -94.41 125.41 39.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.326 . . . . 0.0 109.301 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.2 m -101.1 121.95 42.73 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -108.96 141.65 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -103.74 126.77 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.72 149.78 51.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.503 -0.748 . . . . 0.0 109.712 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -103.67 123.46 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 2.1 p -144.91 166.34 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.055 -1.028 . . . . 0.0 110.19 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.6 mt-10 -109.9 152.19 42.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.27 -28.03 34.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.207 1.938 . . . . 0.0 111.28 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 t -85.34 -2.2 57.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.012 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.87 146.98 51.54 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.803 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -88.61 143.49 26.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.76 -42.38 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 108.483 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -60.25 -44.2 95.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.643 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.39 -40.0 85.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.96 -33.23 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -70.84 -35.08 72.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.89 82.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -54.57 -48.76 71.69 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.89 -37.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.68 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -61.99 -48.78 78.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -67.3 -33.11 74.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 111.115 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -45.45 12.54 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.789 -1.194 . . . . 0.0 111.179 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -88.98 -24.96 22.27 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.736 -1.228 . . . . 0.0 109.833 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 1.07 90.09 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.146 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.97 134.35 35.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 120.596 -1.532 . . . . 0.0 108.873 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.91 154.45 67.13 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.553 1.502 . . . . 0.0 112.035 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.69 -17.94 37.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.594 2.196 . . . . 0.0 112.302 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 77.9 m-20 -79.54 -4.82 53.15 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.763 -1.21 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -107.2 -28.07 10.16 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.263 -0.898 . . . . 0.0 110.735 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -112.89 146.69 38.5 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.393 -0.817 . . . . 0.0 110.621 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.0 120.59 27.87 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.0 mt -90.43 126.19 35.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 0.0 110.844 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.6 mp -119.63 137.03 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 109.349 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -119.0 136.09 54.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.93 -112.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 108.655 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.23 4.86 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.53 147.71 52.56 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.148 -1.207 . . . . 0.0 109.545 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -90.21 116.86 28.52 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.8 mt -55.66 123.51 14.31 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 109.926 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.46 140.75 45.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.715 0.769 . . . . 0.0 109.343 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 15.8 p-10 -64.52 155.28 33.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.688 -0.632 . . . . 0.0 110.958 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.76 2.05 56.29 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.377 -0.827 . . . . 0.0 112.072 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -133.9 172.48 12.74 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.745 -1.444 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -105.26 154.67 19.93 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.165 -0.959 . . . . 0.0 110.994 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.67 -34.35 64.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.432 -0.792 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -62.55 -16.7 57.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.73 -16.87 63.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.82 . . . . 0.0 109.443 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -105.46 11.03 33.04 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 53.61 46.83 25.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.651 -1.281 . . . . 0.0 109.468 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.605 ' CG2' ' H ' ' A' ' 62' ' ' GLN . 75.9 mt -87.47 -176.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 0.0 109.349 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.605 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.0 pt20 -157.79 158.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 110.29 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -54.58 151.08 8.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.426 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 68.4 14.95 9.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.603 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.0 mp -96.46 146.52 24.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -93.18 134.58 35.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 108.624 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.71 121.43 45.01 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.479 -0.763 . . . . 0.0 109.88 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.19 151.95 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -93.1 147.55 22.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.965 -1.084 . . . . 0.0 109.46 -179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 39' ' ' ASP . 4.7 mtp180 -69.57 -20.3 63.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.88 -165.23 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.035 -1.041 . . . . 0.0 109.336 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.404 HH21 ' HD3' ' A' ' 74' ' ' ARG . 2.4 ttp180 -148.98 -26.66 0.3 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.235 -0.916 . . . . 0.0 109.526 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.54 -10.4 64.59 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 CA-C-O 117.962 -1.466 . . . . 0.0 109.706 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.0 138.39 36.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.91 162.57 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 37.3 m-85 -124.98 141.73 51.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.313 -0.867 . . . . 0.0 109.398 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.89 116.62 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.335 -0.853 . . . . 0.0 109.005 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.4 114.74 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.415 -0.803 . . . . 0.0 108.911 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -90.97 165.75 13.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tp -70.38 -23.48 62.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.4 p -81.27 -0.15 39.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.033 . . . . 0.0 109.45 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.29 15.74 66.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -93.15 122.06 35.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.868 -1.372 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -99.34 121.61 41.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.534 -0.729 . . . . 0.0 109.401 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.33 139.8 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.661 -0.649 . . . . 0.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.9 p -101.91 127.43 48.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.567 -0.708 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.1 mt -131.18 151.27 51.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.557 -0.714 . . . . 0.0 109.587 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -115.64 131.85 56.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.81 176.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.988 -1.07 . . . . 0.0 110.099 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.23 150.22 40.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.85 -32.1 46.55 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.876 1.717 . . . . 0.0 110.906 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -84.42 2.77 39.18 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.531 -0.731 . . . . 0.0 109.245 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.47 145.79 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.911 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -85.39 160.38 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.459 -0.775 . . . . 0.0 108.935 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.611 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 2.4 mp -61.22 -39.37 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.061 -1.025 . . . . 0.0 108.26 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -35.87 81.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -69.74 -38.92 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 109.606 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -72.45 -33.09 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.577 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 49.6 mttp -68.01 -34.17 76.0 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -51.46 -45.79 62.83 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 30' ' ' ILE . 97.1 mt -66.14 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.885 . . . . 0.0 109.801 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.5 -48.88 79.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 110.053 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -68.98 -31.95 71.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.317 -0.865 . . . . 0.0 111.052 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -82.92 -48.19 10.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.919 -1.113 . . . . 0.0 111.489 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.775 -1.203 . . . . 0.0 109.986 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.51 3.21 82.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.131 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.12 123.67 66.72 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.75 -1.441 . . . . 0.0 108.764 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.34 130.16 20.64 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.143 1.229 . . . . 0.0 112.267 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.53 -34.2 25.6 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.258 1.972 . . . . 0.0 113.444 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.45 -1.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.326 -0.859 . . . . 0.0 110.803 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' C ' HE21 ' A' ' 41' ' ' GLN . 48.0 tp60 -109.47 -21.68 12.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 0.0 110.052 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 HE21 ' C ' ' A' ' 40' ' ' GLN . 24.1 mm-40 -103.31 138.31 40.26 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.141 -0.974 . . . . 0.0 111.412 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' NH2' ' HG3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -121.14 105.34 10.5 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.04 125.14 34.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.98 -1.075 . . . . 0.0 110.239 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mt -123.5 145.18 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 47' ' ' GLY . 84.3 t80 -148.8 145.91 27.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.616 -0.678 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.86 8.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.29 16.14 51.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -121.55 146.31 47.07 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.998 -1.295 . . . . 0.0 108.853 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.48 115.82 23.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.74 119.51 5.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.941 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.82 173.35 7.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.188 -0.945 . . . . 0.0 109.89 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -94.67 149.15 21.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 110.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.7 -11.05 69.81 Favored Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.445 -0.784 . . . . 0.0 111.331 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -96.46 174.66 6.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.79 -1.418 . . . . 0.0 109.448 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -115.31 152.47 32.72 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.992 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -57.56 -41.01 80.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.493 -0.755 . . . . 0.0 109.75 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -58.95 -23.76 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 109.328 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.67 -17.09 62.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.357 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.33 3.71 35.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.0 110.314 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.27 45.13 27.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.743 -1.223 . . . . 0.0 109.413 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 91.0 mt -72.24 173.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 109.159 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.505 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 59.6 mt-30 -137.38 142.2 41.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -53.48 148.14 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.857 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 68.0 12.14 8.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.734 -0.604 . . . . 0.0 110.561 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.7 mp -95.93 151.34 19.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -98.57 132.36 44.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.185 -0.947 . . . . 0.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -107.22 113.68 27.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.634 -0.666 . . . . 0.0 109.508 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.58 150.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.0 mp -84.32 -105.35 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -84.08 -89.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.71 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.57 168.67 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.689 -1.257 . . . . 0.0 110.483 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -167.53 -8.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.546 -0.721 . . . . 0.0 109.36 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.7 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.916 -1.491 . . . . 0.0 109.676 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.325 0.583 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.68 163.73 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -122.46 132.74 54.49 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -99.12 112.82 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.024 -1.047 . . . . 0.0 108.852 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -89.68 114.5 26.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.748 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -93.84 162.03 14.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.321 -0.862 . . . . 0.0 109.842 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.97 -19.49 64.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.814 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -81.69 -5.55 58.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.998 . . . . 0.0 109.595 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.78 14.88 58.94 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -93.87 124.68 38.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.886 -1.361 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 m -102.01 124.22 47.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.532 -0.73 . . . . 0.0 109.043 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -114.99 140.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.562 -0.712 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -102.2 128.35 48.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -128.65 147.97 50.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 16' ' ' GLU . 27.2 mp0 -110.68 127.88 55.48 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.28 179.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.975 -1.078 . . . . 0.0 110.262 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -113.05 151.68 44.35 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.14 -30.42 46.75 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.993 1.795 . . . . 0.0 110.899 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -84.94 4.8 31.87 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.62 145.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 0.0 108.881 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -92.2 148.17 22.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -50.47 -40.76 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.085 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.68 -43.88 90.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.256 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -69.51 -37.0 76.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.92 -32.61 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -70.31 -32.69 70.56 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.74 96.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.12 -47.26 85.91 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.391 0.615 . . . . 0.0 109.418 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.44 -39.78 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.61 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.86 -47.06 88.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 109.966 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.43 -23.64 58.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.956 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -84.89 -51.71 6.54 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.807 -1.183 . . . . 0.0 111.295 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -91.18 -24.0 20.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.65 -1.281 . . . . 0.0 109.902 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.41 4.19 88.04 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.964 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.32 121.75 67.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.776 -1.426 . . . . 0.0 109.12 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.41 150.35 5.72 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.633 1.556 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.64 -28.77 25.42 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.595 2.197 . . . . 0.0 112.483 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.76 -3.32 27.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.56 -6.11 24.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.57 153.75 50.89 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.211 -0.931 . . . . 0.0 110.945 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -129.77 120.78 25.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 44' ' ' ILE . 26.7 mt -86.67 123.15 31.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.992 -1.068 . . . . 0.0 111.275 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.6 mp -116.46 133.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.547 0.689 . . . . 0.0 109.17 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 47' ' ' GLY . 60.5 t80 -145.95 140.78 27.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.143 -0.973 . . . . 0.0 108.801 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 8.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 109.288 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.81 23.23 26.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -126.94 147.14 50.11 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.146 -1.208 . . . . 0.0 109.53 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -89.95 112.09 23.37 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.41 122.93 10.65 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.496 -0.753 . . . . 0.0 109.759 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -93.05 148.07 22.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.156 -0.965 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.22 131.88 47.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.942 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.65 64.27 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.309 -0.869 . . . . 0.0 111.403 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 54' ' ' ARG . 15.5 ttt180 -89.55 156.4 18.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.402 -1.646 . . . . 0.0 109.783 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -98.23 148.01 24.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.186 -0.946 . . . . 0.0 110.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.86 -38.94 76.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 109.871 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -57.9 -28.07 63.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.992 . . . . 0.0 110.004 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.44 -16.82 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.39 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -101.86 0.54 35.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.413 -0.804 . . . . 0.0 110.133 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 m120 52.03 49.11 21.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 96.6 mt -75.67 176.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 17.4 tt0 -132.44 138.2 47.55 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.27 -0.894 . . . . 0.0 109.662 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -52.41 149.57 5.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 110.543 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.893 -0.505 . . . . 0.0 110.953 179.503 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -90.24 128.27 36.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.096 -1.003 . . . . 0.0 108.659 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.71 125.13 53.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.67 147.3 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 108.77 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.205 0.526 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 tt -144.57 165.78 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.5 m-85 -130.86 157.74 42.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.18 121.06 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 108.596 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.8 tttm -91.86 122.64 34.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.153 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 8' ' ' LEU . 30.0 m -96.25 161.36 13.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.456 ' N ' HG22 ' A' ' 7' ' ' THR . 24.3 mt -62.65 -23.08 66.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -81.64 -0.65 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 16.25 66.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -91.18 117.78 29.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.043 -1.269 . . . . 0.0 109.37 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -93.61 118.52 31.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.475 -0.766 . . . . 0.0 109.169 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -107.63 139.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.754 . . . . 0.0 109.274 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.31 129.03 53.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 109.779 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.27 150.01 51.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.473 -0.767 . . . . 0.0 109.66 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -106.66 126.41 52.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.72 176.03 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.076 -1.015 . . . . 0.0 110.243 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -112.77 151.58 44.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.0 -33.01 64.27 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.818 1.679 . . . . 0.0 110.669 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -85.71 3.91 39.0 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.576 -0.703 . . . . 0.0 109.221 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.38 149.22 48.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 p -96.69 147.16 24.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.526 -0.734 . . . . 0.0 109.694 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.53 -41.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.226 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.13 -45.02 96.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.775 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -68.26 -37.4 80.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.728 . . . . 0.0 109.674 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -70.48 -31.32 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.273 -0.892 . . . . 0.0 109.901 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.46 -33.33 71.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.53 97.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -59.72 -44.94 93.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.84 -40.82 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.369 -0.832 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.59 -45.38 93.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.831 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.39 -35.6 80.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 111.284 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -89.16 -44.34 10.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.54 -27.09 22.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.75 -1.219 . . . . 0.0 110.063 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.21 83.11 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.037 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.7 mt -91.09 119.11 68.88 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.702 -1.469 . . . . 0.0 109.339 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.57 149.56 6.93 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.69 1.593 . . . . 0.0 112.326 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.06 -22.98 29.97 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.74 -6.01 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.795 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.13 -4.44 35.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 109.812 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -140.01 155.82 46.91 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.073 -1.017 . . . . 0.0 111.35 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.436 HH21 ' HD3' ' A' ' 42' ' ' ARG . 13.6 mtt180 -127.78 133.34 49.46 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.7 mt -96.93 123.59 40.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 109.79 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.1 mp -112.54 138.81 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' GLY . 89.9 t80 -147.5 137.74 23.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.025 . . . . 0.0 109.059 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 11.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.369 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 92.6 23.94 24.86 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -128.11 147.18 50.53 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.122 -1.222 . . . . 0.0 109.47 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -90.15 111.69 22.92 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.04 118.14 3.0 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.551 -0.718 . . . . 0.0 109.267 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -94.76 142.74 27.11 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.178 -0.951 . . . . 0.0 109.074 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.15 137.56 57.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.524 -0.735 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.78 -13.15 57.89 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -96.61 154.7 17.13 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.959 1.879 . . . . 0.0 110.367 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -99.07 152.36 19.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.025 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.61 -37.55 68.28 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.343 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -59.09 -21.46 59.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.894 -1.128 . . . . 0.0 109.732 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -70.77 -16.88 62.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -105.51 9.65 33.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.326 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 52.23 47.63 24.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.0 mt -79.75 172.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.421 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' HG22 ' A' ' 61' ' ' ILE . 29.7 mt-30 -144.03 146.95 33.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.05 -1.031 . . . . 0.0 110.062 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.32 147.71 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.622 -0.674 . . . . 0.0 110.425 179.573 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -93.05 131.89 37.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.289 -0.882 . . . . 0.0 108.766 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.65 128.73 55.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.02 150.71 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 108.757 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.314 0.578 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -146.34 167.57 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 44.1 m-85 -124.78 134.85 52.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.96 113.61 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -90.77 113.58 25.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 8' ' ' LEU . 29.3 m -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.227 -0.92 . . . . 0.0 109.761 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' N ' HG22 ' A' ' 7' ' ' THR . 7.6 tp -64.05 -21.53 66.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 110.111 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -81.25 1.32 32.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.033 -1.042 . . . . 0.0 109.641 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.96 80.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -87.77 125.56 34.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.319 . . . . 0.0 109.121 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -105.77 122.19 45.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.576 -0.703 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.91 138.28 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.7 m -105.8 135.71 46.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 0.0 109.998 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.15 156.15 48.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 109.579 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -109.4 127.11 54.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -143.57 164.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 109.923 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 62.8 mm-40 -103.89 149.63 37.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.63 -31.48 32.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.949 1.766 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 t -82.8 -0.62 48.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.441 -0.787 . . . . 0.0 109.406 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 146.81 54.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -87.88 157.66 18.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.922 . . . . 0.0 109.048 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.573 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.1 mp -56.71 -42.07 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 108.499 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -64.03 -41.22 97.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -64.3 -36.95 85.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.029 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -74.7 -29.0 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -67.43 -37.51 83.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.45 44.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -49.04 -46.96 45.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.68 -36.63 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.867 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -70.78 -48.4 54.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.81 -28.21 67.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -97.53 -41.57 8.1 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.811 -1.18 . . . . 0.0 111.208 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -93.12 -19.96 20.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.771 -1.205 . . . . 0.0 110.125 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.09 18.45 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.956 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.98 119.96 79.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 120.731 -1.453 . . . . 0.0 108.775 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.35 129.68 19.79 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.199 1.266 . . . . 0.0 112.294 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -49.92 -36.61 44.17 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.213 1.942 . . . . 0.0 112.991 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.08 -0.85 8.41 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -100.02 -3.95 31.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.153 -0.967 . . . . 0.0 110.361 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.25 153.82 47.89 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 110.434 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -128.61 109.88 11.75 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.13 125.73 33.71 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.655 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.39 148.17 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.621 0.724 . . . . 0.0 109.599 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 47' ' ' GLY . 80.7 t80 -149.83 142.38 24.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.369 -0.832 . . . . 0.0 109.058 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.63 5.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.04 9.96 56.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.47 148.63 40.57 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.091 -1.24 . . . . 0.0 109.202 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -82.19 116.53 21.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.82 121.04 10.13 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.363 -0.836 . . . . 0.0 109.497 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -90.69 173.51 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.666 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.59 140.4 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.335 -0.853 . . . . 0.0 110.905 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.61 53.4 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.278 -0.889 . . . . 0.0 111.612 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.72 ' HG2' HH21 ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.63 176.26 9.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.01 -1.288 . . . . 0.0 110.446 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -113.15 145.36 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.55 -37.71 70.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.522 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -59.91 -26.29 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.79 -17.85 51.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.602 -0.686 . . . . 0.0 109.531 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.25 3.07 32.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.41 -0.806 . . . . 0.0 110.258 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.78 47.22 24.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.706 -1.246 . . . . 0.0 109.583 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 62' ' ' GLN . 63.4 mt -68.93 169.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.7 tp-100 -135.46 139.82 44.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -54.08 147.82 12.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 110.895 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.696 -0.628 . . . . 0.0 110.765 179.396 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.8 mp . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -98.24 129.3 44.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -112.81 118.43 34.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.72 145.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.497 1.917 0 O-C-N 120.914 -1.116 . . . . 0.0 110.072 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 121.411 0.625 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -145.22 166.63 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -127.08 143.07 51.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.284 -0.885 . . . . 0.0 109.608 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.88 121.33 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.288 -0.882 . . . . 0.0 108.837 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -94.97 123.98 38.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -98.95 153.4 18.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 0.0 109.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.0 mp -59.93 -18.3 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.3 p -81.53 -3.0 51.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.022 -1.049 . . . . 0.0 109.625 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.84 69.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -93.43 121.21 34.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.855 -1.38 . . . . 0.0 109.561 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 m -103.89 129.78 51.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.474 -0.767 . . . . 0.0 109.292 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 tt -126.36 145.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.613 -0.679 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -105.53 137.18 43.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.58 -0.7 . . . . 0.0 109.552 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.4 mt -129.1 149.46 50.91 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.484 -0.76 . . . . 0.0 109.578 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.01 125.54 51.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.87 176.17 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.99 -1.069 . . . . 0.0 110.271 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -110.31 154.0 43.11 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.85 -33.54 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.023 1.816 . . . . 0.0 110.765 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.2 m -84.37 4.62 30.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.563 -0.71 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.98 147.92 50.89 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.004 -1.079 . . . . 0.0 108.951 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 p -92.64 150.45 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.309 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -53.97 -40.0 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.56 -43.6 98.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.19 -37.65 84.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.45 -28.79 36.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -70.28 -35.46 73.75 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.73 84.54 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -55.53 -47.33 76.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.732 -0.605 . . . . 0.0 109.443 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.06 -39.52 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.37 -0.831 . . . . 0.0 109.5 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.05 -45.08 93.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.37 -31.97 73.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 111.299 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -94.72 -41.6 9.18 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.802 -1.186 . . . . 0.0 111.534 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -91.65 -23.54 19.8 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.761 -1.212 . . . . 0.0 110.051 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.65 -1.47 29.21 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.059 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -83.96 118.85 72.42 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.413 . . . . 0.0 109.506 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.91 149.82 7.39 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.67 1.58 . . . . 0.0 112.027 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.68 -25.24 29.17 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.508 2.139 . . . . 0.0 112.464 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.61 -2.06 24.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 109.724 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -101.13 -7.81 22.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.237 -0.915 . . . . 0.0 110.013 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -143.04 158.88 43.19 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.008 -1.058 . . . . 0.0 110.962 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.456 HH21 ' HD3' ' A' ' 42' ' ' ARG . 1.6 mtp180 -132.12 121.24 23.46 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.58 121.85 28.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.07 -1.019 . . . . 0.0 110.604 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mm -115.94 133.45 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -119.12 134.95 54.9 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.04 -113.45 0.65 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.995 -1.065 . . . . 0.0 108.582 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.11 26.93 5.2 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.08 150.67 46.59 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.244 -1.151 . . . . 0.0 109.233 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -91.28 113.35 25.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 59' ' ' TYR . 89.8 mt -55.08 122.2 10.44 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.666 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.76 171.19 9.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.77 134.26 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.28 -19.07 55.43 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.752 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.59 160.75 26.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.581 -1.541 . . . . 0.0 109.095 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 p -102.58 152.97 20.55 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.478 -0.764 . . . . 0.0 109.245 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.83 -38.98 70.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.048 . . . . 0.0 109.311 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -61.22 -17.82 55.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.104 -0.998 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.5 -18.45 63.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE1' HD23 ' A' ' 50' ' ' LEU . 22.8 m-85 -108.2 7.81 27.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.574 -0.703 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 t30 50.56 47.09 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.53 -1.356 . . . . 0.0 109.562 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.637 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.8 mt -72.97 173.96 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.637 ' N ' HG22 ' A' ' 61' ' ' ILE . 66.0 mt-30 -133.07 137.93 46.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.89 151.02 4.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 110.516 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.986 -0.446 . . . . 0.0 110.851 179.75 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.25 130.74 38.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.31 118.81 37.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.814 . . . . 0.0 109.98 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.19 146.77 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.1 mp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.979 -1.076 . . . . 0.0 109.352 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.277 0.561 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 67' ' ' LEU . 4.9 mp -133.19 153.48 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -120.26 135.37 55.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.763 -1.211 . . . . 0.0 109.377 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.81 116.48 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.15 115.76 28.28 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.8 m -97.76 163.22 12.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.408 -0.808 . . . . 0.0 109.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.9 mp -68.67 -17.87 64.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 p -81.45 -1.45 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.053 -1.03 . . . . 0.0 109.751 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.12 13.69 73.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -91.26 131.84 36.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.027 -1.278 . . . . 0.0 109.307 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.8 m -107.38 113.22 26.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.163 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -106.54 139.64 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.596 -0.69 . . . . 0.0 109.221 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -108.73 134.67 51.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.672 -0.642 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.1 mt -125.92 143.91 50.89 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.749 . . . . 0.0 109.593 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -105.51 125.2 50.72 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.35 178.76 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.952 -1.093 . . . . 0.0 110.242 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 155.2 42.38 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.5 -34.74 32.68 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.056 1.838 . . . . 0.0 110.728 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 t -81.4 5.69 16.77 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.612 -0.68 . . . . 0.0 109.318 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' A' ' 26' ' ' VAL . 21.1 t0 -68.76 145.51 53.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 109.052 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.0 p -91.93 152.65 19.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.197 -0.939 . . . . 0.0 109.257 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -58.07 -35.18 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.961 -1.087 . . . . 0.0 109.124 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.68 -51.11 68.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.27 -33.86 76.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.866 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 22' ' ' THR . 96.8 t -73.25 -34.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' NZ ' HD12 ' A' ' 43' ' ' LEU . 28.2 mmtm -62.75 -35.38 79.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.39 63.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -49.42 -47.59 47.86 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.99 -36.22 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.31 -48.84 69.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.11 -26.26 65.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.007 . . . . 0.0 111.5 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -91.77 -47.61 7.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.758 -1.214 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 7.5 mp0 -87.18 -27.0 23.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.8 -1.188 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 -2.3 87.14 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.194 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.98 118.45 68.92 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.65 -1.5 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.51 152.65 3.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.564 1.509 . . . . 0.0 112.421 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.79 -17.97 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.706 2.27 . . . . 0.0 112.292 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -78.12 -3.76 44.0 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.123 -0.986 . . . . 0.0 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -112.32 -15.16 13.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -114.78 142.39 46.6 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.495 -0.753 . . . . 0.0 110.652 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HD3' HH21 ' A' ' 42' ' ' ARG . 3.4 mtm180 -129.17 119.23 23.73 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.568 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.0 mt -91.35 122.83 34.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 111.278 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -110.95 140.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.7 t80 -150.77 136.38 18.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 108.726 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.67 2.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 99.36 21.39 15.12 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 140.8 50.67 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.68 120.3 24.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.12 118.99 7.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.451 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.59 147.07 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.148 -0.97 . . . . 0.0 109.056 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.5 p-10 -61.77 138.08 58.3 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.767 . . . . 0.0 110.674 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.81 56.35 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.401 -0.812 . . . . 0.0 112.003 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.76 164.16 17.76 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 120.073 1.937 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -101.53 146.01 28.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.313 -0.867 . . . . 0.0 111.021 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.11 -39.25 63.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.387 -0.821 . . . . 0.0 109.645 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -68.66 -18.75 64.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.89 . . . . 0.0 109.166 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.81 -17.9 61.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.73 . . . . 0.0 109.898 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -107.74 9.85 28.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 54.8 25.32 6.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 109.419 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 18.9 mt -51.76 170.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 95.0 mm-40 -137.75 141.1 40.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.381 -0.825 . . . . 0.0 109.781 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -57.35 155.69 8.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.132 -0.98 . . . . 0.0 110.233 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 122.002 -0.436 . . . . 0.0 110.967 179.638 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -96.26 130.41 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.52 128.87 56.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.407 -0.808 . . . . 0.0 109.811 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.88 149.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 71' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.702 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.452 ' CG2' HD13 ' A' ' 67' ' ' LEU . 34.3 mm -117.45 153.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -127.03 127.36 44.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.506 -1.371 . . . . 0.0 108.64 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.68 124.9 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.712 -1.243 . . . . 0.0 109.464 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -102.31 123.31 45.89 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -101.1 153.54 19.49 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.288 -0.882 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.28 -18.41 37.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 p -81.33 -1.01 43.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.345 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.73 86.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.81 116.18 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.926 -1.337 . . . . 0.0 110.032 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -104.68 134.85 47.15 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -130.73 143.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 14' ' ' THR . 15.1 t -100.68 130.38 46.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.238 -0.914 . . . . 0.0 109.944 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.89 145.23 50.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 0.0 109.703 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -106.27 126.63 52.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.35 -176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 110.048 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -117.68 152.07 49.3 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.29 -33.3 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.062 1.841 . . . . 0.0 110.882 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -83.47 2.51 36.42 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 26' ' ' VAL . 2.4 t70 -66.89 148.37 52.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.839 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 159.37 16.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.394 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.59 -38.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.8 -47.87 83.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.929 . . . . 0.0 110.027 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -63.76 -46.21 86.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.865 . . . . 0.0 109.906 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' OD2' ' A' ' 21' ' ' ASP . 96.8 t -63.23 -30.92 50.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.572 -0.705 . . . . 0.0 109.556 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -69.38 -32.56 71.67 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.55 -58.46 8.5 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 29' ' ' LYS . 1.3 mptm? -49.5 -43.26 45.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.513 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -63.51 -44.52 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.252 -0.905 . . . . 0.0 109.745 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.71 -48.14 67.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -64.52 -19.45 65.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.828 . . . . 0.0 111.517 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -98.19 -47.48 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.737 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -90.26 -27.64 19.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.859 -1.151 . . . . 0.0 109.772 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.32 84.2 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.087 -1.008 . . . . 0.0 111.038 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -90.05 116.57 66.69 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.716 -1.461 . . . . 0.0 108.98 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.33 149.34 6.6 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.541 1.494 . . . . 0.0 112.094 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.82 -28.44 24.96 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.532 2.155 . . . . 0.0 112.386 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.16 -1.92 28.6 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.023 -1.048 . . . . 0.0 109.703 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -106.41 1.61 25.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -141.1 154.74 46.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -0.93 . . . . 0.0 111.267 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.403 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.5 mtm180 -130.54 128.57 41.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.66 121.12 37.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.548 -0.72 . . . . 0.0 111.494 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.99 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.61 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.5 t80 -133.8 134.94 43.48 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.06 -9.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 111.79 18.56 7.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -120.63 152.1 38.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.215 -1.168 . . . . 0.0 109.569 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -91.26 110.71 22.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.31 108.81 0.46 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.771 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.4 150.36 27.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.471 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.47 137.42 57.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.33 -0.856 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.18 -12.62 65.26 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.253 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -84.72 177.89 7.86 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.301 -1.705 . . . . 0.0 109.529 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.2 p -121.85 149.69 43.0 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.419 -0.8 . . . . 0.0 110.933 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -57.1 -41.97 79.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.615 -0.678 . . . . 0.0 109.313 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -57.23 -37.03 71.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.666 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.08 -20.52 6.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 109.553 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -101.83 11.31 38.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.158 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 46.99 48.04 15.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.926 -1.109 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.2 mt -73.4 175.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.344 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.624 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 tp-100 -144.88 147.52 32.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.986 -1.071 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -55.41 149.36 13.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.848 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.807 -0.558 . . . . 0.0 110.788 179.194 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.2 mp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -104.21 129.26 51.98 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.99 124.66 51.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.864 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.64 145.96 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.2 mp . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.039 -1.038 . . . . 0.0 108.872 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.592 0.711 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.82 167.6 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.0 m-85 -131.21 132.26 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.99 -1.069 . . . . 0.0 109.714 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.48 120.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 109.364 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -97.61 112.66 24.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 8' ' ' LEU . 33.8 m -94.58 160.16 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.296 -0.878 . . . . 0.0 109.613 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 7' ' ' THR . 35.8 mt -63.21 -20.79 65.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.996 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -81.53 -0.04 40.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.508 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 12.44 79.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -83.41 122.31 28.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.29 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -100.64 119.28 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -117.09 131.67 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.6 m -98.21 129.4 44.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.418 -0.801 . . . . 0.0 109.726 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -129.72 148.11 51.57 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.608 -0.683 . . . . 0.0 109.618 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.26 131.49 55.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.87 -175.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.966 -1.084 . . . . 0.0 110.079 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.8 149.18 41.95 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.13 -30.56 38.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.075 1.85 . . . . 0.0 110.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -83.56 2.18 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.73 147.1 50.96 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 p -89.96 156.92 18.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.43 -36.39 40.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.82 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.95 -48.77 75.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.803 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.75 -36.91 80.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 0.0 109.903 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.47 -28.73 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -67.66 -38.01 83.19 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -57.66 11.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -48.13 -45.23 32.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.361 -0.837 . . . . 0.0 109.41 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.85 -39.73 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.491 -0.756 . . . . 0.0 109.791 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -71.05 -51.09 27.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.98 -18.4 64.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 111.541 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -98.1 -47.63 5.42 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.641 -1.287 . . . . 0.0 110.764 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -93.53 -27.62 16.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.857 -1.152 . . . . 0.0 110.108 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.48 6.99 88.13 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.115 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.06 115.61 63.23 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.661 -1.494 . . . . 0.0 109.133 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.7 146.6 10.92 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.629 1.552 . . . . 0.0 112.247 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.94 -26.29 26.89 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.354 2.036 . . . . 0.0 112.432 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.09 -0.27 21.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.082 -1.011 . . . . 0.0 109.917 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -107.97 2.01 22.95 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.0 109.653 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -145.67 157.87 43.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.856 -1.153 . . . . 0.0 111.548 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -129.53 119.02 22.99 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 44' ' ' ILE . 16.5 mt -88.38 115.26 25.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.881 -1.137 . . . . 0.0 110.428 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.3 mp -109.04 144.75 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.594 ' C ' ' H ' ' A' ' 47' ' ' GLY . 66.6 t80 -147.15 133.48 19.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.093 . . . . 0.0 108.381 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 -5.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.634 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.01 16.34 10.71 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.2 144.99 47.42 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.084 -1.244 . . . . 0.0 109.655 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.88 119.2 25.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.31 114.88 6.38 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.811 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.99 154.66 19.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.905 -1.122 . . . . 0.0 108.994 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -63.52 140.49 58.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.504 -0.747 . . . . 0.0 111.203 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.65 -17.39 59.21 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.618 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 54' ' ' ARG . 3.0 mtp180 -76.04 176.58 7.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.219 -1.754 . . . . 0.0 109.556 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 57' ' ' SER . 38.3 m -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.519 -0.738 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -55.73 -41.37 73.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.364 -0.835 . . . . 0.0 109.645 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.4 ' H ' HG22 ' A' ' 55' ' ' THR . 85.0 p -60.34 -33.5 72.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.22 -20.07 9.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.627 -0.67 . . . . 0.0 109.717 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.4 3.86 35.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.101 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 m120 48.91 47.09 21.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 109.624 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.7 mt -69.17 177.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.398 -0.814 . . . . 0.0 109.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.669 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.3 tp-100 -135.52 138.84 43.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.157 -0.965 . . . . 0.0 109.801 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -52.54 146.94 9.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 110.563 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.761 -0.587 . . . . 0.0 110.856 179.33 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -107.76 130.88 54.92 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 69' ' ' LEU . 5.5 tt -116.35 117.84 31.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.514 -0.742 . . . . 0.0 109.502 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' N ' HD23 ' A' ' 69' ' ' LEU . 52.2 t -109.83 144.7 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 71' ' ' LEU . 9.8 mp . . . . . 0 N--CA 1.5 2.037 0 O-C-N 120.9 -1.125 . . . . 0.0 110.936 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.261 0.553 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -132.68 159.1 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -121.12 138.08 54.36 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.431 -0.793 . . . . 0.0 109.543 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.53 113.87 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.055 -1.028 . . . . 0.0 108.875 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -90.47 115.12 27.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.127 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.4 p -94.3 158.35 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 109.507 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.04 -16.81 63.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 9' ' ' THR . 84.8 m -81.53 -10.08 59.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.438 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 10.15 55.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.86 126.63 36.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.373 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -105.84 121.93 45.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 13' ' ' ILE . 3.4 mp -113.22 144.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -116.47 138.85 51.05 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.724 -0.61 . . . . 0.0 109.782 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -113.39 129.07 56.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.16 176.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.0 -1.063 . . . . 0.0 110.173 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -109.45 151.86 42.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.21 -34.36 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.062 1.841 . . . . 0.0 110.824 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -82.4 3.94 26.06 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.27 148.84 51.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.856 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -88.97 158.08 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 109.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -59.27 -42.96 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 108.42 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.33 -39.13 89.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.855 . . . . 0.0 110.129 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -68.82 -41.99 77.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.805 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -69.18 -31.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.133 -0.979 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -67.72 -34.71 77.4 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.52 83.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -42.94 85.05 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.94 -42.97 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.842 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.18 -43.32 98.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 0.0 109.895 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.99 -34.99 78.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 111.189 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -91.8 -39.82 11.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.761 -1.212 . . . . 0.0 111.531 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -93.37 -17.13 23.89 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.841 -1.162 . . . . 0.0 110.112 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -1.92 37.68 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.973 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.6 mt -81.43 134.21 51.88 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.701 -1.47 . . . . 0.0 109.039 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.92 160.86 48.02 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.688 1.592 . . . . 0.0 111.982 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 -24.69 32.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.765 2.31 . . . . 0.0 112.331 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -81.88 -1.81 48.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.023 -1.048 . . . . 0.0 110.315 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.99 -31.8 6.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.04 -1.038 . . . . 0.0 109.905 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.12 136.74 37.92 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.643 HH21 ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -126.07 111.96 15.3 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.8 mt -93.81 129.74 40.08 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.668 0.747 . . . . 0.0 112.094 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mt -124.07 140.41 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.452 0.644 . . . . 0.0 109.592 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.64 137.66 53.74 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.68 -115.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.911 -1.118 . . . . 0.0 108.465 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.75 30.23 4.94 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 145.96 52.17 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.291 -1.123 . . . . 0.0 109.651 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -88.09 120.05 29.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -57.17 119.43 6.36 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.499 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 32.0 mt-10 -95.71 168.93 10.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.36 -0.838 . . . . 0.0 109.377 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.76 142.18 27.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 111.292 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.08 6.39 55.86 Favored Glycine 0 N--CA 1.502 3.064 0 O-C-N 121.433 -0.792 . . . . 0.0 111.859 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' NH2' ' OE1' ' A' ' 51' ' ' GLU . 5.2 mtp180 -121.4 171.26 8.9 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 118.736 1.268 . . . . 0.0 109.783 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -106.37 149.08 27.34 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.078 -1.014 . . . . 0.0 110.945 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.09 -37.01 68.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 109.609 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.7 p -61.48 -21.15 63.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.84 -17.35 64.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.397 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -103.62 8.74 37.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.752 . . . . 0.0 110.493 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 57.13 47.62 16.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.628 -1.295 . . . . 0.0 109.437 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 62' ' ' GLN . 87.3 mt -80.28 174.48 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.383 -0.823 . . . . 0.0 109.131 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.618 ' N ' HG22 ' A' ' 61' ' ' ILE . 20.0 pt20 -152.95 154.5 35.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.885 -1.134 . . . . 0.0 110.055 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -54.68 147.95 13.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 122.122 -0.361 . . . . 0.0 111.159 179.867 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.7 mp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -90.82 133.73 34.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.295 -0.878 . . . . 0.0 108.777 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -110.8 123.7 50.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.508 -0.745 . . . . 0.0 110.142 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.8 146.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.502 2.159 0 O-C-N 120.874 -1.141 . . . . 0.0 109.972 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.328 0.585 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -143.97 166.29 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.33 141.76 51.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.327 -0.858 . . . . 0.0 109.703 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.88 117.02 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 0.0 108.893 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -89.75 114.13 25.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 108.974 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 160.86 15.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.407 -0.808 . . . . 0.0 109.904 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 8' ' ' LEU . 10.1 mp -69.34 -19.36 63.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.78 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -81.49 -4.13 55.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 109.49 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 12.96 62.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.68 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.367 . . . . 0.0 109.333 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -99.13 117.72 34.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.452 -0.78 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.8 139.98 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.447 -0.783 . . . . 0.0 109.118 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 14' ' ' THR . 11.6 t -113.3 135.43 53.86 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.716 -0.615 . . . . 0.0 109.676 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.04 159.89 40.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.467 -0.771 . . . . 0.0 109.7 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -115.76 132.11 56.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.43 176.69 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.004 -1.06 . . . . 0.0 110.19 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -107.23 153.81 40.88 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.08 -35.78 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.009 1.806 . . . . 0.0 110.754 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -83.35 4.83 25.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.638 -0.664 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.82 143.92 57.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.0 108.703 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -85.86 145.24 27.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 109.415 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.557 HG23 ' HZ2' ' A' ' 27' ' ' LYS . 1.9 mp -50.25 -41.09 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 108.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.77 -40.93 94.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -71.19 -35.92 71.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.8 -36.0 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 0.0 109.415 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HZ2' HG23 ' A' ' 23' ' ' ILE . 51.6 mttp -69.58 -30.77 68.62 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.72 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -53.45 -43.75 68.32 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mm -61.44 -46.07 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.7 -43.09 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.89 -32.89 72.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.374 -0.829 . . . . 0.0 111.249 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.14 -40.35 8.85 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.828 -1.17 . . . . 0.0 111.159 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.6 -21.92 25.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.767 -1.208 . . . . 0.0 109.656 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.51 53.31 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.999 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -91.09 134.39 30.13 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.838 -1.389 . . . . 0.0 108.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 131.26 20.92 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.22 1.28 . . . . 0.0 111.871 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.68 -19.14 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.341 2.027 . . . . 0.0 113.729 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.71 -8.5 56.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 110.605 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -109.02 -22.62 12.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.255 -0.903 . . . . 0.0 109.95 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -107.16 143.49 35.28 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.83 0.824 . . . . 0.0 110.998 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.71 124.61 43.12 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -93.65 121.43 35.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.442 -1.411 . . . . 0.0 110.024 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mm -112.17 129.93 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 83.9 t80 -146.91 139.84 25.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 108.903 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.63 3.25 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 109.298 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.38 19.92 26.53 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -127.98 151.86 48.62 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.125 -1.22 . . . . 0.0 109.641 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.61 113.27 25.27 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.07 117.53 2.61 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.307 -0.87 . . . . 0.0 109.87 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.02 173.7 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.229 -0.919 . . . . 0.0 109.804 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.29 146.35 25.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 0.0 111.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.77 10.68 55.06 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.412 -0.805 . . . . 0.0 111.552 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -129.06 160.84 31.52 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.763 -1.433 . . . . 0.0 110.612 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -89.44 146.83 24.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HG ' HD12 ' A' ' 61' ' ' ILE . 14.9 tp -55.65 -27.49 50.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.0 p -71.2 -16.45 62.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.075 -1.015 . . . . 0.0 109.236 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.42 -16.81 57.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.581 -0.7 . . . . 0.0 109.458 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.04 10.56 34.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 53.08 26.03 4.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.558 -1.339 . . . . 0.0 109.63 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 6.0 mt -52.39 170.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.323 -0.86 . . . . 0.0 108.724 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 52.2 mt-30 -138.83 142.68 38.66 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -58.04 153.62 14.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.662 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.668 -0.645 . . . . 0.0 110.565 179.605 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -90.52 128.78 36.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 108.618 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.71 122.54 48.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.614 -0.679 . . . . 0.0 109.792 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.13 150.47 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.4 mp . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 108.99 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.332 0.587 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -143.86 166.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -129.4 135.65 48.96 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.192 -0.943 . . . . 0.0 109.721 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.19 119.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 0.0 108.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -95.62 120.88 36.65 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 9' ' ' THR . 18.8 m -97.37 145.7 25.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.351 -0.843 . . . . 0.0 109.376 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -61.59 -13.77 24.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 7' ' ' THR . 56.9 m -81.55 -9.99 59.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.031 . . . . 0.0 109.556 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 2.5 55.85 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -91.37 136.39 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.937 -1.331 . . . . 0.0 109.273 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -123.94 134.41 53.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.468 -0.77 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.5 145.15 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.597 -0.689 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 136.75 41.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 109.797 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -126.81 146.24 50.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.55 -0.718 . . . . 0.0 109.544 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -105.88 125.34 50.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.83 174.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.349 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 12.5 mp0 -108.54 154.01 41.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.25 -35.06 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.923 1.749 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 t -84.28 4.84 29.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.512 -0.743 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.74 148.79 51.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.957 -1.089 . . . . 0.0 108.526 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -87.82 152.38 22.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 mp -56.14 -39.85 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -64.12 -42.04 97.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -65.25 -38.2 89.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -72.63 -29.22 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.459 -0.775 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -69.71 -34.5 73.99 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -54.27 47.58 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -49.53 -44.54 46.51 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.437 0.637 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.35 -38.18 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -63.25 -47.96 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 109.916 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -70.38 -20.05 62.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.197 -0.94 . . . . 0.0 111.268 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -93.65 -50.89 5.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.835 -1.166 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -87.67 -24.44 23.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.879 -1.138 . . . . 0.0 109.805 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.03 3.9 89.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.137 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 134.79 32.44 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.705 -1.468 . . . . 0.0 109.039 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.83 156.03 66.74 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.579 1.519 . . . . 0.0 111.951 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.36 -18.35 38.95 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.946 2.431 . . . . 0.0 112.578 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.76 -1.6 43.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 110.039 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -112.67 -23.04 10.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.136 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -115.63 144.78 43.41 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.67 118.29 22.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -85.92 121.25 28.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.67 0.747 . . . . 0.0 111.616 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -107.47 150.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -139.49 130.04 25.74 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.32 -119.5 1.51 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.62 27.61 7.87 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -135.65 -174.85 3.76 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.917 -1.343 . . . . 0.0 109.283 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -121.68 126.06 48.1 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.167 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.26 118.49 5.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.14 168.0 11.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.251 -0.906 . . . . 0.0 109.641 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.62 146.82 23.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.31 -0.868 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.46 60.85 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.341 -0.849 . . . . 0.0 111.657 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -123.66 164.12 19.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.118 -1.225 . . . . 0.0 110.189 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -96.79 147.85 23.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.922 -1.111 . . . . 0.0 110.749 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.79 -31.72 62.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -62.26 -23.58 66.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.66 -16.38 48.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -104.83 0.76 28.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 52.98 44.07 30.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.713 -1.242 . . . . 0.0 109.508 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.3 mt -66.87 174.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.209 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 5.8 tp-100 -135.82 140.41 44.19 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.186 -0.946 . . . . 0.0 110.009 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -51.76 143.59 12.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 110.568 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -101.81 131.89 47.88 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.68 126.58 55.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 109.496 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.4 147.43 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.3 mp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 120.915 -1.116 . . . . 0.0 108.841 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.4 0.619 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.13 166.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.72 132.31 51.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.26 116.69 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.058 -1.026 . . . . 0.0 109.001 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.04 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -92.43 153.85 18.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -59.84 -23.99 63.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 109.918 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 9' ' ' THR . 84.5 m -81.23 -6.67 59.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.568 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 1.41 63.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -73.65 113.57 10.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.908 -1.348 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.5 m -97.51 130.1 44.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.38 140.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 14' ' ' THR . 13.9 t -104.17 132.7 50.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.251 -0.905 . . . . 0.0 109.845 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -128.73 147.27 50.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.484 0.659 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -111.15 130.42 55.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.41 -178.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.021 -1.049 . . . . 0.0 110.054 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.18 154.57 46.22 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.74 -33.68 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.179 1.92 . . . . 0.0 110.71 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -84.34 5.69 25.99 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -69.14 146.51 52.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.0 108.871 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -93.76 152.69 18.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -57.55 -36.27 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 109.058 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.55 -53.03 61.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.978 . . . . 0.0 110.198 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.79 -37.67 87.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.359 -0.838 . . . . 0.0 109.931 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.69 -28.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -68.88 -34.93 76.25 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -56.75 17.71 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -49.65 -46.13 49.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.625 -0.672 . . . . 0.0 109.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.08 -41.71 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 109.722 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -68.9 -45.64 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 111.629 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -98.41 -48.22 5.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.646 -1.284 . . . . 0.0 111.065 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' HD12 ' A' ' 36' ' ' ILE . 26.6 tt0 -86.64 -28.51 23.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.763 -1.21 . . . . 0.0 109.673 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 5.91 88.42 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.379 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.415 HD12 ' CD ' ' A' ' 34' ' ' GLU . 28.8 mt -91.35 119.35 68.68 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 120.557 -1.555 . . . . 0.0 108.9 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 144.02 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.567 1.512 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 -18.09 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.459 2.106 . . . . 0.0 112.226 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.16 -11.2 60.81 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.103 -0.998 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -110.06 -29.23 8.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -85.48 137.25 33.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.509 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -124.49 111.49 15.76 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -93.25 124.47 37.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.589 -0.694 . . . . 0.0 111.199 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.29 138.08 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.658 -0.651 . . . . 0.0 109.355 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 85.6 t80 -140.26 139.39 35.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.447 -0.783 . . . . 0.0 109.154 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 67.1 -10.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.64 -0.663 . . . . 0.0 109.32 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.91 8.3 24.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -112.86 149.74 32.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.089 -1.242 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -83.4 116.73 22.62 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.85 120.68 12.38 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.687 -0.633 . . . . 0.0 110.068 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.9 151.33 20.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.92 138.62 57.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 111.186 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.68 71.54 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.474 -0.766 . . . . 0.0 111.231 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -82.57 166.9 18.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.706 -1.467 . . . . 0.0 111.075 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -111.39 145.42 38.94 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.663 0.744 . . . . 0.0 111.402 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.76 -43.54 90.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.667 -0.646 . . . . 0.0 109.788 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -55.58 -34.28 64.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.25 -20.77 29.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.388 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -103.8 5.1 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.27 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 48.1 41.56 15.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.789 -1.194 . . . . 0.0 109.694 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 62' ' ' GLN . 56.2 mt -60.1 169.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.365 -0.834 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.563 ' N ' HG22 ' A' ' 61' ' ' ILE . 62.9 mt-30 -129.05 134.62 48.18 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.789 0.804 . . . . 0.0 109.848 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -54.85 150.29 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 110.797 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.87 -0.518 . . . . 0.0 110.741 179.302 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.7 mp . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 1.6 m80 -102.43 127.94 49.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.357 -0.839 . . . . 0.0 109.202 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -109.38 111.5 23.09 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.502 -0.749 . . . . 0.0 109.494 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.2 t -116.87 142.57 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.961 HD22 ' H ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.007 -1.058 . . . . 0.0 109.605 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.342 0.591 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.96 163.0 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.9 145.39 48.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.336 -0.852 . . . . 0.0 109.69 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.86 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.392 -0.818 . . . . 0.0 108.885 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.18 114.86 26.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -88.79 156.45 18.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.27 -24.44 64.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -81.38 -5.33 57.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 16.96 53.75 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.67 115.08 27.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.912 -1.346 . . . . 0.0 109.398 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -91.9 118.49 30.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.11 145.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.551 -0.718 . . . . 0.0 109.12 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 t -111.38 134.83 52.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.639 -0.663 . . . . 0.0 109.667 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 mt -127.89 146.59 50.58 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.497 -0.752 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.36 123.37 46.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.73 177.46 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.976 -1.078 . . . . 0.0 110.043 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.17 164.06 15.58 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -77.57 -37.07 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 110.705 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -80.52 7.77 9.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -66.41 150.24 49.2 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.81 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 m -94.07 164.16 13.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -70.11 -40.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.035 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -63.07 -43.86 97.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -68.01 -40.01 83.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.471 -0.768 . . . . 0.0 109.679 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 22' ' ' THR . 95.7 t -71.24 -31.5 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -68.64 -32.38 72.18 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.98 81.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.84 -44.86 78.39 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.2 mt -62.34 -42.56 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.416 -0.803 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' GLY . 47.9 tt0 -65.35 -44.11 88.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.96 -33.54 73.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 111.149 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -93.86 -41.16 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.823 -1.173 . . . . 0.0 111.17 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -89.44 -26.01 21.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.676 -1.265 . . . . 0.0 109.907 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 80.21 7.28 88.68 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.189 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.45 116.81 66.6 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.803 -1.41 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.84 150.17 6.81 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.665 1.577 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.07 -19.46 34.63 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.675 2.25 . . . . 0.0 112.605 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.7 -4.49 46.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -107.93 -12.52 15.15 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -113.45 140.86 47.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.352 -0.842 . . . . 0.0 110.508 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -127.44 108.93 11.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.78 125.19 33.05 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.743 0.782 . . . . 0.0 111.695 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.39 134.48 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.461 0.648 . . . . 0.0 109.265 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLY . 65.9 t80 -148.6 142.43 25.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 109.225 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.71 8.26 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.733 . . . . 0.0 109.37 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 93.68 18.96 36.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -129.32 152.03 49.33 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.28 117.52 29.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 17.5 mt -54.32 115.51 2.13 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.227 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -88.57 146.54 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.027 . . . . 0.0 108.994 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.07 135.6 57.82 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.387 -0.821 . . . . 0.0 109.909 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -14.8 57.3 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.256 -0.902 . . . . 0.0 112.792 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -91.72 160.83 15.15 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.219 2.01 . . . . 0.0 110.559 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -105.54 151.08 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.567 0.698 . . . . 0.0 109.374 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.97 -39.06 65.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.995 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -60.27 -20.57 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.544 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.49 -19.64 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.582 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -107.32 8.66 29.87 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 0.0 110.397 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 52.09 49.07 21.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.676 -1.265 . . . . 0.0 109.675 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 62' ' ' GLN . 69.7 mt -76.92 172.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.488 -0.758 . . . . 0.0 109.132 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.606 ' N ' HG22 ' A' ' 61' ' ' ILE . 90.8 mt-30 -138.62 142.15 39.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.114 -0.991 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.27 152.53 6.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 110.44 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 122.048 -0.407 . . . . 0.0 110.884 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -89.88 129.89 36.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.1 -1.0 . . . . 0.0 108.956 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.2 tt -105.49 114.56 28.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.512 -0.743 . . . . 0.0 110.037 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.4 t -114.82 147.05 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 122.222 1.011 . . . . 0.0 110.735 -178.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.424 0.63 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.07 168.42 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -127.98 131.66 49.24 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.29 -0.881 . . . . 0.0 109.561 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.12 117.18 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 108.91 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -91.85 113.89 26.28 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -92.93 164.05 13.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.492 -0.755 . . . . 0.0 109.975 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -72.72 -19.02 61.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.035 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.3 p -81.38 -0.4 41.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 0.0 109.649 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 12.34 71.34 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -93.16 132.26 37.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.325 . . . . 0.0 109.057 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -116.14 130.87 57.01 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.28 143.3 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.643 -0.661 . . . . 0.0 109.468 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 t -103.62 138.08 40.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 109.782 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.2 mt -131.98 153.37 50.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.536 -0.727 . . . . 0.0 109.567 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -107.13 124.45 49.71 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -143.5 163.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.0 mt-10 -101.36 152.31 37.95 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -36.05 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.936 1.757 . . . . 0.0 111.338 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.9 p -79.77 4.73 15.48 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.385 -0.822 . . . . 0.0 109.288 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.28 146.02 49.18 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.483 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.4 p -89.34 154.38 20.13 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.93 -37.84 43.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.016 -1.053 . . . . 0.0 108.748 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.2 -44.32 95.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.7 -36.37 83.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.932 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.22 -30.31 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.489 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.22 -35.72 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.9 49.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -50.42 -46.84 56.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.64 -37.76 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.56 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.26 -47.15 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.8 -25.7 68.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 111.423 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -95.5 -48.8 5.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.9 -24.8 23.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.837 -1.165 . . . . 0.0 110.025 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.65 -1.6 88.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.233 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -80.68 134.28 54.25 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.657 -1.496 . . . . 0.0 108.571 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 131.8 20.78 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.36 1.373 . . . . 0.0 112.051 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -46.12 -23.21 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.237 1.958 . . . . 0.0 113.553 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -73.91 -2.68 24.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 110.59 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -113.64 -22.6 10.17 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -100.75 137.52 39.03 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.154 0.978 . . . . 0.0 111.212 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.5 104.41 9.64 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.15 122.02 33.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.799 -1.188 . . . . 0.0 110.075 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 mt -122.73 145.83 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 47' ' ' GLY . 74.9 t80 -149.96 144.84 26.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.64 6.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.94 15.97 49.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.47 139.95 52.81 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.074 -1.251 . . . . 0.0 109.027 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -78.59 118.69 20.95 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.24 118.91 6.0 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 109.861 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -90.62 150.18 21.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.194 -0.942 . . . . 0.0 109.936 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -66.33 134.91 53.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 110.752 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.99 -16.29 57.42 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 121.301 -0.874 . . . . 0.0 111.897 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.462 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -92.66 149.06 21.57 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-N 119.9 1.85 . . . . 0.0 109.997 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -90.81 154.48 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.587 0.708 . . . . 0.0 110.068 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.21 -36.28 72.89 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -61.94 -20.24 63.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.062 . . . . 0.0 109.188 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.37 -16.27 64.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.463 -0.773 . . . . 0.0 109.726 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -109.33 7.55 25.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.459 -0.776 . . . . 0.0 110.348 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 51.71 45.7 27.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.658 -1.276 . . . . 0.0 109.552 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 62' ' ' GLN . 88.9 mt -71.88 174.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.258 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.625 ' N ' HG22 ' A' ' 61' ' ' ILE . 15.6 tt0 -135.88 140.13 43.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.19 -0.944 . . . . 0.0 109.702 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -53.15 149.81 6.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.967 -0.458 . . . . 0.0 110.976 179.507 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.23 130.88 41.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.23 118.75 36.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.399 -0.813 . . . . 0.0 109.789 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.47 148.81 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.297 -1.686 0 O-C-N 120.806 -1.184 . . . . 0.0 109.302 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.507 0.67 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.1 pt -140.36 163.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 41.1 m-85 -121.75 136.12 54.94 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 114.03 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -90.64 117.37 29.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 109.031 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.7 p -92.12 160.64 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.882 . . . . 0.0 109.597 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -65.21 -20.1 66.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 85.1 m -81.67 -9.32 59.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 109.544 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.06 16.56 43.89 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -94.34 121.06 35.48 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.322 . . . . 0.0 109.563 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 m -96.65 121.33 38.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.293 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.36 141.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.488 -0.757 . . . . 0.0 109.236 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.9 p -107.53 131.64 54.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.668 . . . . 0.0 109.667 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -132.52 153.0 51.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.536 -0.728 . . . . 0.0 109.567 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.74 130.04 56.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.2 178.81 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -112.62 153.03 45.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.86 -31.51 47.61 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.997 1.798 . . . . 0.0 110.644 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 5.13 33.77 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.577 -0.702 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -69.58 146.64 51.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -95.59 148.8 22.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 109.387 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -54.2 -39.23 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.086 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.44 -47.69 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.892 . . . . 0.0 109.848 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -68.36 -37.27 80.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.758 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.19 -29.72 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -70.99 -33.99 70.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.37 76.88 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -54.12 -48.25 70.95 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -65.69 -38.08 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -59.13 -48.03 83.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.476 -0.765 . . . . 0.0 109.974 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.09 -35.06 77.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.464 -0.772 . . . . 0.0 111.198 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -79.81 -50.43 10.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.817 -1.177 . . . . 0.0 111.462 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.94 -10.08 49.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.757 -1.215 . . . . 0.0 110.015 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.24 27.13 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.68 134.27 37.97 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.744 -1.445 . . . . 0.0 108.79 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.69 156.93 59.94 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 0.0 112.073 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.43 -18.32 38.64 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.743 2.295 . . . . 0.0 112.781 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.51 -5.4 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -109.34 -27.92 9.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 109.311 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -96.86 134.72 39.82 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.244 -0.91 . . . . 0.0 110.657 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.509 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -118.83 109.21 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.93 129.89 38.69 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.683 -1.261 . . . . 0.0 111.817 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.17 141.13 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.487 0.661 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -119.54 137.41 53.85 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 -112.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.025 -1.047 . . . . 0.0 108.851 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.41 28.95 5.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -129.42 140.31 51.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.177 -1.19 . . . . 0.0 109.421 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -82.95 117.44 22.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CE1' ' A' ' 59' ' ' TYR . 93.7 mt -56.15 121.27 9.06 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.24 148.42 22.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 2.4 p30 -66.35 136.28 55.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 110.871 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.23 57.83 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.426 -0.796 . . . . 0.0 112.051 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.74 170.0 14.65 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.105 -1.821 . . . . 0.0 110.591 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 m -108.17 147.81 30.78 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.313 0.577 . . . . 0.0 109.802 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -56.04 -41.85 75.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -60.49 -20.57 60.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.35 -18.03 64.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CE1' HD23 ' A' ' 50' ' ' LEU . 21.0 m-85 -106.09 6.87 31.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.485 -0.76 . . . . 0.0 110.308 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 54.22 39.82 31.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.4 mt -64.05 169.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 61' ' ' ILE . 53.4 tt0 -138.62 143.2 39.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.283 -0.885 . . . . 0.0 110.029 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.24 145.41 13.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 110.654 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.756 -0.59 . . . . 0.0 110.774 179.33 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -92.53 128.61 38.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 0.0 108.885 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.13 117.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.796 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.4 145.47 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.9 mp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 110.016 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.375 0.607 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -145.17 165.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -125.07 137.58 54.2 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.202 -0.936 . . . . 0.0 109.454 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.33 121.38 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.656 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -93.95 118.02 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -93.58 154.08 18.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.97 -19.3 64.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.078 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -82.11 -1.46 48.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 109.726 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.08 9.83 69.92 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -92.23 116.42 28.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.047 -1.267 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -101.81 132.01 47.81 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 109.104 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tt -129.45 145.42 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.509 -0.745 . . . . 0.0 109.44 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -102.71 139.18 38.62 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.56 -0.713 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -130.19 149.74 51.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.619 -0.676 . . . . 0.0 109.43 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -111.09 129.87 55.79 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.69 178.54 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.981 -1.074 . . . . 0.0 110.139 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.27 153.49 44.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.54 -33.68 45.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.998 1.799 . . . . 0.0 110.762 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 m -84.94 4.71 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.422 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.67 145.46 53.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.973 -1.079 . . . . 0.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -91.91 162.61 14.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.86 -40.96 90.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.144 -0.972 . . . . 0.0 108.696 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -62.21 -43.73 98.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.73 -41.59 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.116 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.63 -29.07 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.02 . . . . 0.0 109.455 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -35.13 78.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.56 82.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.75 -44.3 77.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.72 -39.3 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.61 -45.62 91.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 109.93 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.61 -30.28 68.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 111.187 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -88.25 -46.68 9.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.78 -1.2 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -89.21 -19.84 24.92 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.638 -1.289 . . . . 0.0 110.017 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.07 4.68 56.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.065 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -89.82 122.48 67.93 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.684 -1.48 . . . . 0.0 109.3 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.31 149.55 6.33 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.633 1.555 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.35 -19.5 33.25 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.32 -2.8 33.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -111.65 -25.25 9.63 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.15 -0.969 . . . . 0.0 110.271 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -97.59 136.03 38.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -122.37 115.82 22.95 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.02 125.56 41.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.59 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -121.73 141.16 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 87.1 t80 -150.32 144.68 25.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.099 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 61.66 12.11 4.36 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.56 67.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.48 148.93 44.56 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.124 -1.221 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -84.26 113.53 21.18 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -54.53 123.17 12.28 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.745 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.64 143.27 27.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.148 -0.97 . . . . 0.0 109.13 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.9 133.91 56.01 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.417 -0.802 . . . . 0.0 109.602 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -16.23 56.91 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.35 -0.844 . . . . 0.0 112.086 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -81.97 164.28 21.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 119.977 -1.896 . . . . 0.0 109.108 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 m -104.93 147.56 27.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.47 -41.89 81.54 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -59.46 -23.73 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.166 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.98 -18.52 64.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -107.19 5.87 28.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.517 -0.739 . . . . 0.0 110.106 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 49.91 48.33 21.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.615 -1.303 . . . . 0.0 109.681 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.91 165.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 108.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -126.79 135.22 50.75 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.402 -0.811 . . . . 0.0 109.75 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.11 146.21 6.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 122.133 -0.355 . . . . 0.0 110.959 179.675 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -97.79 126.37 43.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.194 -0.941 . . . . 0.0 108.999 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.85 117.59 34.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 109.585 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 71' ' ' LEU . 59.1 t -103.65 143.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.495 1.812 0 O-C-N 120.888 -1.132 . . . . 0.0 109.608 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.453 0.644 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -145.66 166.81 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 61.2 m-85 -121.13 136.55 54.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.79 118.7 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.64 120.75 36.45 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -97.03 153.88 17.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.82 -18.88 58.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.364 -0.835 . . . . 0.0 110.16 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -81.54 -1.47 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.18 70.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.15 118.01 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.978 -1.307 . . . . 0.0 109.659 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -103.34 130.35 50.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.327 -0.858 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -131.11 138.28 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.462 -0.773 . . . . 0.0 109.732 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -97.69 142.44 29.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -132.83 155.5 48.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.461 -0.775 . . . . 0.0 109.613 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -106.81 125.55 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.37 165.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.071 -1.018 . . . . 0.0 109.969 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 39.2 mt-10 -107.67 154.06 41.09 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.52 -29.1 31.14 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.157 1.905 . . . . 0.0 111.113 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -88.7 1.26 55.43 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 151.27 47.17 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.962 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.8 p -96.66 150.94 20.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.257 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -54.4 -36.75 35.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.065 -1.022 . . . . 0.0 108.863 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.32 -42.81 92.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 109.935 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -67.78 -37.74 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.96 -31.05 39.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.581 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.63 -34.98 76.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.89 78.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.3 -46.88 79.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.3 mt -63.07 -42.16 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.23 -46.11 85.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 109.974 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.02 -30.57 71.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 111.442 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -96.07 -43.74 7.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.879 -1.138 . . . . 0.0 111.278 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -87.9 -27.26 22.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.813 -1.179 . . . . 0.0 109.945 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.34 77.15 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.106 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -76.18 133.67 71.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.706 -1.467 . . . . 0.0 108.616 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.23 133.15 20.6 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.36 1.373 . . . . 0.0 112.143 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.89 -25.45 2.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 113.155 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -77.81 -3.63 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.95 -1.094 . . . . 0.0 110.338 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -111.78 -29.89 7.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -107.23 143.42 35.48 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.825 0.821 . . . . 0.0 111.016 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.453 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.4 mtp180 -130.38 125.43 34.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.7 mt -96.43 122.79 39.71 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.032 -1.043 . . . . 0.0 111.186 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.3 mp -118.97 134.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.84 134.79 55.12 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 -109.45 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.081 -1.012 . . . . 0.0 108.792 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.5 33.34 3.31 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -133.83 154.6 50.91 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.065 -1.256 . . . . 0.0 109.598 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -99.3 116.09 30.68 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -53.6 120.05 5.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.97 142.62 27.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.893 . . . . 0.0 109.795 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.27 135.46 57.48 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.453 -0.779 . . . . 0.0 110.31 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 -18.6 54.83 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.358 -0.839 . . . . 0.0 111.943 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.438 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -90.66 159.89 16.15 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.022 1.911 . . . . 0.0 109.996 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -102.72 154.55 19.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.587 -0.696 . . . . 0.0 109.927 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.65 -37.39 73.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.345 -0.847 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -56.74 -18.71 13.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.008 -1.058 . . . . 0.0 109.533 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -76.22 -19.44 58.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.89 -11.92 17.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.466 -0.771 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 t30 60.58 48.01 7.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.032 -1.042 . . . . 0.0 109.577 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 62' ' ' GLN . 97.2 mt -70.36 171.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.141 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 61' ' ' ILE . 26.0 mm100 -128.27 136.16 50.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -53.6 148.1 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.703 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' OE2' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.646 -0.659 . . . . 0.0 110.308 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -95.76 126.14 40.82 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.077 -1.015 . . . . 0.0 108.835 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tp -101.23 113.28 26.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' C ' HD12 ' A' ' 71' ' ' LEU . 44.1 t -106.43 138.25 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 70' ' ' VAL . 9.2 mp . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.214 -0.928 . . . . 0.0 109.279 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.324 0.583 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.14 166.53 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.33 158.51 39.62 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.02 124.73 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.1 119.64 31.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.489 -0.757 . . . . 0.0 109.094 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -91.14 151.97 20.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -58.82 -19.3 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 109.754 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 9' ' ' THR . 89.8 m -81.37 -6.71 59.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.136 -0.978 . . . . 0.0 109.402 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.67 59.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -94.09 118.94 32.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.314 . . . . 0.0 109.611 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -94.86 122.9 37.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.054 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -115.26 145.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.572 -0.705 . . . . 0.0 109.12 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 14' ' ' THR . 12.2 t -106.6 131.7 53.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.714 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -129.71 150.44 51.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.458 -0.776 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -110.91 128.7 55.9 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.88 174.51 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 110.317 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -107.93 152.88 41.86 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.61 -34.18 26.16 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.967 1.778 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -85.66 1.78 47.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.57 -0.706 . . . . 0.0 109.233 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.67 147.91 44.35 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.996 -1.081 . . . . 0.0 108.522 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.4 p -89.0 155.81 19.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 108.847 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -56.73 -42.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.043 -1.035 . . . . 0.0 108.237 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.81 -37.89 89.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -69.48 -41.63 75.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.6 t -66.76 -28.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.245 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -72.92 -35.42 67.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.38 92.42 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.99 -44.93 94.67 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.0 -37.58 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.42 -0.8 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -59.61 -47.96 83.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.923 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -66.77 -34.82 78.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 111.274 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -85.22 -46.13 11.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 111.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -85.03 -27.24 26.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.67 -1.269 . . . . 0.0 109.72 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.66 3.58 79.32 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.441 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -93.29 124.34 57.97 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.673 -1.487 . . . . 0.0 108.716 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.39 130.34 21.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.294 1.329 . . . . 0.0 112.368 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -49.47 -24.56 9.17 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.223 1.949 . . . . 0.0 113.423 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.21 -9.22 58.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.645 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -103.65 -23.57 13.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -98.25 138.48 35.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 0.0 110.761 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -122.61 112.05 17.52 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 44' ' ' ILE . 14.6 mt -88.5 122.84 32.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.185 -0.947 . . . . 0.0 111.097 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.616 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.9 mp -115.34 132.72 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -119.96 135.53 54.87 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 -112.76 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.014 -1.054 . . . . 0.0 109.087 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.98 28.62 5.82 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -140.13 179.2 6.77 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.881 -1.364 . . . . 0.0 109.474 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -109.63 156.45 20.2 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 50' ' ' LEU . 4.3 mm? -83.32 108.63 16.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.095 -1.003 . . . . 0.0 108.358 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' CD ' HH21 ' A' ' 54' ' ' ARG . 40.4 tt0 -80.71 152.5 28.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.68 142.27 30.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.529 -0.732 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.02 10.47 51.96 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.301 -0.875 . . . . 0.0 111.714 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.62 HH21 ' CD ' ' A' ' 51' ' ' GLU . 3.9 mtp180 -129.69 172.87 11.17 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.893 -1.357 . . . . 0.0 109.721 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -103.59 149.73 24.63 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.037 -1.039 . . . . 0.0 111.235 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -56.65 -32.54 65.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.461 -0.774 . . . . 0.0 109.491 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -62.11 -19.27 62.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.087 -1.008 . . . . 0.0 109.213 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.35 -16.88 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.421 -0.799 . . . . 0.0 109.614 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.502 ' CE1' HD13 ' A' ' 50' ' ' LEU . 13.4 m-85 -103.91 10.98 36.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.427 -0.796 . . . . 0.0 110.238 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 52.46 42.46 31.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.612 -1.305 . . . . 0.0 109.416 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 62' ' ' GLN . 60.6 mt -71.4 170.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.561 ' N ' HG22 ' A' ' 61' ' ' ILE . 42.4 mt-30 -143.8 147.05 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.086 -1.009 . . . . 0.0 110.068 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -52.94 145.78 12.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 110.587 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.821 -0.549 . . . . 0.0 110.607 179.482 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -97.78 130.94 44.69 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.9 tt -103.36 116.89 33.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 109.666 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 69' ' ' LEU . 46.7 t -108.05 146.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.498 1.954 0 O-C-N 120.861 -1.149 . . . . 0.0 111.047 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -145.84 166.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -128.84 150.4 50.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.93 -1.107 . . . . 0.0 110.131 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.55 123.72 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.365 -0.835 . . . . 0.0 108.866 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -97.66 123.5 41.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 8' ' ' LEU . 34.4 m -98.6 158.95 15.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' N ' HG22 ' A' ' 7' ' ' THR . 22.3 mt -63.25 -16.31 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.924 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -82.04 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.097 -1.002 . . . . 0.0 109.641 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.83 64.97 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -94.86 133.69 38.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.312 . . . . 0.0 109.281 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.9 m -114.88 129.2 56.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 109.126 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -125.49 145.06 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.72 -0.612 . . . . 0.0 109.494 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -103.45 136.89 42.34 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.712 . . . . 0.0 109.847 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -131.99 151.75 51.55 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -103.29 122.86 45.67 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.05 164.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.114 -0.991 . . . . 0.0 110.076 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 65.0 mt-10 -107.23 151.81 40.94 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.1 -30.91 37.76 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.091 1.861 . . . . 0.0 111.04 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -82.95 -0.8 50.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.52 147.88 52.21 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.671 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.3 p -90.77 153.98 19.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 109.005 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.61 -38.9 44.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.846 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.3 -45.1 89.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 109.876 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -63.21 -36.97 85.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.983 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.28 -27.97 22.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -67.53 -38.26 83.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.51 45.55 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -48.92 -43.9 39.84 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.526 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.15 -28.61 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.014 -1.054 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -61.94 -50.31 72.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 109.871 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -72.78 -28.8 62.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -81.39 -47.52 13.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.865 -1.147 . . . . 0.0 111.039 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.14 -17.79 25.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.715 -1.241 . . . . 0.0 109.73 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.04 52.02 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.286 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -93.23 125.07 55.9 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.665 -1.491 . . . . 0.0 109.304 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.32 149.05 6.88 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.482 1.455 . . . . 0.0 112.145 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.69 -26.92 32.58 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.357 2.038 . . . . 0.0 112.29 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.33 -2.36 13.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -110.85 -13.32 14.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.02 -1.05 . . . . 0.0 109.689 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -110.05 137.75 47.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -119.81 111.02 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 17.2 mt -92.46 120.17 32.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.3 mp -113.98 144.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -123.29 140.49 52.96 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.07 -112.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.098 -1.002 . . . . 0.0 108.56 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.43 6.19 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -125.12 144.09 50.6 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.014 -1.286 . . . . 0.0 109.366 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -74.68 147.9 41.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.523 HD23 ' CE1' ' A' ' 59' ' ' TYR . 96.5 mt -88.16 114.79 25.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.821 -1.174 . . . . 0.0 108.842 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 21.6 mp0 -81.3 175.72 10.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 108.912 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 39.3 p-10 -95.49 135.65 36.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.72 -0.613 . . . . 0.0 111.577 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.93 -8.22 61.12 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.998 -1.064 . . . . 0.0 112.18 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 5.8 mtt180 -95.18 154.8 17.01 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 120.307 -1.702 . . . . 0.0 109.306 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 p -92.87 149.79 21.03 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.016 -1.053 . . . . 0.0 110.895 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -53.75 -33.68 56.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 109.636 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 m -64.82 -13.63 56.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.06 -1.025 . . . . 0.0 109.085 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.17 -17.22 61.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.547 -0.721 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.523 ' CE1' HD23 ' A' ' 50' ' ' LEU . 19.0 m-85 -110.68 8.19 22.55 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 0.0 110.13 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 54.76 45.73 26.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.346 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 62' ' ' GLN . 86.5 mt -75.04 172.1 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.177 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.604 ' N ' HG22 ' A' ' 61' ' ' ILE . 81.3 mt-30 -139.32 142.12 37.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -51.8 151.61 3.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.225 -0.922 . . . . 0.0 110.336 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 122.059 -0.4 . . . . 0.0 110.793 179.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.4 127.74 38.0 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.5 tt -106.16 113.25 26.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 ' N ' HD23 ' A' ' 69' ' ' LEU . 61.8 t -111.72 141.37 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 71' ' ' LEU . 1.2 mm? . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 0.0 109.615 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.349 0.595 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 3' ' ' ILE . 9.6 tt -141.38 163.9 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 28.4 m-85 -126.72 157.04 40.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.47 119.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -91.29 120.56 32.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 109.366 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -95.83 166.04 12.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.57 -22.12 65.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.154 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.52 -3.2 52.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.632 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 17.32 60.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -94.41 125.41 39.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.326 . . . . 0.0 109.301 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.2 m -101.1 121.95 42.73 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -108.96 141.65 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.424 HG22 ' CE2' ' A' ' 4' ' ' PHE . 79.0 p -103.74 126.77 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.72 149.78 51.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.503 -0.748 . . . . 0.0 109.712 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -103.67 123.46 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.1 p -144.91 166.34 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.055 -1.028 . . . . 0.0 110.19 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.6 mt-10 -109.9 152.19 42.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.27 -28.03 34.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.207 1.938 . . . . 0.0 111.28 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 t -85.34 -2.2 57.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.012 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 26' ' ' VAL . 9.9 t0 -62.87 146.98 51.54 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.803 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -88.61 143.49 26.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.7 mp -49.76 -42.38 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 108.483 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -60.25 -44.2 95.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.643 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.39 -40.0 85.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' OD2' ' A' ' 21' ' ' ASP . 60.9 t -63.96 -33.23 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.623 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -70.84 -35.08 72.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.89 82.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -54.57 -48.76 71.69 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.89 -37.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.68 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -61.99 -48.78 78.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -67.3 -33.11 74.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 111.115 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -45.45 12.54 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.789 -1.194 . . . . 0.0 111.179 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -88.98 -24.96 22.27 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.736 -1.228 . . . . 0.0 109.833 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 1.07 90.09 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.146 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.97 134.35 35.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 120.596 -1.532 . . . . 0.0 108.873 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.91 154.45 67.13 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.553 1.502 . . . . 0.0 112.035 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.69 -17.94 37.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.594 2.196 . . . . 0.0 112.302 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.54 -4.82 53.15 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.763 -1.21 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -107.2 -28.07 10.16 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.263 -0.898 . . . . 0.0 110.735 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -112.89 146.69 38.5 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.393 -0.817 . . . . 0.0 110.621 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.0 120.59 27.87 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.0 mt -90.43 126.19 35.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 0.0 110.844 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.6 mp -119.63 137.03 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 109.349 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -119.0 136.09 54.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.93 -112.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 108.655 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.23 4.86 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.53 147.71 52.56 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.148 -1.207 . . . . 0.0 109.545 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -90.21 116.86 28.52 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.8 mt -55.66 123.51 14.31 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 109.926 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.46 140.75 45.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.715 0.769 . . . . 0.0 109.343 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.8 p-10 -64.52 155.28 33.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.688 -0.632 . . . . 0.0 110.958 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.76 2.05 56.29 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.377 -0.827 . . . . 0.0 112.072 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -133.9 172.48 12.74 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.745 -1.444 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -105.26 154.67 19.93 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.165 -0.959 . . . . 0.0 110.994 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.67 -34.35 64.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.432 -0.792 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -62.55 -16.7 57.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.73 -16.87 63.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.82 . . . . 0.0 109.443 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -105.46 11.03 33.04 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 53.61 46.83 25.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.651 -1.281 . . . . 0.0 109.468 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 62' ' ' GLN . 75.9 mt -87.47 -176.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 0.0 109.349 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.764 ' H ' HG22 ' A' ' 61' ' ' ILE . 10.0 pt20 -157.79 158.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 110.29 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -54.58 151.08 8.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.426 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.603 179.643 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -93.18 134.58 35.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 108.624 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.71 121.43 45.01 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.479 -0.763 . . . . 0.0 109.88 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.19 151.95 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.965 -1.084 . . . . 0.0 109.46 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.371 0.605 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.91 162.57 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 37.3 m-85 -124.98 141.73 51.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.313 -0.867 . . . . 0.0 109.398 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.89 116.62 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.335 -0.853 . . . . 0.0 109.005 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.4 114.74 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.415 -0.803 . . . . 0.0 108.911 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -90.97 165.75 13.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tp -70.38 -23.48 62.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.4 p -81.27 -0.15 39.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.033 . . . . 0.0 109.45 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.29 15.74 66.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -93.15 122.06 35.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.868 -1.372 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -99.34 121.61 41.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.534 -0.729 . . . . 0.0 109.401 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.33 139.8 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.661 -0.649 . . . . 0.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.9 p -101.91 127.43 48.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.567 -0.708 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.1 mt -131.18 151.27 51.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.557 -0.714 . . . . 0.0 109.587 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -115.64 131.85 56.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.81 176.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.988 -1.07 . . . . 0.0 110.099 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.23 150.22 40.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.85 -32.1 46.55 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.876 1.717 . . . . 0.0 110.906 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -84.42 2.77 39.18 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.531 -0.731 . . . . 0.0 109.245 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.47 145.79 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.911 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -85.39 160.38 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.459 -0.775 . . . . 0.0 108.935 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.4 mp -61.22 -39.37 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.061 -1.025 . . . . 0.0 108.26 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -35.87 81.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -69.74 -38.92 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 109.606 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -72.45 -33.09 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.577 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' NZ ' ' CG2' ' A' ' 23' ' ' ILE . 49.6 mttp -68.01 -34.17 76.0 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -51.46 -45.79 62.83 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.885 . . . . 0.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.5 -48.88 79.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 110.053 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -68.98 -31.95 71.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.317 -0.865 . . . . 0.0 111.052 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -82.92 -48.19 10.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.919 -1.113 . . . . 0.0 111.489 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.775 -1.203 . . . . 0.0 109.986 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.51 3.21 82.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.131 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.12 123.67 66.72 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.75 -1.441 . . . . 0.0 108.764 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.34 130.16 20.64 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.143 1.229 . . . . 0.0 112.267 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.53 -34.2 25.6 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.258 1.972 . . . . 0.0 113.444 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.45 -1.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.326 -0.859 . . . . 0.0 110.803 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -109.47 -21.68 12.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 0.0 110.052 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -103.31 138.31 40.26 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.141 -0.974 . . . . 0.0 111.412 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -121.14 105.34 10.5 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.04 125.14 34.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.98 -1.075 . . . . 0.0 110.239 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mt -123.5 145.18 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' C ' ' H ' ' A' ' 47' ' ' GLY . 84.3 t80 -148.8 145.91 27.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.616 -0.678 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.86 8.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.29 16.14 51.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -121.55 146.31 47.07 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.998 -1.295 . . . . 0.0 108.853 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.48 115.82 23.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.74 119.51 5.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.941 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.82 173.35 7.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.188 -0.945 . . . . 0.0 109.89 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -94.67 149.15 21.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 110.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.7 -11.05 69.81 Favored Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.445 -0.784 . . . . 0.0 111.331 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -96.46 174.66 6.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.79 -1.418 . . . . 0.0 109.448 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -115.31 152.47 32.72 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.992 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -57.56 -41.01 80.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.493 -0.755 . . . . 0.0 109.75 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -58.95 -23.76 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 109.328 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.67 -17.09 62.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.357 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.33 3.71 35.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.0 110.314 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.27 45.13 27.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.743 -1.223 . . . . 0.0 109.413 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.0 mt -72.24 173.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 109.159 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' N ' HG22 ' A' ' 61' ' ' ILE . 59.6 mt-30 -137.38 142.2 41.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -53.48 148.14 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.857 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.734 -0.604 . . . . 0.0 110.561 179.463 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.7 mp . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -98.57 132.36 44.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.185 -0.947 . . . . 0.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -107.22 113.68 27.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.634 -0.666 . . . . 0.0 109.508 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.0 t -108.58 150.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.804 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -100.52 141.2 33.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 109.801 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.68 163.73 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -122.46 132.74 54.49 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -99.12 112.82 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.024 -1.047 . . . . 0.0 108.852 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -89.68 114.5 26.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.748 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -93.84 162.03 14.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.321 -0.862 . . . . 0.0 109.842 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.97 -19.49 64.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.814 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -81.69 -5.55 58.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.998 . . . . 0.0 109.595 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.78 14.88 58.94 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -93.87 124.68 38.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.886 -1.361 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 m -102.01 124.22 47.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.532 -0.73 . . . . 0.0 109.043 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -114.99 140.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.562 -0.712 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -102.2 128.35 48.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -128.65 147.97 50.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 16' ' ' GLU . 27.2 mp0 -110.68 127.88 55.48 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.28 179.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.975 -1.078 . . . . 0.0 110.262 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -113.05 151.68 44.35 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.14 -30.42 46.75 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.993 1.795 . . . . 0.0 110.899 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -84.94 4.8 31.87 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.62 145.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 0.0 108.881 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -92.2 148.17 22.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -50.47 -40.76 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.085 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.68 -43.88 90.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.256 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -69.51 -37.0 76.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.92 -32.61 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -70.31 -32.69 70.56 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.74 96.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.12 -47.26 85.91 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.391 0.615 . . . . 0.0 109.418 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.44 -39.78 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.61 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.86 -47.06 88.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 109.966 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.43 -23.64 58.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.956 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -84.89 -51.71 6.54 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.807 -1.183 . . . . 0.0 111.295 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -91.18 -24.0 20.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.65 -1.281 . . . . 0.0 109.902 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.41 4.19 88.04 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.964 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.32 121.75 67.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.776 -1.426 . . . . 0.0 109.12 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.41 150.35 5.72 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.633 1.556 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.64 -28.77 25.42 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.595 2.197 . . . . 0.0 112.483 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.76 -3.32 27.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.56 -6.11 24.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.57 153.75 50.89 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.211 -0.931 . . . . 0.0 110.945 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -129.77 120.78 25.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 44' ' ' ILE . 26.7 mt -86.67 123.15 31.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.992 -1.068 . . . . 0.0 111.275 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.6 mp -116.46 133.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.547 0.689 . . . . 0.0 109.17 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 47' ' ' GLY . 60.5 t80 -145.95 140.78 27.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.143 -0.973 . . . . 0.0 108.801 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 8.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 109.288 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.81 23.23 26.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -126.94 147.14 50.11 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.146 -1.208 . . . . 0.0 109.53 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -89.95 112.09 23.37 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.41 122.93 10.65 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.496 -0.753 . . . . 0.0 109.759 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -93.05 148.07 22.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.156 -0.965 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.22 131.88 47.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.942 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.65 64.27 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.309 -0.869 . . . . 0.0 111.403 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 54' ' ' ARG . 15.5 ttt180 -89.55 156.4 18.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.402 -1.646 . . . . 0.0 109.783 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -98.23 148.01 24.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.186 -0.946 . . . . 0.0 110.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.86 -38.94 76.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 109.871 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -57.9 -28.07 63.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.992 . . . . 0.0 110.004 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.44 -16.82 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.39 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -101.86 0.54 35.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.413 -0.804 . . . . 0.0 110.133 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 m120 52.03 49.11 21.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 96.6 mt -75.67 176.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 17.4 tt0 -132.44 138.2 47.55 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.27 -0.894 . . . . 0.0 109.662 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -52.41 149.57 5.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 110.543 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 64.56 13.65 8.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.893 -0.505 . . . . 0.0 110.953 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.465 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -94.69 143.0 26.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.033 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -90.24 128.27 36.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.096 -1.003 . . . . 0.0 108.659 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.71 125.13 53.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.67 147.3 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.5 mp -79.9 -82.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 108.77 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -150.18 176.62 10.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 110.648 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.63 130.87 34.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 110.711 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.71 141.43 43.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.98 -171.38 44.42 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 118.981 -1.58 . . . . 0.0 110.837 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 -96.08 137.01 35.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 tt -144.57 165.78 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.5 m-85 -130.86 157.74 42.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.18 121.06 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 108.596 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.8 tttm -91.86 122.64 34.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.153 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 8' ' ' LEU . 30.0 m -96.25 161.36 13.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.456 ' N ' HG22 ' A' ' 7' ' ' THR . 24.3 mt -62.65 -23.08 66.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -81.64 -0.65 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 16.25 66.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -91.18 117.78 29.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.043 -1.269 . . . . 0.0 109.37 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -93.61 118.52 31.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.475 -0.766 . . . . 0.0 109.169 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -107.63 139.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.754 . . . . 0.0 109.274 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.31 129.03 53.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 109.779 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.27 150.01 51.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.473 -0.767 . . . . 0.0 109.66 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -106.66 126.41 52.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.72 176.03 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.076 -1.015 . . . . 0.0 110.243 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -112.77 151.58 44.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.0 -33.01 64.27 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.818 1.679 . . . . 0.0 110.669 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -85.71 3.91 39.0 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.576 -0.703 . . . . 0.0 109.221 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.38 149.22 48.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 p -96.69 147.16 24.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.526 -0.734 . . . . 0.0 109.694 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.53 -41.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.226 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.13 -45.02 96.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.775 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -68.26 -37.4 80.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.728 . . . . 0.0 109.674 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -70.48 -31.32 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.273 -0.892 . . . . 0.0 109.901 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.46 -33.33 71.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.53 97.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -59.72 -44.94 93.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.84 -40.82 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.369 -0.832 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.59 -45.38 93.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.831 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.39 -35.6 80.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 111.284 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -89.16 -44.34 10.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.54 -27.09 22.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.75 -1.219 . . . . 0.0 110.063 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.21 83.11 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.037 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.7 mt -91.09 119.11 68.88 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.702 -1.469 . . . . 0.0 109.339 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.57 149.56 6.93 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.69 1.593 . . . . 0.0 112.326 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.06 -22.98 29.97 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.74 -6.01 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.795 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.13 -4.44 35.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 109.812 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -140.01 155.82 46.91 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.073 -1.017 . . . . 0.0 111.35 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.436 HH21 ' HD3' ' A' ' 42' ' ' ARG . 13.6 mtt180 -127.78 133.34 49.46 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.7 mt -96.93 123.59 40.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 109.79 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.1 mp -112.54 138.81 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' GLY . 89.9 t80 -147.5 137.74 23.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.025 . . . . 0.0 109.059 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 11.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.369 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 92.6 23.94 24.86 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -128.11 147.18 50.53 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.122 -1.222 . . . . 0.0 109.47 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -90.15 111.69 22.92 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.04 118.14 3.0 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.551 -0.718 . . . . 0.0 109.267 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -94.76 142.74 27.11 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.178 -0.951 . . . . 0.0 109.074 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.15 137.56 57.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.524 -0.735 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.78 -13.15 57.89 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -96.61 154.7 17.13 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.959 1.879 . . . . 0.0 110.367 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -99.07 152.36 19.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.025 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.61 -37.55 68.28 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.343 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -59.09 -21.46 59.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.894 -1.128 . . . . 0.0 109.732 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -70.77 -16.88 62.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -105.51 9.65 33.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.326 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 52.23 47.63 24.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.0 mt -79.75 172.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.421 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' HG22 ' A' ' 61' ' ' ILE . 29.7 mt-30 -144.03 146.95 33.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.05 -1.031 . . . . 0.0 110.062 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.32 147.71 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 67.52 16.09 9.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.622 -0.674 . . . . 0.0 110.425 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.6 mp -96.12 147.31 23.87 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -93.05 131.89 37.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.289 -0.882 . . . . 0.0 108.766 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.65 128.73 55.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.02 150.71 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.2 mp -79.88 -78.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 108.757 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -167.91 -164.43 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 0.0 110.836 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.04 109.73 1.91 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 109.766 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 75' ' ' GLY . 2.0 ttm180 -59.81 -31.04 69.34 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 74' ' ' ARG . . . -60.21 -121.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -104.03 148.44 26.22 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.387 -0.82 . . . . 0.0 109.758 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -146.34 167.57 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 44.1 m-85 -124.78 134.85 52.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.96 113.61 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -90.77 113.58 25.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 8' ' ' LEU . 29.3 m -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.227 -0.92 . . . . 0.0 109.761 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' N ' HG22 ' A' ' 7' ' ' THR . 7.6 tp -64.05 -21.53 66.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 110.111 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -81.25 1.32 32.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.033 -1.042 . . . . 0.0 109.641 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.96 80.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -87.77 125.56 34.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.319 . . . . 0.0 109.121 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -105.77 122.19 45.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.576 -0.703 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.91 138.28 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.7 m -105.8 135.71 46.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 0.0 109.998 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.15 156.15 48.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 109.579 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -109.4 127.11 54.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -143.57 164.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 109.923 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 62.8 mm-40 -103.89 149.63 37.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.63 -31.48 32.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.949 1.766 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 t -82.8 -0.62 48.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.441 -0.787 . . . . 0.0 109.406 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 146.81 54.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -87.88 157.66 18.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.922 . . . . 0.0 109.048 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.573 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.1 mp -56.71 -42.07 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 108.499 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -64.03 -41.22 97.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -64.3 -36.95 85.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.029 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -74.7 -29.0 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -67.43 -37.51 83.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.45 44.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -49.04 -46.96 45.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.68 -36.63 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.867 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -70.78 -48.4 54.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.81 -28.21 67.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -97.53 -41.57 8.1 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.811 -1.18 . . . . 0.0 111.208 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -93.12 -19.96 20.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.771 -1.205 . . . . 0.0 110.125 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.09 18.45 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.956 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.98 119.96 79.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 120.731 -1.453 . . . . 0.0 108.775 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.35 129.68 19.79 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.199 1.266 . . . . 0.0 112.294 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -49.92 -36.61 44.17 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.213 1.942 . . . . 0.0 112.991 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.08 -0.85 8.41 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 52.7 tt0 -100.02 -3.95 31.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.153 -0.967 . . . . 0.0 110.361 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.25 153.82 47.89 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 110.434 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' NH1' ' H ' ' A' ' 73' ' ' LEU . 22.1 mtm180 -128.61 109.88 11.75 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.13 125.73 33.71 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.655 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.39 148.17 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.621 0.724 . . . . 0.0 109.599 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 47' ' ' GLY . 80.7 t80 -149.83 142.38 24.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.369 -0.832 . . . . 0.0 109.058 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.63 5.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.04 9.96 56.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.47 148.63 40.57 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.091 -1.24 . . . . 0.0 109.202 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -82.19 116.53 21.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.82 121.04 10.13 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.363 -0.836 . . . . 0.0 109.497 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -90.69 173.51 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.666 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.59 140.4 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.335 -0.853 . . . . 0.0 110.905 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.61 53.4 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.278 -0.889 . . . . 0.0 111.612 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.72 ' HG2' HH21 ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.63 176.26 9.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.01 -1.288 . . . . 0.0 110.446 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -113.15 145.36 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.55 -37.71 70.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.522 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -59.91 -26.29 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.79 -17.85 51.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.602 -0.686 . . . . 0.0 109.531 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.25 3.07 32.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.41 -0.806 . . . . 0.0 110.258 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.78 47.22 24.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.706 -1.246 . . . . 0.0 109.583 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 62' ' ' GLN . 63.4 mt -68.93 169.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.7 tp-100 -135.46 139.82 44.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -54.08 147.82 12.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 110.895 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 68.04 12.44 8.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.696 -0.628 . . . . 0.0 110.765 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.421 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.8 mp -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 108.97 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -98.24 129.3 44.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -112.81 118.43 34.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.72 145.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 71' ' ' LEU . 10.6 mp -89.17 152.56 21.54 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.914 -1.116 . . . . 0.0 110.072 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.409 HH21 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -50.5 117.68 2.58 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.178 -0.951 . . . . 0.0 108.645 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.617 ' H ' ' NH1' ' A' ' 42' ' ' ARG . 45.2 mt -78.92 145.61 33.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.1 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.511 ' NH2' ' CG ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -65.0 119.99 11.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 11.98 82.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.176 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.736 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.83 147.86 27.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 109.875 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -145.22 166.63 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -127.08 143.07 51.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.284 -0.885 . . . . 0.0 109.608 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.88 121.33 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.288 -0.882 . . . . 0.0 108.837 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -94.97 123.98 38.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -98.95 153.4 18.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 0.0 109.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.0 mp -59.93 -18.3 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.3 p -81.53 -3.0 51.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.022 -1.049 . . . . 0.0 109.625 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.84 69.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -93.43 121.21 34.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.855 -1.38 . . . . 0.0 109.561 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 m -103.89 129.78 51.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.474 -0.767 . . . . 0.0 109.292 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 tt -126.36 145.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.613 -0.679 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -105.53 137.18 43.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.58 -0.7 . . . . 0.0 109.552 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.4 mt -129.1 149.46 50.91 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.484 -0.76 . . . . 0.0 109.578 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.01 125.54 51.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.87 176.17 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.99 -1.069 . . . . 0.0 110.271 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -110.31 154.0 43.11 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.85 -33.54 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.023 1.816 . . . . 0.0 110.765 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.2 m -84.37 4.62 30.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.563 -0.71 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.98 147.92 50.89 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.004 -1.079 . . . . 0.0 108.951 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 p -92.64 150.45 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.309 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -53.97 -40.0 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.56 -43.6 98.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.19 -37.65 84.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.45 -28.79 36.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -70.28 -35.46 73.75 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.73 84.54 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -55.53 -47.33 76.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.732 -0.605 . . . . 0.0 109.443 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.06 -39.52 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.37 -0.831 . . . . 0.0 109.5 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.05 -45.08 93.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.37 -31.97 73.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 111.299 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -94.72 -41.6 9.18 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.802 -1.186 . . . . 0.0 111.534 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -91.65 -23.54 19.8 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.761 -1.212 . . . . 0.0 110.051 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.65 -1.47 29.21 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.059 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -83.96 118.85 72.42 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.413 . . . . 0.0 109.506 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.91 149.82 7.39 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.67 1.58 . . . . 0.0 112.027 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.68 -25.24 29.17 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.508 2.139 . . . . 0.0 112.464 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.61 -2.06 24.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 109.724 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -101.13 -7.81 22.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.237 -0.915 . . . . 0.0 110.013 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -143.04 158.88 43.19 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.008 -1.058 . . . . 0.0 110.962 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 HH21 ' HD3' ' A' ' 42' ' ' ARG . 1.6 mtp180 -132.12 121.24 23.46 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.58 121.85 28.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.07 -1.019 . . . . 0.0 110.604 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mm -115.94 133.45 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -119.12 134.95 54.9 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.04 -113.45 0.65 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.995 -1.065 . . . . 0.0 108.582 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.11 26.93 5.2 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.08 150.67 46.59 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.244 -1.151 . . . . 0.0 109.233 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -91.28 113.35 25.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 59' ' ' TYR . 89.8 mt -55.08 122.2 10.44 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.666 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.76 171.19 9.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.77 134.26 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.28 -19.07 55.43 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.752 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.59 160.75 26.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.581 -1.541 . . . . 0.0 109.095 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 p -102.58 152.97 20.55 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.478 -0.764 . . . . 0.0 109.245 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.83 -38.98 70.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.048 . . . . 0.0 109.311 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -61.22 -17.82 55.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.104 -0.998 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.5 -18.45 63.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE1' HD23 ' A' ' 50' ' ' LEU . 22.8 m-85 -108.2 7.81 27.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.574 -0.703 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 t30 50.56 47.09 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.53 -1.356 . . . . 0.0 109.562 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.637 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.8 mt -72.97 173.96 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.637 ' N ' HG22 ' A' ' 61' ' ' ILE . 66.0 mt-30 -133.07 137.93 46.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.89 151.02 4.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 110.516 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 65.71 11.55 7.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.986 -0.446 . . . . 0.0 110.851 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.42 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.6 mp -95.6 143.65 26.71 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.25 130.74 38.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.31 118.81 37.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.814 . . . . 0.0 109.98 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.19 146.77 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.1 mp -83.3 -92.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.979 -1.076 . . . . 0.0 109.352 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.29 -84.75 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.924 -1.11 . . . . 0.0 109.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.3 mp 48.86 47.42 21.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.082 -1.012 . . . . 0.0 110.485 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 118.53 15.16 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.279 -1.513 . . . . 0.0 108.113 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.52 -84.53 0.09 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.354 0.597 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.1 136.29 39.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.611 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 67' ' ' LEU . 4.9 mp -133.19 153.48 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -120.26 135.37 55.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.763 -1.211 . . . . 0.0 109.377 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.81 116.48 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.15 115.76 28.28 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.8 m -97.76 163.22 12.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.408 -0.808 . . . . 0.0 109.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.9 mp -68.67 -17.87 64.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 p -81.45 -1.45 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.053 -1.03 . . . . 0.0 109.751 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.12 13.69 73.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -91.26 131.84 36.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.027 -1.278 . . . . 0.0 109.307 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.8 m -107.38 113.22 26.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.163 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -106.54 139.64 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.596 -0.69 . . . . 0.0 109.221 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -108.73 134.67 51.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.672 -0.642 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.1 mt -125.92 143.91 50.89 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.749 . . . . 0.0 109.593 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -105.51 125.2 50.72 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.35 178.76 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.952 -1.093 . . . . 0.0 110.242 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 155.2 42.38 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.5 -34.74 32.68 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.056 1.838 . . . . 0.0 110.728 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 t -81.4 5.69 16.77 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.612 -0.68 . . . . 0.0 109.318 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' A' ' 26' ' ' VAL . 21.1 t0 -68.76 145.51 53.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 109.052 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.0 p -91.93 152.65 19.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.197 -0.939 . . . . 0.0 109.257 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -58.07 -35.18 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.961 -1.087 . . . . 0.0 109.124 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.68 -51.11 68.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.27 -33.86 76.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.866 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 22' ' ' THR . 96.8 t -73.25 -34.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' NZ ' HD12 ' A' ' 43' ' ' LEU . 28.2 mmtm -62.75 -35.38 79.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.39 63.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -49.42 -47.59 47.86 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.99 -36.22 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.31 -48.84 69.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.11 -26.26 65.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.007 . . . . 0.0 111.5 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -91.77 -47.61 7.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.758 -1.214 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 7.5 mp0 -87.18 -27.0 23.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.8 -1.188 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 -2.3 87.14 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.194 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.98 118.45 68.92 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.65 -1.5 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.51 152.65 3.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.564 1.509 . . . . 0.0 112.421 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.79 -17.97 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.706 2.27 . . . . 0.0 112.292 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -78.12 -3.76 44.0 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.123 -0.986 . . . . 0.0 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -112.32 -15.16 13.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -114.78 142.39 46.6 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.495 -0.753 . . . . 0.0 110.652 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' NH1' ' HG ' ' A' ' 73' ' ' LEU . 3.4 mtm180 -129.17 119.23 23.73 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.568 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.0 mt -91.35 122.83 34.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 111.278 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -110.95 140.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.7 t80 -150.77 136.38 18.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 108.726 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.67 2.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 99.36 21.39 15.12 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 140.8 50.67 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.68 120.3 24.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.12 118.99 7.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.451 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.59 147.07 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.148 -0.97 . . . . 0.0 109.056 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.5 p-10 -61.77 138.08 58.3 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.767 . . . . 0.0 110.674 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.81 56.35 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.401 -0.812 . . . . 0.0 112.003 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.76 164.16 17.76 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 120.073 1.937 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -101.53 146.01 28.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.313 -0.867 . . . . 0.0 111.021 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.11 -39.25 63.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.387 -0.821 . . . . 0.0 109.645 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -68.66 -18.75 64.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.89 . . . . 0.0 109.166 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.81 -17.9 61.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.73 . . . . 0.0 109.898 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -107.74 9.85 28.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 54.8 25.32 6.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 109.419 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 18.9 mt -51.76 170.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 95.0 mm-40 -137.75 141.1 40.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.381 -0.825 . . . . 0.0 109.781 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 65' ' ' SEP . 62.9 pttt -57.35 155.69 8.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.132 -0.98 . . . . 0.0 110.233 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 63.7 5.52 2.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 122.002 -0.436 . . . . 0.0 110.967 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.44 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.489 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.2 mp -96.04 150.59 20.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -96.26 130.41 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.52 128.87 56.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.407 -0.808 . . . . 0.0 109.811 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.88 149.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 71' ' ' LEU . 9.3 mp -79.96 -82.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.702 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' CG ' HH21 ' A' ' 72' ' ' ARG . 1.2 mtt-85 -143.33 170.48 15.69 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.14 -0.975 . . . . 0.0 110.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HG ' ' NH1' ' A' ' 42' ' ' ARG . 11.2 mt -63.18 152.87 36.23 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.218 -0.926 . . . . 0.0 109.231 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -65.79 160.43 23.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.51 132.74 1.72 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 CA-C-O 117.956 -1.469 . . . . 0.0 109.707 -179.635 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' VAL . 61.5 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.292 0.568 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.36 115.82 28.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.842 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.452 ' CG2' HD13 ' A' ' 67' ' ' LEU . 34.3 mm -117.45 153.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -127.03 127.36 44.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.506 -1.371 . . . . 0.0 108.64 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.68 124.9 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.712 -1.243 . . . . 0.0 109.464 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -102.31 123.31 45.89 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -101.1 153.54 19.49 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.288 -0.882 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.28 -18.41 37.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 p -81.33 -1.01 43.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.345 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.73 86.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.81 116.18 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.926 -1.337 . . . . 0.0 110.032 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -104.68 134.85 47.15 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -130.73 143.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 t -100.68 130.38 46.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.238 -0.914 . . . . 0.0 109.944 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.89 145.23 50.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 0.0 109.703 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -106.27 126.63 52.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.2 m -144.35 -176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 110.048 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -117.68 152.07 49.3 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.29 -33.3 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.062 1.841 . . . . 0.0 110.882 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -83.47 2.51 36.42 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 26' ' ' VAL . 2.4 t70 -66.89 148.37 52.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.839 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 159.37 16.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.394 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.59 -38.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.8 -47.87 83.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.929 . . . . 0.0 110.027 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -63.76 -46.21 86.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.865 . . . . 0.0 109.906 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' OD2' ' A' ' 21' ' ' ASP . 96.8 t -63.23 -30.92 50.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.572 -0.705 . . . . 0.0 109.556 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -69.38 -32.56 71.67 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.55 -58.46 8.5 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 1.3 mptm? -49.5 -43.26 45.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.513 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -63.51 -44.52 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.252 -0.905 . . . . 0.0 109.745 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.71 -48.14 67.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -64.52 -19.45 65.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.828 . . . . 0.0 111.517 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -98.19 -47.48 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.737 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -90.26 -27.64 19.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.859 -1.151 . . . . 0.0 109.772 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.32 84.2 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.087 -1.008 . . . . 0.0 111.038 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -90.05 116.57 66.69 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.716 -1.461 . . . . 0.0 108.98 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.33 149.34 6.6 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.541 1.494 . . . . 0.0 112.094 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.82 -28.44 24.96 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.532 2.155 . . . . 0.0 112.386 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.16 -1.92 28.6 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.023 -1.048 . . . . 0.0 109.703 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -106.41 1.61 25.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -141.1 154.74 46.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -0.93 . . . . 0.0 111.267 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.403 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.5 mtm180 -130.54 128.57 41.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.66 121.12 37.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.548 -0.72 . . . . 0.0 111.494 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.99 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.61 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.5 t80 -133.8 134.94 43.48 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.06 -9.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 111.79 18.56 7.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -120.63 152.1 38.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.215 -1.168 . . . . 0.0 109.569 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -91.26 110.71 22.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.31 108.81 0.46 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.771 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.4 150.36 27.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.471 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.47 137.42 57.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.33 -0.856 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.18 -12.62 65.26 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.253 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -84.72 177.89 7.86 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.301 -1.705 . . . . 0.0 109.529 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.2 p -121.85 149.69 43.0 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.419 -0.8 . . . . 0.0 110.933 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -57.1 -41.97 79.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.615 -0.678 . . . . 0.0 109.313 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -57.23 -37.03 71.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.666 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.08 -20.52 6.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 109.553 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -101.83 11.31 38.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.158 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 46.99 48.04 15.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.926 -1.109 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.2 mt -73.4 175.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.344 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.624 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 tp-100 -144.88 147.52 32.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.986 -1.071 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -55.41 149.36 13.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.848 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 68.45 27.01 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.807 -0.558 . . . . 0.0 110.788 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.426 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 8.2 mp -94.28 157.12 16.19 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -104.21 129.26 51.98 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.99 124.66 51.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.864 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.64 145.96 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.2 mp -79.45 151.87 30.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.039 -1.038 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.497 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 1.3 ptt180 -43.33 -62.06 1.17 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.026 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 1.8 tt 56.5 51.63 11.02 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.578 -1.326 . . . . 0.0 109.911 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.663 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.1 OUTLIER 48.46 -105.61 0.15 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 109.086 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.81 38.02 0.66 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 CA-C-O 117.749 -1.584 . . . . 0.0 109.263 -179.53 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 17' ' ' VAL . 18.1 mmt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.3 140.71 36.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.408 -0.807 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.82 167.6 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.0 m-85 -131.21 132.26 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.99 -1.069 . . . . 0.0 109.714 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.48 120.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 109.364 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -97.61 112.66 24.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 8' ' ' LEU . 33.8 m -94.58 160.16 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.296 -0.878 . . . . 0.0 109.613 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 7' ' ' THR . 35.8 mt -63.21 -20.79 65.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.996 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -81.53 -0.04 40.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.508 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 12.44 79.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -83.41 122.31 28.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.29 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -100.64 119.28 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -117.09 131.67 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.6 m -98.21 129.4 44.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.418 -0.801 . . . . 0.0 109.726 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -129.72 148.11 51.57 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.608 -0.683 . . . . 0.0 109.618 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.26 131.49 55.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -145.87 -175.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.966 -1.084 . . . . 0.0 110.079 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.8 149.18 41.95 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.13 -30.56 38.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.075 1.85 . . . . 0.0 110.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -83.56 2.18 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.73 147.1 50.96 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 p -89.96 156.92 18.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.43 -36.39 40.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.82 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.95 -48.77 75.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.803 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.75 -36.91 80.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 0.0 109.903 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.47 -28.73 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -67.66 -38.01 83.19 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -57.66 11.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -48.13 -45.23 32.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.361 -0.837 . . . . 0.0 109.41 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.85 -39.73 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.491 -0.756 . . . . 0.0 109.791 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -71.05 -51.09 27.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.98 -18.4 64.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 111.541 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -98.1 -47.63 5.42 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.641 -1.287 . . . . 0.0 110.764 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -93.53 -27.62 16.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.857 -1.152 . . . . 0.0 110.108 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.48 6.99 88.13 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.115 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.06 115.61 63.23 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.661 -1.494 . . . . 0.0 109.133 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.7 146.6 10.92 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.629 1.552 . . . . 0.0 112.247 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.94 -26.29 26.89 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.354 2.036 . . . . 0.0 112.432 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.09 -0.27 21.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.082 -1.011 . . . . 0.0 109.917 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -107.97 2.01 22.95 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.0 109.653 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -145.67 157.87 43.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.856 -1.153 . . . . 0.0 111.548 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -129.53 119.02 22.99 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 44' ' ' ILE . 16.5 mt -88.38 115.26 25.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.881 -1.137 . . . . 0.0 110.428 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -109.04 144.75 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.594 ' C ' ' H ' ' A' ' 47' ' ' GLY . 66.6 t80 -147.15 133.48 19.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.093 . . . . 0.0 108.381 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 -5.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.634 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.01 16.34 10.71 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.2 144.99 47.42 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.084 -1.244 . . . . 0.0 109.655 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.88 119.2 25.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.31 114.88 6.38 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.811 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.99 154.66 19.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.905 -1.122 . . . . 0.0 108.994 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -63.52 140.49 58.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.504 -0.747 . . . . 0.0 111.203 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.65 -17.39 59.21 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.618 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 54' ' ' ARG . 3.0 mtp180 -76.04 176.58 7.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.219 -1.754 . . . . 0.0 109.556 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 57' ' ' SER . 38.3 m -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.519 -0.738 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -55.73 -41.37 73.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.364 -0.835 . . . . 0.0 109.645 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.4 ' H ' HG22 ' A' ' 55' ' ' THR . 85.0 p -60.34 -33.5 72.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.22 -20.07 9.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.627 -0.67 . . . . 0.0 109.717 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.4 3.86 35.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.101 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 m120 48.91 47.09 21.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 109.624 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.7 mt -69.17 177.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.398 -0.814 . . . . 0.0 109.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.669 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.3 tp-100 -135.52 138.84 43.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.157 -0.965 . . . . 0.0 109.801 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -52.54 146.94 9.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 110.563 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 67.32 18.12 10.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.761 -0.587 . . . . 0.0 110.856 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.416 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.3 mp -93.03 157.38 16.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -107.76 130.88 54.92 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.5 tt -116.35 117.84 31.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.514 -0.742 . . . . 0.0 109.502 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' N ' HD23 ' A' ' 69' ' ' LEU . 52.2 t -109.83 144.7 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 71' ' ' LEU . 9.8 mp -94.08 159.3 15.22 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.9 -1.125 . . . . 0.0 110.936 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -69.19 127.79 34.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.862 -0.524 . . . . 0.0 110.407 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.6 tp -56.31 -61.9 2.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -76.71 159.9 29.8 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.335 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.61 95.82 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.718 179.733 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.7 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -98.93 138.19 36.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -0.845 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -132.68 159.1 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -121.12 138.08 54.36 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.431 -0.793 . . . . 0.0 109.543 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.53 113.87 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.055 -1.028 . . . . 0.0 108.875 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -90.47 115.12 27.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.127 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.4 p -94.3 158.35 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 109.507 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.04 -16.81 63.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 9' ' ' THR . 84.8 m -81.53 -10.08 59.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.438 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 10.15 55.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.86 126.63 36.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.373 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -105.84 121.93 45.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 13' ' ' ILE . 3.4 mp -113.22 144.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -116.47 138.85 51.05 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.724 -0.61 . . . . 0.0 109.782 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -113.39 129.07 56.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -145.16 176.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.0 -1.063 . . . . 0.0 110.173 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -109.45 151.86 42.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.21 -34.36 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.062 1.841 . . . . 0.0 110.824 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -82.4 3.94 26.06 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.27 148.84 51.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.856 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -88.97 158.08 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 109.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -59.27 -42.96 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 108.42 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.33 -39.13 89.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.855 . . . . 0.0 110.129 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -68.82 -41.99 77.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.805 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -69.18 -31.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.133 -0.979 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -67.72 -34.71 77.4 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.52 83.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -42.94 85.05 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.94 -42.97 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.842 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.18 -43.32 98.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 0.0 109.895 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.99 -34.99 78.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 111.189 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -91.8 -39.82 11.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.761 -1.212 . . . . 0.0 111.531 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -93.37 -17.13 23.89 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.841 -1.162 . . . . 0.0 110.112 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -1.92 37.68 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.973 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.6 mt -81.43 134.21 51.88 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.701 -1.47 . . . . 0.0 109.039 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.92 160.86 48.02 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.688 1.592 . . . . 0.0 111.982 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 -24.69 32.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.765 2.31 . . . . 0.0 112.331 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -81.88 -1.81 48.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.023 -1.048 . . . . 0.0 110.315 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.99 -31.8 6.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.04 -1.038 . . . . 0.0 109.905 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.12 136.74 37.92 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.643 HH21 ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -126.07 111.96 15.3 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.8 mt -93.81 129.74 40.08 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.668 0.747 . . . . 0.0 112.094 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mt -124.07 140.41 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.452 0.644 . . . . 0.0 109.592 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.64 137.66 53.74 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.68 -115.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.911 -1.118 . . . . 0.0 108.465 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.75 30.23 4.94 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 145.96 52.17 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.291 -1.123 . . . . 0.0 109.651 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -88.09 120.05 29.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -57.17 119.43 6.36 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.499 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 32.0 mt-10 -95.71 168.93 10.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.36 -0.838 . . . . 0.0 109.377 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.76 142.18 27.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 111.292 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.08 6.39 55.86 Favored Glycine 0 N--CA 1.502 3.064 0 O-C-N 121.433 -0.792 . . . . 0.0 111.859 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' NH2' ' OE1' ' A' ' 51' ' ' GLU . 5.2 mtp180 -121.4 171.26 8.9 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 118.736 1.268 . . . . 0.0 109.783 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -106.37 149.08 27.34 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.078 -1.014 . . . . 0.0 110.945 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.09 -37.01 68.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 109.609 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.7 p -61.48 -21.15 63.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.84 -17.35 64.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.397 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -103.62 8.74 37.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.752 . . . . 0.0 110.493 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 57.13 47.62 16.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.628 -1.295 . . . . 0.0 109.437 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 62' ' ' GLN . 87.3 mt -80.28 174.48 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.383 -0.823 . . . . 0.0 109.131 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.618 ' N ' HG22 ' A' ' 61' ' ' ILE . 20.0 pt20 -152.95 154.5 35.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.885 -1.134 . . . . 0.0 110.055 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -54.68 147.95 13.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 69.35 14.9 8.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.122 -0.361 . . . . 0.0 111.159 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.502 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.7 mp -95.61 147.49 23.53 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -90.82 133.73 34.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.295 -0.878 . . . . 0.0 108.777 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -110.8 123.7 50.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.508 -0.745 . . . . 0.0 110.142 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.8 146.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 mp -93.38 155.86 17.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.874 -1.141 . . . . 0.0 109.972 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.13 126.52 27.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.237 -0.915 . . . . 0.0 109.18 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.6 132.77 47.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.4 HH21 ' HD3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -176.73 115.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.873 -1.142 . . . . 0.0 109.179 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 49.32 53.74 18.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -100.51 142.51 31.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 109.863 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -143.97 166.29 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.33 141.76 51.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.327 -0.858 . . . . 0.0 109.703 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.88 117.02 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 0.0 108.893 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -89.75 114.13 25.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 108.974 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 160.86 15.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.407 -0.808 . . . . 0.0 109.904 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.1 mp -69.34 -19.36 63.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.78 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -81.49 -4.13 55.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 109.49 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 12.96 62.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.68 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.367 . . . . 0.0 109.333 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -99.13 117.72 34.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.452 -0.78 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.8 139.98 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.447 -0.783 . . . . 0.0 109.118 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 14' ' ' THR . 11.6 t -113.3 135.43 53.86 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.716 -0.615 . . . . 0.0 109.676 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.04 159.89 40.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.467 -0.771 . . . . 0.0 109.7 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -115.76 132.11 56.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.43 176.69 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.004 -1.06 . . . . 0.0 110.19 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -107.23 153.81 40.88 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.08 -35.78 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.009 1.806 . . . . 0.0 110.754 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -83.35 4.83 25.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.638 -0.664 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.82 143.92 57.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.0 108.703 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -85.86 145.24 27.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 109.415 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.557 HG23 ' HZ2' ' A' ' 27' ' ' LYS . 1.9 mp -50.25 -41.09 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 108.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.77 -40.93 94.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -71.19 -35.92 71.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.8 -36.0 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 0.0 109.415 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HZ2' HG23 ' A' ' 23' ' ' ILE . 51.6 mttp -69.58 -30.77 68.62 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.72 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -53.45 -43.75 68.32 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mm -61.44 -46.07 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.7 -43.09 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.89 -32.89 72.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.374 -0.829 . . . . 0.0 111.249 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.14 -40.35 8.85 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.828 -1.17 . . . . 0.0 111.159 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.6 -21.92 25.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.767 -1.208 . . . . 0.0 109.656 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.51 53.31 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.999 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -91.09 134.39 30.13 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.838 -1.389 . . . . 0.0 108.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 131.26 20.92 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.22 1.28 . . . . 0.0 111.871 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.68 -19.14 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.341 2.027 . . . . 0.0 113.729 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.71 -8.5 56.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 110.605 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -109.02 -22.62 12.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.255 -0.903 . . . . 0.0 109.95 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -107.16 143.49 35.28 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.83 0.824 . . . . 0.0 110.998 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.71 124.61 43.12 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -93.65 121.43 35.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.442 -1.411 . . . . 0.0 110.024 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mm -112.17 129.93 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 83.9 t80 -146.91 139.84 25.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 108.903 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.63 3.25 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 109.298 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.38 19.92 26.53 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -127.98 151.86 48.62 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.125 -1.22 . . . . 0.0 109.641 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.61 113.27 25.27 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.07 117.53 2.61 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.307 -0.87 . . . . 0.0 109.87 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.02 173.7 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.229 -0.919 . . . . 0.0 109.804 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.29 146.35 25.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 0.0 111.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.77 10.68 55.06 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.412 -0.805 . . . . 0.0 111.552 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -129.06 160.84 31.52 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.763 -1.433 . . . . 0.0 110.612 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -89.44 146.83 24.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HG ' HD12 ' A' ' 61' ' ' ILE . 14.9 tp -55.65 -27.49 50.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.0 p -71.2 -16.45 62.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.075 -1.015 . . . . 0.0 109.236 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.42 -16.81 57.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.581 -0.7 . . . . 0.0 109.458 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.04 10.56 34.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 53.08 26.03 4.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.558 -1.339 . . . . 0.0 109.63 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 6.0 mt -52.39 170.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.323 -0.86 . . . . 0.0 108.724 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 52.2 mt-30 -138.83 142.68 38.66 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 65' ' ' SEP . 56.2 pttt -58.04 153.62 14.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.662 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 64.72 6.31 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.668 -0.645 . . . . 0.0 110.565 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.433 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.1 mp -95.38 142.92 27.19 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -90.52 128.78 36.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 108.618 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.71 122.54 48.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.614 -0.679 . . . . 0.0 109.792 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.13 150.47 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.4 mp -99.02 157.94 15.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 108.99 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.666 HH11 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -61.94 125.6 24.4 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 108.987 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.666 ' HB2' HH11 ' A' ' 72' ' ' ARG . 8.8 mp -60.86 163.1 6.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.345 -0.847 . . . . 0.0 110.159 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -152.41 165.32 35.4 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.18 101.24 0.22 Allowed Glycine 0 N--CA 1.499 2.877 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.6 mmt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.8 144.53 30.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.37 -0.831 . . . . 0.0 109.649 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -143.86 166.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -129.4 135.65 48.96 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.192 -0.943 . . . . 0.0 109.721 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.19 119.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 0.0 108.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -95.62 120.88 36.65 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 9' ' ' THR . 18.8 m -97.37 145.7 25.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.351 -0.843 . . . . 0.0 109.376 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -61.59 -13.77 24.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 7' ' ' THR . 56.9 m -81.55 -9.99 59.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.031 . . . . 0.0 109.556 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 2.5 55.85 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -91.37 136.39 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.937 -1.331 . . . . 0.0 109.273 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -123.94 134.41 53.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.468 -0.77 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.5 145.15 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.597 -0.689 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 136.75 41.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 109.797 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -126.81 146.24 50.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.55 -0.718 . . . . 0.0 109.544 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -105.88 125.34 50.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.3 m -145.83 174.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.349 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 12.5 mp0 -108.54 154.01 41.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.25 -35.06 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.923 1.749 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 t -84.28 4.84 29.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.512 -0.743 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.74 148.79 51.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.957 -1.089 . . . . 0.0 108.526 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -87.82 152.38 22.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 mp -56.14 -39.85 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -64.12 -42.04 97.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -65.25 -38.2 89.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -72.63 -29.22 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.459 -0.775 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -69.71 -34.5 73.99 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -54.27 47.58 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -49.53 -44.54 46.51 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.437 0.637 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.35 -38.18 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -63.25 -47.96 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 109.916 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -70.38 -20.05 62.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.197 -0.94 . . . . 0.0 111.268 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -93.65 -50.89 5.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.835 -1.166 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -87.67 -24.44 23.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.879 -1.138 . . . . 0.0 109.805 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.03 3.9 89.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.137 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 134.79 32.44 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.705 -1.468 . . . . 0.0 109.039 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.83 156.03 66.74 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.579 1.519 . . . . 0.0 111.951 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.36 -18.35 38.95 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.946 2.431 . . . . 0.0 112.578 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.76 -1.6 43.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 110.039 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -112.67 -23.04 10.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.136 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -115.63 144.78 43.41 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.67 118.29 22.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -85.92 121.25 28.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.67 0.747 . . . . 0.0 111.616 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -107.47 150.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -139.49 130.04 25.74 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.32 -119.5 1.51 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.62 27.61 7.87 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -135.65 -174.85 3.76 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.917 -1.343 . . . . 0.0 109.283 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -121.68 126.06 48.1 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.167 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.26 118.49 5.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.14 168.0 11.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.251 -0.906 . . . . 0.0 109.641 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.62 146.82 23.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.31 -0.868 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.46 60.85 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.341 -0.849 . . . . 0.0 111.657 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -123.66 164.12 19.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.118 -1.225 . . . . 0.0 110.189 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -96.79 147.85 23.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.922 -1.111 . . . . 0.0 110.749 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.79 -31.72 62.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -62.26 -23.58 66.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.66 -16.38 48.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -104.83 0.76 28.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 52.98 44.07 30.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.713 -1.242 . . . . 0.0 109.508 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.3 mt -66.87 174.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.209 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 5.8 tp-100 -135.82 140.41 44.19 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.186 -0.946 . . . . 0.0 110.009 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -51.76 143.59 12.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 69.15 17.23 8.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 110.568 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.507 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 7.4 mp -94.22 153.76 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -101.81 131.89 47.88 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.68 126.58 55.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 109.496 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.4 147.43 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.3 mp -93.82 154.31 17.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.915 -1.116 . . . . 0.0 108.841 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -55.68 -11.72 1.02 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.756 -1.215 . . . . 0.0 110.018 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.6 mt -61.32 -10.23 6.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 108.988 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -159.26 144.47 15.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.88 -116.64 0.41 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.546 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -101.17 140.91 34.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.427 -0.796 . . . . 0.0 109.929 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.13 166.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.72 132.31 51.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.26 116.69 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.058 -1.026 . . . . 0.0 109.001 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.04 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -92.43 153.85 18.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -59.84 -23.99 63.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 109.918 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 9' ' ' THR . 84.5 m -81.23 -6.67 59.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.568 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 1.41 63.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -73.65 113.57 10.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.908 -1.348 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.5 m -97.51 130.1 44.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.38 140.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 14' ' ' THR . 13.9 t -104.17 132.7 50.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.251 -0.905 . . . . 0.0 109.845 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -128.73 147.27 50.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.484 0.659 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -111.15 130.42 55.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.41 -178.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.021 -1.049 . . . . 0.0 110.054 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.18 154.57 46.22 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.74 -33.68 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.179 1.92 . . . . 0.0 110.71 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -84.34 5.69 25.99 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -69.14 146.51 52.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.0 108.871 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -93.76 152.69 18.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -57.55 -36.27 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 109.058 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.55 -53.03 61.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.978 . . . . 0.0 110.198 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.79 -37.67 87.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.359 -0.838 . . . . 0.0 109.931 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.69 -28.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -68.88 -34.93 76.25 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -56.75 17.71 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -49.65 -46.13 49.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.625 -0.672 . . . . 0.0 109.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.08 -41.71 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 109.722 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -68.9 -45.64 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 111.629 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -98.41 -48.22 5.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.646 -1.284 . . . . 0.0 111.065 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' HD12 ' A' ' 36' ' ' ILE . 26.6 tt0 -86.64 -28.51 23.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.763 -1.21 . . . . 0.0 109.673 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 5.91 88.42 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.379 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.415 HD12 ' CD ' ' A' ' 34' ' ' GLU . 28.8 mt -91.35 119.35 68.68 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 120.557 -1.555 . . . . 0.0 108.9 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 144.02 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.567 1.512 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 -18.09 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.459 2.106 . . . . 0.0 112.226 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.16 -11.2 60.81 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.103 -0.998 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -110.06 -29.23 8.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -85.48 137.25 33.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.509 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -124.49 111.49 15.76 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -93.25 124.47 37.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.589 -0.694 . . . . 0.0 111.199 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.29 138.08 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.658 -0.651 . . . . 0.0 109.355 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 85.6 t80 -140.26 139.39 35.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.447 -0.783 . . . . 0.0 109.154 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 67.1 -10.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.64 -0.663 . . . . 0.0 109.32 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.91 8.3 24.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -112.86 149.74 32.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.089 -1.242 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -83.4 116.73 22.62 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.85 120.68 12.38 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.687 -0.633 . . . . 0.0 110.068 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.9 151.33 20.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.92 138.62 57.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 111.186 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.68 71.54 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.474 -0.766 . . . . 0.0 111.231 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -82.57 166.9 18.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.706 -1.467 . . . . 0.0 111.075 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -111.39 145.42 38.94 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.663 0.744 . . . . 0.0 111.402 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.76 -43.54 90.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.667 -0.646 . . . . 0.0 109.788 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -55.58 -34.28 64.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.25 -20.77 29.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.388 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -103.8 5.1 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.27 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 48.1 41.56 15.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.789 -1.194 . . . . 0.0 109.694 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 62' ' ' GLN . 56.2 mt -60.1 169.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.365 -0.834 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.563 ' N ' HG22 ' A' ' 61' ' ' ILE . 62.9 mt-30 -129.05 134.62 48.18 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.789 0.804 . . . . 0.0 109.848 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -54.85 150.29 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 110.797 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 67.17 10.45 7.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.87 -0.518 . . . . 0.0 110.741 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.448 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 67' ' ' LEU . 8.7 mp -92.7 156.73 16.86 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 1.6 m80 -102.43 127.94 49.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.357 -0.839 . . . . 0.0 109.202 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -109.38 111.5 23.09 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.502 -0.749 . . . . 0.0 109.494 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.2 t -116.87 142.57 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.961 HD22 ' H ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -79.75 -93.53 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.007 -1.058 . . . . 0.0 109.605 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -164.38 -11.14 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.131 -0.981 . . . . 0.0 108.412 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' H ' ' H ' ' A' ' 72' ' ' ARG . 42.6 mt 51.38 -141.68 0.77 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.408 -1.432 . . . . 0.0 109.028 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.659 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -61.78 -31.35 71.55 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 108.452 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.91 -105.05 0.9 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 117.898 -1.501 . . . . 0.0 109.771 179.308 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -101.71 141.57 34.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.394 -0.816 . . . . 0.0 109.685 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.96 163.0 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.9 145.39 48.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.336 -0.852 . . . . 0.0 109.69 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.86 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.392 -0.818 . . . . 0.0 108.885 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.18 114.86 26.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -88.79 156.45 18.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.27 -24.44 64.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -81.38 -5.33 57.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 16.96 53.75 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.67 115.08 27.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.912 -1.346 . . . . 0.0 109.398 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -91.9 118.49 30.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.11 145.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.551 -0.718 . . . . 0.0 109.12 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 t -111.38 134.83 52.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.639 -0.663 . . . . 0.0 109.667 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 mt -127.89 146.59 50.58 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.497 -0.752 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.36 123.37 46.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.73 177.46 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.976 -1.078 . . . . 0.0 110.043 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.17 164.06 15.58 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -77.57 -37.07 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 110.705 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -80.52 7.77 9.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -66.41 150.24 49.2 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.81 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 m -94.07 164.16 13.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -70.11 -40.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.035 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -63.07 -43.86 97.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -68.01 -40.01 83.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.471 -0.768 . . . . 0.0 109.679 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 22' ' ' THR . 95.7 t -71.24 -31.5 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -68.64 -32.38 72.18 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.98 81.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.84 -44.86 78.39 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.2 mt -62.34 -42.56 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.416 -0.803 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' GLY . 47.9 tt0 -65.35 -44.11 88.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.96 -33.54 73.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 111.149 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -93.86 -41.16 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.823 -1.173 . . . . 0.0 111.17 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -89.44 -26.01 21.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.676 -1.265 . . . . 0.0 109.907 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 80.21 7.28 88.68 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.189 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.45 116.81 66.6 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.803 -1.41 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.84 150.17 6.81 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.665 1.577 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.07 -19.46 34.63 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.675 2.25 . . . . 0.0 112.605 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.7 -4.49 46.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -107.93 -12.52 15.15 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -113.45 140.86 47.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.352 -0.842 . . . . 0.0 110.508 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -127.44 108.93 11.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.78 125.19 33.05 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.743 0.782 . . . . 0.0 111.695 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.39 134.48 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.461 0.648 . . . . 0.0 109.265 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLY . 65.9 t80 -148.6 142.43 25.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 109.225 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.71 8.26 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.733 . . . . 0.0 109.37 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 93.68 18.96 36.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -129.32 152.03 49.33 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.28 117.52 29.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 17.5 mt -54.32 115.51 2.13 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.227 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -88.57 146.54 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.027 . . . . 0.0 108.994 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.07 135.6 57.82 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.387 -0.821 . . . . 0.0 109.909 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -14.8 57.3 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.256 -0.902 . . . . 0.0 112.792 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -91.72 160.83 15.15 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.219 2.01 . . . . 0.0 110.559 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -105.54 151.08 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.567 0.698 . . . . 0.0 109.374 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.97 -39.06 65.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.995 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -60.27 -20.57 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.544 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.49 -19.64 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.582 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -107.32 8.66 29.87 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 0.0 110.397 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 52.09 49.07 21.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.676 -1.265 . . . . 0.0 109.675 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 62' ' ' GLN . 69.7 mt -76.92 172.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.488 -0.758 . . . . 0.0 109.132 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.606 ' N ' HG22 ' A' ' 61' ' ' ILE . 90.8 mt-30 -138.62 142.15 39.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.114 -0.991 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.27 152.53 6.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 110.44 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 65.0 10.04 5.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.048 -0.407 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.492 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -95.66 143.66 26.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -89.88 129.89 36.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.1 -1.0 . . . . 0.0 108.956 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.2 tt -105.49 114.56 28.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.512 -0.743 . . . . 0.0 110.037 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.4 t -114.82 147.05 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.06 -171.71 2.6 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.222 1.011 . . . . 0.0 110.735 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -65.55 138.75 58.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.939 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.59 143.27 54.91 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.5 -45.88 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 118.669 -1.213 . . . . 0.0 108.562 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.05 77.14 0.03 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.15 149.61 25.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.742 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.07 168.42 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -127.98 131.66 49.24 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.29 -0.881 . . . . 0.0 109.561 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.12 117.18 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 108.91 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -91.85 113.89 26.28 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -92.93 164.05 13.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.492 -0.755 . . . . 0.0 109.975 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -72.72 -19.02 61.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.035 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.3 p -81.38 -0.4 41.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 0.0 109.649 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 12.34 71.34 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -93.16 132.26 37.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.325 . . . . 0.0 109.057 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -116.14 130.87 57.01 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.28 143.3 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.643 -0.661 . . . . 0.0 109.468 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 t -103.62 138.08 40.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 109.782 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.2 mt -131.98 153.37 50.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.536 -0.727 . . . . 0.0 109.567 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -107.13 124.45 49.71 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -143.5 163.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.0 mt-10 -101.36 152.31 37.95 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -36.05 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.936 1.757 . . . . 0.0 111.338 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.9 p -79.77 4.73 15.48 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.385 -0.822 . . . . 0.0 109.288 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.28 146.02 49.18 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.483 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.4 p -89.34 154.38 20.13 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.93 -37.84 43.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.016 -1.053 . . . . 0.0 108.748 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.2 -44.32 95.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.7 -36.37 83.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.932 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.22 -30.31 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.489 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.22 -35.72 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.9 49.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -50.42 -46.84 56.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.64 -37.76 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.56 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.26 -47.15 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.8 -25.7 68.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 111.423 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -95.5 -48.8 5.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.9 -24.8 23.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.837 -1.165 . . . . 0.0 110.025 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.65 -1.6 88.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.233 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -80.68 134.28 54.25 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.657 -1.496 . . . . 0.0 108.571 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 131.8 20.78 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.36 1.373 . . . . 0.0 112.051 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -46.12 -23.21 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.237 1.958 . . . . 0.0 113.553 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -73.91 -2.68 24.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 110.59 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -113.64 -22.6 10.17 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -100.75 137.52 39.03 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.154 0.978 . . . . 0.0 111.212 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.5 104.41 9.64 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.15 122.02 33.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.799 -1.188 . . . . 0.0 110.075 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 mt -122.73 145.83 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 47' ' ' GLY . 74.9 t80 -149.96 144.84 26.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.64 6.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.94 15.97 49.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.47 139.95 52.81 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.074 -1.251 . . . . 0.0 109.027 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -78.59 118.69 20.95 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.24 118.91 6.0 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 109.861 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -90.62 150.18 21.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.194 -0.942 . . . . 0.0 109.936 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -66.33 134.91 53.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 110.752 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.99 -16.29 57.42 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 121.301 -0.874 . . . . 0.0 111.897 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.462 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -92.66 149.06 21.57 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-N 119.9 1.85 . . . . 0.0 109.997 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -90.81 154.48 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.587 0.708 . . . . 0.0 110.068 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.21 -36.28 72.89 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -61.94 -20.24 63.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.062 . . . . 0.0 109.188 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.37 -16.27 64.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.463 -0.773 . . . . 0.0 109.726 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -109.33 7.55 25.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.459 -0.776 . . . . 0.0 110.348 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 51.71 45.7 27.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.658 -1.276 . . . . 0.0 109.552 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 62' ' ' GLN . 88.9 mt -71.88 174.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.258 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.625 ' N ' HG22 ' A' ' 61' ' ' ILE . 15.6 tt0 -135.88 140.13 43.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.19 -0.944 . . . . 0.0 109.702 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -53.15 149.81 6.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 64.54 13.91 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.967 -0.458 . . . . 0.0 110.976 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.413 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.2 mp -94.42 149.29 21.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.23 130.88 41.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.23 118.75 36.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.399 -0.813 . . . . 0.0 109.789 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.47 148.81 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp -81.2 -76.96 0.22 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.806 -1.184 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.88 174.03 13.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 109.775 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -93.2 -25.11 17.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.0 110.054 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -70.56 -2.6 14.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.661 -1.274 . . . . 0.0 109.315 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.91 35.86 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.286 0.565 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -103.78 145.26 30.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.445 -0.784 . . . . 0.0 110.014 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.1 pt -140.36 163.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 41.1 m-85 -121.75 136.12 54.94 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 114.03 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -90.64 117.37 29.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 109.031 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.7 p -92.12 160.64 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.882 . . . . 0.0 109.597 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -65.21 -20.1 66.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 85.1 m -81.67 -9.32 59.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 109.544 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.06 16.56 43.89 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -94.34 121.06 35.48 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.322 . . . . 0.0 109.563 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 m -96.65 121.33 38.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.293 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.36 141.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.488 -0.757 . . . . 0.0 109.236 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.9 p -107.53 131.64 54.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.668 . . . . 0.0 109.667 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -132.52 153.0 51.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.536 -0.728 . . . . 0.0 109.567 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.74 130.04 56.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.2 178.81 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -112.62 153.03 45.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.86 -31.51 47.61 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.997 1.798 . . . . 0.0 110.644 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 5.13 33.77 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.577 -0.702 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -69.58 146.64 51.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -95.59 148.8 22.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 109.387 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -54.2 -39.23 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.086 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.44 -47.69 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.892 . . . . 0.0 109.848 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -68.36 -37.27 80.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.758 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.19 -29.72 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -70.99 -33.99 70.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.37 76.88 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -54.12 -48.25 70.95 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -65.69 -38.08 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -59.13 -48.03 83.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.476 -0.765 . . . . 0.0 109.974 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.09 -35.06 77.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.464 -0.772 . . . . 0.0 111.198 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -79.81 -50.43 10.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.817 -1.177 . . . . 0.0 111.462 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.94 -10.08 49.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.757 -1.215 . . . . 0.0 110.015 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.24 27.13 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.68 134.27 37.97 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.744 -1.445 . . . . 0.0 108.79 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.69 156.93 59.94 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 0.0 112.073 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.43 -18.32 38.64 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.743 2.295 . . . . 0.0 112.781 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.51 -5.4 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -109.34 -27.92 9.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 109.311 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -96.86 134.72 39.82 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.244 -0.91 . . . . 0.0 110.657 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.509 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -118.83 109.21 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.93 129.89 38.69 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.683 -1.261 . . . . 0.0 111.817 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.17 141.13 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.487 0.661 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -119.54 137.41 53.85 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 -112.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.025 -1.047 . . . . 0.0 108.851 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.41 28.95 5.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -129.42 140.31 51.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.177 -1.19 . . . . 0.0 109.421 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -82.95 117.44 22.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CE1' ' A' ' 59' ' ' TYR . 93.7 mt -56.15 121.27 9.06 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.24 148.42 22.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 2.4 p30 -66.35 136.28 55.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 110.871 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.23 57.83 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.426 -0.796 . . . . 0.0 112.051 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.74 170.0 14.65 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.105 -1.821 . . . . 0.0 110.591 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 m -108.17 147.81 30.78 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.313 0.577 . . . . 0.0 109.802 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -56.04 -41.85 75.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -60.49 -20.57 60.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.35 -18.03 64.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CE1' HD23 ' A' ' 50' ' ' LEU . 21.0 m-85 -106.09 6.87 31.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.485 -0.76 . . . . 0.0 110.308 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 54.22 39.82 31.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.4 mt -64.05 169.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 61' ' ' ILE . 53.4 tt0 -138.62 143.2 39.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.283 -0.885 . . . . 0.0 110.029 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.24 145.41 13.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 110.654 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 69.88 14.48 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.756 -0.59 . . . . 0.0 110.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.48 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.5 mp -95.8 145.88 24.99 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -92.53 128.61 38.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 0.0 108.885 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.13 117.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.796 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.4 145.47 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.9 mp -82.29 -82.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 110.016 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HG3' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -149.95 171.81 16.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.129 -0.982 . . . . 0.0 110.315 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.97 124.95 46.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -72.94 135.14 45.0 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.088 -1.632 . . . . 0.0 109.443 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.51 89.58 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.591 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' VAL . 66.7 mtt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.15 142.03 33.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -145.17 165.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -125.07 137.58 54.2 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.202 -0.936 . . . . 0.0 109.454 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.33 121.38 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.656 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -93.95 118.02 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -93.58 154.08 18.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.97 -19.3 64.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.078 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -82.11 -1.46 48.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 109.726 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.08 9.83 69.92 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -92.23 116.42 28.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.047 -1.267 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -101.81 132.01 47.81 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 109.104 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tt -129.45 145.42 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.509 -0.745 . . . . 0.0 109.44 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -102.71 139.18 38.62 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.56 -0.713 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -130.19 149.74 51.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.619 -0.676 . . . . 0.0 109.43 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -111.09 129.87 55.79 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -146.69 178.54 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.981 -1.074 . . . . 0.0 110.139 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.27 153.49 44.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.54 -33.68 45.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.998 1.799 . . . . 0.0 110.762 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 m -84.94 4.71 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.422 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.67 145.46 53.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.973 -1.079 . . . . 0.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -91.91 162.61 14.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.86 -40.96 90.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.144 -0.972 . . . . 0.0 108.696 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -62.21 -43.73 98.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.73 -41.59 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.116 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.63 -29.07 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.02 . . . . 0.0 109.455 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -35.13 78.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.56 82.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.75 -44.3 77.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.72 -39.3 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.61 -45.62 91.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 109.93 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.61 -30.28 68.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 111.187 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -88.25 -46.68 9.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.78 -1.2 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -89.21 -19.84 24.92 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.638 -1.289 . . . . 0.0 110.017 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.07 4.68 56.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.065 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -89.82 122.48 67.93 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.684 -1.48 . . . . 0.0 109.3 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.31 149.55 6.33 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.633 1.555 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.35 -19.5 33.25 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.32 -2.8 33.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -111.65 -25.25 9.63 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.15 -0.969 . . . . 0.0 110.271 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -97.59 136.03 38.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -122.37 115.82 22.95 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.02 125.56 41.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.59 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -121.73 141.16 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 87.1 t80 -150.32 144.68 25.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.099 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 61.66 12.11 4.36 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.56 67.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.48 148.93 44.56 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.124 -1.221 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -84.26 113.53 21.18 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -54.53 123.17 12.28 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.745 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.64 143.27 27.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.148 -0.97 . . . . 0.0 109.13 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.9 133.91 56.01 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.417 -0.802 . . . . 0.0 109.602 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -16.23 56.91 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.35 -0.844 . . . . 0.0 112.086 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -81.97 164.28 21.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 119.977 -1.896 . . . . 0.0 109.108 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 m -104.93 147.56 27.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.47 -41.89 81.54 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -59.46 -23.73 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.166 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.98 -18.52 64.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -107.19 5.87 28.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.517 -0.739 . . . . 0.0 110.106 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 49.91 48.33 21.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.615 -1.303 . . . . 0.0 109.681 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.91 165.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 108.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -126.79 135.22 50.75 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.402 -0.811 . . . . 0.0 109.75 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.11 146.21 6.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 66.99 16.09 10.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 122.133 -0.355 . . . . 0.0 110.959 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 mp -95.19 153.24 17.75 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -97.79 126.37 43.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.194 -0.941 . . . . 0.0 108.999 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.85 117.59 34.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 109.585 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 71' ' ' LEU . 59.1 t -103.65 143.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.3 mp -94.64 112.5 24.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.888 -1.132 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.83 -88.64 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.977 0.894 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 71' ' ' LEU . 13.6 tp -111.19 147.51 34.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -59.44 -37.3 77.74 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.436 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.74 170.49 23.4 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.52 151.59 24.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.386 -0.821 . . . . 0.0 109.735 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -145.66 166.81 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 61.2 m-85 -121.13 136.55 54.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.79 118.7 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.64 120.75 36.45 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -97.03 153.88 17.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.82 -18.88 58.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.364 -0.835 . . . . 0.0 110.16 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -81.54 -1.47 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.18 70.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.15 118.01 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.978 -1.307 . . . . 0.0 109.659 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -103.34 130.35 50.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.327 -0.858 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -131.11 138.28 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.462 -0.773 . . . . 0.0 109.732 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -97.69 142.44 29.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -132.83 155.5 48.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.461 -0.775 . . . . 0.0 109.613 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -106.81 125.55 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.37 165.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.071 -1.018 . . . . 0.0 109.969 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 39.2 mt-10 -107.67 154.06 41.09 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.52 -29.1 31.14 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.157 1.905 . . . . 0.0 111.113 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -88.7 1.26 55.43 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 151.27 47.17 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.962 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.8 p -96.66 150.94 20.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.257 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -54.4 -36.75 35.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.065 -1.022 . . . . 0.0 108.863 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.32 -42.81 92.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 109.935 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -67.78 -37.74 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.96 -31.05 39.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.581 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.63 -34.98 76.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.89 78.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.3 -46.88 79.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.3 mt -63.07 -42.16 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.23 -46.11 85.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 109.974 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.02 -30.57 71.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 111.442 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -96.07 -43.74 7.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.879 -1.138 . . . . 0.0 111.278 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -87.9 -27.26 22.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.813 -1.179 . . . . 0.0 109.945 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.34 77.15 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.106 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -76.18 133.67 71.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.706 -1.467 . . . . 0.0 108.616 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.23 133.15 20.6 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.36 1.373 . . . . 0.0 112.143 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.89 -25.45 2.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 113.155 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -77.81 -3.63 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.95 -1.094 . . . . 0.0 110.338 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -111.78 -29.89 7.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -107.23 143.42 35.48 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.825 0.821 . . . . 0.0 111.016 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.453 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.4 mtp180 -130.38 125.43 34.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.7 mt -96.43 122.79 39.71 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.032 -1.043 . . . . 0.0 111.186 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.3 mp -118.97 134.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.84 134.79 55.12 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 -109.45 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.081 -1.012 . . . . 0.0 108.792 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.5 33.34 3.31 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -133.83 154.6 50.91 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.065 -1.256 . . . . 0.0 109.598 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -99.3 116.09 30.68 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -53.6 120.05 5.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.97 142.62 27.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.893 . . . . 0.0 109.795 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.27 135.46 57.48 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.453 -0.779 . . . . 0.0 110.31 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 -18.6 54.83 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.358 -0.839 . . . . 0.0 111.943 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.438 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -90.66 159.89 16.15 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.022 1.911 . . . . 0.0 109.996 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -102.72 154.55 19.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.587 -0.696 . . . . 0.0 109.927 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.65 -37.39 73.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.345 -0.847 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -56.74 -18.71 13.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.008 -1.058 . . . . 0.0 109.533 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -76.22 -19.44 58.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.89 -11.92 17.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.466 -0.771 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 t30 60.58 48.01 7.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.032 -1.042 . . . . 0.0 109.577 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 62' ' ' GLN . 97.2 mt -70.36 171.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.141 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 61' ' ' ILE . 26.0 mm100 -128.27 136.16 50.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -53.6 148.1 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.703 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' OE2' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 68.77 11.88 8.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.646 -0.659 . . . . 0.0 110.308 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.509 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.1 mp -95.57 154.31 17.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -95.76 126.14 40.82 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.077 -1.015 . . . . 0.0 108.835 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tp -101.23 113.28 26.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' C ' HD12 ' A' ' 71' ' ' LEU . 44.1 t -106.43 138.25 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 70' ' ' VAL . 9.2 mp -108.15 167.4 10.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.214 -0.928 . . . . 0.0 109.279 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 112.17 5.6 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.8 tp -82.3 -53.22 6.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HG3' ' NH2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.61 117.19 10.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.315 0.579 . . . . 0.0 110.254 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.88 -126.28 3.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.085 -1.397 . . . . 0.0 110.086 -179.442 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -99.81 143.16 30.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.14 166.53 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.33 158.51 39.62 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.02 124.73 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.1 119.64 31.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.489 -0.757 . . . . 0.0 109.094 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -91.14 151.97 20.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -58.82 -19.3 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 109.754 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 9' ' ' THR . 89.8 m -81.37 -6.71 59.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.136 -0.978 . . . . 0.0 109.402 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.67 59.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -94.09 118.94 32.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.314 . . . . 0.0 109.611 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -94.86 122.9 37.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.054 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -115.26 145.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.572 -0.705 . . . . 0.0 109.12 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 14' ' ' THR . 12.2 t -106.6 131.7 53.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.714 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -129.71 150.44 51.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.458 -0.776 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -110.91 128.7 55.9 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.88 174.51 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 110.317 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -107.93 152.88 41.86 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.61 -34.18 26.16 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.967 1.778 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -85.66 1.78 47.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.57 -0.706 . . . . 0.0 109.233 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.67 147.91 44.35 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.996 -1.081 . . . . 0.0 108.522 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.4 p -89.0 155.81 19.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 108.847 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.2 mp -56.73 -42.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.043 -1.035 . . . . 0.0 108.237 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.81 -37.89 89.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -69.48 -41.63 75.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.6 t -66.76 -28.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.245 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -72.92 -35.42 67.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.38 92.42 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.99 -44.93 94.67 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.0 -37.58 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.42 -0.8 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -59.61 -47.96 83.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.923 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -66.77 -34.82 78.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 111.274 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -85.22 -46.13 11.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 111.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -85.03 -27.24 26.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.67 -1.269 . . . . 0.0 109.72 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.66 3.58 79.32 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.441 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -93.29 124.34 57.97 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.673 -1.487 . . . . 0.0 108.716 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.39 130.34 21.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.294 1.329 . . . . 0.0 112.368 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -49.47 -24.56 9.17 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.223 1.949 . . . . 0.0 113.423 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.21 -9.22 58.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.645 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -103.65 -23.57 13.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -98.25 138.48 35.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 0.0 110.761 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.59 HH21 ' HA ' ' A' ' 72' ' ' ARG . 9.7 mtp180 -122.61 112.05 17.52 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 44' ' ' ILE . 14.6 mt -88.5 122.84 32.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.185 -0.947 . . . . 0.0 111.097 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.616 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.9 mp -115.34 132.72 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -119.96 135.53 54.87 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 -112.76 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.014 -1.054 . . . . 0.0 109.087 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.98 28.62 5.82 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -140.13 179.2 6.77 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.881 -1.364 . . . . 0.0 109.474 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -109.63 156.45 20.2 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 50' ' ' LEU . 4.3 mm? -83.32 108.63 16.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.095 -1.003 . . . . 0.0 108.358 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' CD ' HH21 ' A' ' 54' ' ' ARG . 40.4 tt0 -80.71 152.5 28.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.68 142.27 30.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.529 -0.732 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.02 10.47 51.96 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.301 -0.875 . . . . 0.0 111.714 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.62 HH21 ' CD ' ' A' ' 51' ' ' GLU . 3.9 mtp180 -129.69 172.87 11.17 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.893 -1.357 . . . . 0.0 109.721 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -103.59 149.73 24.63 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.037 -1.039 . . . . 0.0 111.235 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -56.65 -32.54 65.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.461 -0.774 . . . . 0.0 109.491 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -62.11 -19.27 62.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.087 -1.008 . . . . 0.0 109.213 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.35 -16.88 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.421 -0.799 . . . . 0.0 109.614 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.502 ' CE1' HD13 ' A' ' 50' ' ' LEU . 13.4 m-85 -103.91 10.98 36.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.427 -0.796 . . . . 0.0 110.238 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 52.46 42.46 31.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.612 -1.305 . . . . 0.0 109.416 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 62' ' ' GLN . 60.6 mt -71.4 170.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.561 ' N ' HG22 ' A' ' 61' ' ' ILE . 42.4 mt-30 -143.8 147.05 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.086 -1.009 . . . . 0.0 110.068 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -52.94 145.78 12.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 110.587 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.32 14.51 8.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.821 -0.549 . . . . 0.0 110.607 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 67' ' ' LEU . 11.0 mp -99.99 155.83 17.49 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -97.78 130.94 44.69 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.9 tt -103.36 116.89 33.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 109.666 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 69' ' ' LEU . 46.7 t -108.05 146.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.6 mp -82.42 -102.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.861 -1.149 . . . . 0.0 111.047 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HA ' HH21 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -163.78 -29.79 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 -179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.16 -58.16 3.65 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.624 -0.673 . . . . 0.0 110.016 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -71.75 86.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.766 0.793 . . . . 0.0 109.326 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.25 -8.14 0.13 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.827 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.53 144.97 29.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.309 -0.87 . . . . 0.0 109.405 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -145.84 166.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -128.84 150.4 50.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.93 -1.107 . . . . 0.0 110.131 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.55 123.72 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.365 -0.835 . . . . 0.0 108.866 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -97.66 123.5 41.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 8' ' ' LEU . 34.4 m -98.6 158.95 15.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' N ' HG22 ' A' ' 7' ' ' THR . 22.3 mt -63.25 -16.31 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.924 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -82.04 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.097 -1.002 . . . . 0.0 109.641 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.83 64.97 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -94.86 133.69 38.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.312 . . . . 0.0 109.281 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.9 m -114.88 129.2 56.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 109.126 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -125.49 145.06 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.72 -0.612 . . . . 0.0 109.494 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -103.45 136.89 42.34 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.712 . . . . 0.0 109.847 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -131.99 151.75 51.55 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -103.29 122.86 45.67 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.05 164.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.114 -0.991 . . . . 0.0 110.076 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 65.0 mt-10 -107.23 151.81 40.94 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.1 -30.91 37.76 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.091 1.861 . . . . 0.0 111.04 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -82.95 -0.8 50.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.52 147.88 52.21 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.671 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.3 p -90.77 153.98 19.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 109.005 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.61 -38.9 44.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.846 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.3 -45.1 89.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 109.876 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -63.21 -36.97 85.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.983 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.28 -27.97 22.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -67.53 -38.26 83.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.51 45.55 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -48.92 -43.9 39.84 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.526 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.15 -28.61 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.014 -1.054 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -61.94 -50.31 72.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 109.871 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -72.78 -28.8 62.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -81.39 -47.52 13.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.865 -1.147 . . . . 0.0 111.039 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.14 -17.79 25.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.715 -1.241 . . . . 0.0 109.73 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.04 52.02 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.286 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -93.23 125.07 55.9 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.665 -1.491 . . . . 0.0 109.304 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.32 149.05 6.88 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.482 1.455 . . . . 0.0 112.145 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.69 -26.92 32.58 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.357 2.038 . . . . 0.0 112.29 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.33 -2.36 13.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -110.85 -13.32 14.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.02 -1.05 . . . . 0.0 109.689 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -110.05 137.75 47.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -119.81 111.02 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 17.2 mt -92.46 120.17 32.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -113.98 144.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -123.29 140.49 52.96 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.07 -112.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.098 -1.002 . . . . 0.0 108.56 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.43 6.19 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -125.12 144.09 50.6 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.014 -1.286 . . . . 0.0 109.366 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -74.68 147.9 41.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.523 HD23 ' CE1' ' A' ' 59' ' ' TYR . 96.5 mt -88.16 114.79 25.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.821 -1.174 . . . . 0.0 108.842 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 21.6 mp0 -81.3 175.72 10.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 108.912 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 39.3 p-10 -95.49 135.65 36.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.72 -0.613 . . . . 0.0 111.577 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.93 -8.22 61.12 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.998 -1.064 . . . . 0.0 112.18 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 5.8 mtt180 -95.18 154.8 17.01 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 120.307 -1.702 . . . . 0.0 109.306 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 p -92.87 149.79 21.03 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.016 -1.053 . . . . 0.0 110.895 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -53.75 -33.68 56.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 109.636 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 m -64.82 -13.63 56.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.06 -1.025 . . . . 0.0 109.085 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.17 -17.22 61.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.547 -0.721 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.523 ' CE1' HD23 ' A' ' 50' ' ' LEU . 19.0 m-85 -110.68 8.19 22.55 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 0.0 110.13 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 54.76 45.73 26.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.346 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 62' ' ' GLN . 86.5 mt -75.04 172.1 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.177 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.604 ' N ' HG22 ' A' ' 61' ' ' ILE . 81.3 mt-30 -139.32 142.12 37.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -51.8 151.61 3.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.225 -0.922 . . . . 0.0 110.336 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 64.71 14.86 9.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.059 -0.4 . . . . 0.0 110.793 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.95 150.57 20.31 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.4 127.74 38.0 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.5 tt -106.16 113.25 26.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 ' N ' HD23 ' A' ' 69' ' ' LEU . 61.8 t -111.72 141.37 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.816 HD22 ' N ' ' A' ' 71' ' ' LEU . 1.2 mm? -90.35 157.35 17.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 0.0 109.615 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.38 134.56 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -113.55 142.03 46.45 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.517 -0.739 . . . . 0.0 109.854 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.654 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -156.77 144.79 19.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.683 -1.261 . . . . 0.0 110.427 177.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 26.11 63.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.56 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.236 0.541 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -99.8 141.6 32.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.657 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 3' ' ' ILE . 9.6 tt -141.38 163.9 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 28.4 m-85 -126.72 157.04 40.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.47 119.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -91.29 120.56 32.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 109.366 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -95.83 166.04 12.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.57 -22.12 65.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.154 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.52 -3.2 52.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.632 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 17.32 60.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -94.41 125.41 39.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.326 . . . . 0.0 109.301 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.2 m -101.1 121.95 42.73 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -108.96 141.65 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.424 HG22 ' CE2' ' A' ' 4' ' ' PHE . 79.0 p -103.74 126.77 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.72 149.78 51.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.503 -0.748 . . . . 0.0 109.712 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -103.67 123.46 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.1 p -144.91 166.34 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.055 -1.028 . . . . 0.0 110.19 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.6 mt-10 -109.9 152.19 42.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.27 -28.03 34.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.207 1.938 . . . . 0.0 111.28 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 t -85.34 -2.2 57.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.012 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 26' ' ' VAL . 9.9 t0 -62.87 146.98 51.54 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.803 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -88.61 143.49 26.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.7 mp -49.76 -42.38 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 108.483 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -60.25 -44.2 95.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.643 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.39 -40.0 85.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' OD2' ' A' ' 21' ' ' ASP . 60.9 t -63.96 -33.23 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.623 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -70.84 -35.08 72.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.89 82.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -54.57 -48.76 71.69 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.89 -37.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.68 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -61.99 -48.78 78.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -67.3 -33.11 74.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 111.115 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -45.45 12.54 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.789 -1.194 . . . . 0.0 111.179 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -88.98 -24.96 22.27 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.736 -1.228 . . . . 0.0 109.833 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 1.07 90.09 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.146 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.97 134.35 35.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 120.596 -1.532 . . . . 0.0 108.873 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.91 154.45 67.13 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.553 1.502 . . . . 0.0 112.035 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.69 -17.94 37.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.594 2.196 . . . . 0.0 112.302 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.511 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 77.9 m-20 -79.54 -4.82 53.15 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.763 -1.21 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -107.2 -28.07 10.16 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.263 -0.898 . . . . 0.0 110.735 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -112.89 146.69 38.5 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.393 -0.817 . . . . 0.0 110.621 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.0 120.59 27.87 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.0 mt -90.43 126.19 35.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 0.0 110.844 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.6 mp -119.63 137.03 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 109.349 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -119.0 136.09 54.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.93 -112.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 108.655 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.23 4.86 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.53 147.71 52.56 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.148 -1.207 . . . . 0.0 109.545 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -90.21 116.86 28.52 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.8 mt -55.66 123.51 14.31 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 109.926 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.46 140.75 45.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.715 0.769 . . . . 0.0 109.343 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.8 p-10 -64.52 155.28 33.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.688 -0.632 . . . . 0.0 110.958 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.76 2.05 56.29 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.377 -0.827 . . . . 0.0 112.072 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -133.9 172.48 12.74 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.745 -1.444 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -105.26 154.67 19.93 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.165 -0.959 . . . . 0.0 110.994 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.67 -34.35 64.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.432 -0.792 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -62.55 -16.7 57.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.73 -16.87 63.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.82 . . . . 0.0 109.443 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -105.46 11.03 33.04 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 53.61 46.83 25.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.651 -1.281 . . . . 0.0 109.468 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 62' ' ' GLN . 75.9 mt -87.47 -176.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 0.0 109.349 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.764 ' H ' HG22 ' A' ' 61' ' ' ILE . 10.0 pt20 -157.79 158.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 110.29 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -54.58 151.08 8.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.426 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 68.4 14.95 9.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.603 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.42 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.0 mp -96.46 146.52 24.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -93.18 134.58 35.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 108.624 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.71 121.43 45.01 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.479 -0.763 . . . . 0.0 109.88 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.19 151.95 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -93.1 147.55 22.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.965 -1.084 . . . . 0.0 109.46 -179.431 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' NH2' ' HA ' ' A' ' 39' ' ' ASP . 4.7 mtp180 -69.57 -20.3 63.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 73' ' ' LEU . 5.5 mp -82.88 -165.23 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.035 -1.041 . . . . 0.0 109.336 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.445 HH21 ' HD3' ' A' ' 74' ' ' ARG . 2.4 ttp180 -148.98 -26.66 0.3 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.235 -0.916 . . . . 0.0 109.526 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.54 -10.4 64.59 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 CA-C-O 117.962 -1.466 . . . . 0.0 109.706 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.0 138.39 36.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.91 162.57 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 37.3 m-85 -124.98 141.73 51.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.313 -0.867 . . . . 0.0 109.398 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.89 116.62 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.335 -0.853 . . . . 0.0 109.005 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.4 114.74 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.415 -0.803 . . . . 0.0 108.911 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -90.97 165.75 13.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tp -70.38 -23.48 62.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.4 p -81.27 -0.15 39.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.033 . . . . 0.0 109.45 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.29 15.74 66.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -93.15 122.06 35.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.868 -1.372 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -99.34 121.61 41.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.534 -0.729 . . . . 0.0 109.401 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.33 139.8 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.661 -0.649 . . . . 0.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.9 p -101.91 127.43 48.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.567 -0.708 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.1 mt -131.18 151.27 51.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.557 -0.714 . . . . 0.0 109.587 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -115.64 131.85 56.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.81 176.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.988 -1.07 . . . . 0.0 110.099 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.23 150.22 40.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.85 -32.1 46.55 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.876 1.717 . . . . 0.0 110.906 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -84.42 2.77 39.18 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.531 -0.731 . . . . 0.0 109.245 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.47 145.79 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.911 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -85.39 160.38 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.459 -0.775 . . . . 0.0 108.935 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.4 mp -61.22 -39.37 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.061 -1.025 . . . . 0.0 108.26 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -35.87 81.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -69.74 -38.92 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 109.606 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -72.45 -33.09 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.577 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' NZ ' ' CG2' ' A' ' 23' ' ' ILE . 49.6 mttp -68.01 -34.17 76.0 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -51.46 -45.79 62.83 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.885 . . . . 0.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.5 -48.88 79.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 110.053 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -68.98 -31.95 71.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.317 -0.865 . . . . 0.0 111.052 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -82.92 -48.19 10.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.919 -1.113 . . . . 0.0 111.489 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.775 -1.203 . . . . 0.0 109.986 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.51 3.21 82.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.131 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.12 123.67 66.72 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.75 -1.441 . . . . 0.0 108.764 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.34 130.16 20.64 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.143 1.229 . . . . 0.0 112.267 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.53 -34.2 25.6 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.258 1.972 . . . . 0.0 113.444 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.45 -1.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.326 -0.859 . . . . 0.0 110.803 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -109.47 -21.68 12.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 0.0 110.052 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -103.31 138.31 40.26 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.141 -0.974 . . . . 0.0 111.412 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -121.14 105.34 10.5 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.04 125.14 34.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.98 -1.075 . . . . 0.0 110.239 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mt -123.5 145.18 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' C ' ' H ' ' A' ' 47' ' ' GLY . 84.3 t80 -148.8 145.91 27.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.616 -0.678 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.86 8.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.29 16.14 51.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -121.55 146.31 47.07 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.998 -1.295 . . . . 0.0 108.853 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.48 115.82 23.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.74 119.51 5.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.941 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.82 173.35 7.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.188 -0.945 . . . . 0.0 109.89 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -94.67 149.15 21.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 110.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.7 -11.05 69.81 Favored Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.445 -0.784 . . . . 0.0 111.331 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -96.46 174.66 6.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.79 -1.418 . . . . 0.0 109.448 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -115.31 152.47 32.72 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.992 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -57.56 -41.01 80.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.493 -0.755 . . . . 0.0 109.75 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -58.95 -23.76 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 109.328 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.67 -17.09 62.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.357 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.33 3.71 35.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.0 110.314 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.27 45.13 27.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.743 -1.223 . . . . 0.0 109.413 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.0 mt -72.24 173.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 109.159 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' N ' HG22 ' A' ' 61' ' ' ILE . 59.6 mt-30 -137.38 142.2 41.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -53.48 148.14 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.857 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 68.0 12.14 8.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.734 -0.604 . . . . 0.0 110.561 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.415 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.7 mp -95.93 151.34 19.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -98.57 132.36 44.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.185 -0.947 . . . . 0.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -107.22 113.68 27.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.634 -0.666 . . . . 0.0 109.508 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.0 t -108.58 150.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp -84.32 -105.35 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -84.08 -89.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.71 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.57 168.67 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.689 -1.257 . . . . 0.0 110.483 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -167.53 -8.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.546 -0.721 . . . . 0.0 109.36 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.7 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.916 -1.491 . . . . 0.0 109.676 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.325 0.583 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.68 163.73 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -122.46 132.74 54.49 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -99.12 112.82 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.024 -1.047 . . . . 0.0 108.852 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -89.68 114.5 26.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.748 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -93.84 162.03 14.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.321 -0.862 . . . . 0.0 109.842 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.97 -19.49 64.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.814 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -81.69 -5.55 58.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.998 . . . . 0.0 109.595 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.78 14.88 58.94 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -93.87 124.68 38.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.886 -1.361 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 m -102.01 124.22 47.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.532 -0.73 . . . . 0.0 109.043 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -114.99 140.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.562 -0.712 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -102.2 128.35 48.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -128.65 147.97 50.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 16' ' ' GLU . 27.2 mp0 -110.68 127.88 55.48 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.28 179.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.975 -1.078 . . . . 0.0 110.262 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -113.05 151.68 44.35 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.14 -30.42 46.75 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.993 1.795 . . . . 0.0 110.899 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -84.94 4.8 31.87 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.62 145.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 0.0 108.881 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -92.2 148.17 22.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -50.47 -40.76 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.085 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.68 -43.88 90.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.256 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -69.51 -37.0 76.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.92 -32.61 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -70.31 -32.69 70.56 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.74 96.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.12 -47.26 85.91 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.391 0.615 . . . . 0.0 109.418 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.44 -39.78 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.61 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.86 -47.06 88.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 109.966 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.43 -23.64 58.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.956 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -84.89 -51.71 6.54 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.807 -1.183 . . . . 0.0 111.295 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -91.18 -24.0 20.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.65 -1.281 . . . . 0.0 109.902 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.41 4.19 88.04 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.964 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.32 121.75 67.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.776 -1.426 . . . . 0.0 109.12 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.41 150.35 5.72 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.633 1.556 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.64 -28.77 25.42 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.595 2.197 . . . . 0.0 112.483 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.76 -3.32 27.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.56 -6.11 24.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.57 153.75 50.89 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.211 -0.931 . . . . 0.0 110.945 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -129.77 120.78 25.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 44' ' ' ILE . 26.7 mt -86.67 123.15 31.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.992 -1.068 . . . . 0.0 111.275 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.6 mp -116.46 133.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.547 0.689 . . . . 0.0 109.17 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 47' ' ' GLY . 60.5 t80 -145.95 140.78 27.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.143 -0.973 . . . . 0.0 108.801 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 8.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 109.288 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.81 23.23 26.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -126.94 147.14 50.11 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.146 -1.208 . . . . 0.0 109.53 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -89.95 112.09 23.37 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.41 122.93 10.65 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.496 -0.753 . . . . 0.0 109.759 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -93.05 148.07 22.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.156 -0.965 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.22 131.88 47.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.942 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.65 64.27 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.309 -0.869 . . . . 0.0 111.403 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 54' ' ' ARG . 15.5 ttt180 -89.55 156.4 18.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.402 -1.646 . . . . 0.0 109.783 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -98.23 148.01 24.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.186 -0.946 . . . . 0.0 110.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.86 -38.94 76.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 109.871 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -57.9 -28.07 63.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.992 . . . . 0.0 110.004 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.44 -16.82 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.39 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -101.86 0.54 35.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.413 -0.804 . . . . 0.0 110.133 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 m120 52.03 49.11 21.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 96.6 mt -75.67 176.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 17.4 tt0 -132.44 138.2 47.55 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.27 -0.894 . . . . 0.0 109.662 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -52.41 149.57 5.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 110.543 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.893 -0.505 . . . . 0.0 110.953 179.503 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -90.24 128.27 36.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.096 -1.003 . . . . 0.0 108.659 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.71 125.13 53.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.67 147.3 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 108.77 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.205 0.526 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 tt -144.57 165.78 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.5 m-85 -130.86 157.74 42.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.18 121.06 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 108.596 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.8 tttm -91.86 122.64 34.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.153 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 8' ' ' LEU . 30.0 m -96.25 161.36 13.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.456 ' N ' HG22 ' A' ' 7' ' ' THR . 24.3 mt -62.65 -23.08 66.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -81.64 -0.65 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 16.25 66.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -91.18 117.78 29.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.043 -1.269 . . . . 0.0 109.37 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -93.61 118.52 31.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.475 -0.766 . . . . 0.0 109.169 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -107.63 139.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.754 . . . . 0.0 109.274 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.31 129.03 53.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 109.779 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.27 150.01 51.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.473 -0.767 . . . . 0.0 109.66 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -106.66 126.41 52.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.72 176.03 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.076 -1.015 . . . . 0.0 110.243 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -112.77 151.58 44.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.0 -33.01 64.27 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.818 1.679 . . . . 0.0 110.669 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -85.71 3.91 39.0 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.576 -0.703 . . . . 0.0 109.221 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.38 149.22 48.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 p -96.69 147.16 24.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.526 -0.734 . . . . 0.0 109.694 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.53 -41.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.226 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.13 -45.02 96.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.775 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.26 -37.4 80.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.728 . . . . 0.0 109.674 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -70.48 -31.32 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.273 -0.892 . . . . 0.0 109.901 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.46 -33.33 71.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.53 97.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -59.72 -44.94 93.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.84 -40.82 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.369 -0.832 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.59 -45.38 93.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.831 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.39 -35.6 80.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 111.284 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -89.16 -44.34 10.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.54 -27.09 22.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.75 -1.219 . . . . 0.0 110.063 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.21 83.11 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.037 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.7 mt -91.09 119.11 68.88 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.702 -1.469 . . . . 0.0 109.339 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.57 149.56 6.93 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.69 1.593 . . . . 0.0 112.326 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.06 -22.98 29.97 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.74 -6.01 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.795 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.13 -4.44 35.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 109.812 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -140.01 155.82 46.91 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.073 -1.017 . . . . 0.0 111.35 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.436 HH21 ' HD3' ' A' ' 42' ' ' ARG . 13.6 mtt180 -127.78 133.34 49.46 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.7 mt -96.93 123.59 40.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 109.79 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.1 mp -112.54 138.81 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' GLY . 89.9 t80 -147.5 137.74 23.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.025 . . . . 0.0 109.059 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 11.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.369 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 92.6 23.94 24.86 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -128.11 147.18 50.53 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.122 -1.222 . . . . 0.0 109.47 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -90.15 111.69 22.92 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.04 118.14 3.0 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.551 -0.718 . . . . 0.0 109.267 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -94.76 142.74 27.11 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.178 -0.951 . . . . 0.0 109.074 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.15 137.56 57.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.524 -0.735 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.78 -13.15 57.89 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -96.61 154.7 17.13 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.959 1.879 . . . . 0.0 110.367 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -99.07 152.36 19.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.025 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.61 -37.55 68.28 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.343 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -59.09 -21.46 59.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.894 -1.128 . . . . 0.0 109.732 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -70.77 -16.88 62.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -105.51 9.65 33.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.326 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 52.23 47.63 24.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.0 mt -79.75 172.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.421 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' HG22 ' A' ' 61' ' ' ILE . 29.7 mt-30 -144.03 146.95 33.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.05 -1.031 . . . . 0.0 110.062 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.32 147.71 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.622 -0.674 . . . . 0.0 110.425 179.573 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -93.05 131.89 37.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.289 -0.882 . . . . 0.0 108.766 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.65 128.73 55.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.02 150.71 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 108.757 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.314 0.578 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -146.34 167.57 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 44.1 m-85 -124.78 134.85 52.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.96 113.61 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -90.77 113.58 25.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 8' ' ' LEU . 29.3 m -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.227 -0.92 . . . . 0.0 109.761 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' N ' HG22 ' A' ' 7' ' ' THR . 7.6 tp -64.05 -21.53 66.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 110.111 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -81.25 1.32 32.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.033 -1.042 . . . . 0.0 109.641 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.96 80.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -87.77 125.56 34.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.319 . . . . 0.0 109.121 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -105.77 122.19 45.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.576 -0.703 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.91 138.28 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.7 m -105.8 135.71 46.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 0.0 109.998 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.15 156.15 48.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 109.579 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -109.4 127.11 54.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -143.57 164.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 109.923 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 62.8 mm-40 -103.89 149.63 37.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.63 -31.48 32.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.949 1.766 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 t -82.8 -0.62 48.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.441 -0.787 . . . . 0.0 109.406 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 146.81 54.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -87.88 157.66 18.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.922 . . . . 0.0 109.048 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.573 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.1 mp -56.71 -42.07 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 108.499 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -64.03 -41.22 97.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -64.3 -36.95 85.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.029 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -74.7 -29.0 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -67.43 -37.51 83.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.45 44.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -49.04 -46.96 45.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.581 HG21 HE22 ' A' ' 41' ' ' GLN . 97.3 mt -62.68 -36.63 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.867 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -70.78 -48.4 54.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.81 -28.21 67.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -97.53 -41.57 8.1 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.811 -1.18 . . . . 0.0 111.208 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -93.12 -19.96 20.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.771 -1.205 . . . . 0.0 110.125 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.09 18.45 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.956 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.98 119.96 79.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 120.731 -1.453 . . . . 0.0 108.775 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.35 129.68 19.79 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.199 1.266 . . . . 0.0 112.294 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -49.92 -36.61 44.17 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.213 1.942 . . . . 0.0 112.991 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.08 -0.85 8.41 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -100.02 -3.95 31.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.153 -0.967 . . . . 0.0 110.361 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.581 HE22 HG21 ' A' ' 30' ' ' ILE . 15.7 pt20 -139.25 153.82 47.89 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 110.434 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -128.61 109.88 11.75 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.13 125.73 33.71 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.655 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.39 148.17 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.621 0.724 . . . . 0.0 109.599 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 47' ' ' GLY . 80.7 t80 -149.83 142.38 24.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.369 -0.832 . . . . 0.0 109.058 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.63 5.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.04 9.96 56.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.47 148.63 40.57 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.091 -1.24 . . . . 0.0 109.202 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -82.19 116.53 21.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.82 121.04 10.13 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.363 -0.836 . . . . 0.0 109.497 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -90.69 173.51 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.666 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.59 140.4 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.335 -0.853 . . . . 0.0 110.905 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.61 53.4 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.278 -0.889 . . . . 0.0 111.612 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.72 ' HG2' HH21 ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.63 176.26 9.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.01 -1.288 . . . . 0.0 110.446 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -113.15 145.36 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.55 -37.71 70.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.522 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -59.91 -26.29 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.79 -17.85 51.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.602 -0.686 . . . . 0.0 109.531 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.25 3.07 32.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.41 -0.806 . . . . 0.0 110.258 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.78 47.22 24.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.706 -1.246 . . . . 0.0 109.583 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 62' ' ' GLN . 63.4 mt -68.93 169.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.7 tp-100 -135.46 139.82 44.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -54.08 147.82 12.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 110.895 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.696 -0.628 . . . . 0.0 110.765 179.396 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.8 mp . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -98.24 129.3 44.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -112.81 118.43 34.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.72 145.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.497 1.917 0 O-C-N 120.914 -1.116 . . . . 0.0 110.072 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 121.411 0.625 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -145.22 166.63 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -127.08 143.07 51.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.284 -0.885 . . . . 0.0 109.608 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.88 121.33 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.288 -0.882 . . . . 0.0 108.837 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -94.97 123.98 38.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -98.95 153.4 18.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 0.0 109.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.0 mp -59.93 -18.3 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.3 p -81.53 -3.0 51.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.022 -1.049 . . . . 0.0 109.625 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.84 69.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -93.43 121.21 34.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.855 -1.38 . . . . 0.0 109.561 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 m -103.89 129.78 51.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.474 -0.767 . . . . 0.0 109.292 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 tt -126.36 145.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.613 -0.679 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -105.53 137.18 43.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.58 -0.7 . . . . 0.0 109.552 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.4 mt -129.1 149.46 50.91 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.484 -0.76 . . . . 0.0 109.578 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.01 125.54 51.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.87 176.17 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.99 -1.069 . . . . 0.0 110.271 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -110.31 154.0 43.11 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.85 -33.54 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.023 1.816 . . . . 0.0 110.765 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.2 m -84.37 4.62 30.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.563 -0.71 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.98 147.92 50.89 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.004 -1.079 . . . . 0.0 108.951 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 p -92.64 150.45 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.309 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -53.97 -40.0 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.56 -43.6 98.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.19 -37.65 84.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.45 -28.79 36.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -70.28 -35.46 73.75 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.73 84.54 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -55.53 -47.33 76.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.732 -0.605 . . . . 0.0 109.443 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.06 -39.52 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.37 -0.831 . . . . 0.0 109.5 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.05 -45.08 93.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.37 -31.97 73.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 111.299 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -94.72 -41.6 9.18 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.802 -1.186 . . . . 0.0 111.534 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -91.65 -23.54 19.8 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.761 -1.212 . . . . 0.0 110.051 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.65 -1.47 29.21 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.059 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -83.96 118.85 72.42 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.413 . . . . 0.0 109.506 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.91 149.82 7.39 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.67 1.58 . . . . 0.0 112.027 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.68 -25.24 29.17 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.508 2.139 . . . . 0.0 112.464 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.61 -2.06 24.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 109.724 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -101.13 -7.81 22.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.237 -0.915 . . . . 0.0 110.013 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -143.04 158.88 43.19 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.008 -1.058 . . . . 0.0 110.962 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.456 HH21 ' HD3' ' A' ' 42' ' ' ARG . 1.6 mtp180 -132.12 121.24 23.46 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.58 121.85 28.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.07 -1.019 . . . . 0.0 110.604 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mm -115.94 133.45 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -119.12 134.95 54.9 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.04 -113.45 0.65 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.995 -1.065 . . . . 0.0 108.582 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.11 26.93 5.2 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.08 150.67 46.59 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.244 -1.151 . . . . 0.0 109.233 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -91.28 113.35 25.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 59' ' ' TYR . 89.8 mt -55.08 122.2 10.44 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.666 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.76 171.19 9.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.77 134.26 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.28 -19.07 55.43 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.752 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.59 160.75 26.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.581 -1.541 . . . . 0.0 109.095 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 p -102.58 152.97 20.55 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.478 -0.764 . . . . 0.0 109.245 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.83 -38.98 70.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.048 . . . . 0.0 109.311 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -61.22 -17.82 55.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.104 -0.998 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.5 -18.45 63.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE1' HD23 ' A' ' 50' ' ' LEU . 22.8 m-85 -108.2 7.81 27.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.574 -0.703 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 t30 50.56 47.09 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.53 -1.356 . . . . 0.0 109.562 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.637 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.8 mt -72.97 173.96 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.637 ' N ' HG22 ' A' ' 61' ' ' ILE . 66.0 mt-30 -133.07 137.93 46.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.89 151.02 4.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 110.516 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.986 -0.446 . . . . 0.0 110.851 179.75 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.25 130.74 38.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.31 118.81 37.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.814 . . . . 0.0 109.98 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.19 146.77 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.1 mp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.979 -1.076 . . . . 0.0 109.352 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.277 0.561 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 67' ' ' LEU . 4.9 mp -133.19 153.48 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -120.26 135.37 55.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.763 -1.211 . . . . 0.0 109.377 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.81 116.48 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.15 115.76 28.28 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.8 m -97.76 163.22 12.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.408 -0.808 . . . . 0.0 109.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.9 mp -68.67 -17.87 64.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 p -81.45 -1.45 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.053 -1.03 . . . . 0.0 109.751 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.12 13.69 73.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -91.26 131.84 36.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.027 -1.278 . . . . 0.0 109.307 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.8 m -107.38 113.22 26.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.163 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -106.54 139.64 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.596 -0.69 . . . . 0.0 109.221 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -108.73 134.67 51.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.672 -0.642 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.1 mt -125.92 143.91 50.89 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.749 . . . . 0.0 109.593 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -105.51 125.2 50.72 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.35 178.76 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.952 -1.093 . . . . 0.0 110.242 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 155.2 42.38 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.5 -34.74 32.68 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.056 1.838 . . . . 0.0 110.728 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 t -81.4 5.69 16.77 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.612 -0.68 . . . . 0.0 109.318 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' A' ' 26' ' ' VAL . 21.1 t0 -68.76 145.51 53.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 109.052 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.0 p -91.93 152.65 19.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.197 -0.939 . . . . 0.0 109.257 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -58.07 -35.18 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.961 -1.087 . . . . 0.0 109.124 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.68 -51.11 68.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.27 -33.86 76.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.866 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 22' ' ' THR . 96.8 t -73.25 -34.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' NZ ' HD12 ' A' ' 43' ' ' LEU . 28.2 mmtm -62.75 -35.38 79.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.39 63.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -49.42 -47.59 47.86 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.99 -36.22 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.31 -48.84 69.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.11 -26.26 65.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.007 . . . . 0.0 111.5 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -91.77 -47.61 7.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.758 -1.214 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 7.5 mp0 -87.18 -27.0 23.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.8 -1.188 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 -2.3 87.14 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.194 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.98 118.45 68.92 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.65 -1.5 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.51 152.65 3.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.564 1.509 . . . . 0.0 112.421 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.79 -17.97 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.706 2.27 . . . . 0.0 112.292 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -78.12 -3.76 44.0 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.123 -0.986 . . . . 0.0 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -112.32 -15.16 13.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -114.78 142.39 46.6 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.495 -0.753 . . . . 0.0 110.652 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HD3' HH21 ' A' ' 42' ' ' ARG . 3.4 mtm180 -129.17 119.23 23.73 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.568 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.0 mt -91.35 122.83 34.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 111.278 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -110.95 140.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.7 t80 -150.77 136.38 18.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 108.726 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.67 2.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 99.36 21.39 15.12 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 140.8 50.67 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.68 120.3 24.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.12 118.99 7.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.451 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.59 147.07 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.148 -0.97 . . . . 0.0 109.056 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.5 p-10 -61.77 138.08 58.3 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.767 . . . . 0.0 110.674 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.81 56.35 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.401 -0.812 . . . . 0.0 112.003 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.76 164.16 17.76 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 120.073 1.937 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -101.53 146.01 28.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.313 -0.867 . . . . 0.0 111.021 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.11 -39.25 63.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.387 -0.821 . . . . 0.0 109.645 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -68.66 -18.75 64.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.89 . . . . 0.0 109.166 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.81 -17.9 61.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.73 . . . . 0.0 109.898 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -107.74 9.85 28.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 54.8 25.32 6.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 109.419 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 18.9 mt -51.76 170.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 95.0 mm-40 -137.75 141.1 40.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.381 -0.825 . . . . 0.0 109.781 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -57.35 155.69 8.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.132 -0.98 . . . . 0.0 110.233 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 122.002 -0.436 . . . . 0.0 110.967 179.638 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -96.26 130.41 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.52 128.87 56.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.407 -0.808 . . . . 0.0 109.811 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.88 149.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 71' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.702 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.452 ' CG2' HD13 ' A' ' 67' ' ' LEU . 34.3 mm -117.45 153.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -127.03 127.36 44.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.506 -1.371 . . . . 0.0 108.64 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.68 124.9 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.712 -1.243 . . . . 0.0 109.464 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -102.31 123.31 45.89 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -101.1 153.54 19.49 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.288 -0.882 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.28 -18.41 37.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 p -81.33 -1.01 43.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.345 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.73 86.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.81 116.18 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.926 -1.337 . . . . 0.0 110.032 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -104.68 134.85 47.15 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -130.73 143.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 t -100.68 130.38 46.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.238 -0.914 . . . . 0.0 109.944 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.89 145.23 50.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 0.0 109.703 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -106.27 126.63 52.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.35 -176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 110.048 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -117.68 152.07 49.3 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.29 -33.3 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.062 1.841 . . . . 0.0 110.882 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -83.47 2.51 36.42 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 26' ' ' VAL . 2.4 t70 -66.89 148.37 52.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.839 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 159.37 16.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.394 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.59 -38.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.8 -47.87 83.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.929 . . . . 0.0 110.027 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.76 -46.21 86.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.865 . . . . 0.0 109.906 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' OD2' ' A' ' 21' ' ' ASP . 96.8 t -63.23 -30.92 50.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.572 -0.705 . . . . 0.0 109.556 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -69.38 -32.56 71.67 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.55 -58.46 8.5 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 1.3 mptm? -49.5 -43.26 45.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.513 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.421 HG21 HE22 ' A' ' 41' ' ' GLN . 91.0 mt -63.51 -44.52 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.252 -0.905 . . . . 0.0 109.745 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.71 -48.14 67.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -64.52 -19.45 65.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.828 . . . . 0.0 111.517 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -98.19 -47.48 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.737 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -90.26 -27.64 19.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.859 -1.151 . . . . 0.0 109.772 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.32 84.2 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.087 -1.008 . . . . 0.0 111.038 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -90.05 116.57 66.69 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.716 -1.461 . . . . 0.0 108.98 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.33 149.34 6.6 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.541 1.494 . . . . 0.0 112.094 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.82 -28.44 24.96 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.532 2.155 . . . . 0.0 112.386 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.16 -1.92 28.6 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.023 -1.048 . . . . 0.0 109.703 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -106.41 1.61 25.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.421 HE22 HG21 ' A' ' 30' ' ' ILE . 14.9 pt20 -141.1 154.74 46.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -0.93 . . . . 0.0 111.267 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.403 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.5 mtm180 -130.54 128.57 41.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.66 121.12 37.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.548 -0.72 . . . . 0.0 111.494 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.99 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.61 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.5 t80 -133.8 134.94 43.48 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.06 -9.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 111.79 18.56 7.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -120.63 152.1 38.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.215 -1.168 . . . . 0.0 109.569 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -91.26 110.71 22.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.31 108.81 0.46 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.771 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.4 150.36 27.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.471 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.47 137.42 57.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.33 -0.856 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.18 -12.62 65.26 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.253 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -84.72 177.89 7.86 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.301 -1.705 . . . . 0.0 109.529 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.2 p -121.85 149.69 43.0 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.419 -0.8 . . . . 0.0 110.933 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -57.1 -41.97 79.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.615 -0.678 . . . . 0.0 109.313 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -57.23 -37.03 71.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.666 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.08 -20.52 6.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 109.553 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -101.83 11.31 38.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.158 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 46.99 48.04 15.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.926 -1.109 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.2 mt -73.4 175.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.344 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.624 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 tp-100 -144.88 147.52 32.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.986 -1.071 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -55.41 149.36 13.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.848 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.807 -0.558 . . . . 0.0 110.788 179.194 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 8.2 mp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 8.0 m-70 -104.21 129.26 51.98 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.99 124.66 51.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.864 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.64 145.96 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.2 mp . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.039 -1.038 . . . . 0.0 108.872 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.592 0.711 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.82 167.6 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.0 m-85 -131.21 132.26 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.99 -1.069 . . . . 0.0 109.714 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.48 120.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 109.364 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -97.61 112.66 24.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 8' ' ' LEU . 33.8 m -94.58 160.16 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.296 -0.878 . . . . 0.0 109.613 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 7' ' ' THR . 35.8 mt -63.21 -20.79 65.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.996 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -81.53 -0.04 40.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.508 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 12.44 79.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -83.41 122.31 28.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.29 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -100.64 119.28 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -117.09 131.67 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.6 m -98.21 129.4 44.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.418 -0.801 . . . . 0.0 109.726 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -129.72 148.11 51.57 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.608 -0.683 . . . . 0.0 109.618 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.26 131.49 55.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.87 -175.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.966 -1.084 . . . . 0.0 110.079 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.8 149.18 41.95 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.13 -30.56 38.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.075 1.85 . . . . 0.0 110.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -83.56 2.18 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.73 147.1 50.96 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 p -89.96 156.92 18.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.43 -36.39 40.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.82 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.95 -48.77 75.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.803 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.75 -36.91 80.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 0.0 109.903 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.47 -28.73 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -67.66 -38.01 83.19 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -57.66 11.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -48.13 -45.23 32.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.361 -0.837 . . . . 0.0 109.41 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.85 -39.73 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.491 -0.756 . . . . 0.0 109.791 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -71.05 -51.09 27.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.98 -18.4 64.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 111.541 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -98.1 -47.63 5.42 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.641 -1.287 . . . . 0.0 110.764 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -93.53 -27.62 16.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.857 -1.152 . . . . 0.0 110.108 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.48 6.99 88.13 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.115 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.06 115.61 63.23 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.661 -1.494 . . . . 0.0 109.133 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.7 146.6 10.92 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.629 1.552 . . . . 0.0 112.247 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.94 -26.29 26.89 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.354 2.036 . . . . 0.0 112.432 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.09 -0.27 21.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.082 -1.011 . . . . 0.0 109.917 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -107.97 2.01 22.95 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.0 109.653 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -145.67 157.87 43.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.856 -1.153 . . . . 0.0 111.548 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -129.53 119.02 22.99 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 44' ' ' ILE . 16.5 mt -88.38 115.26 25.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.881 -1.137 . . . . 0.0 110.428 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.3 mp -109.04 144.75 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.594 ' C ' ' H ' ' A' ' 47' ' ' GLY . 66.6 t80 -147.15 133.48 19.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.093 . . . . 0.0 108.381 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 -5.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.634 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.01 16.34 10.71 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.2 144.99 47.42 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.084 -1.244 . . . . 0.0 109.655 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.88 119.2 25.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.31 114.88 6.38 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.811 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.99 154.66 19.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.905 -1.122 . . . . 0.0 108.994 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -63.52 140.49 58.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.504 -0.747 . . . . 0.0 111.203 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.65 -17.39 59.21 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.618 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 54' ' ' ARG . 3.0 mtp180 -76.04 176.58 7.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.219 -1.754 . . . . 0.0 109.556 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 57' ' ' SER . 38.3 m -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.519 -0.738 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -55.73 -41.37 73.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.364 -0.835 . . . . 0.0 109.645 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.4 ' H ' HG22 ' A' ' 55' ' ' THR . 85.0 p -60.34 -33.5 72.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.22 -20.07 9.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.627 -0.67 . . . . 0.0 109.717 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.4 3.86 35.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.101 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 m120 48.91 47.09 21.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 109.624 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.7 mt -69.17 177.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.398 -0.814 . . . . 0.0 109.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.669 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.3 tp-100 -135.52 138.84 43.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.157 -0.965 . . . . 0.0 109.801 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -52.54 146.94 9.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 110.563 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.761 -0.587 . . . . 0.0 110.856 179.33 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -107.76 130.88 54.92 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 69' ' ' LEU . 5.5 tt -116.35 117.84 31.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.514 -0.742 . . . . 0.0 109.502 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' N ' HD23 ' A' ' 69' ' ' LEU . 52.2 t -109.83 144.7 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 71' ' ' LEU . 9.8 mp . . . . . 0 N--CA 1.5 2.037 0 O-C-N 120.9 -1.125 . . . . 0.0 110.936 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.261 0.553 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -132.68 159.1 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -121.12 138.08 54.36 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.431 -0.793 . . . . 0.0 109.543 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.53 113.87 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.055 -1.028 . . . . 0.0 108.875 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -90.47 115.12 27.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.127 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.4 p -94.3 158.35 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 109.507 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.04 -16.81 63.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 9' ' ' THR . 84.8 m -81.53 -10.08 59.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.438 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 10.15 55.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.86 126.63 36.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.373 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -105.84 121.93 45.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 13' ' ' ILE . 3.4 mp -113.22 144.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -116.47 138.85 51.05 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.724 -0.61 . . . . 0.0 109.782 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -113.39 129.07 56.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.16 176.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.0 -1.063 . . . . 0.0 110.173 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -109.45 151.86 42.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.21 -34.36 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.062 1.841 . . . . 0.0 110.824 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -82.4 3.94 26.06 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.27 148.84 51.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.856 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -88.97 158.08 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 109.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -59.27 -42.96 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 108.42 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.33 -39.13 89.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.855 . . . . 0.0 110.129 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -68.82 -41.99 77.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.805 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -69.18 -31.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.133 -0.979 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -67.72 -34.71 77.4 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.52 83.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -42.94 85.05 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.94 -42.97 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.842 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.18 -43.32 98.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 0.0 109.895 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.99 -34.99 78.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 111.189 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -91.8 -39.82 11.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.761 -1.212 . . . . 0.0 111.531 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -93.37 -17.13 23.89 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.841 -1.162 . . . . 0.0 110.112 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -1.92 37.68 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.973 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.6 mt -81.43 134.21 51.88 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.701 -1.47 . . . . 0.0 109.039 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.92 160.86 48.02 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.688 1.592 . . . . 0.0 111.982 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 -24.69 32.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.765 2.31 . . . . 0.0 112.331 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -81.88 -1.81 48.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.023 -1.048 . . . . 0.0 110.315 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.99 -31.8 6.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.04 -1.038 . . . . 0.0 109.905 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.12 136.74 37.92 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.643 HH21 ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -126.07 111.96 15.3 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.8 mt -93.81 129.74 40.08 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.668 0.747 . . . . 0.0 112.094 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mt -124.07 140.41 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.452 0.644 . . . . 0.0 109.592 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.64 137.66 53.74 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.68 -115.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.911 -1.118 . . . . 0.0 108.465 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.75 30.23 4.94 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 145.96 52.17 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.291 -1.123 . . . . 0.0 109.651 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -88.09 120.05 29.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -57.17 119.43 6.36 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.499 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 32.0 mt-10 -95.71 168.93 10.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.36 -0.838 . . . . 0.0 109.377 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.76 142.18 27.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 111.292 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.08 6.39 55.86 Favored Glycine 0 N--CA 1.502 3.064 0 O-C-N 121.433 -0.792 . . . . 0.0 111.859 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' NH2' ' OE1' ' A' ' 51' ' ' GLU . 5.2 mtp180 -121.4 171.26 8.9 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 118.736 1.268 . . . . 0.0 109.783 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -106.37 149.08 27.34 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.078 -1.014 . . . . 0.0 110.945 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.09 -37.01 68.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 109.609 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.7 p -61.48 -21.15 63.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.84 -17.35 64.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.397 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -103.62 8.74 37.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.752 . . . . 0.0 110.493 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 57.13 47.62 16.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.628 -1.295 . . . . 0.0 109.437 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 62' ' ' GLN . 87.3 mt -80.28 174.48 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.383 -0.823 . . . . 0.0 109.131 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.618 ' N ' HG22 ' A' ' 61' ' ' ILE . 20.0 pt20 -152.95 154.5 35.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.885 -1.134 . . . . 0.0 110.055 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -54.68 147.95 13.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 122.122 -0.361 . . . . 0.0 111.159 179.867 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.7 mp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -90.82 133.73 34.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.295 -0.878 . . . . 0.0 108.777 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -110.8 123.7 50.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.508 -0.745 . . . . 0.0 110.142 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.8 146.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.502 2.159 0 O-C-N 120.874 -1.141 . . . . 0.0 109.972 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.328 0.585 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -143.97 166.29 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.33 141.76 51.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.327 -0.858 . . . . 0.0 109.703 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.88 117.02 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 0.0 108.893 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -89.75 114.13 25.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 108.974 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 160.86 15.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.407 -0.808 . . . . 0.0 109.904 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 8' ' ' LEU . 10.1 mp -69.34 -19.36 63.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.78 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -81.49 -4.13 55.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 109.49 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 12.96 62.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.68 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.367 . . . . 0.0 109.333 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -99.13 117.72 34.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.452 -0.78 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.8 139.98 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.447 -0.783 . . . . 0.0 109.118 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 14' ' ' THR . 11.6 t -113.3 135.43 53.86 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.716 -0.615 . . . . 0.0 109.676 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.04 159.89 40.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.467 -0.771 . . . . 0.0 109.7 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -115.76 132.11 56.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.43 176.69 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.004 -1.06 . . . . 0.0 110.19 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -107.23 153.81 40.88 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.08 -35.78 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.009 1.806 . . . . 0.0 110.754 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -83.35 4.83 25.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.638 -0.664 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.82 143.92 57.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.0 108.703 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -85.86 145.24 27.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 109.415 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.557 HG23 ' HZ2' ' A' ' 27' ' ' LYS . 1.9 mp -50.25 -41.09 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 108.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.77 -40.93 94.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.92 71.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.8 -36.0 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 0.0 109.415 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HZ2' HG23 ' A' ' 23' ' ' ILE . 51.6 mttp -69.58 -30.77 68.62 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.72 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -53.45 -43.75 68.32 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mm -61.44 -46.07 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.7 -43.09 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.89 -32.89 72.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.374 -0.829 . . . . 0.0 111.249 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.14 -40.35 8.85 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.828 -1.17 . . . . 0.0 111.159 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.6 -21.92 25.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.767 -1.208 . . . . 0.0 109.656 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.51 53.31 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.999 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -91.09 134.39 30.13 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.838 -1.389 . . . . 0.0 108.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 131.26 20.92 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.22 1.28 . . . . 0.0 111.871 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.68 -19.14 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.341 2.027 . . . . 0.0 113.729 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.71 -8.5 56.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 110.605 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -109.02 -22.62 12.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.255 -0.903 . . . . 0.0 109.95 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -107.16 143.49 35.28 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.83 0.824 . . . . 0.0 110.998 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.71 124.61 43.12 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -93.65 121.43 35.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.442 -1.411 . . . . 0.0 110.024 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mm -112.17 129.93 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 83.9 t80 -146.91 139.84 25.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 108.903 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.63 3.25 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 109.298 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.38 19.92 26.53 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -127.98 151.86 48.62 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.125 -1.22 . . . . 0.0 109.641 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.61 113.27 25.27 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.07 117.53 2.61 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.307 -0.87 . . . . 0.0 109.87 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.02 173.7 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.229 -0.919 . . . . 0.0 109.804 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.29 146.35 25.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 0.0 111.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.77 10.68 55.06 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.412 -0.805 . . . . 0.0 111.552 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -129.06 160.84 31.52 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.763 -1.433 . . . . 0.0 110.612 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -89.44 146.83 24.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HG ' HD12 ' A' ' 61' ' ' ILE . 14.9 tp -55.65 -27.49 50.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.0 p -71.2 -16.45 62.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.075 -1.015 . . . . 0.0 109.236 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.42 -16.81 57.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.581 -0.7 . . . . 0.0 109.458 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.04 10.56 34.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 53.08 26.03 4.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.558 -1.339 . . . . 0.0 109.63 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 6.0 mt -52.39 170.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.323 -0.86 . . . . 0.0 108.724 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 52.2 mt-30 -138.83 142.68 38.66 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -58.04 153.62 14.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.662 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.668 -0.645 . . . . 0.0 110.565 179.605 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -90.52 128.78 36.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 108.618 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.71 122.54 48.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.614 -0.679 . . . . 0.0 109.792 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.13 150.47 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.4 mp . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 108.99 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.332 0.587 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -143.86 166.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -129.4 135.65 48.96 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.192 -0.943 . . . . 0.0 109.721 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.19 119.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 0.0 108.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -95.62 120.88 36.65 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 9' ' ' THR . 18.8 m -97.37 145.7 25.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.351 -0.843 . . . . 0.0 109.376 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -61.59 -13.77 24.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 7' ' ' THR . 56.9 m -81.55 -9.99 59.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.031 . . . . 0.0 109.556 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 2.5 55.85 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -91.37 136.39 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.937 -1.331 . . . . 0.0 109.273 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -123.94 134.41 53.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.468 -0.77 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.5 145.15 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.597 -0.689 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 136.75 41.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 109.797 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -126.81 146.24 50.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.55 -0.718 . . . . 0.0 109.544 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -105.88 125.34 50.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.83 174.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.349 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 12.5 mp0 -108.54 154.01 41.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.25 -35.06 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.923 1.749 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 t -84.28 4.84 29.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.512 -0.743 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.74 148.79 51.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.957 -1.089 . . . . 0.0 108.526 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -87.82 152.38 22.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 mp -56.14 -39.85 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -64.12 -42.04 97.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -65.25 -38.2 89.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -72.63 -29.22 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.459 -0.775 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -69.71 -34.5 73.99 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -54.27 47.58 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -49.53 -44.54 46.51 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.437 0.637 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.35 -38.18 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -63.25 -47.96 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 109.916 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -70.38 -20.05 62.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.197 -0.94 . . . . 0.0 111.268 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -93.65 -50.89 5.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.835 -1.166 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -87.67 -24.44 23.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.879 -1.138 . . . . 0.0 109.805 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.03 3.9 89.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.137 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 134.79 32.44 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.705 -1.468 . . . . 0.0 109.039 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.83 156.03 66.74 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.579 1.519 . . . . 0.0 111.951 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.36 -18.35 38.95 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.946 2.431 . . . . 0.0 112.578 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.76 -1.6 43.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 110.039 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -112.67 -23.04 10.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.136 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -115.63 144.78 43.41 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.67 118.29 22.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -85.92 121.25 28.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.67 0.747 . . . . 0.0 111.616 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -107.47 150.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -139.49 130.04 25.74 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.32 -119.5 1.51 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.62 27.61 7.87 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -135.65 -174.85 3.76 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.917 -1.343 . . . . 0.0 109.283 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -121.68 126.06 48.1 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.167 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.26 118.49 5.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.14 168.0 11.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.251 -0.906 . . . . 0.0 109.641 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.62 146.82 23.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.31 -0.868 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.46 60.85 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.341 -0.849 . . . . 0.0 111.657 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -123.66 164.12 19.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.118 -1.225 . . . . 0.0 110.189 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -96.79 147.85 23.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.922 -1.111 . . . . 0.0 110.749 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.79 -31.72 62.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -62.26 -23.58 66.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.66 -16.38 48.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -104.83 0.76 28.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 52.98 44.07 30.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.713 -1.242 . . . . 0.0 109.508 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.3 mt -66.87 174.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.209 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 5.8 tp-100 -135.82 140.41 44.19 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.186 -0.946 . . . . 0.0 110.009 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -51.76 143.59 12.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 110.568 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -101.81 131.89 47.88 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.68 126.58 55.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 109.496 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.4 147.43 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.3 mp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 120.915 -1.116 . . . . 0.0 108.841 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.4 0.619 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.13 166.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.72 132.31 51.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.26 116.69 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.058 -1.026 . . . . 0.0 109.001 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.04 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -92.43 153.85 18.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -59.84 -23.99 63.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 109.918 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 9' ' ' THR . 84.5 m -81.23 -6.67 59.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.568 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 1.41 63.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -73.65 113.57 10.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.908 -1.348 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.5 m -97.51 130.1 44.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.38 140.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 14' ' ' THR . 13.9 t -104.17 132.7 50.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.251 -0.905 . . . . 0.0 109.845 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -128.73 147.27 50.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.484 0.659 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -111.15 130.42 55.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.41 -178.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.021 -1.049 . . . . 0.0 110.054 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.18 154.57 46.22 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.74 -33.68 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.179 1.92 . . . . 0.0 110.71 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -84.34 5.69 25.99 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -69.14 146.51 52.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.0 108.871 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -93.76 152.69 18.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -57.55 -36.27 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 109.058 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.55 -53.03 61.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.978 . . . . 0.0 110.198 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.79 -37.67 87.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.359 -0.838 . . . . 0.0 109.931 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.69 -28.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -68.88 -34.93 76.25 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -56.75 17.71 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -49.65 -46.13 49.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.625 -0.672 . . . . 0.0 109.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.08 -41.71 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 109.722 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -68.9 -45.64 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 111.629 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -98.41 -48.22 5.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.646 -1.284 . . . . 0.0 111.065 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' HD12 ' A' ' 36' ' ' ILE . 26.6 tt0 -86.64 -28.51 23.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.763 -1.21 . . . . 0.0 109.673 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 5.91 88.42 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.379 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.415 HD12 ' CD ' ' A' ' 34' ' ' GLU . 28.8 mt -91.35 119.35 68.68 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 120.557 -1.555 . . . . 0.0 108.9 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 144.02 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.567 1.512 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 -18.09 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.459 2.106 . . . . 0.0 112.226 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.16 -11.2 60.81 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.103 -0.998 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -110.06 -29.23 8.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -85.48 137.25 33.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.509 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -124.49 111.49 15.76 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -93.25 124.47 37.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.589 -0.694 . . . . 0.0 111.199 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.29 138.08 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.658 -0.651 . . . . 0.0 109.355 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 85.6 t80 -140.26 139.39 35.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.447 -0.783 . . . . 0.0 109.154 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 67.1 -10.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.64 -0.663 . . . . 0.0 109.32 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.91 8.3 24.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -112.86 149.74 32.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.089 -1.242 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -83.4 116.73 22.62 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.85 120.68 12.38 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.687 -0.633 . . . . 0.0 110.068 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.9 151.33 20.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.92 138.62 57.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 111.186 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.68 71.54 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.474 -0.766 . . . . 0.0 111.231 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -82.57 166.9 18.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.706 -1.467 . . . . 0.0 111.075 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -111.39 145.42 38.94 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.663 0.744 . . . . 0.0 111.402 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.76 -43.54 90.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.667 -0.646 . . . . 0.0 109.788 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -55.58 -34.28 64.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.25 -20.77 29.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.388 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -103.8 5.1 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.27 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 48.1 41.56 15.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.789 -1.194 . . . . 0.0 109.694 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 62' ' ' GLN . 56.2 mt -60.1 169.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.365 -0.834 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.563 ' N ' HG22 ' A' ' 61' ' ' ILE . 62.9 mt-30 -129.05 134.62 48.18 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.789 0.804 . . . . 0.0 109.848 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -54.85 150.29 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 110.797 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.87 -0.518 . . . . 0.0 110.741 179.302 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.7 mp . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 1.6 m80 -102.43 127.94 49.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.357 -0.839 . . . . 0.0 109.202 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -109.38 111.5 23.09 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.502 -0.749 . . . . 0.0 109.494 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.2 t -116.87 142.57 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.961 HD22 ' H ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.007 -1.058 . . . . 0.0 109.605 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.342 0.591 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.96 163.0 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.9 145.39 48.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.336 -0.852 . . . . 0.0 109.69 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.86 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.392 -0.818 . . . . 0.0 108.885 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.18 114.86 26.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -88.79 156.45 18.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.27 -24.44 64.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -81.38 -5.33 57.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 16.96 53.75 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.67 115.08 27.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.912 -1.346 . . . . 0.0 109.398 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -91.9 118.49 30.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.11 145.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.551 -0.718 . . . . 0.0 109.12 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 t -111.38 134.83 52.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.639 -0.663 . . . . 0.0 109.667 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 mt -127.89 146.59 50.58 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.497 -0.752 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.36 123.37 46.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.73 177.46 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.976 -1.078 . . . . 0.0 110.043 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.17 164.06 15.58 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -77.57 -37.07 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 110.705 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -80.52 7.77 9.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -66.41 150.24 49.2 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.81 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 m -94.07 164.16 13.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -70.11 -40.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.035 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -63.07 -43.86 97.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -68.01 -40.01 83.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.471 -0.768 . . . . 0.0 109.679 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 22' ' ' THR . 95.7 t -71.24 -31.5 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -68.64 -32.38 72.18 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.98 81.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.84 -44.86 78.39 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.2 mt -62.34 -42.56 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.416 -0.803 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.1 tt0 -65.35 -44.11 88.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.96 -33.54 73.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 111.149 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -93.86 -41.16 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.823 -1.173 . . . . 0.0 111.17 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -89.44 -26.01 21.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.676 -1.265 . . . . 0.0 109.907 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 80.21 7.28 88.68 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.189 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.45 116.81 66.6 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.803 -1.41 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.84 150.17 6.81 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.665 1.577 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.07 -19.46 34.63 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.675 2.25 . . . . 0.0 112.605 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.7 -4.49 46.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -107.93 -12.52 15.15 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -113.45 140.86 47.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.352 -0.842 . . . . 0.0 110.508 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -127.44 108.93 11.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.78 125.19 33.05 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.743 0.782 . . . . 0.0 111.695 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.39 134.48 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.461 0.648 . . . . 0.0 109.265 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLY . 65.9 t80 -148.6 142.43 25.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 109.225 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.71 8.26 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.733 . . . . 0.0 109.37 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 93.68 18.96 36.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -129.32 152.03 49.33 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.28 117.52 29.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 17.5 mt -54.32 115.51 2.13 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.227 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -88.57 146.54 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.027 . . . . 0.0 108.994 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.07 135.6 57.82 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.387 -0.821 . . . . 0.0 109.909 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -14.8 57.3 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.256 -0.902 . . . . 0.0 112.792 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -91.72 160.83 15.15 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.219 2.01 . . . . 0.0 110.559 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -105.54 151.08 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.567 0.698 . . . . 0.0 109.374 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.97 -39.06 65.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.995 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -60.27 -20.57 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.544 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.49 -19.64 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.582 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -107.32 8.66 29.87 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 0.0 110.397 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 52.09 49.07 21.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.676 -1.265 . . . . 0.0 109.675 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 62' ' ' GLN . 69.7 mt -76.92 172.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.488 -0.758 . . . . 0.0 109.132 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.606 ' N ' HG22 ' A' ' 61' ' ' ILE . 90.8 mt-30 -138.62 142.15 39.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.114 -0.991 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.27 152.53 6.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 110.44 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 122.048 -0.407 . . . . 0.0 110.884 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -89.88 129.89 36.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.1 -1.0 . . . . 0.0 108.956 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.2 tt -105.49 114.56 28.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.512 -0.743 . . . . 0.0 110.037 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.4 t -114.82 147.05 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 122.222 1.011 . . . . 0.0 110.735 -178.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.424 0.63 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.07 168.42 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -127.98 131.66 49.24 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.29 -0.881 . . . . 0.0 109.561 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.12 117.18 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 108.91 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -91.85 113.89 26.28 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -92.93 164.05 13.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.492 -0.755 . . . . 0.0 109.975 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -72.72 -19.02 61.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.035 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.3 p -81.38 -0.4 41.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 0.0 109.649 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 12.34 71.34 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -93.16 132.26 37.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.325 . . . . 0.0 109.057 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -116.14 130.87 57.01 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.28 143.3 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.643 -0.661 . . . . 0.0 109.468 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 t -103.62 138.08 40.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 109.782 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.2 mt -131.98 153.37 50.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.536 -0.727 . . . . 0.0 109.567 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -107.13 124.45 49.71 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -143.5 163.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.0 mt-10 -101.36 152.31 37.95 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -36.05 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.936 1.757 . . . . 0.0 111.338 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.9 p -79.77 4.73 15.48 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.385 -0.822 . . . . 0.0 109.288 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.28 146.02 49.18 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.483 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.4 p -89.34 154.38 20.13 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.93 -37.84 43.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.016 -1.053 . . . . 0.0 108.748 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.2 -44.32 95.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.7 -36.37 83.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.932 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.22 -30.31 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.489 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.22 -35.72 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.9 49.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -50.42 -46.84 56.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.64 -37.76 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.56 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.26 -47.15 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.8 -25.7 68.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 111.423 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -95.5 -48.8 5.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.9 -24.8 23.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.837 -1.165 . . . . 0.0 110.025 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.65 -1.6 88.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.233 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -80.68 134.28 54.25 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.657 -1.496 . . . . 0.0 108.571 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 131.8 20.78 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.36 1.373 . . . . 0.0 112.051 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -46.12 -23.21 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.237 1.958 . . . . 0.0 113.553 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -73.91 -2.68 24.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 110.59 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.64 -22.6 10.17 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -100.75 137.52 39.03 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.154 0.978 . . . . 0.0 111.212 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.5 104.41 9.64 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.15 122.02 33.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.799 -1.188 . . . . 0.0 110.075 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 mt -122.73 145.83 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 47' ' ' GLY . 74.9 t80 -149.96 144.84 26.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.64 6.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.94 15.97 49.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.47 139.95 52.81 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.074 -1.251 . . . . 0.0 109.027 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -78.59 118.69 20.95 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.24 118.91 6.0 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 109.861 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -90.62 150.18 21.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.194 -0.942 . . . . 0.0 109.936 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -66.33 134.91 53.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 110.752 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.99 -16.29 57.42 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 121.301 -0.874 . . . . 0.0 111.897 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.462 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -92.66 149.06 21.57 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-N 119.9 1.85 . . . . 0.0 109.997 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -90.81 154.48 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.587 0.708 . . . . 0.0 110.068 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.21 -36.28 72.89 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -61.94 -20.24 63.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.062 . . . . 0.0 109.188 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.37 -16.27 64.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.463 -0.773 . . . . 0.0 109.726 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -109.33 7.55 25.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.459 -0.776 . . . . 0.0 110.348 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 51.71 45.7 27.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.658 -1.276 . . . . 0.0 109.552 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 62' ' ' GLN . 88.9 mt -71.88 174.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.258 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.625 ' N ' HG22 ' A' ' 61' ' ' ILE . 15.6 tt0 -135.88 140.13 43.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.19 -0.944 . . . . 0.0 109.702 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -53.15 149.81 6.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.967 -0.458 . . . . 0.0 110.976 179.507 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.23 130.88 41.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.23 118.75 36.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.399 -0.813 . . . . 0.0 109.789 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.47 148.81 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.297 -1.686 0 O-C-N 120.806 -1.184 . . . . 0.0 109.302 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.507 0.67 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.1 pt -140.36 163.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 41.1 m-85 -121.75 136.12 54.94 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 114.03 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -90.64 117.37 29.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 109.031 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.7 p -92.12 160.64 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.882 . . . . 0.0 109.597 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -65.21 -20.1 66.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 85.1 m -81.67 -9.32 59.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 109.544 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.06 16.56 43.89 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -94.34 121.06 35.48 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.322 . . . . 0.0 109.563 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 m -96.65 121.33 38.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.293 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.36 141.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.488 -0.757 . . . . 0.0 109.236 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.9 p -107.53 131.64 54.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.668 . . . . 0.0 109.667 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -132.52 153.0 51.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.536 -0.728 . . . . 0.0 109.567 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.74 130.04 56.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.2 178.81 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -112.62 153.03 45.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.86 -31.51 47.61 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.997 1.798 . . . . 0.0 110.644 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 5.13 33.77 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.577 -0.702 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -69.58 146.64 51.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -95.59 148.8 22.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 109.387 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -54.2 -39.23 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.086 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.44 -47.69 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.892 . . . . 0.0 109.848 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -68.36 -37.27 80.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.758 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.19 -29.72 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -70.99 -33.99 70.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.37 76.88 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -54.12 -48.25 70.95 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -65.69 -38.08 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -59.13 -48.03 83.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.476 -0.765 . . . . 0.0 109.974 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.09 -35.06 77.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.464 -0.772 . . . . 0.0 111.198 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -79.81 -50.43 10.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.817 -1.177 . . . . 0.0 111.462 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.94 -10.08 49.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.757 -1.215 . . . . 0.0 110.015 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.24 27.13 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.68 134.27 37.97 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.744 -1.445 . . . . 0.0 108.79 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.69 156.93 59.94 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 0.0 112.073 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.43 -18.32 38.64 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.743 2.295 . . . . 0.0 112.781 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.51 -5.4 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -109.34 -27.92 9.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 109.311 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -96.86 134.72 39.82 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.244 -0.91 . . . . 0.0 110.657 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.509 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -118.83 109.21 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.93 129.89 38.69 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.683 -1.261 . . . . 0.0 111.817 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.17 141.13 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.487 0.661 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -119.54 137.41 53.85 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 -112.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.025 -1.047 . . . . 0.0 108.851 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.41 28.95 5.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -129.42 140.31 51.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.177 -1.19 . . . . 0.0 109.421 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -82.95 117.44 22.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CE1' ' A' ' 59' ' ' TYR . 93.7 mt -56.15 121.27 9.06 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.24 148.42 22.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 2.4 p30 -66.35 136.28 55.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 110.871 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.23 57.83 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.426 -0.796 . . . . 0.0 112.051 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.74 170.0 14.65 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.105 -1.821 . . . . 0.0 110.591 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 m -108.17 147.81 30.78 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.313 0.577 . . . . 0.0 109.802 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -56.04 -41.85 75.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -60.49 -20.57 60.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.35 -18.03 64.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CE1' HD23 ' A' ' 50' ' ' LEU . 21.0 m-85 -106.09 6.87 31.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.485 -0.76 . . . . 0.0 110.308 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 54.22 39.82 31.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.4 mt -64.05 169.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 61' ' ' ILE . 53.4 tt0 -138.62 143.2 39.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.283 -0.885 . . . . 0.0 110.029 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.24 145.41 13.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 110.654 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.756 -0.59 . . . . 0.0 110.774 179.33 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -92.53 128.61 38.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 0.0 108.885 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.13 117.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.796 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.4 145.47 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.9 mp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 110.016 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.375 0.607 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -145.17 165.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -125.07 137.58 54.2 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.202 -0.936 . . . . 0.0 109.454 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.33 121.38 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.656 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -93.95 118.02 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -93.58 154.08 18.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.97 -19.3 64.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.078 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -82.11 -1.46 48.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 109.726 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.08 9.83 69.92 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -92.23 116.42 28.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.047 -1.267 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -101.81 132.01 47.81 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 109.104 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tt -129.45 145.42 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.509 -0.745 . . . . 0.0 109.44 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -102.71 139.18 38.62 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.56 -0.713 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -130.19 149.74 51.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.619 -0.676 . . . . 0.0 109.43 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -111.09 129.87 55.79 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.69 178.54 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.981 -1.074 . . . . 0.0 110.139 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.27 153.49 44.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.54 -33.68 45.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.998 1.799 . . . . 0.0 110.762 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 m -84.94 4.71 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.422 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.67 145.46 53.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.973 -1.079 . . . . 0.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -91.91 162.61 14.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.86 -40.96 90.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.144 -0.972 . . . . 0.0 108.696 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -62.21 -43.73 98.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.73 -41.59 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.116 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.63 -29.07 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.02 . . . . 0.0 109.455 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -35.13 78.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.56 82.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.75 -44.3 77.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.72 -39.3 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -59.61 -45.62 91.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 109.93 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.61 -30.28 68.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 111.187 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -88.25 -46.68 9.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.78 -1.2 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -89.21 -19.84 24.92 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.638 -1.289 . . . . 0.0 110.017 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.07 4.68 56.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.065 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -89.82 122.48 67.93 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.684 -1.48 . . . . 0.0 109.3 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.31 149.55 6.33 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.633 1.555 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.35 -19.5 33.25 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.32 -2.8 33.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -111.65 -25.25 9.63 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.15 -0.969 . . . . 0.0 110.271 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -97.59 136.03 38.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -122.37 115.82 22.95 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.02 125.56 41.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.59 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -121.73 141.16 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 87.1 t80 -150.32 144.68 25.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.099 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 61.66 12.11 4.36 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.56 67.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.48 148.93 44.56 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.124 -1.221 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -84.26 113.53 21.18 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -54.53 123.17 12.28 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.745 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.64 143.27 27.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.148 -0.97 . . . . 0.0 109.13 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.9 133.91 56.01 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.417 -0.802 . . . . 0.0 109.602 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -16.23 56.91 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.35 -0.844 . . . . 0.0 112.086 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -81.97 164.28 21.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 119.977 -1.896 . . . . 0.0 109.108 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 m -104.93 147.56 27.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.47 -41.89 81.54 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -59.46 -23.73 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.166 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.98 -18.52 64.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -107.19 5.87 28.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.517 -0.739 . . . . 0.0 110.106 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 49.91 48.33 21.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.615 -1.303 . . . . 0.0 109.681 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.91 165.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 108.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -126.79 135.22 50.75 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.402 -0.811 . . . . 0.0 109.75 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.11 146.21 6.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 122.133 -0.355 . . . . 0.0 110.959 179.675 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -97.79 126.37 43.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.194 -0.941 . . . . 0.0 108.999 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.85 117.59 34.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 109.585 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 71' ' ' LEU . 59.1 t -103.65 143.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.3 mp . . . . . 0 N--CA 1.495 1.812 0 O-C-N 120.888 -1.132 . . . . 0.0 109.608 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.453 0.644 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -145.66 166.81 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 61.2 m-85 -121.13 136.55 54.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.79 118.7 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.64 120.75 36.45 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -97.03 153.88 17.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.82 -18.88 58.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.364 -0.835 . . . . 0.0 110.16 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -81.54 -1.47 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.18 70.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.15 118.01 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.978 -1.307 . . . . 0.0 109.659 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -103.34 130.35 50.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.327 -0.858 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -131.11 138.28 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.462 -0.773 . . . . 0.0 109.732 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -97.69 142.44 29.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -132.83 155.5 48.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.461 -0.775 . . . . 0.0 109.613 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -106.81 125.55 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.37 165.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.071 -1.018 . . . . 0.0 109.969 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 39.2 mt-10 -107.67 154.06 41.09 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.52 -29.1 31.14 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.157 1.905 . . . . 0.0 111.113 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -88.7 1.26 55.43 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 151.27 47.17 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.962 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.8 p -96.66 150.94 20.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.257 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -54.4 -36.75 35.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.065 -1.022 . . . . 0.0 108.863 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.32 -42.81 92.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 109.935 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 25' ' ' ASN . 2.1 m120 -67.78 -37.74 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 109.682 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.96 -31.05 39.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.581 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.63 -34.98 76.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.89 78.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.3 -46.88 79.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.3 mt -63.07 -42.16 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.23 -46.11 85.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 109.974 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.02 -30.57 71.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 111.442 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -96.07 -43.74 7.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.879 -1.138 . . . . 0.0 111.278 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -87.9 -27.26 22.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.813 -1.179 . . . . 0.0 109.945 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.34 77.15 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.106 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -76.18 133.67 71.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.706 -1.467 . . . . 0.0 108.616 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.23 133.15 20.6 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.36 1.373 . . . . 0.0 112.143 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.89 -25.45 2.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 113.155 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -77.81 -3.63 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.95 -1.094 . . . . 0.0 110.338 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -111.78 -29.89 7.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -107.23 143.42 35.48 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.825 0.821 . . . . 0.0 111.016 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.453 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.4 mtp180 -130.38 125.43 34.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.7 mt -96.43 122.79 39.71 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.032 -1.043 . . . . 0.0 111.186 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.3 mp -118.97 134.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.84 134.79 55.12 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 -109.45 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.081 -1.012 . . . . 0.0 108.792 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.5 33.34 3.31 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -133.83 154.6 50.91 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.065 -1.256 . . . . 0.0 109.598 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -99.3 116.09 30.68 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -53.6 120.05 5.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.97 142.62 27.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.893 . . . . 0.0 109.795 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.27 135.46 57.48 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.453 -0.779 . . . . 0.0 110.31 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 -18.6 54.83 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.358 -0.839 . . . . 0.0 111.943 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.438 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -90.66 159.89 16.15 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.022 1.911 . . . . 0.0 109.996 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -102.72 154.55 19.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.587 -0.696 . . . . 0.0 109.927 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.65 -37.39 73.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.345 -0.847 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -56.74 -18.71 13.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.008 -1.058 . . . . 0.0 109.533 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -76.22 -19.44 58.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.89 -11.92 17.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.466 -0.771 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 t30 60.58 48.01 7.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.032 -1.042 . . . . 0.0 109.577 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 62' ' ' GLN . 97.2 mt -70.36 171.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.141 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 61' ' ' ILE . 26.0 mm100 -128.27 136.16 50.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -53.6 148.1 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.703 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' OE2' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.646 -0.659 . . . . 0.0 110.308 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.1 mp . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 4.7 m-70 -95.76 126.14 40.82 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.077 -1.015 . . . . 0.0 108.835 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tp -101.23 113.28 26.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' C ' HD12 ' A' ' 71' ' ' LEU . 44.1 t -106.43 138.25 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 70' ' ' VAL . 9.2 mp . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.214 -0.928 . . . . 0.0 109.279 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.324 0.583 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.14 166.53 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.33 158.51 39.62 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.02 124.73 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.1 119.64 31.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.489 -0.757 . . . . 0.0 109.094 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -91.14 151.97 20.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -58.82 -19.3 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 109.754 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 9' ' ' THR . 89.8 m -81.37 -6.71 59.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.136 -0.978 . . . . 0.0 109.402 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.67 59.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -94.09 118.94 32.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.314 . . . . 0.0 109.611 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -94.86 122.9 37.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.054 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -115.26 145.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.572 -0.705 . . . . 0.0 109.12 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 14' ' ' THR . 12.2 t -106.6 131.7 53.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.714 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -129.71 150.44 51.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.458 -0.776 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -110.91 128.7 55.9 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.88 174.51 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 110.317 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -107.93 152.88 41.86 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.61 -34.18 26.16 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.967 1.778 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -85.66 1.78 47.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.57 -0.706 . . . . 0.0 109.233 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.67 147.91 44.35 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.996 -1.081 . . . . 0.0 108.522 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.4 p -89.0 155.81 19.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 108.847 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -56.73 -42.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.043 -1.035 . . . . 0.0 108.237 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.81 -37.89 89.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -69.48 -41.63 75.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.6 t -66.76 -28.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.245 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -72.92 -35.42 67.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.38 92.42 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.99 -44.93 94.67 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.0 -37.58 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.42 -0.8 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.61 -47.96 83.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.923 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -66.77 -34.82 78.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 111.274 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -85.22 -46.13 11.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 111.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -85.03 -27.24 26.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.67 -1.269 . . . . 0.0 109.72 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.66 3.58 79.32 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.441 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -93.29 124.34 57.97 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.673 -1.487 . . . . 0.0 108.716 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.39 130.34 21.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.294 1.329 . . . . 0.0 112.368 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -49.47 -24.56 9.17 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.223 1.949 . . . . 0.0 113.423 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.21 -9.22 58.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.645 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -103.65 -23.57 13.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -98.25 138.48 35.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 0.0 110.761 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -122.61 112.05 17.52 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 44' ' ' ILE . 14.6 mt -88.5 122.84 32.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.185 -0.947 . . . . 0.0 111.097 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.616 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.9 mp -115.34 132.72 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -119.96 135.53 54.87 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 -112.76 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.014 -1.054 . . . . 0.0 109.087 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.98 28.62 5.82 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -140.13 179.2 6.77 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.881 -1.364 . . . . 0.0 109.474 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -109.63 156.45 20.2 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 50' ' ' LEU . 4.3 mm? -83.32 108.63 16.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.095 -1.003 . . . . 0.0 108.358 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' CD ' HH21 ' A' ' 54' ' ' ARG . 40.4 tt0 -80.71 152.5 28.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.68 142.27 30.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.529 -0.732 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.02 10.47 51.96 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.301 -0.875 . . . . 0.0 111.714 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.62 HH21 ' CD ' ' A' ' 51' ' ' GLU . 3.9 mtp180 -129.69 172.87 11.17 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.893 -1.357 . . . . 0.0 109.721 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -103.59 149.73 24.63 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.037 -1.039 . . . . 0.0 111.235 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -56.65 -32.54 65.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.461 -0.774 . . . . 0.0 109.491 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -62.11 -19.27 62.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.087 -1.008 . . . . 0.0 109.213 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.35 -16.88 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.421 -0.799 . . . . 0.0 109.614 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.502 ' CE1' HD13 ' A' ' 50' ' ' LEU . 13.4 m-85 -103.91 10.98 36.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.427 -0.796 . . . . 0.0 110.238 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 52.46 42.46 31.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.612 -1.305 . . . . 0.0 109.416 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 62' ' ' GLN . 60.6 mt -71.4 170.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.561 ' N ' HG22 ' A' ' 61' ' ' ILE . 42.4 mt-30 -143.8 147.05 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.086 -1.009 . . . . 0.0 110.068 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -52.94 145.78 12.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 110.587 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.821 -0.549 . . . . 0.0 110.607 179.482 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -97.78 130.94 44.69 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.9 tt -103.36 116.89 33.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 109.666 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 69' ' ' LEU . 46.7 t -108.05 146.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.498 1.954 0 O-C-N 120.861 -1.149 . . . . 0.0 111.047 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -145.84 166.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -128.84 150.4 50.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.93 -1.107 . . . . 0.0 110.131 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.55 123.72 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.365 -0.835 . . . . 0.0 108.866 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -97.66 123.5 41.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 8' ' ' LEU . 34.4 m -98.6 158.95 15.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' N ' HG22 ' A' ' 7' ' ' THR . 22.3 mt -63.25 -16.31 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.924 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -82.04 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.097 -1.002 . . . . 0.0 109.641 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.83 64.97 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -94.86 133.69 38.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.312 . . . . 0.0 109.281 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.9 m -114.88 129.2 56.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 109.126 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -125.49 145.06 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.72 -0.612 . . . . 0.0 109.494 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -103.45 136.89 42.34 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.712 . . . . 0.0 109.847 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -131.99 151.75 51.55 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -103.29 122.86 45.67 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.05 164.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.114 -0.991 . . . . 0.0 110.076 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 65.0 mt-10 -107.23 151.81 40.94 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.1 -30.91 37.76 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.091 1.861 . . . . 0.0 111.04 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -82.95 -0.8 50.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.52 147.88 52.21 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.671 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.3 p -90.77 153.98 19.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 109.005 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.61 -38.9 44.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.846 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.3 -45.1 89.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 109.876 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.21 -36.97 85.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.983 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.28 -27.97 22.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -67.53 -38.26 83.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.51 45.55 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -48.92 -43.9 39.84 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.526 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.15 -28.61 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.014 -1.054 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -61.94 -50.31 72.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 109.871 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -72.78 -28.8 62.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -81.39 -47.52 13.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.865 -1.147 . . . . 0.0 111.039 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.14 -17.79 25.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.715 -1.241 . . . . 0.0 109.73 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.04 52.02 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.286 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -93.23 125.07 55.9 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.665 -1.491 . . . . 0.0 109.304 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.32 149.05 6.88 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.482 1.455 . . . . 0.0 112.145 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.69 -26.92 32.58 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.357 2.038 . . . . 0.0 112.29 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.33 -2.36 13.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -110.85 -13.32 14.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.02 -1.05 . . . . 0.0 109.689 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -110.05 137.75 47.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -119.81 111.02 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 17.2 mt -92.46 120.17 32.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.3 mp -113.98 144.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -123.29 140.49 52.96 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.07 -112.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.098 -1.002 . . . . 0.0 108.56 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.43 6.19 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -125.12 144.09 50.6 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.014 -1.286 . . . . 0.0 109.366 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -74.68 147.9 41.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.523 HD23 ' CE1' ' A' ' 59' ' ' TYR . 96.5 mt -88.16 114.79 25.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.821 -1.174 . . . . 0.0 108.842 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 21.6 mp0 -81.3 175.72 10.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 108.912 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 39.3 p-10 -95.49 135.65 36.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.72 -0.613 . . . . 0.0 111.577 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.93 -8.22 61.12 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.998 -1.064 . . . . 0.0 112.18 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 5.8 mtt180 -95.18 154.8 17.01 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 120.307 -1.702 . . . . 0.0 109.306 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 p -92.87 149.79 21.03 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.016 -1.053 . . . . 0.0 110.895 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -53.75 -33.68 56.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 109.636 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 m -64.82 -13.63 56.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.06 -1.025 . . . . 0.0 109.085 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.17 -17.22 61.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.547 -0.721 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.523 ' CE1' HD23 ' A' ' 50' ' ' LEU . 19.0 m-85 -110.68 8.19 22.55 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 0.0 110.13 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 54.76 45.73 26.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.346 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 62' ' ' GLN . 86.5 mt -75.04 172.1 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.177 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.604 ' N ' HG22 ' A' ' 61' ' ' ILE . 81.3 mt-30 -139.32 142.12 37.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -51.8 151.61 3.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.225 -0.922 . . . . 0.0 110.336 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 122.059 -0.4 . . . . 0.0 110.793 179.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.4 127.74 38.0 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.5 tt -106.16 113.25 26.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 ' N ' HD23 ' A' ' 69' ' ' LEU . 61.8 t -111.72 141.37 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 71' ' ' LEU . 1.2 mm? . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 0.0 109.615 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.349 0.595 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 3' ' ' ILE . 9.6 tt -141.38 163.9 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 28.4 m-85 -126.72 157.04 40.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.47 119.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -91.29 120.56 32.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 109.366 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -95.83 166.04 12.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.57 -22.12 65.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.154 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.52 -3.2 52.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.632 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 17.32 60.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -94.41 125.41 39.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.326 . . . . 0.0 109.301 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.2 m -101.1 121.95 42.73 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -108.96 141.65 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.424 HG22 ' CE2' ' A' ' 4' ' ' PHE . 79.0 p -103.74 126.77 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.72 149.78 51.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.503 -0.748 . . . . 0.0 109.712 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -103.67 123.46 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.1 p -144.91 166.34 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.055 -1.028 . . . . 0.0 110.19 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.6 mt-10 -109.9 152.19 42.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.27 -28.03 34.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.207 1.938 . . . . 0.0 111.28 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 t -85.34 -2.2 57.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.012 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 26' ' ' VAL . 9.9 t0 -62.87 146.98 51.54 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.803 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -88.61 143.49 26.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.7 mp -49.76 -42.38 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 108.483 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -60.25 -44.2 95.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.643 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.39 -40.0 85.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' OD2' ' A' ' 21' ' ' ASP . 60.9 t -63.96 -33.23 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.623 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -70.84 -35.08 72.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.89 82.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -54.57 -48.76 71.69 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.89 -37.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.68 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -61.99 -48.78 78.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -67.3 -33.11 74.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 111.115 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -45.45 12.54 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.789 -1.194 . . . . 0.0 111.179 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -88.98 -24.96 22.27 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.736 -1.228 . . . . 0.0 109.833 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 1.07 90.09 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.146 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.97 134.35 35.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 120.596 -1.532 . . . . 0.0 108.873 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.91 154.45 67.13 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.553 1.502 . . . . 0.0 112.035 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.69 -17.94 37.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.594 2.196 . . . . 0.0 112.302 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.54 -4.82 53.15 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.763 -1.21 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -107.2 -28.07 10.16 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.263 -0.898 . . . . 0.0 110.735 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -112.89 146.69 38.5 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.393 -0.817 . . . . 0.0 110.621 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.0 120.59 27.87 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.0 mt -90.43 126.19 35.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 0.0 110.844 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.6 mp -119.63 137.03 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 109.349 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -119.0 136.09 54.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.93 -112.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 108.655 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.23 4.86 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.53 147.71 52.56 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.148 -1.207 . . . . 0.0 109.545 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -90.21 116.86 28.52 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.8 mt -55.66 123.51 14.31 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 109.926 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.46 140.75 45.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.715 0.769 . . . . 0.0 109.343 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.8 p-10 -64.52 155.28 33.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.688 -0.632 . . . . 0.0 110.958 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.76 2.05 56.29 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.377 -0.827 . . . . 0.0 112.072 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -133.9 172.48 12.74 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.745 -1.444 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -105.26 154.67 19.93 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.165 -0.959 . . . . 0.0 110.994 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.67 -34.35 64.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.432 -0.792 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -62.55 -16.7 57.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.73 -16.87 63.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.82 . . . . 0.0 109.443 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -105.46 11.03 33.04 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 53.61 46.83 25.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.651 -1.281 . . . . 0.0 109.468 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 62' ' ' GLN . 75.9 mt -87.47 -176.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 0.0 109.349 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.764 ' H ' HG22 ' A' ' 61' ' ' ILE . 10.0 pt20 -157.79 158.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 110.29 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -54.58 151.08 8.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.426 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.603 179.643 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -93.18 134.58 35.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 108.624 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.71 121.43 45.01 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.479 -0.763 . . . . 0.0 109.88 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.19 151.95 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.965 -1.084 . . . . 0.0 109.46 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.371 0.605 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.91 162.57 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 37.3 m-85 -124.98 141.73 51.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.313 -0.867 . . . . 0.0 109.398 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.89 116.62 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.335 -0.853 . . . . 0.0 109.005 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.4 114.74 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.415 -0.803 . . . . 0.0 108.911 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -90.97 165.75 13.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tp -70.38 -23.48 62.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.4 p -81.27 -0.15 39.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.033 . . . . 0.0 109.45 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.29 15.74 66.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -93.15 122.06 35.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.868 -1.372 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -99.34 121.61 41.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.534 -0.729 . . . . 0.0 109.401 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.33 139.8 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.661 -0.649 . . . . 0.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.9 p -101.91 127.43 48.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.567 -0.708 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.1 mt -131.18 151.27 51.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.557 -0.714 . . . . 0.0 109.587 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -115.64 131.85 56.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.81 176.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.988 -1.07 . . . . 0.0 110.099 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.23 150.22 40.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.85 -32.1 46.55 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.876 1.717 . . . . 0.0 110.906 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -84.42 2.77 39.18 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.531 -0.731 . . . . 0.0 109.245 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.47 145.79 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.911 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -85.39 160.38 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.459 -0.775 . . . . 0.0 108.935 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.4 mp -61.22 -39.37 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.061 -1.025 . . . . 0.0 108.26 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -35.87 81.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -69.74 -38.92 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 109.606 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -72.45 -33.09 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.577 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' NZ ' ' CG2' ' A' ' 23' ' ' ILE . 49.6 mttp -68.01 -34.17 76.0 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -51.46 -45.79 62.83 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.885 . . . . 0.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.5 -48.88 79.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 110.053 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -68.98 -31.95 71.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.317 -0.865 . . . . 0.0 111.052 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -82.92 -48.19 10.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.919 -1.113 . . . . 0.0 111.489 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.775 -1.203 . . . . 0.0 109.986 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.51 3.21 82.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.131 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.12 123.67 66.72 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.75 -1.441 . . . . 0.0 108.764 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.34 130.16 20.64 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.143 1.229 . . . . 0.0 112.267 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.53 -34.2 25.6 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.258 1.972 . . . . 0.0 113.444 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.45 -1.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.326 -0.859 . . . . 0.0 110.803 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.482 ' C ' HE21 ' A' ' 41' ' ' GLN . 48.0 tp60 -109.47 -21.68 12.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 0.0 110.052 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 40' ' ' GLN . 24.1 mm-40 -103.31 138.31 40.26 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.141 -0.974 . . . . 0.0 111.412 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -121.14 105.34 10.5 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.04 125.14 34.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.98 -1.075 . . . . 0.0 110.239 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mt -123.5 145.18 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' C ' ' H ' ' A' ' 47' ' ' GLY . 84.3 t80 -148.8 145.91 27.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.616 -0.678 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.86 8.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.29 16.14 51.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -121.55 146.31 47.07 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.998 -1.295 . . . . 0.0 108.853 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.48 115.82 23.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.74 119.51 5.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.941 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.82 173.35 7.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.188 -0.945 . . . . 0.0 109.89 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -94.67 149.15 21.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 110.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.7 -11.05 69.81 Favored Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.445 -0.784 . . . . 0.0 111.331 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -96.46 174.66 6.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.79 -1.418 . . . . 0.0 109.448 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -115.31 152.47 32.72 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.992 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -57.56 -41.01 80.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.493 -0.755 . . . . 0.0 109.75 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -58.95 -23.76 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 109.328 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.67 -17.09 62.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.357 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.33 3.71 35.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.0 110.314 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.27 45.13 27.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.743 -1.223 . . . . 0.0 109.413 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.0 mt -72.24 173.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 109.159 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' N ' HG22 ' A' ' 61' ' ' ILE . 59.6 mt-30 -137.38 142.2 41.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -53.48 148.14 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.857 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.734 -0.604 . . . . 0.0 110.561 179.463 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.7 mp . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -98.57 132.36 44.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.185 -0.947 . . . . 0.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -107.22 113.68 27.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.634 -0.666 . . . . 0.0 109.508 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.0 t -108.58 150.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.804 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -100.52 141.2 33.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 109.801 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -140.68 163.73 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -122.46 132.74 54.49 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -99.12 112.82 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.024 -1.047 . . . . 0.0 108.852 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -89.68 114.5 26.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.748 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -93.84 162.03 14.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.321 -0.862 . . . . 0.0 109.842 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.97 -19.49 64.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.814 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -81.69 -5.55 58.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.102 -0.998 . . . . 0.0 109.595 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.78 14.88 58.94 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -93.87 124.68 38.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.886 -1.361 . . . . 0.0 109.533 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.8 m -102.01 124.22 47.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.532 -0.73 . . . . 0.0 109.043 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -114.99 140.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.562 -0.712 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -102.2 128.35 48.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -128.65 147.97 50.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CD ' ' N ' ' A' ' 16' ' ' GLU . 27.2 mp0 -110.68 127.88 55.48 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.28 179.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.975 -1.078 . . . . 0.0 110.262 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -113.05 151.68 44.35 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.14 -30.42 46.75 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.993 1.795 . . . . 0.0 110.899 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -84.94 4.8 31.87 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.62 145.88 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 0.0 108.881 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -92.2 148.17 22.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -50.47 -40.76 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.982 -1.074 . . . . 0.0 109.085 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.68 -43.88 90.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.256 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -69.51 -37.0 76.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.92 -32.61 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -70.31 -32.69 70.56 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.74 96.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -59.12 -47.26 85.91 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.391 0.615 . . . . 0.0 109.418 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.44 -39.78 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.61 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.86 -47.06 88.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 109.966 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -74.43 -23.64 58.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.956 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -84.89 -51.71 6.54 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.807 -1.183 . . . . 0.0 111.295 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -91.18 -24.0 20.06 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.65 -1.281 . . . . 0.0 109.902 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.41 4.19 88.04 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.964 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.32 121.75 67.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 120.776 -1.426 . . . . 0.0 109.12 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.41 150.35 5.72 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.633 1.556 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.64 -28.77 25.42 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.595 2.197 . . . . 0.0 112.483 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.76 -3.32 27.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.56 -6.11 24.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.57 153.75 50.89 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.211 -0.931 . . . . 0.0 110.945 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -129.77 120.78 25.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 44' ' ' ILE . 26.7 mt -86.67 123.15 31.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.992 -1.068 . . . . 0.0 111.275 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.6 mp -116.46 133.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.547 0.689 . . . . 0.0 109.17 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 47' ' ' GLY . 60.5 t80 -145.95 140.78 27.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.143 -0.973 . . . . 0.0 108.801 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 8.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 109.288 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.81 23.23 26.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -126.94 147.14 50.11 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.146 -1.208 . . . . 0.0 109.53 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -89.95 112.09 23.37 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.41 122.93 10.65 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.496 -0.753 . . . . 0.0 109.759 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -93.05 148.07 22.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.156 -0.965 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.22 131.88 47.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.942 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.65 64.27 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.309 -0.869 . . . . 0.0 111.403 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 54' ' ' ARG . 15.5 ttt180 -89.55 156.4 18.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.402 -1.646 . . . . 0.0 109.783 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -98.23 148.01 24.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.186 -0.946 . . . . 0.0 110.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.86 -38.94 76.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 109.871 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -57.9 -28.07 63.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.992 . . . . 0.0 110.004 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.44 -16.82 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.39 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -101.86 0.54 35.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.413 -0.804 . . . . 0.0 110.133 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 m120 52.03 49.11 21.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 96.6 mt -75.67 176.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 17.4 tt0 -132.44 138.2 47.55 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.27 -0.894 . . . . 0.0 109.662 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -52.41 149.57 5.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 110.543 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 64.56 13.65 8.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.893 -0.505 . . . . 0.0 110.953 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.465 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -94.69 143.0 26.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.033 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -90.24 128.27 36.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.096 -1.003 . . . . 0.0 108.659 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -111.71 125.13 53.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.545 -0.722 . . . . 0.0 109.803 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.67 147.3 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.5 mp -79.9 -82.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 108.77 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -150.18 176.62 10.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 110.648 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.63 130.87 34.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 110.711 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -56.71 141.43 43.96 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.98 -171.38 44.42 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 118.981 -1.58 . . . . 0.0 110.837 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 -96.08 137.01 35.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 tt -144.57 165.78 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.5 m-85 -130.86 157.74 42.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.18 121.06 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 108.596 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.8 tttm -91.86 122.64 34.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.153 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 8' ' ' LEU . 30.0 m -96.25 161.36 13.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.456 ' N ' HG22 ' A' ' 7' ' ' THR . 24.3 mt -62.65 -23.08 66.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -81.64 -0.65 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 16.25 66.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -91.18 117.78 29.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.043 -1.269 . . . . 0.0 109.37 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -93.61 118.52 31.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.475 -0.766 . . . . 0.0 109.169 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -107.63 139.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.754 . . . . 0.0 109.274 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.31 129.03 53.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.498 -0.751 . . . . 0.0 109.779 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.27 150.01 51.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.473 -0.767 . . . . 0.0 109.66 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -106.66 126.41 52.24 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.72 176.03 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.076 -1.015 . . . . 0.0 110.243 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -112.77 151.58 44.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.0 -33.01 64.27 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.818 1.679 . . . . 0.0 110.669 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -85.71 3.91 39.0 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.576 -0.703 . . . . 0.0 109.221 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.38 149.22 48.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 p -96.69 147.16 24.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.526 -0.734 . . . . 0.0 109.694 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.53 -41.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.226 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.13 -45.02 96.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.775 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.26 -37.4 80.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.728 . . . . 0.0 109.674 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -70.48 -31.32 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.273 -0.892 . . . . 0.0 109.901 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.46 -33.33 71.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.53 97.74 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -59.72 -44.94 93.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.84 -40.82 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.369 -0.832 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.59 -45.38 93.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.831 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.39 -35.6 80.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 111.284 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -89.16 -44.34 10.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.54 -27.09 22.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.75 -1.219 . . . . 0.0 110.063 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.21 83.11 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.037 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.7 mt -91.09 119.11 68.88 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.702 -1.469 . . . . 0.0 109.339 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.57 149.56 6.93 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.69 1.593 . . . . 0.0 112.326 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.06 -22.98 29.97 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.454 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.74 -6.01 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.795 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.13 -4.44 35.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 109.812 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -140.01 155.82 46.91 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.073 -1.017 . . . . 0.0 111.35 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.436 HH21 ' HD3' ' A' ' 42' ' ' ARG . 13.6 mtt180 -127.78 133.34 49.46 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.7 mt -96.93 123.59 40.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.975 -1.078 . . . . 0.0 109.79 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.1 mp -112.54 138.81 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 47' ' ' GLY . 89.9 t80 -147.5 137.74 23.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.059 -1.025 . . . . 0.0 109.059 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 11.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.369 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 92.6 23.94 24.86 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -128.11 147.18 50.53 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.122 -1.222 . . . . 0.0 109.47 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -90.15 111.69 22.92 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.04 118.14 3.0 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.551 -0.718 . . . . 0.0 109.267 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -94.76 142.74 27.11 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.178 -0.951 . . . . 0.0 109.074 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.15 137.56 57.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.524 -0.735 . . . . 0.0 109.998 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.78 -13.15 57.89 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -96.61 154.7 17.13 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.959 1.879 . . . . 0.0 110.367 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 p -99.07 152.36 19.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.025 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.61 -37.55 68.28 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.343 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.4 m -59.09 -21.46 59.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.894 -1.128 . . . . 0.0 109.732 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -70.77 -16.88 62.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.547 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -105.51 9.65 33.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.326 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 52.23 47.63 24.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.804 -1.185 . . . . 0.0 109.231 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.0 mt -79.75 172.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.421 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.603 ' N ' HG22 ' A' ' 61' ' ' ILE . 29.7 mt-30 -144.03 146.95 33.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.05 -1.031 . . . . 0.0 110.062 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.32 147.71 7.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 67.52 16.09 9.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.622 -0.674 . . . . 0.0 110.425 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.6 mp -96.12 147.31 23.87 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -93.05 131.89 37.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.289 -0.882 . . . . 0.0 108.766 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.65 128.73 55.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.02 150.71 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.2 mp -79.88 -78.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.177 -0.952 . . . . 0.0 108.757 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -167.91 -164.43 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 0.0 110.836 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.04 109.73 1.91 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 109.766 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 75' ' ' GLY . 2.0 ttm180 -59.81 -31.04 69.34 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 74' ' ' ARG . . . -60.21 -121.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -104.03 148.44 26.22 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.387 -0.82 . . . . 0.0 109.758 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -146.34 167.57 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 44.1 m-85 -124.78 134.85 52.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.96 113.61 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 109.034 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -90.77 113.58 25.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 8' ' ' LEU . 29.3 m -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.227 -0.92 . . . . 0.0 109.761 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' N ' HG22 ' A' ' 7' ' ' THR . 7.6 tp -64.05 -21.53 66.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 110.111 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -81.25 1.32 32.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.033 -1.042 . . . . 0.0 109.641 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.96 80.21 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -87.77 125.56 34.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.319 . . . . 0.0 109.121 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.6 m -105.77 122.19 45.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.576 -0.703 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.91 138.28 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.7 m -105.8 135.71 46.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 0.0 109.998 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.15 156.15 48.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 109.579 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -109.4 127.11 54.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -143.57 164.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 109.923 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 62.8 mm-40 -103.89 149.63 37.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.63 -31.48 32.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.949 1.766 . . . . 0.0 111.162 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 t -82.8 -0.62 48.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.441 -0.787 . . . . 0.0 109.406 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 146.81 54.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.081 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p -87.88 157.66 18.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.922 . . . . 0.0 109.048 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.573 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.1 mp -56.71 -42.07 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 108.499 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -64.03 -41.22 97.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -64.3 -36.95 85.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.029 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -74.7 -29.0 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -67.43 -37.51 83.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.45 44.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -49.04 -46.96 45.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.581 HG21 HE22 ' A' ' 41' ' ' GLN . 97.3 mt -62.68 -36.63 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.867 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -70.78 -48.4 54.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.81 -28.21 67.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -97.53 -41.57 8.1 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.811 -1.18 . . . . 0.0 111.208 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -93.12 -19.96 20.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.771 -1.205 . . . . 0.0 110.125 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.09 18.45 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.243 -0.979 . . . . 0.0 110.956 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.98 119.96 79.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 120.731 -1.453 . . . . 0.0 108.775 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.35 129.68 19.79 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.199 1.266 . . . . 0.0 112.294 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -49.92 -36.61 44.17 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.213 1.942 . . . . 0.0 112.991 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -70.08 -0.85 8.41 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 52.7 tt0 -100.02 -3.95 31.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.153 -0.967 . . . . 0.0 110.361 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.581 HE22 HG21 ' A' ' 30' ' ' ILE . 15.7 pt20 -139.25 153.82 47.89 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 110.434 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' NH1' ' H ' ' A' ' 73' ' ' LEU . 22.1 mtm180 -128.61 109.88 11.75 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.13 125.73 33.71 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.655 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.39 148.17 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.621 0.724 . . . . 0.0 109.599 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 47' ' ' GLY . 80.7 t80 -149.83 142.38 24.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.369 -0.832 . . . . 0.0 109.058 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.63 5.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.04 9.96 56.64 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.47 148.63 40.57 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.091 -1.24 . . . . 0.0 109.202 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -82.19 116.53 21.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.82 121.04 10.13 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.363 -0.836 . . . . 0.0 109.497 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -90.69 173.51 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.666 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.59 140.4 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.335 -0.853 . . . . 0.0 110.905 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.18 -19.61 53.4 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.278 -0.889 . . . . 0.0 111.612 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.72 ' HG2' HH21 ' A' ' 54' ' ' ARG . 0.0 OUTLIER -82.63 176.26 9.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.01 -1.288 . . . . 0.0 110.446 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -113.15 145.36 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.55 -37.71 70.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.522 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -59.91 -26.29 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.79 -17.85 51.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.602 -0.686 . . . . 0.0 109.531 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.25 3.07 32.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.41 -0.806 . . . . 0.0 110.258 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.78 47.22 24.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.706 -1.246 . . . . 0.0 109.583 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 62' ' ' GLN . 63.4 mt -68.93 169.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.7 tp-100 -135.46 139.82 44.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -54.08 147.82 12.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 110.895 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 68.04 12.44 8.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.696 -0.628 . . . . 0.0 110.765 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.421 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.8 mp -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.491 -0.756 . . . . 0.0 108.97 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -98.24 129.3 44.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -112.81 118.43 34.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.72 145.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 71' ' ' LEU . 10.6 mp -89.17 152.56 21.54 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.914 -1.116 . . . . 0.0 110.072 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.409 HH21 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -50.5 117.68 2.58 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.178 -0.951 . . . . 0.0 108.645 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.617 ' H ' ' NH1' ' A' ' 42' ' ' ARG . 45.2 mt -78.92 145.61 33.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.1 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.511 ' NH2' ' CG ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -65.0 119.99 11.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 11.98 82.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 119.552 -1.309 . . . . 0.0 111.176 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.736 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.83 147.86 27.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 109.875 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -145.22 166.63 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -127.08 143.07 51.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.284 -0.885 . . . . 0.0 109.608 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.88 121.33 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.288 -0.882 . . . . 0.0 108.837 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -94.97 123.98 38.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -98.95 153.4 18.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 0.0 109.384 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.0 mp -59.93 -18.3 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.3 p -81.53 -3.0 51.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.022 -1.049 . . . . 0.0 109.625 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.84 69.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -93.43 121.21 34.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.855 -1.38 . . . . 0.0 109.561 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 m -103.89 129.78 51.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.474 -0.767 . . . . 0.0 109.292 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 tt -126.36 145.73 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.613 -0.679 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -105.53 137.18 43.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.58 -0.7 . . . . 0.0 109.552 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.4 mt -129.1 149.46 50.91 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.484 -0.76 . . . . 0.0 109.578 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.01 125.54 51.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.87 176.17 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.99 -1.069 . . . . 0.0 110.271 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -110.31 154.0 43.11 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.85 -33.54 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.023 1.816 . . . . 0.0 110.765 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.2 m -84.37 4.62 30.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.563 -0.71 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.98 147.92 50.89 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.004 -1.079 . . . . 0.0 108.951 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 p -92.64 150.45 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.309 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.5 mm -53.97 -40.0 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.09 -1.006 . . . . 0.0 108.974 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.56 -43.6 98.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.19 -37.65 84.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.45 -28.79 36.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -70.28 -35.46 73.75 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.73 84.54 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -55.53 -47.33 76.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.732 -0.605 . . . . 0.0 109.443 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.06 -39.52 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.37 -0.831 . . . . 0.0 109.5 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.05 -45.08 93.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.37 -31.97 73.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 111.299 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -94.72 -41.6 9.18 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.802 -1.186 . . . . 0.0 111.534 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -91.65 -23.54 19.8 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.761 -1.212 . . . . 0.0 110.051 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.65 -1.47 29.21 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.059 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -83.96 118.85 72.42 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.413 . . . . 0.0 109.506 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.91 149.82 7.39 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.67 1.58 . . . . 0.0 112.027 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.68 -25.24 29.17 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.508 2.139 . . . . 0.0 112.464 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.61 -2.06 24.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 109.724 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -101.13 -7.81 22.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.237 -0.915 . . . . 0.0 110.013 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -143.04 158.88 43.19 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.008 -1.058 . . . . 0.0 110.962 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 HH21 ' HD3' ' A' ' 42' ' ' ARG . 1.6 mtp180 -132.12 121.24 23.46 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.58 121.85 28.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.07 -1.019 . . . . 0.0 110.604 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.8 mm -115.94 133.45 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -119.12 134.95 54.9 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.04 -113.45 0.65 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.995 -1.065 . . . . 0.0 108.582 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.11 26.93 5.2 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.08 150.67 46.59 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.244 -1.151 . . . . 0.0 109.233 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -91.28 113.35 25.59 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 59' ' ' TYR . 89.8 mt -55.08 122.2 10.44 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.666 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.76 171.19 9.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.77 134.26 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.28 -19.07 55.43 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.752 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.59 160.75 26.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.581 -1.541 . . . . 0.0 109.095 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 p -102.58 152.97 20.55 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.478 -0.764 . . . . 0.0 109.245 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.83 -38.98 70.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.022 -1.048 . . . . 0.0 109.311 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.3 m -61.22 -17.82 55.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.104 -0.998 . . . . 0.0 109.693 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.5 -18.45 63.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE1' HD23 ' A' ' 50' ' ' LEU . 22.8 m-85 -108.2 7.81 27.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.574 -0.703 . . . . 0.0 110.402 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 t30 50.56 47.09 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.53 -1.356 . . . . 0.0 109.562 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.637 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.8 mt -72.97 173.96 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.637 ' N ' HG22 ' A' ' 61' ' ' ILE . 66.0 mt-30 -133.07 137.93 46.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.89 151.02 4.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 110.516 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 65.71 11.55 7.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.986 -0.446 . . . . 0.0 110.851 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.42 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.6 mp -95.6 143.65 26.71 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.25 130.74 38.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.31 118.81 37.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.814 . . . . 0.0 109.98 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.19 146.77 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.1 mp -83.3 -92.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.979 -1.076 . . . . 0.0 109.352 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.29 -84.75 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.924 -1.11 . . . . 0.0 109.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.3 mp 48.86 47.42 21.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.082 -1.012 . . . . 0.0 110.485 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 118.53 15.16 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.279 -1.513 . . . . 0.0 108.113 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.52 -84.53 0.09 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.354 0.597 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -99.1 136.29 39.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.611 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 67' ' ' LEU . 4.9 mp -133.19 153.48 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -120.26 135.37 55.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.763 -1.211 . . . . 0.0 109.377 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.81 116.48 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.137 -0.977 . . . . 0.0 109.007 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.15 115.76 28.28 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.8 m -97.76 163.22 12.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.408 -0.808 . . . . 0.0 109.662 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.9 mp -68.67 -17.87 64.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 p -81.45 -1.45 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.053 -1.03 . . . . 0.0 109.751 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.12 13.69 73.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -91.26 131.84 36.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.027 -1.278 . . . . 0.0 109.307 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.8 m -107.38 113.22 26.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.163 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -106.54 139.64 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.596 -0.69 . . . . 0.0 109.221 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -108.73 134.67 51.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.672 -0.642 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.1 mt -125.92 143.91 50.89 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.749 . . . . 0.0 109.593 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -105.51 125.2 50.72 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.35 178.76 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.952 -1.093 . . . . 0.0 110.242 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 155.2 42.38 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.5 -34.74 32.68 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.056 1.838 . . . . 0.0 110.728 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 t -81.4 5.69 16.77 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.612 -0.68 . . . . 0.0 109.318 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' A' ' 26' ' ' VAL . 21.1 t0 -68.76 145.51 53.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 109.052 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.0 p -91.93 152.65 19.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.197 -0.939 . . . . 0.0 109.257 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -58.07 -35.18 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.961 -1.087 . . . . 0.0 109.124 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.68 -51.11 68.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.27 -33.86 76.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.866 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 22' ' ' THR . 96.8 t -73.25 -34.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' NZ ' HD12 ' A' ' 43' ' ' LEU . 28.2 mmtm -62.75 -35.38 79.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.39 63.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -49.42 -47.59 47.86 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.99 -36.22 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.31 -48.84 69.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.11 -26.26 65.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.007 . . . . 0.0 111.5 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -91.77 -47.61 7.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.758 -1.214 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 7.5 mp0 -87.18 -27.0 23.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.8 -1.188 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 -2.3 87.14 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.194 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.98 118.45 68.92 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.65 -1.5 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.51 152.65 3.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.564 1.509 . . . . 0.0 112.421 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.79 -17.97 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.706 2.27 . . . . 0.0 112.292 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -78.12 -3.76 44.0 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.123 -0.986 . . . . 0.0 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -112.32 -15.16 13.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -114.78 142.39 46.6 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.495 -0.753 . . . . 0.0 110.652 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' NH1' ' HG ' ' A' ' 73' ' ' LEU . 3.4 mtm180 -129.17 119.23 23.73 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.568 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.0 mt -91.35 122.83 34.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 111.278 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -110.95 140.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.7 t80 -150.77 136.38 18.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 108.726 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.67 2.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 99.36 21.39 15.12 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 140.8 50.67 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.68 120.3 24.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.12 118.99 7.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.451 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.59 147.07 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.148 -0.97 . . . . 0.0 109.056 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.5 p-10 -61.77 138.08 58.3 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.767 . . . . 0.0 110.674 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.81 56.35 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.401 -0.812 . . . . 0.0 112.003 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.76 164.16 17.76 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 120.073 1.937 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -101.53 146.01 28.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.313 -0.867 . . . . 0.0 111.021 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.11 -39.25 63.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.387 -0.821 . . . . 0.0 109.645 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -68.66 -18.75 64.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.89 . . . . 0.0 109.166 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.81 -17.9 61.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.73 . . . . 0.0 109.898 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -107.74 9.85 28.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.414 -0.804 . . . . 0.0 110.053 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 54.8 25.32 6.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 109.419 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 18.9 mt -51.76 170.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 95.0 mm-40 -137.75 141.1 40.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.381 -0.825 . . . . 0.0 109.781 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 65' ' ' SEP . 62.9 pttt -57.35 155.69 8.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.132 -0.98 . . . . 0.0 110.233 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 63.7 5.52 2.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 122.002 -0.436 . . . . 0.0 110.967 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.44 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.489 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.2 mp -96.04 150.59 20.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -96.26 130.41 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.52 128.87 56.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.407 -0.808 . . . . 0.0 109.811 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.88 149.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 71' ' ' LEU . 9.3 mp -79.96 -82.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.702 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' CG ' HH21 ' A' ' 72' ' ' ARG . 1.2 mtt-85 -143.33 170.48 15.69 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.14 -0.975 . . . . 0.0 110.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HG ' ' NH1' ' A' ' 42' ' ' ARG . 11.2 mt -63.18 152.87 36.23 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.218 -0.926 . . . . 0.0 109.231 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -65.79 160.43 23.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.51 132.74 1.72 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 CA-C-O 117.956 -1.469 . . . . 0.0 109.707 -179.635 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' VAL . 61.5 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.292 0.568 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.36 115.82 28.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.842 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.452 ' CG2' HD13 ' A' ' 67' ' ' LEU . 34.3 mm -117.45 153.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -127.03 127.36 44.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.506 -1.371 . . . . 0.0 108.64 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.68 124.9 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.712 -1.243 . . . . 0.0 109.464 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -102.31 123.31 45.89 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -101.1 153.54 19.49 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.288 -0.882 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -59.28 -18.41 37.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 p -81.33 -1.01 43.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.345 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.73 86.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -81.81 116.18 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.926 -1.337 . . . . 0.0 110.032 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -104.68 134.85 47.15 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.4 pt -130.73 143.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 t -100.68 130.38 46.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.238 -0.914 . . . . 0.0 109.944 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.89 145.23 50.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 0.0 109.703 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -106.27 126.63 52.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.2 m -144.35 -176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 110.048 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -117.68 152.07 49.3 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.29 -33.3 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.062 1.841 . . . . 0.0 110.882 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -83.47 2.51 36.42 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 26' ' ' VAL . 2.4 t70 -66.89 148.37 52.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.839 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 159.37 16.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.394 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.59 -38.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.8 -47.87 83.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.929 . . . . 0.0 110.027 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.76 -46.21 86.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.865 . . . . 0.0 109.906 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' OD2' ' A' ' 21' ' ' ASP . 96.8 t -63.23 -30.92 50.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.572 -0.705 . . . . 0.0 109.556 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -69.38 -32.56 71.67 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.55 -58.46 8.5 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 1.3 mptm? -49.5 -43.26 45.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.513 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG21 HE22 ' A' ' 41' ' ' GLN . 91.0 mt -63.51 -44.52 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.252 -0.905 . . . . 0.0 109.745 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.71 -48.14 67.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -64.52 -19.45 65.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.828 . . . . 0.0 111.517 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -98.19 -47.48 5.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.737 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -90.26 -27.64 19.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.859 -1.151 . . . . 0.0 109.772 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.0 8.32 84.2 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.087 -1.008 . . . . 0.0 111.038 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -90.05 116.57 66.69 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.716 -1.461 . . . . 0.0 108.98 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.33 149.34 6.6 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.541 1.494 . . . . 0.0 112.094 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.82 -28.44 24.96 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.532 2.155 . . . . 0.0 112.386 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.16 -1.92 28.6 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.023 -1.048 . . . . 0.0 109.703 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -106.41 1.61 25.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.421 HE22 HG21 ' A' ' 30' ' ' ILE . 14.9 pt20 -141.1 154.74 46.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -0.93 . . . . 0.0 111.267 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.403 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.5 mtm180 -130.54 128.57 41.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.66 121.12 37.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.548 -0.72 . . . . 0.0 111.494 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.99 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.61 ' C ' ' H ' ' A' ' 47' ' ' GLY . 81.5 t80 -133.8 134.94 43.48 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.06 -9.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 111.79 18.56 7.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -120.63 152.1 38.62 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.215 -1.168 . . . . 0.0 109.569 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -91.26 110.71 22.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.31 108.81 0.46 Allowed 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.771 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.4 150.36 27.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.471 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.47 137.42 57.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.33 -0.856 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.18 -12.62 65.26 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.253 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -84.72 177.89 7.86 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.301 -1.705 . . . . 0.0 109.529 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.2 p -121.85 149.69 43.0 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.419 -0.8 . . . . 0.0 110.933 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -57.1 -41.97 79.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.615 -0.678 . . . . 0.0 109.313 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -57.23 -37.03 71.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.666 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.08 -20.52 6.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 109.553 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -101.83 11.31 38.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.158 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 46.99 48.04 15.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.926 -1.109 . . . . 0.0 109.804 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.2 mt -73.4 175.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.344 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.624 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 tp-100 -144.88 147.52 32.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.986 -1.071 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -55.41 149.36 13.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.848 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 68.45 27.01 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.807 -0.558 . . . . 0.0 110.788 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.426 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 8.2 mp -94.28 157.12 16.19 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 8.0 m-70 -104.21 129.26 51.98 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.99 124.66 51.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.864 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.64 145.96 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.2 mp -79.45 151.87 30.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.039 -1.038 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.497 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 1.3 ptt180 -43.33 -62.06 1.17 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.026 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 1.8 tt 56.5 51.63 11.02 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.578 -1.326 . . . . 0.0 109.911 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.663 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.1 OUTLIER 48.46 -105.61 0.15 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 109.086 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.81 38.02 0.66 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 CA-C-O 117.749 -1.584 . . . . 0.0 109.263 -179.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 17' ' ' VAL . 18.1 mmt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.3 140.71 36.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.408 -0.807 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.82 167.6 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 39.0 m-85 -131.21 132.26 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.99 -1.069 . . . . 0.0 109.714 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.48 120.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 109.364 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -97.61 112.66 24.44 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 8' ' ' LEU . 33.8 m -94.58 160.16 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.296 -0.878 . . . . 0.0 109.613 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 7' ' ' THR . 35.8 mt -63.21 -20.79 65.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.996 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -81.53 -0.04 40.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.508 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 12.44 79.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -83.41 122.31 28.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.29 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -100.64 119.28 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -117.09 131.67 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.6 m -98.21 129.4 44.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.418 -0.801 . . . . 0.0 109.726 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 mt -129.72 148.11 51.57 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.608 -0.683 . . . . 0.0 109.618 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -113.26 131.49 55.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -145.87 -175.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.966 -1.084 . . . . 0.0 110.079 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.8 149.18 41.95 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.13 -30.56 38.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.075 1.85 . . . . 0.0 110.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -83.56 2.18 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.73 147.1 50.96 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 p -89.96 156.92 18.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.43 -36.39 40.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.82 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.95 -48.77 75.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.803 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.75 -36.91 80.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 0.0 109.903 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.47 -28.73 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -67.66 -38.01 83.19 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -57.66 11.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -48.13 -45.23 32.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.361 -0.837 . . . . 0.0 109.41 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.85 -39.73 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.491 -0.756 . . . . 0.0 109.791 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -71.05 -51.09 27.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.98 -18.4 64.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 111.541 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -98.1 -47.63 5.42 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.641 -1.287 . . . . 0.0 110.764 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -93.53 -27.62 16.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.857 -1.152 . . . . 0.0 110.108 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.48 6.99 88.13 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.115 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.06 115.61 63.23 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 120.661 -1.494 . . . . 0.0 109.133 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.7 146.6 10.92 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.629 1.552 . . . . 0.0 112.247 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.94 -26.29 26.89 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.354 2.036 . . . . 0.0 112.432 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.09 -0.27 21.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.082 -1.011 . . . . 0.0 109.917 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -107.97 2.01 22.95 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.249 -0.907 . . . . 0.0 109.653 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -145.67 157.87 43.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.856 -1.153 . . . . 0.0 111.548 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -129.53 119.02 22.99 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 44' ' ' ILE . 16.5 mt -88.38 115.26 25.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.881 -1.137 . . . . 0.0 110.428 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -109.04 144.75 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.594 ' C ' ' H ' ' A' ' 47' ' ' GLY . 66.6 t80 -147.15 133.48 19.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.093 . . . . 0.0 108.381 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 -5.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.634 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.01 16.34 10.71 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.2 144.99 47.42 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.084 -1.244 . . . . 0.0 109.655 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.88 119.2 25.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.31 114.88 6.38 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.811 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.99 154.66 19.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.905 -1.122 . . . . 0.0 108.994 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -63.52 140.49 58.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.504 -0.747 . . . . 0.0 111.203 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.65 -17.39 59.21 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.618 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 54' ' ' ARG . 3.0 mtp180 -76.04 176.58 7.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.219 -1.754 . . . . 0.0 109.556 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 57' ' ' SER . 38.3 m -122.61 147.41 46.45 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.519 -0.738 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -55.73 -41.37 73.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.364 -0.835 . . . . 0.0 109.645 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.4 ' H ' HG22 ' A' ' 55' ' ' THR . 85.0 p -60.34 -33.5 72.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.22 -20.07 9.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.627 -0.67 . . . . 0.0 109.717 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.4 3.86 35.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.101 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 m120 48.91 47.09 21.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 109.624 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.7 mt -69.17 177.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.398 -0.814 . . . . 0.0 109.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.669 ' N ' HG22 ' A' ' 61' ' ' ILE . 9.3 tp-100 -135.52 138.84 43.48 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.157 -0.965 . . . . 0.0 109.801 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -52.54 146.94 9.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 110.563 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 67.32 18.12 10.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.761 -0.587 . . . . 0.0 110.856 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.416 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.3 mp -93.03 157.38 16.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -107.76 130.88 54.92 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.5 tt -116.35 117.84 31.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.514 -0.742 . . . . 0.0 109.502 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' N ' HD23 ' A' ' 69' ' ' LEU . 52.2 t -109.83 144.7 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 71' ' ' LEU . 9.8 mp -94.08 159.3 15.22 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.9 -1.125 . . . . 0.0 110.936 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -69.19 127.79 34.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.862 -0.524 . . . . 0.0 110.407 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.6 tp -56.31 -61.9 2.09 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -76.71 159.9 29.8 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.335 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.61 95.82 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.718 179.733 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.7 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -98.93 138.19 36.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -0.845 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -132.68 159.1 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -121.12 138.08 54.36 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.431 -0.793 . . . . 0.0 109.543 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.53 113.87 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.055 -1.028 . . . . 0.0 108.875 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -90.47 115.12 27.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.127 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.4 p -94.3 158.35 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.239 -0.913 . . . . 0.0 109.507 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.04 -16.81 63.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 9' ' ' THR . 84.8 m -81.53 -10.08 59.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.438 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 10.15 55.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.86 126.63 36.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.866 -1.373 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -105.84 121.93 45.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 13' ' ' ILE . 3.4 mp -113.22 144.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -116.47 138.85 51.05 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.724 -0.61 . . . . 0.0 109.782 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -113.39 129.07 56.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -145.16 176.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.0 -1.063 . . . . 0.0 110.173 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -109.45 151.86 42.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.21 -34.36 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.062 1.841 . . . . 0.0 110.824 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -82.4 3.94 26.06 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.27 148.84 51.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.856 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -88.97 158.08 18.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 109.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.2 mp -59.27 -42.96 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 108.42 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.33 -39.13 89.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.855 . . . . 0.0 110.129 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -68.82 -41.99 77.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.805 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -69.18 -31.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.133 -0.979 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -67.72 -34.71 77.4 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.52 83.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -42.94 85.05 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.94 -42.97 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.842 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.18 -43.32 98.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 0.0 109.895 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -62.99 -34.99 78.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 111.189 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -91.8 -39.82 11.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.761 -1.212 . . . . 0.0 111.531 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -93.37 -17.13 23.89 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.841 -1.162 . . . . 0.0 110.112 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.04 -1.92 37.68 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.973 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.6 mt -81.43 134.21 51.88 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.701 -1.47 . . . . 0.0 109.039 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.92 160.86 48.02 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.688 1.592 . . . . 0.0 111.982 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 -24.69 32.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.765 2.31 . . . . 0.0 112.331 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -81.88 -1.81 48.99 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.023 -1.048 . . . . 0.0 110.315 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.99 -31.8 6.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.04 -1.038 . . . . 0.0 109.905 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.12 136.74 37.92 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.643 HH21 ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -126.07 111.96 15.3 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.8 mt -93.81 129.74 40.08 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.668 0.747 . . . . 0.0 112.094 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mt -124.07 140.41 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.452 0.644 . . . . 0.0 109.592 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.64 137.66 53.74 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.68 -115.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.911 -1.118 . . . . 0.0 108.465 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.75 30.23 4.94 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 145.96 52.17 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.291 -1.123 . . . . 0.0 109.651 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -88.09 120.05 29.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.9 mt -57.17 119.43 6.36 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.499 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 32.0 mt-10 -95.71 168.93 10.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.36 -0.838 . . . . 0.0 109.377 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.76 142.18 27.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 111.292 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.08 6.39 55.86 Favored Glycine 0 N--CA 1.502 3.064 0 O-C-N 121.433 -0.792 . . . . 0.0 111.859 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' NH2' ' OE1' ' A' ' 51' ' ' GLU . 5.2 mtp180 -121.4 171.26 8.9 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 118.736 1.268 . . . . 0.0 109.783 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -106.37 149.08 27.34 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.078 -1.014 . . . . 0.0 110.945 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.09 -37.01 68.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 109.609 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.7 p -61.48 -21.15 63.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.84 -17.35 64.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.417 -0.802 . . . . 0.0 109.397 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -103.62 8.74 37.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.752 . . . . 0.0 110.493 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 57.13 47.62 16.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.628 -1.295 . . . . 0.0 109.437 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 62' ' ' GLN . 87.3 mt -80.28 174.48 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.383 -0.823 . . . . 0.0 109.131 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.618 ' N ' HG22 ' A' ' 61' ' ' ILE . 20.0 pt20 -152.95 154.5 35.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.885 -1.134 . . . . 0.0 110.055 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -54.68 147.95 13.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 69.35 14.9 8.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.122 -0.361 . . . . 0.0 111.159 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.502 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.7 mp -95.61 147.49 23.53 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -90.82 133.73 34.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.295 -0.878 . . . . 0.0 108.777 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -110.8 123.7 50.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.508 -0.745 . . . . 0.0 110.142 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.8 146.79 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 mp -93.38 155.86 17.13 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.874 -1.141 . . . . 0.0 109.972 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.13 126.52 27.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.237 -0.915 . . . . 0.0 109.18 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.6 132.77 47.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.4 HH21 ' HD3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -176.73 115.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.873 -1.142 . . . . 0.0 109.179 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 49.32 53.74 18.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -100.51 142.51 31.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 109.863 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -143.97 166.29 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.33 141.76 51.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.327 -0.858 . . . . 0.0 109.703 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.88 117.02 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 0.0 108.893 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -89.75 114.13 25.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 108.974 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 160.86 15.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.407 -0.808 . . . . 0.0 109.904 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.1 mp -69.34 -19.36 63.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.78 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -81.49 -4.13 55.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 109.49 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.27 12.96 62.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.68 124.28 36.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.367 . . . . 0.0 109.333 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -99.13 117.72 34.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.452 -0.78 . . . . 0.0 109.218 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.8 139.98 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.447 -0.783 . . . . 0.0 109.118 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 14' ' ' THR . 11.6 t -113.3 135.43 53.86 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.716 -0.615 . . . . 0.0 109.676 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.04 159.89 40.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.467 -0.771 . . . . 0.0 109.7 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -115.76 132.11 56.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.43 176.69 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.004 -1.06 . . . . 0.0 110.19 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -107.23 153.81 40.88 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.08 -35.78 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.009 1.806 . . . . 0.0 110.754 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -83.35 4.83 25.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.638 -0.664 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.82 143.92 57.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.0 108.703 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -85.86 145.24 27.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 109.415 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.557 HG23 ' HZ2' ' A' ' 27' ' ' LYS . 1.9 mp -50.25 -41.09 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 108.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.77 -40.93 94.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.92 71.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.8 -36.0 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 0.0 109.415 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HZ2' HG23 ' A' ' 23' ' ' ILE . 51.6 mttp -69.58 -30.77 68.62 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.72 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -53.45 -43.75 68.32 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mm -61.44 -46.07 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.7 -43.09 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.89 -32.89 72.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.374 -0.829 . . . . 0.0 111.249 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.14 -40.35 8.85 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.828 -1.17 . . . . 0.0 111.159 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.6 -21.92 25.07 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.767 -1.208 . . . . 0.0 109.656 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.51 53.31 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.999 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -91.09 134.39 30.13 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.838 -1.389 . . . . 0.0 108.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 131.26 20.92 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.22 1.28 . . . . 0.0 111.871 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.68 -19.14 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.341 2.027 . . . . 0.0 113.729 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.71 -8.5 56.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 110.605 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -109.02 -22.62 12.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.255 -0.903 . . . . 0.0 109.95 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -107.16 143.49 35.28 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.83 0.824 . . . . 0.0 110.998 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.71 124.61 43.12 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -93.65 121.43 35.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.442 -1.411 . . . . 0.0 110.024 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.9 mm -112.17 129.93 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 83.9 t80 -146.91 139.84 25.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 108.903 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.63 3.25 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 109.298 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 96.38 19.92 26.53 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -127.98 151.86 48.62 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.125 -1.22 . . . . 0.0 109.641 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -90.61 113.27 25.27 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -51.07 117.53 2.61 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.307 -0.87 . . . . 0.0 109.87 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.02 173.7 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.229 -0.919 . . . . 0.0 109.804 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.29 146.35 25.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 0.0 111.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.77 10.68 55.06 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.412 -0.805 . . . . 0.0 111.552 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -129.06 160.84 31.52 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.763 -1.433 . . . . 0.0 110.612 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -89.44 146.83 24.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.015 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HG ' HD12 ' A' ' 61' ' ' ILE . 14.9 tp -55.65 -27.49 50.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.0 p -71.2 -16.45 62.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.075 -1.015 . . . . 0.0 109.236 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.42 -16.81 57.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.581 -0.7 . . . . 0.0 109.458 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.04 10.56 34.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 53.08 26.03 4.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.558 -1.339 . . . . 0.0 109.63 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 6.0 mt -52.39 170.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.323 -0.86 . . . . 0.0 108.724 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 52.2 mt-30 -138.83 142.68 38.66 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 65' ' ' SEP . 56.2 pttt -58.04 153.62 14.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.662 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 64.72 6.31 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.668 -0.645 . . . . 0.0 110.565 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.433 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.1 mp -95.38 142.92 27.19 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -90.52 128.78 36.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 108.618 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.71 122.54 48.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.614 -0.679 . . . . 0.0 109.792 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.13 150.47 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.4 mp -99.02 157.94 15.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.078 -1.014 . . . . 0.0 108.99 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.666 HH11 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -61.94 125.6 24.4 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 108.987 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.666 ' HB2' HH11 ' A' ' 72' ' ' ARG . 8.8 mp -60.86 163.1 6.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.345 -0.847 . . . . 0.0 110.159 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -152.41 165.32 35.4 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.18 101.24 0.22 Allowed Glycine 0 N--CA 1.499 2.877 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.6 mmt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -101.8 144.53 30.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.37 -0.831 . . . . 0.0 109.649 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -143.86 166.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -129.4 135.65 48.96 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.192 -0.943 . . . . 0.0 109.721 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.19 119.36 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 0.0 108.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -95.62 120.88 36.65 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 9' ' ' THR . 18.8 m -97.37 145.7 25.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.351 -0.843 . . . . 0.0 109.376 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -61.59 -13.77 24.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.872 . . . . 0.0 110.082 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 7' ' ' THR . 56.9 m -81.55 -9.99 59.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.031 . . . . 0.0 109.556 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.15 2.5 55.85 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -91.37 136.39 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.937 -1.331 . . . . 0.0 109.273 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -123.94 134.41 53.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.468 -0.77 . . . . 0.0 109.186 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.5 145.15 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.597 -0.689 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 136.75 41.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.406 -0.809 . . . . 0.0 109.797 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -126.81 146.24 50.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.55 -0.718 . . . . 0.0 109.544 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -105.88 125.34 50.88 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.3 m -145.83 174.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.992 -1.068 . . . . 0.0 110.349 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 12.5 mp0 -108.54 154.01 41.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.25 -35.06 33.74 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.923 1.749 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 t -84.28 4.84 29.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.512 -0.743 . . . . 0.0 109.44 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.74 148.79 51.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.957 -1.089 . . . . 0.0 108.526 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 p -87.82 152.38 22.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.066 -1.021 . . . . 0.0 109.264 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 mp -56.14 -39.85 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -64.12 -42.04 97.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -65.25 -38.2 89.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -72.63 -29.22 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.459 -0.775 . . . . 0.0 109.435 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -69.71 -34.5 73.99 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.4 -54.27 47.58 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -49.53 -44.54 46.51 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.437 0.637 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -65.35 -38.18 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -63.25 -47.96 80.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 109.916 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -70.38 -20.05 62.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.197 -0.94 . . . . 0.0 111.268 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -93.65 -50.89 5.18 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.835 -1.166 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -87.67 -24.44 23.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.879 -1.138 . . . . 0.0 109.805 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.03 3.9 89.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.137 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.0 mt -89.15 134.79 32.44 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.705 -1.468 . . . . 0.0 109.039 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.83 156.03 66.74 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.579 1.519 . . . . 0.0 111.951 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.36 -18.35 38.95 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.946 2.431 . . . . 0.0 112.578 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.76 -1.6 43.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 110.039 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -112.67 -23.04 10.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.136 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -115.63 144.78 43.41 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.67 118.29 22.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -85.92 121.25 28.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.67 0.747 . . . . 0.0 111.616 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -107.47 150.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -139.49 130.04 25.74 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.32 -119.5 1.51 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.62 27.61 7.87 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -135.65 -174.85 3.76 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.917 -1.343 . . . . 0.0 109.283 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -121.68 126.06 48.1 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.167 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.26 118.49 5.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -93.14 168.0 11.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.251 -0.906 . . . . 0.0 109.641 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.62 146.82 23.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.31 -0.868 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.46 60.85 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 121.341 -0.849 . . . . 0.0 111.657 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -123.66 164.12 19.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.118 -1.225 . . . . 0.0 110.189 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -96.79 147.85 23.51 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.922 -1.111 . . . . 0.0 110.749 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.79 -31.72 62.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.315 -0.865 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -62.26 -23.58 66.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.66 -16.38 48.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -104.83 0.76 28.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 52.98 44.07 30.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.713 -1.242 . . . . 0.0 109.508 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 62' ' ' GLN . 90.3 mt -66.87 174.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 109.209 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' N ' HG22 ' A' ' 61' ' ' ILE . 5.8 tp-100 -135.82 140.41 44.19 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.186 -0.946 . . . . 0.0 110.009 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -51.76 143.59 12.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 69.15 17.23 8.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 110.568 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.507 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 7.4 mp -94.22 153.76 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -101.81 131.89 47.88 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.68 126.58 55.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 109.496 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.4 147.43 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.3 mp -93.82 154.31 17.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.915 -1.116 . . . . 0.0 108.841 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -55.68 -11.72 1.02 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.756 -1.215 . . . . 0.0 110.018 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.6 mt -61.32 -10.23 6.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 108.988 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -159.26 144.47 15.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.88 -116.64 0.41 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.546 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -101.17 140.91 34.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.427 -0.796 . . . . 0.0 109.929 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.13 166.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.72 132.31 51.16 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.26 116.69 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.058 -1.026 . . . . 0.0 109.001 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.04 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -92.43 153.85 18.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.389 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -59.84 -23.99 63.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 109.918 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 9' ' ' THR . 84.5 m -81.23 -6.67 59.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.568 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 1.41 63.43 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -73.65 113.57 10.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.908 -1.348 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.5 m -97.51 130.1 44.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.558 -0.714 . . . . 0.0 109.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.38 140.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 14' ' ' THR . 13.9 t -104.17 132.7 50.15 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.251 -0.905 . . . . 0.0 109.845 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -128.73 147.27 50.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.484 0.659 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -111.15 130.42 55.63 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.41 -178.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.021 -1.049 . . . . 0.0 110.054 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.18 154.57 46.22 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.74 -33.68 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.179 1.92 . . . . 0.0 110.71 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -84.34 5.69 25.99 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -69.14 146.51 52.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.0 108.871 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -93.76 152.69 18.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -57.55 -36.27 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 109.058 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.55 -53.03 61.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.978 . . . . 0.0 110.198 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.79 -37.67 87.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.359 -0.838 . . . . 0.0 109.931 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.69 -28.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -68.88 -34.93 76.25 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -56.75 17.71 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -49.65 -46.13 49.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.625 -0.672 . . . . 0.0 109.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.08 -41.71 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 109.722 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -68.9 -45.64 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 111.629 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -98.41 -48.22 5.12 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.646 -1.284 . . . . 0.0 111.065 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' HD12 ' A' ' 36' ' ' ILE . 26.6 tt0 -86.64 -28.51 23.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.763 -1.21 . . . . 0.0 109.673 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.26 5.91 88.42 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.379 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.415 HD12 ' CD ' ' A' ' 34' ' ' GLU . 28.8 mt -91.35 119.35 68.68 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 120.557 -1.555 . . . . 0.0 108.9 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.56 144.02 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.567 1.512 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 -18.09 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.459 2.106 . . . . 0.0 112.226 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.16 -11.2 60.81 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.103 -0.998 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -110.06 -29.23 8.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -85.48 137.25 33.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.509 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -124.49 111.49 15.76 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -93.25 124.47 37.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.589 -0.694 . . . . 0.0 111.199 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.29 138.08 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.658 -0.651 . . . . 0.0 109.355 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 47' ' ' GLY . 85.6 t80 -140.26 139.39 35.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.447 -0.783 . . . . 0.0 109.154 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 67.1 -10.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.64 -0.663 . . . . 0.0 109.32 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 110.91 8.3 24.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -112.86 149.74 32.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.089 -1.242 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -83.4 116.73 22.62 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.85 120.68 12.38 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.687 -0.633 . . . . 0.0 110.068 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.9 151.33 20.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -65.92 138.62 57.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 111.186 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.68 71.54 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 121.474 -0.766 . . . . 0.0 111.231 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -82.57 166.9 18.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.706 -1.467 . . . . 0.0 111.075 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -111.39 145.42 38.94 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.663 0.744 . . . . 0.0 111.402 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.76 -43.54 90.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.667 -0.646 . . . . 0.0 109.788 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -55.58 -34.28 64.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.25 -20.77 29.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.456 -0.778 . . . . 0.0 109.388 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -103.8 5.1 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.27 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 48.1 41.56 15.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.789 -1.194 . . . . 0.0 109.694 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 62' ' ' GLN . 56.2 mt -60.1 169.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.365 -0.834 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.563 ' N ' HG22 ' A' ' 61' ' ' ILE . 62.9 mt-30 -129.05 134.62 48.18 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.789 0.804 . . . . 0.0 109.848 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -54.85 150.29 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 110.797 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 67.17 10.45 7.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.87 -0.518 . . . . 0.0 110.741 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.448 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 67' ' ' LEU . 8.7 mp -92.7 156.73 16.86 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 1.6 m80 -102.43 127.94 49.25 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.357 -0.839 . . . . 0.0 109.202 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -109.38 111.5 23.09 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.502 -0.749 . . . . 0.0 109.494 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.2 t -116.87 142.57 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.961 HD22 ' H ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -79.75 -93.53 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.007 -1.058 . . . . 0.0 109.605 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -164.38 -11.14 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.131 -0.981 . . . . 0.0 108.412 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' H ' ' H ' ' A' ' 72' ' ' ARG . 42.6 mt 51.38 -141.68 0.77 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.408 -1.432 . . . . 0.0 109.028 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.659 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -61.78 -31.35 71.55 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 108.452 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.91 -105.05 0.9 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 117.898 -1.501 . . . . 0.0 109.771 179.308 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -101.71 141.57 34.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.394 -0.816 . . . . 0.0 109.685 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.96 163.0 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.9 145.39 48.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.336 -0.852 . . . . 0.0 109.69 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.86 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.392 -0.818 . . . . 0.0 108.885 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.18 114.86 26.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -88.79 156.45 18.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.27 -24.44 64.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 110.007 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -81.38 -5.33 57.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 16.96 53.75 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.67 115.08 27.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.912 -1.346 . . . . 0.0 109.398 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -91.9 118.49 30.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.11 145.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.551 -0.718 . . . . 0.0 109.12 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 t -111.38 134.83 52.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.639 -0.663 . . . . 0.0 109.667 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.3 mt -127.89 146.59 50.58 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.497 -0.752 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.36 123.37 46.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.73 177.46 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.976 -1.078 . . . . 0.0 110.043 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.17 164.06 15.58 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -77.57 -37.07 1.03 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 110.705 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -80.52 7.77 9.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -66.41 150.24 49.2 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.81 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 m -94.07 164.16 13.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -70.11 -40.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.035 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -63.07 -43.86 97.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -68.01 -40.01 83.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.471 -0.768 . . . . 0.0 109.679 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 22' ' ' THR . 95.7 t -71.24 -31.5 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -68.64 -32.38 72.18 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.98 81.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.84 -44.86 78.39 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.2 mt -62.34 -42.56 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.416 -0.803 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.1 tt0 -65.35 -44.11 88.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.96 -33.54 73.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 111.149 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -93.86 -41.16 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.823 -1.173 . . . . 0.0 111.17 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -89.44 -26.01 21.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.676 -1.265 . . . . 0.0 109.907 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 80.21 7.28 88.68 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.189 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.45 116.81 66.6 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.803 -1.41 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.84 150.17 6.81 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.665 1.577 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.07 -19.46 34.63 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.675 2.25 . . . . 0.0 112.605 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.7 -4.49 46.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -107.93 -12.52 15.15 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -113.45 140.86 47.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.352 -0.842 . . . . 0.0 110.508 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -127.44 108.93 11.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.78 125.19 33.05 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.743 0.782 . . . . 0.0 111.695 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.39 134.48 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.461 0.648 . . . . 0.0 109.265 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLY . 65.9 t80 -148.6 142.43 25.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 109.225 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.71 8.26 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.733 . . . . 0.0 109.37 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 93.68 18.96 36.12 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -129.32 152.03 49.33 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.28 117.52 29.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 17.5 mt -54.32 115.51 2.13 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.227 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -88.57 146.54 25.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.027 . . . . 0.0 108.994 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.07 135.6 57.82 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.387 -0.821 . . . . 0.0 109.909 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -14.8 57.3 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.256 -0.902 . . . . 0.0 112.792 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -91.72 160.83 15.15 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.219 2.01 . . . . 0.0 110.559 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -105.54 151.08 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.567 0.698 . . . . 0.0 109.374 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.97 -39.06 65.65 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.995 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -60.27 -20.57 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.544 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.49 -19.64 63.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.582 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -107.32 8.66 29.87 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 0.0 110.397 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 52.09 49.07 21.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.676 -1.265 . . . . 0.0 109.675 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 62' ' ' GLN . 69.7 mt -76.92 172.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.488 -0.758 . . . . 0.0 109.132 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.606 ' N ' HG22 ' A' ' 61' ' ' ILE . 90.8 mt-30 -138.62 142.15 39.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.114 -0.991 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.27 152.53 6.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 110.44 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 65.0 10.04 5.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.048 -0.407 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.492 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -95.66 143.66 26.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -89.88 129.89 36.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.1 -1.0 . . . . 0.0 108.956 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.2 tt -105.49 114.56 28.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.512 -0.743 . . . . 0.0 110.037 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.4 t -114.82 147.05 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.06 -171.71 2.6 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.222 1.011 . . . . 0.0 110.735 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -65.55 138.75 58.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.939 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.59 143.27 54.91 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.5 -45.88 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 118.669 -1.213 . . . . 0.0 108.562 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.05 77.14 0.03 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.15 149.61 25.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.742 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.07 168.42 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -127.98 131.66 49.24 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.29 -0.881 . . . . 0.0 109.561 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.12 117.18 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 108.91 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -91.85 113.89 26.28 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -92.93 164.05 13.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.492 -0.755 . . . . 0.0 109.975 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -72.72 -19.02 61.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.035 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.3 p -81.38 -0.4 41.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 0.0 109.649 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 12.34 71.34 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -93.16 132.26 37.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.325 . . . . 0.0 109.057 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -116.14 130.87 57.01 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.28 143.3 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.643 -0.661 . . . . 0.0 109.468 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 t -103.62 138.08 40.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.477 -0.764 . . . . 0.0 109.782 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.2 mt -131.98 153.37 50.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.536 -0.727 . . . . 0.0 109.567 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -107.13 124.45 49.71 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -143.5 163.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.0 mt-10 -101.36 152.31 37.95 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.14 -36.05 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.936 1.757 . . . . 0.0 111.338 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.9 p -79.77 4.73 15.48 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.385 -0.822 . . . . 0.0 109.288 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.28 146.02 49.18 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.483 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.4 p -89.34 154.38 20.13 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.93 -37.84 43.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.016 -1.053 . . . . 0.0 108.748 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.2 -44.32 95.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.7 -36.37 83.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.932 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -74.22 -30.31 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.489 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.22 -35.72 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.9 49.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -50.42 -46.84 56.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.43 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.64 -37.76 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.56 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.26 -47.15 68.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.8 -25.7 68.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 111.423 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -95.5 -48.8 5.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.732 -1.23 . . . . 0.0 111.305 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.9 -24.8 23.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.837 -1.165 . . . . 0.0 110.025 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.65 -1.6 88.52 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.233 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -80.68 134.28 54.25 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.657 -1.496 . . . . 0.0 108.571 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 131.8 20.78 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.36 1.373 . . . . 0.0 112.051 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -46.12 -23.21 1.76 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.237 1.958 . . . . 0.0 113.553 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -73.91 -2.68 24.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 110.59 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.64 -22.6 10.17 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -100.75 137.52 39.03 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.154 0.978 . . . . 0.0 111.212 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.5 104.41 9.64 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.15 122.02 33.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.799 -1.188 . . . . 0.0 110.075 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 mt -122.73 145.83 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 47' ' ' GLY . 74.9 t80 -149.96 144.84 26.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.64 6.41 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.94 15.97 49.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.47 139.95 52.81 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.074 -1.251 . . . . 0.0 109.027 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -78.59 118.69 20.95 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.24 118.91 6.0 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 109.861 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -90.62 150.18 21.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.194 -0.942 . . . . 0.0 109.936 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -66.33 134.91 53.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 110.752 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.99 -16.29 57.42 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 121.301 -0.874 . . . . 0.0 111.897 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.462 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -92.66 149.06 21.57 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-N 119.9 1.85 . . . . 0.0 109.997 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -90.81 154.48 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.587 0.708 . . . . 0.0 110.068 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.21 -36.28 72.89 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.4 p -61.94 -20.24 63.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.062 . . . . 0.0 109.188 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.37 -16.27 64.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.463 -0.773 . . . . 0.0 109.726 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -109.33 7.55 25.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.459 -0.776 . . . . 0.0 110.348 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 51.71 45.7 27.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.658 -1.276 . . . . 0.0 109.552 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 62' ' ' GLN . 88.9 mt -71.88 174.57 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.875 . . . . 0.0 109.258 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.625 ' N ' HG22 ' A' ' 61' ' ' ILE . 15.6 tt0 -135.88 140.13 43.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.19 -0.944 . . . . 0.0 109.702 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -53.15 149.81 6.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 64.54 13.91 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.967 -0.458 . . . . 0.0 110.976 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.413 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.2 mp -94.42 149.29 21.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.23 130.88 41.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.23 118.75 36.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.399 -0.813 . . . . 0.0 109.789 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -116.47 148.81 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.0 mp -81.2 -76.96 0.22 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.806 -1.184 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.88 174.03 13.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 109.775 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -93.2 -25.11 17.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.526 -0.734 . . . . 0.0 110.054 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -70.56 -2.6 14.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.661 -1.274 . . . . 0.0 109.315 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.25 30.91 35.86 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.286 0.565 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -103.78 145.26 30.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.445 -0.784 . . . . 0.0 110.014 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.1 pt -140.36 163.7 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 41.1 m-85 -121.75 136.12 54.94 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 114.03 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 108.887 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -90.64 117.37 29.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 109.031 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.7 p -92.12 160.64 15.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.882 . . . . 0.0 109.597 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -65.21 -20.1 66.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 9' ' ' THR . 85.1 m -81.67 -9.32 59.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 109.544 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.06 16.56 43.89 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -94.34 121.06 35.48 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.322 . . . . 0.0 109.563 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 m -96.65 121.33 38.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.293 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.36 141.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.488 -0.757 . . . . 0.0 109.236 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.9 p -107.53 131.64 54.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.668 . . . . 0.0 109.667 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -132.52 153.0 51.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.536 -0.728 . . . . 0.0 109.567 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.74 130.04 56.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.2 178.81 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -112.62 153.03 45.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.86 -31.51 47.61 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.997 1.798 . . . . 0.0 110.644 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 5.13 33.77 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.577 -0.702 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -69.58 146.64 51.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -95.59 148.8 22.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 0.0 109.387 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mm -54.2 -39.23 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.086 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.44 -47.69 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.892 . . . . 0.0 109.848 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -68.36 -37.27 80.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.758 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.19 -29.72 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -70.99 -33.99 70.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.37 76.88 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -54.12 -48.25 70.95 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.0 mt -65.69 -38.08 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -59.13 -48.03 83.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.476 -0.765 . . . . 0.0 109.974 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.09 -35.06 77.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.464 -0.772 . . . . 0.0 111.198 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -79.81 -50.43 10.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.817 -1.177 . . . . 0.0 111.462 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.94 -10.08 49.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.757 -1.215 . . . . 0.0 110.015 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.12 0.24 27.13 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.68 134.27 37.97 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.744 -1.445 . . . . 0.0 108.79 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.69 156.93 59.94 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 0.0 112.073 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.43 -18.32 38.64 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.743 2.295 . . . . 0.0 112.781 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.51 -5.4 56.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -109.34 -27.92 9.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 109.311 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -96.86 134.72 39.82 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.244 -0.91 . . . . 0.0 110.657 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.509 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -118.83 109.21 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.93 129.89 38.69 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.683 -1.261 . . . . 0.0 111.817 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.17 141.13 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.487 0.661 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -119.54 137.41 53.85 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 -112.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.025 -1.047 . . . . 0.0 108.851 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.41 28.95 5.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -129.42 140.31 51.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.177 -1.19 . . . . 0.0 109.421 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -82.95 117.44 22.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CE1' ' A' ' 59' ' ' TYR . 93.7 mt -56.15 121.27 9.06 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.24 148.42 22.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 2.4 p30 -66.35 136.28 55.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 110.871 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.23 57.83 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.426 -0.796 . . . . 0.0 112.051 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.74 170.0 14.65 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.105 -1.821 . . . . 0.0 110.591 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.0 m -108.17 147.81 30.78 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.313 0.577 . . . . 0.0 109.802 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -56.04 -41.85 75.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -60.49 -20.57 60.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.35 -18.03 64.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CE1' HD23 ' A' ' 50' ' ' LEU . 21.0 m-85 -106.09 6.87 31.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.485 -0.76 . . . . 0.0 110.308 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 54.22 39.82 31.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 62' ' ' GLN . 68.4 mt -64.05 169.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 61' ' ' ILE . 53.4 tt0 -138.62 143.2 39.19 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.283 -0.885 . . . . 0.0 110.029 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.24 145.41 13.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 110.654 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 69.88 14.48 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.756 -0.59 . . . . 0.0 110.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.48 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.5 mp -95.8 145.88 24.99 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -92.53 128.61 38.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 0.0 108.885 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.13 117.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.796 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.4 145.47 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.9 mp -82.29 -82.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 110.016 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HG3' ' NH2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -149.95 171.81 16.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.129 -0.982 . . . . 0.0 110.315 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.97 124.95 46.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -72.94 135.14 45.0 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.088 -1.632 . . . . 0.0 109.443 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.51 89.58 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.591 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' VAL . 66.7 mtt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.15 142.03 33.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.447 -0.783 . . . . 0.0 109.802 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -145.17 165.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -125.07 137.58 54.2 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.202 -0.936 . . . . 0.0 109.454 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.33 121.38 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.656 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -93.95 118.02 30.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -93.58 154.08 18.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.97 -19.3 64.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.078 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -82.11 -1.46 48.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 109.726 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.08 9.83 69.92 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -92.23 116.42 28.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.047 -1.267 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -101.81 132.01 47.81 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 109.104 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.3 tt -129.45 145.42 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.509 -0.745 . . . . 0.0 109.44 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -102.71 139.18 38.62 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.56 -0.713 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -130.19 149.74 51.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.619 -0.676 . . . . 0.0 109.43 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -111.09 129.87 55.79 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -146.69 178.54 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.981 -1.074 . . . . 0.0 110.139 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.27 153.49 44.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.54 -33.68 45.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.998 1.799 . . . . 0.0 110.762 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 m -84.94 4.71 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.422 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.67 145.46 53.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.973 -1.079 . . . . 0.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -91.91 162.61 14.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -64.86 -40.96 90.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.144 -0.972 . . . . 0.0 108.696 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -62.21 -43.73 98.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.73 -41.59 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.73 . . . . 0.0 110.116 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.63 -29.07 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.067 -1.02 . . . . 0.0 109.455 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -35.13 78.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.56 82.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.75 -44.3 77.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.72 -39.3 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.729 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -59.61 -45.62 91.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 109.93 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.61 -30.28 68.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 111.187 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -88.25 -46.68 9.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.78 -1.2 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -89.21 -19.84 24.92 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.638 -1.289 . . . . 0.0 110.017 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.07 4.68 56.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.065 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -89.82 122.48 67.93 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.684 -1.48 . . . . 0.0 109.3 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.31 149.55 6.33 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.633 1.555 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.35 -19.5 33.25 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.32 -2.8 33.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.564 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -111.65 -25.25 9.63 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.15 -0.969 . . . . 0.0 110.271 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -97.59 136.03 38.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -122.37 115.82 22.95 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -97.02 125.56 41.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.59 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -121.73 141.16 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 87.1 t80 -150.32 144.68 25.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.099 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 61.66 12.11 4.36 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.56 67.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.48 148.93 44.56 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.124 -1.221 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -84.26 113.53 21.18 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -54.53 123.17 12.28 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.745 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.64 143.27 27.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.148 -0.97 . . . . 0.0 109.13 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.9 133.91 56.01 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.417 -0.802 . . . . 0.0 109.602 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -16.23 56.91 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.35 -0.844 . . . . 0.0 112.086 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -81.97 164.28 21.59 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 119.977 -1.896 . . . . 0.0 109.108 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 m -104.93 147.56 27.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.47 -41.89 81.54 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.271 -0.893 . . . . 0.0 109.551 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -59.46 -23.73 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.166 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.98 -18.52 64.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -107.19 5.87 28.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.517 -0.739 . . . . 0.0 110.106 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 49.91 48.33 21.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.615 -1.303 . . . . 0.0 109.681 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.91 165.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 108.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -126.79 135.22 50.75 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.402 -0.811 . . . . 0.0 109.75 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -51.11 146.21 6.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 66.99 16.09 10.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 122.133 -0.355 . . . . 0.0 110.959 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 mp -95.19 153.24 17.75 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -97.79 126.37 43.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.194 -0.941 . . . . 0.0 108.999 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.85 117.59 34.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 109.585 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 71' ' ' LEU . 59.1 t -103.65 143.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.3 mp -94.64 112.5 24.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.888 -1.132 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.83 -88.64 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.977 0.894 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 71' ' ' LEU . 13.6 tp -111.19 147.51 34.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -59.44 -37.3 77.74 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.436 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.74 170.49 23.4 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.52 151.59 24.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.386 -0.821 . . . . 0.0 109.735 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -145.66 166.81 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 61.2 m-85 -121.13 136.55 54.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.79 118.7 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.64 120.75 36.45 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -97.03 153.88 17.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.82 -18.88 58.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.364 -0.835 . . . . 0.0 110.16 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -81.54 -1.47 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.18 70.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.15 118.01 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.978 -1.307 . . . . 0.0 109.659 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.9 m -103.34 130.35 50.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.327 -0.858 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -131.11 138.28 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.462 -0.773 . . . . 0.0 109.732 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -97.69 142.44 29.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -132.83 155.5 48.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.461 -0.775 . . . . 0.0 109.613 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -106.81 125.55 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.37 165.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.071 -1.018 . . . . 0.0 109.969 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 39.2 mt-10 -107.67 154.06 41.09 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.52 -29.1 31.14 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.157 1.905 . . . . 0.0 111.113 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -88.7 1.26 55.43 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 151.27 47.17 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.962 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.8 p -96.66 150.94 20.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.257 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -54.4 -36.75 35.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.065 -1.022 . . . . 0.0 108.863 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.32 -42.81 92.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 109.935 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 25' ' ' ASN . 2.1 m120 -67.78 -37.74 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 109.682 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.0 t -71.96 -31.05 39.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.581 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.63 -34.98 76.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.89 78.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.3 -46.88 79.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.3 mt -63.07 -42.16 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.23 -46.11 85.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 109.974 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.02 -30.57 71.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.0 111.442 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -96.07 -43.74 7.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.879 -1.138 . . . . 0.0 111.278 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -87.9 -27.26 22.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.813 -1.179 . . . . 0.0 109.945 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.34 77.15 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.106 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.6 mt -76.18 133.67 71.67 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.706 -1.467 . . . . 0.0 108.616 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.23 133.15 20.6 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.36 1.373 . . . . 0.0 112.143 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -45.89 -25.45 2.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 113.155 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -77.81 -3.63 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.95 -1.094 . . . . 0.0 110.338 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -111.78 -29.89 7.52 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -107.23 143.42 35.48 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.825 0.821 . . . . 0.0 111.016 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.453 HH21 ' HD3' ' A' ' 42' ' ' ARG . 7.4 mtp180 -130.38 125.43 34.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.656 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.7 mt -96.43 122.79 39.71 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.032 -1.043 . . . . 0.0 111.186 -177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.3 mp -118.97 134.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -119.84 134.79 55.12 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 -109.45 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.081 -1.012 . . . . 0.0 108.792 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.5 33.34 3.31 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -133.83 154.6 50.91 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.065 -1.256 . . . . 0.0 109.598 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -99.3 116.09 30.68 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.0 mt -53.6 120.05 5.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.97 142.62 27.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.893 . . . . 0.0 109.795 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.27 135.46 57.48 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.453 -0.779 . . . . 0.0 110.31 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 -18.6 54.83 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.358 -0.839 . . . . 0.0 111.943 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.438 HH21 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -90.66 159.89 16.15 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.022 1.911 . . . . 0.0 109.996 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -102.72 154.55 19.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.587 -0.696 . . . . 0.0 109.927 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.65 -37.39 73.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.345 -0.847 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.6 p -56.74 -18.71 13.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.008 -1.058 . . . . 0.0 109.533 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -76.22 -19.44 58.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.89 -11.92 17.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.466 -0.771 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 t30 60.58 48.01 7.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.032 -1.042 . . . . 0.0 109.577 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 62' ' ' GLN . 97.2 mt -70.36 171.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.141 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 61' ' ' ILE . 26.0 mm100 -128.27 136.16 50.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -53.6 148.1 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.703 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' OE2' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 68.77 11.88 8.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.646 -0.659 . . . . 0.0 110.308 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.509 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 67' ' ' LEU . 8.1 mp -95.57 154.31 17.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 4.7 m-70 -95.76 126.14 40.82 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.077 -1.015 . . . . 0.0 108.835 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tp -101.23 113.28 26.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' C ' HD12 ' A' ' 71' ' ' LEU . 44.1 t -106.43 138.25 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 70' ' ' VAL . 9.2 mp -108.15 167.4 10.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.214 -0.928 . . . . 0.0 109.279 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 112.17 5.6 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.8 tp -82.3 -53.22 6.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.837 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HG3' ' NH2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.61 117.19 10.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.315 0.579 . . . . 0.0 110.254 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.88 -126.28 3.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.085 -1.397 . . . . 0.0 110.086 -179.442 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -99.81 143.16 30.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.14 166.53 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.33 158.51 39.62 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.02 124.73 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.1 119.64 31.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.489 -0.757 . . . . 0.0 109.094 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -91.14 151.97 20.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -58.82 -19.3 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 109.754 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 9' ' ' THR . 89.8 m -81.37 -6.71 59.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.136 -0.978 . . . . 0.0 109.402 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.67 59.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -94.09 118.94 32.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.314 . . . . 0.0 109.611 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -94.86 122.9 37.97 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.054 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -115.26 145.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.572 -0.705 . . . . 0.0 109.12 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 14' ' ' THR . 12.2 t -106.6 131.7 53.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.714 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -129.71 150.44 51.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.458 -0.776 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -110.91 128.7 55.9 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.88 174.51 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 110.317 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -107.93 152.88 41.86 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.61 -34.18 26.16 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.967 1.778 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -85.66 1.78 47.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.57 -0.706 . . . . 0.0 109.233 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.67 147.91 44.35 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.996 -1.081 . . . . 0.0 108.522 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.4 p -89.0 155.81 19.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.162 -0.961 . . . . 0.0 108.847 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.2 mp -56.73 -42.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.043 -1.035 . . . . 0.0 108.237 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.81 -37.89 89.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -69.48 -41.63 75.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.6 t -66.76 -28.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.245 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -72.92 -35.42 67.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.38 92.42 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.99 -44.93 94.67 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.0 -37.58 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.42 -0.8 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.61 -47.96 83.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.923 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -66.77 -34.82 78.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 111.274 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -85.22 -46.13 11.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.843 -1.16 . . . . 0.0 111.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -85.03 -27.24 26.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.67 -1.269 . . . . 0.0 109.72 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.66 3.58 79.32 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.441 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -93.29 124.34 57.97 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.673 -1.487 . . . . 0.0 108.716 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.39 130.34 21.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.294 1.329 . . . . 0.0 112.368 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -49.47 -24.56 9.17 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.223 1.949 . . . . 0.0 113.423 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.21 -9.22 58.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.645 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -103.65 -23.57 13.45 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -98.25 138.48 35.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 0.0 110.761 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.59 HH21 ' HA ' ' A' ' 72' ' ' ARG . 9.7 mtp180 -122.61 112.05 17.52 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 44' ' ' ILE . 14.6 mt -88.5 122.84 32.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.185 -0.947 . . . . 0.0 111.097 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.616 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.9 mp -115.34 132.72 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -119.96 135.53 54.87 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 -112.76 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.014 -1.054 . . . . 0.0 109.087 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.98 28.62 5.82 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -140.13 179.2 6.77 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.881 -1.364 . . . . 0.0 109.474 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -109.63 156.45 20.2 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 50' ' ' LEU . 4.3 mm? -83.32 108.63 16.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.095 -1.003 . . . . 0.0 108.358 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' CD ' HH21 ' A' ' 54' ' ' ARG . 40.4 tt0 -80.71 152.5 28.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.68 142.27 30.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.529 -0.732 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.02 10.47 51.96 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 121.301 -0.875 . . . . 0.0 111.714 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.62 HH21 ' CD ' ' A' ' 51' ' ' GLU . 3.9 mtp180 -129.69 172.87 11.17 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.893 -1.357 . . . . 0.0 109.721 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 p -103.59 149.73 24.63 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.037 -1.039 . . . . 0.0 111.235 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -56.65 -32.54 65.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.461 -0.774 . . . . 0.0 109.491 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -62.11 -19.27 62.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.087 -1.008 . . . . 0.0 109.213 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.35 -16.88 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.421 -0.799 . . . . 0.0 109.614 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.502 ' CE1' HD13 ' A' ' 50' ' ' LEU . 13.4 m-85 -103.91 10.98 36.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.427 -0.796 . . . . 0.0 110.238 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 52.46 42.46 31.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.612 -1.305 . . . . 0.0 109.416 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 62' ' ' GLN . 60.6 mt -71.4 170.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.236 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.561 ' N ' HG22 ' A' ' 61' ' ' ILE . 42.4 mt-30 -143.8 147.05 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.086 -1.009 . . . . 0.0 110.068 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -52.94 145.78 12.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 110.587 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.32 14.51 8.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.821 -0.549 . . . . 0.0 110.607 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 67' ' ' LEU . 11.0 mp -99.99 155.83 17.49 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -97.78 130.94 44.69 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.9 tt -103.36 116.89 33.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.439 -0.788 . . . . 0.0 109.666 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 ' N ' HD23 ' A' ' 69' ' ' LEU . 46.7 t -108.05 146.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.6 mp -82.42 -102.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.861 -1.149 . . . . 0.0 111.047 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HA ' HH21 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -163.78 -29.79 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 -179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.16 -58.16 3.65 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.624 -0.673 . . . . 0.0 110.016 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -71.75 86.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.766 0.793 . . . . 0.0 109.326 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.25 -8.14 0.13 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.827 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.53 144.97 29.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.309 -0.87 . . . . 0.0 109.405 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -145.84 166.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -128.84 150.4 50.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.93 -1.107 . . . . 0.0 110.131 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.55 123.72 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.365 -0.835 . . . . 0.0 108.866 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -97.66 123.5 41.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 8' ' ' LEU . 34.4 m -98.6 158.95 15.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' N ' HG22 ' A' ' 7' ' ' THR . 22.3 mt -63.25 -16.31 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.924 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -82.04 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.097 -1.002 . . . . 0.0 109.641 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.83 64.97 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -94.86 133.69 38.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.312 . . . . 0.0 109.281 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.9 m -114.88 129.2 56.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 109.126 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -125.49 145.06 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.72 -0.612 . . . . 0.0 109.494 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -103.45 136.89 42.34 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.712 . . . . 0.0 109.847 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -131.99 151.75 51.55 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -103.29 122.86 45.67 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -144.05 164.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.114 -0.991 . . . . 0.0 110.076 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 65.0 mt-10 -107.23 151.81 40.94 Favored Pre-proline 0 N--CA 1.493 1.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.1 -30.91 37.76 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.091 1.861 . . . . 0.0 111.04 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -82.95 -0.8 50.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.52 147.88 52.21 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.671 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.3 p -90.77 153.98 19.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 109.005 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.61 -38.9 44.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.846 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -64.3 -45.1 89.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.206 -0.934 . . . . 0.0 109.876 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.21 -36.97 85.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.983 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.28 -27.97 22.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.289 -0.882 . . . . 0.0 109.379 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -67.53 -38.26 83.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.51 45.55 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -48.92 -43.9 39.84 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.526 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.15 -28.61 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.014 -1.054 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -61.94 -50.31 72.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 109.871 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -72.78 -28.8 62.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -81.39 -47.52 13.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.865 -1.147 . . . . 0.0 111.039 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.14 -17.79 25.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.715 -1.241 . . . . 0.0 109.73 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.04 52.02 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.286 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -93.23 125.07 55.9 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.665 -1.491 . . . . 0.0 109.304 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.32 149.05 6.88 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.482 1.455 . . . . 0.0 112.145 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.69 -26.92 32.58 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.357 2.038 . . . . 0.0 112.29 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.33 -2.36 13.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -110.85 -13.32 14.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.02 -1.05 . . . . 0.0 109.689 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -110.05 137.75 47.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -119.81 111.02 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 17.2 mt -92.46 120.17 32.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.3 mp -113.98 144.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -123.29 140.49 52.96 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.07 -112.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.098 -1.002 . . . . 0.0 108.56 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.43 6.19 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -125.12 144.09 50.6 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.014 -1.286 . . . . 0.0 109.366 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -74.68 147.9 41.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.523 HD23 ' CE1' ' A' ' 59' ' ' TYR . 96.5 mt -88.16 114.79 25.13 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.821 -1.174 . . . . 0.0 108.842 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 21.6 mp0 -81.3 175.72 10.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.182 -0.949 . . . . 0.0 108.912 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 39.3 p-10 -95.49 135.65 36.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.72 -0.613 . . . . 0.0 111.577 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.93 -8.22 61.12 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.998 -1.064 . . . . 0.0 112.18 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 5.8 mtt180 -95.18 154.8 17.01 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 120.307 -1.702 . . . . 0.0 109.306 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 p -92.87 149.79 21.03 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.016 -1.053 . . . . 0.0 110.895 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -53.75 -33.68 56.52 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.604 -0.685 . . . . 0.0 109.636 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 m -64.82 -13.63 56.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.06 -1.025 . . . . 0.0 109.085 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.17 -17.22 61.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.547 -0.721 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.523 ' CE1' HD23 ' A' ' 50' ' ' LEU . 19.0 m-85 -110.68 8.19 22.55 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 0.0 110.13 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 54.76 45.73 26.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.346 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 62' ' ' GLN . 86.5 mt -75.04 172.1 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.177 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.604 ' N ' HG22 ' A' ' 61' ' ' ILE . 81.3 mt-30 -139.32 142.12 37.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -51.8 151.61 3.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.225 -0.922 . . . . 0.0 110.336 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 64.71 14.86 9.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.059 -0.4 . . . . 0.0 110.793 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.95 150.57 20.31 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.4 127.74 38.0 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 70' ' ' VAL . 2.5 tt -106.16 113.25 26.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.525 -0.735 . . . . 0.0 109.392 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 ' N ' HD23 ' A' ' 69' ' ' LEU . 61.8 t -111.72 141.37 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.816 HD22 ' N ' ' A' ' 71' ' ' LEU . 1.2 mm? -90.35 157.35 17.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 0.0 109.615 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.38 134.56 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -113.55 142.03 46.45 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.517 -0.739 . . . . 0.0 109.854 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.654 ' CG ' HH21 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -156.77 144.79 19.42 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.683 -1.261 . . . . 0.0 110.427 177.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.27 26.11 63.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.56 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.236 0.541 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.8 141.6 32.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.657 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 3' ' ' ILE . 9.6 tt -141.38 163.9 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 28.4 m-85 -126.72 157.04 40.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.47 119.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -91.29 120.56 32.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 109.366 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -95.83 166.04 12.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.57 -22.12 65.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.154 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.52 -3.2 52.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.632 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 17.32 60.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -94.41 125.41 39.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.326 . . . . 0.0 109.301 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.2 m -101.1 121.95 42.73 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -108.96 141.65 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.424 HG22 ' CE2' ' A' ' 4' ' ' PHE . 79.0 p -103.74 126.77 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.72 149.78 51.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.503 -0.748 . . . . 0.0 109.712 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -103.67 123.46 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.1 p -144.91 166.34 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.055 -1.028 . . . . 0.0 110.19 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.6 mt-10 -109.9 152.19 42.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.27 -28.03 34.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.207 1.938 . . . . 0.0 111.28 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.8 t -85.34 -2.2 57.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.012 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 26' ' ' VAL . 9.9 t0 -62.87 146.98 51.54 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.803 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -88.61 143.49 26.92 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 23' ' ' ILE . 1.7 mp -49.76 -42.38 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 108.483 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -60.25 -44.2 95.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.643 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.39 -40.0 85.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 109.504 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG22 ' OD2' ' A' ' 21' ' ' ASP . 60.9 t -63.96 -33.23 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.623 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -70.84 -35.08 72.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.89 82.41 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -54.57 -48.76 71.69 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.89 -37.4 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.68 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -61.99 -48.78 78.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -67.3 -33.11 74.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 111.115 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -84.57 -45.45 12.54 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.789 -1.194 . . . . 0.0 111.179 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -88.98 -24.96 22.27 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.736 -1.228 . . . . 0.0 109.833 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 1.07 90.09 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.146 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.97 134.35 35.39 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 120.596 -1.532 . . . . 0.0 108.873 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.91 154.45 67.13 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.553 1.502 . . . . 0.0 112.035 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.69 -17.94 37.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.594 2.196 . . . . 0.0 112.302 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.511 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 77.9 m-20 -79.54 -4.82 53.15 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.763 -1.21 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -107.2 -28.07 10.16 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.263 -0.898 . . . . 0.0 110.735 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -112.89 146.69 38.5 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.393 -0.817 . . . . 0.0 110.621 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.0 120.59 27.87 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 44' ' ' ILE . 31.0 mt -90.43 126.19 35.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 0.0 110.844 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 43' ' ' LEU . 2.6 mp -119.63 137.03 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 109.349 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -119.0 136.09 54.29 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.93 -112.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 108.655 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.23 4.86 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.53 147.71 52.56 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.148 -1.207 . . . . 0.0 109.545 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -90.21 116.86 28.52 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.8 mt -55.66 123.51 14.31 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 109.926 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.46 140.75 45.8 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.715 0.769 . . . . 0.0 109.343 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 15.8 p-10 -64.52 155.28 33.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.688 -0.632 . . . . 0.0 110.958 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.76 2.05 56.29 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 121.377 -0.827 . . . . 0.0 112.072 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -133.9 172.48 12.74 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.745 -1.444 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -105.26 154.67 19.93 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.165 -0.959 . . . . 0.0 110.994 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.67 -34.35 64.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.432 -0.792 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -62.55 -16.7 57.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.73 -16.87 63.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.82 . . . . 0.0 109.443 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -105.46 11.03 33.04 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 53.61 46.83 25.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.651 -1.281 . . . . 0.0 109.468 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 62' ' ' GLN . 75.9 mt -87.47 -176.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 0.0 109.349 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.764 ' H ' HG22 ' A' ' 61' ' ' ILE . 10.0 pt20 -157.79 158.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 110.29 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -54.58 151.08 8.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.426 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 68.4 14.95 9.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.603 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.42 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.0 mp -96.46 146.52 24.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -93.18 134.58 35.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 108.624 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.71 121.43 45.01 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.479 -0.763 . . . . 0.0 109.88 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.19 151.95 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -93.1 147.55 22.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.965 -1.084 . . . . 0.0 109.46 -179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' NH2' ' HA ' ' A' ' 39' ' ' ASP . 4.7 mtp180 -69.57 -20.3 63.66 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 73' ' ' LEU . 5.5 mp -82.88 -165.23 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.035 -1.041 . . . . 0.0 109.336 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.445 HH21 ' HD3' ' A' ' 74' ' ' ARG . 2.4 ttp180 -148.98 -26.66 0.3 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.235 -0.916 . . . . 0.0 109.526 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.54 -10.4 64.59 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 CA-C-O 117.962 -1.466 . . . . 0.0 109.706 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.0 138.39 36.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -137.91 162.57 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 37.3 m-85 -124.98 141.73 51.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.313 -0.867 . . . . 0.0 109.398 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.89 116.62 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.335 -0.853 . . . . 0.0 109.005 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.4 114.74 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.415 -0.803 . . . . 0.0 108.911 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -90.97 165.75 13.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tp -70.38 -23.48 62.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.4 p -81.27 -0.15 39.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.033 . . . . 0.0 109.45 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.29 15.74 66.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -93.15 122.06 35.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.868 -1.372 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -99.34 121.61 41.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.534 -0.729 . . . . 0.0 109.401 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.33 139.8 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.661 -0.649 . . . . 0.0 109.494 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.9 p -101.91 127.43 48.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.567 -0.708 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.1 mt -131.18 151.27 51.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.557 -0.714 . . . . 0.0 109.587 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -115.64 131.85 56.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.81 176.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.988 -1.07 . . . . 0.0 110.099 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.23 150.22 40.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.85 -32.1 46.55 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.876 1.717 . . . . 0.0 110.906 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -84.42 2.77 39.18 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.531 -0.731 . . . . 0.0 109.245 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -67.47 145.79 54.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.911 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -85.39 160.38 19.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.459 -0.775 . . . . 0.0 108.935 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.4 mp -61.22 -39.37 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.061 -1.025 . . . . 0.0 108.26 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -35.87 81.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -69.74 -38.92 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 109.606 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -72.45 -33.09 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.577 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' NZ ' ' CG2' ' A' ' 23' ' ' ILE . 49.6 mttp -68.01 -34.17 76.0 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -51.46 -45.79 62.83 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.14 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.885 . . . . 0.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.5 -48.88 79.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -0.854 . . . . 0.0 110.053 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -68.98 -31.95 71.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.317 -0.865 . . . . 0.0 111.052 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -82.92 -48.19 10.97 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.919 -1.113 . . . . 0.0 111.489 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.775 -1.203 . . . . 0.0 109.986 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.51 3.21 82.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.131 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.12 123.67 66.72 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.75 -1.441 . . . . 0.0 108.764 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.34 130.16 20.64 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.143 1.229 . . . . 0.0 112.267 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.53 -34.2 25.6 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.258 1.972 . . . . 0.0 113.444 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.45 -1.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.326 -0.859 . . . . 0.0 110.803 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.482 ' C ' HE21 ' A' ' 41' ' ' GLN . 48.0 tp60 -109.47 -21.68 12.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 0.0 110.052 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 40' ' ' GLN . 24.1 mm-40 -103.31 138.31 40.26 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.141 -0.974 . . . . 0.0 111.412 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -121.14 105.34 10.5 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -89.04 125.14 34.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.98 -1.075 . . . . 0.0 110.239 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mt -123.5 145.18 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' C ' ' H ' ' A' ' 47' ' ' GLY . 84.3 t80 -148.8 145.91 27.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.616 -0.678 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.86 8.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 92.29 16.14 51.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -121.55 146.31 47.07 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.998 -1.295 . . . . 0.0 108.853 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.48 115.82 23.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.74 119.51 5.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.941 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.82 173.35 7.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.188 -0.945 . . . . 0.0 109.89 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -94.67 149.15 21.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 110.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.7 -11.05 69.81 Favored Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.445 -0.784 . . . . 0.0 111.331 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' CG ' HH21 ' A' ' 54' ' ' ARG . 0.0 OUTLIER -96.46 174.66 6.75 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.79 -1.418 . . . . 0.0 109.448 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -115.31 152.47 32.72 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.992 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -57.56 -41.01 80.2 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.493 -0.755 . . . . 0.0 109.75 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -58.95 -23.76 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 109.328 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.67 -17.09 62.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.357 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.33 3.71 35.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.0 110.314 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.27 45.13 27.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.743 -1.223 . . . . 0.0 109.413 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 62' ' ' GLN . 91.0 mt -72.24 173.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.368 -0.832 . . . . 0.0 109.159 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' N ' HG22 ' A' ' 61' ' ' ILE . 59.6 mt-30 -137.38 142.2 41.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -53.48 148.14 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.857 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 68.0 12.14 8.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.734 -0.604 . . . . 0.0 110.561 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.415 ' C ' HD12 ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.7 mp -95.93 151.34 19.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -98.57 132.36 44.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.185 -0.947 . . . . 0.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 70' ' ' VAL . 1.6 tt -107.22 113.68 27.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.634 -0.666 . . . . 0.0 109.508 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.0 t -108.58 150.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.0 mp -84.32 -105.35 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -84.08 -89.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.71 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.57 168.67 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.689 -1.257 . . . . 0.0 110.483 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -167.53 -8.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.546 -0.721 . . . . 0.0 109.36 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.7 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.916 -1.491 . . . . 0.0 109.676 179.999 . . . . . . . . 0 0 . 1 stop_ save_